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Abstract  
Herbal medicines (HMs) have been used to supplement, maintain, and treat health 
conditions, and have inspired the development of many Western pharmaceuticals. Migrant 
South Asian (SA) communities in the UK have brought with them their own traditional 
forms of medicine, yet little is known about their current use of HMs in the UK. Consuming 
HMs alongside conventional Western medicines could affect pharmacological treatment and 
lead to herb-drug interactions; hence, healthcare professionals (HCPs) should be aware of 
their patients’ use of HMs. The import of HMs to the UK raises concerns over the quality, 
safety and regulation of HMs. Deoxyribonucleic acid (DNA) barcoding can be used to 
discriminate between different species, and identify contaminants and adulterants, thus can 
be used for the authentication of HMs. 
The South Asian Traditional Medicines (SATMED) questionnaire explored the knowledge 
and use of HMs by diasporic SA communities in the UK. It uncovered a vast range of HMs 
which were used by participants, where ingredients were sourced from, the concurrent use of 
herbal and Western medicines, and how minor ailments were treated. An online survey 
designed to investigate UK based practitioners’ views of HMs revealed that HCPs claimed to 
lack sufficient knowledge of HMs. HCPs said they needed more training on HMs to help 
them make better informed decisions. Tulsi (Ocimum tenuiflorum L.) was identified as a 
culturally and commercially valuable plant, which was used for molecular analysis. A 
variety of tulsi samples were collected for authentication: community samples from SA 
families in the UK, commercial samples, and referenced specimens. Both ITS and trnH-psbA 
regions were successfully used to distinguish between several Ocimum species, and identify 
a potential species substitution. 
This research represents the first time that DNA based methods have been used to 
authenticate medicinal plants species used by migrant SA communities living in the UK. The 
results of this multi-disciplinary study provide a unique contribution to the evolving 
discipline of ethnopharmacology.  
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1.0 Introduction 
1.1 Introduction  
‘’Plant derived medicines have been the first line of defence in maintaining health and 
combating diseases,’’ (Samy et al., 2008). Nerkar (2007) claims that nature has provided a 
pharmacy which people have recognised and taken advantage of. Many Western 
pharmaceuticals have been developed from natural sources and the search for new drug leads 
has often taken scientists back to traditional herbal medicines (Harvey, 2008). Herbal 
medicines (HMs) are still commonly used in many cultures (Williamson, 2002); despite this, 
there is limited documented ethnopharmacological evidence of the use of HMs in the United 
Kingdom (UK).  
The use of HMs is believed to be increasing as people use HMs to replace or complement 
Conventional Western Medicines (CWM), and seek natural ways to supplement a healthy 
lifestyle (Newall et al., 1996; Mintel, 2009). There is a common misconception that HMs are 
natural and therefore safe and free from harmful effects (Vickers, 2000; Ipsos MORI, 2008); 
however, there remains a lack of clinical evidence to support the safety and efficacy of HMs. 
There could be risks associated with the simultaneous consumption of HMs with CWM such 
as herb-drug interactions and adverse effects. To ensure patients are getting the best 
pharmaceutical care, Healthcare Professionals (HCPs) need to recognise that their patients 
may be using HMs in addition to CWM (Shaw et al., 2012). HCPs need to have sufficient 
training and knowledge of HMs to help patients make informed decisions about their health 
(Newall et al., 1996).    
Sandhu and Heinrich (2005) note that, ‘‘in the past decades a significant immigration from 
outside Europe has influenced European societies in a multitude of ways’’ and observe that 
immigrants have brought their own culture, culinary skills, and traditional herbal remedies 
with them. The ethnic diversity in the UK means there is a great wealth of knowledge of 
HMs and variety of HMs which may be used. The increasing migration of people from the 
Indian subcontinent countries of India, Pakistan and Bangladesh (South Asia) to the UK has 
created large South Asian (SA) populations in the UK (Khunti et al., 2009). Results from the 
2001 census revealed that SA ethnic minorities formed 3.9% of the UK population; this 
increased to over 5.3% in the 2011 census (Office for National Statistics, 2012). The SA 
ethnic group is itself very diverse and comprised of different cultures and religions all with 
their own interpretations of traditional herbal medicine; and little is known about the current 
use of HMs by SA populations in the UK. This presents a unique opportunity to explore the 
use of HMs by SA ethnic populations.  
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The import and increased use of HMs in the UK has introduced concerns over the quality, 
safety, and regulation of HMs (Vassou et al., 2015); hence, reliable and efficient methods of 
identification are needed. DNA-based techniques have been developed to authenticate 
medicinal plants used in HMs. These methods can be used to identify the plant species and 
any potential substitutes or adulterants; a relatively new technique which will be explored 
further in this research.  
This chapter will give an overview to the rationale for this study; detailing the aims, 
objectives, and background information to this research. A brief overview of the structure of 
the thesis will explain how the project evolved. 
 
1.2 Research Aims 
The aim of this research is to explore the knowledge and use of traditional herbal remedies 
amongst South Asian communities and healthcare professionals in the UK; followed by the 
collection of specific medicinal plants of interest, which can be genetically tested to confirm 
their identity, using DNA-based techniques. 
 
1.3 Objectives  
1. Explore the knowledge and use of traditional herbal remedies amongst South Asian 
diasporic communities, in the UK; describe where the knowledge originates from. 
2. Obtain insight into UK based healthcare professionals’ knowledge and opinions of 
herbal medicines.   
3. Use DNA barcoding techniques for the identification of herbal medicines and medicinal 
plants used in South Asian communities. 
 
1.4 Background to This Research  
In order to gain perspective on the origins and current use of HMs some background 
information is provided in this section. It explores the origins of traditional HMs, HMs as 
drug leads, the use of HMs, some potential problems associated with HMs (i.e. 
contamination and adulteration), and the regulation of HMs in India and Europe.  
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1.4.1 The Origins of Traditional Herbal Medicines  
Human beings have evolved alongside plants, which have been used as food and medicine 
for millennia (Chevallier, 2007). People learnt by trial and error which plants, seeds, berries 
and fruits were good to eat; as a consequence they became aware of the potential health 
benefits. Hatfield (2007) suggests the precise origins of HMs are unclear, but it is likely to 
have occurred as a by-product of the use of plants in other ways; for example, chewing the 
leaves of a particular plant may have caused the mouth to feel anaesthetised, leading to the 
plant being used for toothache, or a plant rubbed on the skin to wipe a wound may have 
helped it heal establishing its use in wound healing. The knowledge of which plants are 
medicinally beneficial comes from their use as food and traditional cultural backgrounds 
(Chevallier, 2007). Folk practice of medicine, using plants to treat and prevent diseases, 
began as an oral tradition and has been passed down generations, long before written records 
were created (Hatfield, 2007).  
Around the world there are many different cultures which have created their own system of 
traditional medicine to diagnose, prevent and treat illnesses (Wachtel-Galor and Benzie, 
2011). Ayurveda, a traditional Indian medical system, is believed to be more than five-
thousand years old, and is said to be one of the oldest medical systems known; it is a holistic 
approach to managing health and preventing disease (Williamson, 2002; Sharma et al., 
2007). Ancient Chinese traditions dating back to the Stone Age claim that man gradually 
learnt to recognise the properties of plants, and then used them as medicine (Hong, 2004). 
Egyptian papyrus scripts as early as 3000 BC found preserved, contained hundreds of 
hieroglyphics detailing specific medical conditions and herbal treatments (Ehrlich, 2011). 
Pedanius Dioscordes the famous Greek physician published the first European herbal 
pharmacopoeia, around 65 AD, called De Materia Medica. Dioscordes organised all the 
plants in a systematic manner, grouping plants with similar pharmacological actions together 
(Isely, 1994). More recently Saslis-Lagoudakis et al. (2011) demonstrated the applications of 
phylogeny in mapping the pharmacological properties of ethnomedicinal plants and 
bioscreening. Their phylogenetic study comparing cross cultural uses of ethnomedicinal 
plants uncovered that similar traditional uses were found in different areas where the related 
species were available. Throughout history and across the globe plants have been used as the 
primary source of medicine (Hatfield, 2007).  
According to the World Health Organisation (WHO, 2003), “Traditional medicine refers to 
health practices, approaches, knowledge and beliefs incorporating plant, animal and 
mineral based medicines, spiritual therapies, manual techniques and exercises, applied 
singularly or in combination to treat, diagnose and prevent illnesses or maintain well-
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being”. WHO (2008) clarifies that the terms complementary/ alternative/ non-conventional 
medicines are used interchangeably when referring to traditional medicines, and the terms 
allopathic/ conventional are used to refer to Western medicines. Herbal medicines form an 
integral part of Complementary and Alternative Medicines (CAM), which is a broad term 
used to describe hundreds of therapies including: massage, nourishment, exercise, and HMs 
(Kayne, 2002).  
For the purpose of this study the terms herbal medicine(s), traditional herbal medicine(s), 
herbal remedy/remedies, and traditional herbal remedy/remedies will be used 
interchangeably. 
 
1.4.2 Herbal Medicines as Drug Leads    
Approximately 25% of drugs prescribed worldwide are derived from plants (Sahoo et al., 
2010); for example, aspirin based on the chemicals found in willow bark (Salix spp.) is used 
for pain relief and anti-platelet effects, and digoxin from the foxglove plant (Digitalis lanata 
Ehrh.) is used for cardiac disease (Hartmann, 2007; Li and Vederas, 2009). Metformin, an 
oral anti-diabetic drug, often the first line treatment for type 2 diabetics is also derived from 
plants. It originates from French lilac or Goat’s rue (Galega officinalis L.) a plant used in 
traditional medicine for centuries, with the first references documented in 1500 BC by 
Egyptian physicians (Witters, 2001). The use of papaverine from the opium poppy (Papaver 
somniferum L.) as a vasodilator led to the development of verapamil for hypertension. More 
commonly known are the opioid analgesics codeine and morphine for pain relief which are 
also derivatives of the opium poppy (Cragg and Newman, 2013). In 1820 French 
pharmacists Pierre Joseph Pelletier and Joseph Caventou isolated and purified quinine from 
the bark of the cinchona tree (Cinchona officinalis L.) which was used to treat malaria. The 
traditional use of quinine for treating fever and infectious disease dates back to the 1600s 
(Achan et al., 2011). Since then quinine has formed the basis of the development of other 
anti-malarial drugs such as cholorquine and mefloquine. More than 60% of cancer drugs on 
the market or being researched are based on natural products (Wachtel-Galor and Benzie, 
2011); including the vinca alkaloids vinblastine and vincristine isolated from the Madagascar 
periwinkle (Catharanthus roseus L.) (Cragg and Newman, 2013).  
Over the past hundred years developments in technology have revolutionised health care 
across most parts of the world, where once HMs were the only source of medication 
(Wachtel-Galor and Benzie, 2011). Plants have the ability to synthesise a variety of chemical 
compounds which can be consumed by humans for maintaining health, treatment and 
prevention of disease. Advances in chemistry have made it possible to extract, isolate, and 
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synthesise compounds from natural products. This has been a contributory factor to the 
decline in use of plants for primary care and a rise in the use of synthetic drugs (Sahoo et al., 
2010; Dias et al., 2012). Nevertheless, the search for potential therapeutic agents continues, 
with nearly half of the small molecules approved in this decade having originated from 
natural products (Kong et al., 2009; Pandikumar et al., 2011).  
As the process of drug discovery is becoming more expensive, reverting back to traditional 
remedies may provide a cheaper alternative for pharmaceutical companies (Patwardhan and 
Khambholja, 2011). Patwardhan and Mashelkar (2009) claim that as natural products have 
been used for a long time, there is more information available on tolerance and safety 
compared with the development of novel synthetic drugs which have never been used before. 
However, most of this traditional knowledge is still not documented or supported by clinical 
trials. Patwardhan and Mashelkar (2009) propose a “reverse pharmacology approach” 
whereby products traditionally known to have clinical effects are scientifically tested; they 
go on to say, “The novelty of this approach is the combination of living traditional 
knowledge such as Ayurveda and the application of modern technology and processes to 
provide better and safer leads.”  
Natural resources which have been traditionally used by indigenous people have been 
commercially exploited by corporations; this is known as biopiracy (Robinson, 2010). 
Several high profile cases of biopiracy including basmati, neem and turmeric have led to the 
development of guidelines to protect indigenous knowledge and resources (Robinson, 2010). 
In 1995 two scientists in America got a patent for the use of turmeric in wound healing. The 
patent was revoked in 1997 after a complaint was filed by India’s Council of Scientific and 
Industrial Research, who highlighted that turmeric had traditionally been used in wound 
healing for thousands of years (Nobel, 2014). Since then a database (Traditional Knowledge 
Digital Library) to document traditional knowledge of medicinal plants and ancient 
formulations has been developed by the Indian Council of Scientific and Industrial Research, 
Ministry of Science and Technology, and the Department of Ayurveda, Yoga and 
Naturopathy, Unani, Siddha and Homoeopathy (AYUSH) to protect traditional knowledge 
from being exploited by biopiracy (Gupta, 2011). Patenting laws to protect indigenous 
species have been introduced in several countries including China, India, Peru and the 
Philippines (Robinson, 2010). 
Scientists are continuously exploring the benefits natural products offer in anticipation of 
discovering new drug leads and developing novel drugs. Ayyanar and Ignacimuthu (2011) 
suggest further ethnopharmacological studies are required for discovering potential new 
drugs. 
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1.4.3 The Use of Herbal Medicines  
Hatfield (2007) declares that the use of medicinal plants is part of our heritage, but fears this 
valuable knowledge is on the brink of extinction. Despite this, it is estimated that in some 
developing countries more than 80% of the population depend on HMs for primary health 
care (WHO, 2008). Up to 90% of the population in Africa and 70% in India depend on 
traditional medicine to meet their healthcare needs (WHO, 2005). This could be due to 
poverty, a lack of access to or knowledge of modern medicine (Ayyanar and Ignacimuthu, 
2011). In India the HMs market is immense; 960 medicinal plants have been widely 
incorporated into the HMs industry, of which 178 have been identified as high volume due to 
popularity and demand (Sahoo et al., 2010). However, the use of HMs is not limited to 
developing countries; over the past few decades interest in HMs in developed countries has 
been rising (Ernst and White, 2000; Pharmaceutical Press, 2013). In Europe, Germany and 
France are leading in over-the-counter (OTC) sales of HMs, which are readily available even 
in conventional pharmacies (Wachtel-Galor and Benzie, 2011). The WHO (2003) factsheet 
on traditional medicines claims that in Germany 90% of the population have used a natural 
remedy at some time in their life. The HMs market value is steadily growing; the annual 
expenditure on CAM in Australia, Canada and the UK, was estimated to be worth US$ 80 
million, US$ 2400 million, and US$ 2300 million respectively (WHO, 2002a). In the United 
States of America (USA) the use of CAM has been steadily increasing since the 1950s 
(Kessler et al., 2001); in 2011 the annual retail sales value of HMs in the USA was estimated 
to be over US$5.2 billion (Blumenthal, 2012).  
According to market research conducted by Mintel (2009), complementary therapies 
including Ayurvedic medicines, Traditional Chinese Medicine (TCM) and homeopathic 
remedies are becoming more popular in the UK. The report titled ‘Complementary 
medicines- UK, December 2009,’ (Mintel, 2009) identified that the number of people trying 
complementary medicines was increasing, with over twelve-million people reported to have 
used them in the UK in a single year. In 2009 the UK’s complementary medicines market 
was worth £213 million, and a 20% growth was predicted for the next two years (Mintel, 
2009). A survey to explore the publics’ perceptions of HMs in the UK in 2008 was 
commissioned by the Medicines and Healthcare products Regulatory Agency (MHRA). The 
results uncovered that 35% of the population surveyed claimed to have used HMs (Ipsos 
MORI, 2008). In 2013 a review of ten surveys based on UK patients and HMs consumers 
indicated that on average 37% of the population used HMs (Ministry of Foreign Affairs, 
2014). The UK HMs market is relatively strong, especially with a diverse ethnic population 
that is interested in non-Western alternatives (Ministry of Foreign Affairs, 2014). Wachtel-
Galor and Benzie (2011) suggest some of the reasons people use HMs include: cost (i.e. 
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more affordable than conventional therapies), part of traditional background, HMs perceived 
to have less adverse effects than chemical alternatives, to replace or supplement CWM, and 
the notion of natural medicines being safer.  
 
1.4.4 Potential Problems with Herbal Medicines  
 Destruction of Natural Resources  
There may be important implications for the sustainability of natural resources; as the 
increasing demand for HMs could lead to overharvesting of endangered species and 
destruction of natural resources (Wachtel-Galor and Benzie, 2011; Booker et al., 2012). 
Alam and Belt (2009) claim, “Medicinal plant species are depleting at a rapid pace due to 
large-scale, unsustainable collection from their natural habitats.” According to one estimate 
over four thousand economically important species are threatened with extinction due to 
commercial over-harvesting to meet manufacturers demands (Schippmann et al., 2002). 
There are approximately 29,000 plant species protected by the Convention on International 
Trade of Endangered Species (CITES) (Hollingsworth et al., 2011); for instance, American 
Ginseng (Panax quinquefolius L.) is native to the USA and can only be legally harvested in 
nineteen states with special restrictions controlling the growth, harvesting, sales, and export 
(US Fish and Wildlife Services International Affairs, 2015). In Europe there are several plant 
species which are listed as European Protected Species (EPS) under the European Habitats 
Directive, including shore dock (Rumex rupestris Le Gall), traditionally used as an 
astringent, and marsh saxifrage (Saxifraga hirculus L.) (Department for Environment, Food 
and Rural Affairs, 2014). 
The conservation of medicinal plants is of paramount importance as they remain an 
important source for natural ingredients for HMs, and there are potentially many more active 
compounds yet to be screened (Alam and Belt, 2009).   
 
 Standardisation of Herbal Medicines  
Due to natural variance in the chemical composition of plants it can be difficult to 
standardise HMs (Wachtel-Galor and Benzie, 2011). Factors such as the climate, soil, 
genotype, parts of the plants used, time the plants are harvested, storage, drying, and 
manufacturing process can all affect the chemical composition of medicinal plants (Shaw et 
al., 2012); making it difficult to ensure the reproducibility of HMs (Pharmaceutical Press, 
2013). Manufacturers of HMs are required to standardise and quantify the active constituents 
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in formulations according to Pharmacopoeia standards (Waimer and Schwabe, 2011); 
however, if the raw plant material is consumed or unregulated formulations are used it is 
difficult to ascertain the chemical composition of the herbal remedy. 
HMs used in the UK come from all over the world, from a range of traditional medical 
systems including TCM and Ayurveda; therefore, problems with nomenclature and 
standardisation of names can occur (Shaw et al., 2012). In the USA and Europe the Latin 
binomials names are used as the official way of referring to plants; however, traditional 
names may be different and could lead to confusion when selecting the plant species. For 
example, in the Philippines ginseng was popular for its use as a male aphrodisiac but this 
“ginseng” was not the same as the ginseng which belongs to the genus Panax; instead it was 
Jatropha podagrica Hook. commonly known as the Buddha belly plant (Begg and Gaskin, 
1994; Bareja, 2010). It remains unclear how the Buddha belly plant was used instead of 
ginseng; it may have occurred as the plants looked similar, or due to the commercial value of 
ginseng whereby the Buddha belly plant was a cheaper alternative. When the traditional and 
binomials names of species are different it increases the risk of species substitution and 
adulteration, which may be accidental or deliberate. The Royal Botanical Gardens, Kew, has 
created a database called the ‘Medicinal Plants Names Service’ which is a resource for 
searching information about medicinal plant names. As different names may be used for the 
same plant (i.e. in different countries, communities, and languages) and even the Latin 
binomials themselves change; this database has collated all the relevant published 
information about medicinal plant names enabling more accurate communication and 
identification of medicinal plants (Medicinal Plants Names Service, 2015).    
 
 Species Substitution and Adulteration  
Reports of commercially valuable species being substituted for cheaper alternatives have 
been documented (Vassou et al., 2015). Ginseng (Panax ginseng C.A.Mey) has numerous 
health benefits; it has been used for fatigue, enhancement of mental and physical 
performance, and as a male stimulant (Chevailler, 2007). The rising demand for ginseng has 
led to an increased commercial value and a decline in natural resources. Dharmananda 
(2002) identified several cheaper and more abundant species which were used as substitutes 
for ginseng in TCM including: Codonopsis pilosula Nannf. (also known as dang shen or 
poor mans’ ginseng) which is unrelated to ginseng but believed to have a similar action, 
Rumex madaio Makino and Talinum paniculatum (Jacq.) Gaertn. which look similar to 
ginseng roots. 
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A Chinese slimming aid in which Stephania tetrandra S.Moore had been substituted by 
Aristolochia fangchi Y.C.Wu ex L.D.Chow & S.M.Hwang caused renal damage in over one 
hundred patients in Belgium (Vanherweghem, 1998). Stephania tetrandra is traditionally 
referred to as 'Fangchi' or 'Fangji', while Aristolochia fangchi is referred to as ‘Mu Fangchi’ 
or ‘Mu Fangji’; the similar traditional names may explain how the confusion of the species 
occurred (Sim et al., 2013). The chemical composition of the two species is very different; 
aristolochic acids found in Aristolochia species have been known to be nephrotoxic, 
mutagenic, and carcinogenic. The use of Aristolochia species has since been restricted and 
prohibited in several countries including Australia, Canada, Germany, and the UK 
(Vanherweghem, 1998; Michl et al., 2014). 
The World Health Organisation (WHO) has emphasised the need to control the quality of 
HMs by using modern control techniques and standards (WHO, 1998). The application of 
molecular techniques in identifying substitute and adulterant species in HMs has been widely 
investigated; hence, DNA-based techniques have been used to accurately recognise plant 
species in HMs (Howard, 2010). Vassou et al. (2015) highlight the problems of species 
substitution and adulteration in their study of Indian country mallow also known as ‘Bala’ in 
Ayurveda (Sida cordifolia L.). They bought 25 market samples of raw material from thirteen 
states in India. They used DNA barcoding techniques to identify the species of the samples 
collected, and found that none of the samples were Sida cordifolia; instead, 76% were 
identified as other Sida species and the remaining 24% were from other genera. Several of 
the samples were identified as Sida acuta Burm.f. which has six times more ephedrine in 
comparison to Sida cordifolia; this may be associated with adverse effects. The research by 
Vassou et al. (2015) signifies the importance of species authentication of HMs and the 
applications of DNA barcoding for this purpose.  
 
 Contamination of Herbal Medicines  
Substitution of ingredients or species, and contamination with toxic substances may be a 
particular concern especially when HMs are not regulated (Pharmaceutical Press, 2013). On 
several occasions Ayurvedic formulations have been found to contain heavy metals such as 
iron, mercury, and arsenic which can release toxic compounds in the body altering normal 
metabolic pathways, and can cause systemic toxicity (Ernst, 1998; Egbuna and Bose, 2005). 
Saper et al. (2008) found nearly two hundred Ayurvedic preparations bought over the 
internet had detectable levels of heavy metals which were not stated on the label. A British 
poison information centre, in the West Midlands, identified five cases of heavy metal 
contamination within seven years; the products contained lead, zinc, mercury, arsenic, 
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aluminium, and tin. The individuals who had consumed the contaminated HMs had 
concentrations of heavy metals 2-10 times the upper limit of normal physiological values, 
resulting in harmful effects and morbidities (Bayly et al., 1995). 
Contamination with undeclared prescription medicines, mefenamic acid and diazepam, was 
identified in some Chinese HMs; they caused severe adverse effects including 
gastrointestinal bleeding and renal failure (Gertner et al., 1994). HMs contaminated with 
microbes due to poor manufacturing, harvesting, and storage conditions have also been 
documented (Zhang et al., 2012). This identifies that stringent controls need to be reinforced 
over the manufacture, sales and supply of high quality and safe HMs.  
 
 Interactions between Herbal and Conventional Medicines  
Herbal medicines have been used long before written records were created; despite this there 
is still limited clinical evidence to support the safety and efficacy of most HMs (Ernst, 1998). 
The incidence of herb-drug interactions are still not fully known, and there is no reliable 
body of information to assess the potential problems (Wachtel-Galor and Benzie, 2011; 
Williamson et al., 2013).  
An interaction is believed to occur when the effects of a drug are changed by the presence of 
another substance (Baxter, 2008). The effects of the drug may be mimicked or opposed by 
the herbal medicine; which in turn may alter the efficacy of the drug. For example, St John’s 
Wort (Hypericum perforatum L.) is known to be an enzyme inducer, affecting the 
Cytochrome P450 enzymes; it has been associated with reducing levels of ciclosporin 
leading to transplant rejection as the efficacy of the drug was reduced (Graham et al., 2008; 
Williamson et al., 2013). There is an increased risk of toxicity if a drug’s metabolism and 
clearance is inhibited, especially for drugs with a narrow therapeutic range such as digoxin, 
lithium, or theophylline (Colalto, 2010). Due to the lack of controlled research it is difficult 
to ascertain the prevalence of herb-drug interactions. This has been explored further in 
Chapter 3, section 3.4.4.1 (p91). 
 
 Adverse Effects of Herbal Medicines  
There may be many side-effects associated with HMs which are not acknowledged; 
Ravindran et al. (2009) believe, ‘’traditional medicines are generally free of the deleterious 
side effects.’’ In contrary Balaji (2010) expresses concerns of toxicity in using raw plant 
material / extracts by stating, ‘’laboratory findings suggest that turmeric extracts can be 
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toxic to the liver when taken in high doses, or for a prolonged period of time.’’ There are 
several well-known Adverse Drug Reactions (ADRs) caused by the consumption of HMs 
including: burning sensation and skin irritation caused by chillies (Capsicum spp.) or Aloe 
vera L., allergic reactions to celery or nuts, blood disorders associated with garlic, and 
aristolochic acid induced nephrotoxicity (Chevallier, 2007; Michl et al., 2014). 
The Uppsala Monitoring Centre (UMC) collates information on ADRs from over one 
hundred countries and in 2010 it found 12, 679 reports of ADRs linked to HMs (UMC, 
2011). Adverse effects linked to HMs reported included: anaphylaxis, anxiety, dermatitis, 
chest pain, toxicity and death; due to heavy metal and microbial contamination, pesticide 
residues, and also the wrong species of plant used in preparation of the medicine (Sahoo et 
al., 2010). In the UK, the MHRA established the ‘Yellow Card Scheme’ (YCS) to monitor 
the safety of healthcare products including HMs; it was designed to enable HCPs and the 
public to report side-effects and ADRs caused by drugs and HMs (MHRA, 2014a). The 
reporting of herbal ADRs remains low, just 51 reports of herbal ADRs were received by the 
MHRA in 2014 (MHRA, 2014b; MHRA, 2014c).  
 
1.4.5 Regulation of Herbal Medicines  
In response to some of the quality issues identified with HMs, the Department of Ayurveda, 
Yoga and Naturopathy, Unani, Siddha and Homoeopathy (AYUSH) was established by the 
Department of Indian Systems of Medicines and Homoeopathy (ISM&H) in 2003 to regulate 
HMs in India. AYUSH proposed to regulate Ayurvedic formulations made in India that are 
often distributed worldwide, by focusing on research, quality control, and education relating 
to HMs. The Indian government declared that traditional herbal remedies needed scientific 
validation to promote national and international use of HMs which have been used for 
centuries (Sharma, 2000). The responsibility for ensuring the safety and standards of 
Ayurvedic preparations lies with AYUSH. The labelling requirements are clearly stated in 
AYUSH guidelines (Section III, Annex A). The scope of the AYUSH regulation covers, 
“the product requirements, good manufacturing practices, requirements for competence of 
personnel and testing of AYUSH products included in the active pharmaceutical ingredient,” 
(AYUSH, n.d.). An investigation by Saper et al. (2008) found nearly two hundred Ayurvedic 
preparations bought over the internet had detectable levels of heavy metals, which were not 
stated on the label. This highlights that products failing to comply with the guidelines are 
still readily available. There are concerns about the quality and safety of HMs bought online 
as it is difficult to regulate what is being sold via the internet (The Pharmaceutical Journal, 
2002).  
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In Europe, the Traditional Herbal Medicinal Products Directive (THMPD) was passed in 
2004 by the European Parliament and Council of Europe to set out guidelines to regulate the 
use of HMs (Directive 2004/24/EC). Previously HMs could be marketed without an official 
Marketing Authorisation (MA), as long as the unlicensed products were of high quality and 
safe for consumption, as decided by each country on a national level. The 2004/24/EC 
directive led to the development of Traditional Herbal Medicine Registration Scheme 
(THMRS) in the UK, which meant over-the-counter HMs which made a medicinal claim, 
would require a Traditional Herbal Medicine Registration (THR) or a MA, by May 2011. 
The legislation required herbal medicinal products to have at least 30 years of evidence of 
their traditional use in the EU; or 15 years within the EU and 15 years elsewhere for products 
from other countries (European Parliament, 2004). In addition, it required safety data to be 
provided and the manufacturer was obliged to guarantee the quality of the product with 
regards to Good Manufacturing Process (GMP) and European Pharmacopoeia standards. 
Manufacturers were also expected to ensure pharmacovigilance procedures were in place to 
monitor ADRs (Pharmaceutical Press, 2013). The idea was to regulate high quality and safe 
HMs, in addition to giving consumers the confidence in the products they were using. As of 
the 30th April 2011 no unlicensed herbal medicinal product could be sold in the EU unless 
they held a product license. Products on the market before this date were given a three year 
period to sell through, until 30th April 2014.   
The Directive 2004/24/EC defines herbal medicinal products as, “Any medicinal product, 
exclusively containing as active ingredients one or more herbal substances or one or more 
herbal preparations, or one or more such herbal substances in combination with one or 
more such herbal preparations.”  
It also defines: 
- Herbal substances as, “All mainly whole, fragmented or cut plants, plant parts, 
algae, fungi, lichen in an unprocessed, usually dried, form, but sometimes fresh. 
Certain exudates that have not been subjected to a specific treatment are also 
considered to be herbal substances. Herbal substances are precisely defined by the 
plant part used and the botanical name according to the binomial system (genus, 
species, variety and author),”  
 
- Herbal preparations as, “Preparations obtained by subjecting herbal substances to 
treatments such as extraction, distillation, expression, fractionation, purification, 
concentration or fermentation. These include comminuted or powdered herbal 
substances, tinctures, extracts, essential oils, expressed juices and processed 
exudates.” 
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1.5 Overview of the Research Project  
The initial purpose of this research was to explore the use of HMs amongst diasporic SA 
communities in the UK, followed by the identification of plant species in HMs using 
molecular techniques (Appendix 1). As DNA-based identification techniques are a relatively 
new way of authenticating plant species, the research team was interested in studying this 
phenomenon further; with the prospect of developing a specific, fast, and reliable 
identification tool for a selected plant species.    
The first phase of this study was called the South Asian Traditional Medicines (SATMED) 
Project (Chapter 2); whereby, the primary aim of investigating the current use of HMs by SA 
communities in the UK was explored. During the development of the SATMED project a 
questionnaire was designed to explore whether participants were using HMs, what they were 
using, where ingredients were sourced from, and where their knowledge of HMs originated. 
One of the key themes involved exploring whether or not participants shared the information 
about their use of HMs with their Western HCPs. After exploring a ‘patients’ perspective of 
HMs the researcher was intrigued to understand what HCPs thought of HMs. As there is 
very limited research which has looked at UK HCPs knowledge and views of HMs, it was 
anticipated that the results would provide an original contribution to the gap in the existing 
literature. An online survey to explore HCPs personal and professional experiences with 
HMs was created and distributed using social media (Chapter 3).  
From the results of the SATMED questionnaire a medicinal plant or herbal remedy which 
could be used for molecular analysis was identified. Tulsi (Ocimum tenuiflorum L.) was 
selected as the medicinal plant for a case study of the application of DNA analysis for 
confirmation of genetic identity, as tulsi was identified as a culturally and commercially 
valuable plant during the research period (Chapter 4). The cultural, religious and medicinal 
uses of tulsi were investigated during interviews with participants. Tulsi samples from 
participants, commercial sources, and authenticated specimen were collected for DNA 
analysis. This phase of the research was called the ‘Tulsi Project’. 
All three aspects of the research overlap as the concepts are a continuation from each other 
(Figure 1-1). The Venn diagram in Figure 1-1 represents some of the key ideas explored 
within each section and some of the common themes which emerged through this research. 
Ethical approval from the De Montfort University Ethics Committee for each phase of the 
research was obtained separately (Appendix 1 & 2); further details can be found in each 
chapter (Chapter 2, 3, and 4). 
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A detailed introduction in each chapter explains the aims, objectives, and rationale for the 
section. As the methodology was tailored to each phase it is detailed within the specific 
chapter; followed by a detailed analysis of the results and a discussion. The final discussion 
chapter (Chapter 5) summarises the key findings of this research and illustrates how the three 
strands of this investigation integrate and support each other; furthermore, it highlights the 
implications of this research and further work which could be conducted. 
  
Figure 1-1 Venn Diagram to Illustrate the Integration of the Three Phases of the Research 
The Venn diagram shows how the SATMED Project, HCPs survey and the Tulsi Project interlink to explore 
the aims and objectives of this study.  
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2.0 South Asian Traditional 
Medicines (SATMED) Project  
2.1 Introduction  
The migration of South Asians (SAs) to the United Kingdom (UK) has created an ethnically 
diverse population; with SAs forming 5.3% of the total UK population as uncovered by the 
2011 Census (Office for National Statistics, 2012). With the migration of people to the UK 
they have brought with them their own herbal remedies which they may still be using; 
however, there is little documented evidence to support the current use of herbal medicines 
(HMs) by SAs in the UK (Etkin and Elisabetsky, 2005; Sandhu and Heinrich, 2005; Pieroni 
and Torry, 2007). This raises several interesting questions such as where the knowledge 
originates from, how it is transmitted through generations, where ingredients for traditional 
remedies are obtained from, and if HMs are used in conjunction with conventional Western 
medicines (CWM) are Western healthcare professionals (HCPs) aware. The South Asian 
Traditional Medicines (SATMED) project was designed to be an exploratory survey to 
establish the current use of HMs by South Asian (SA) communities in the UK. This chapter 
will summarise the aim and objectives of this research, followed by some background 
information to support the need to conduct this investigation. The methodology will describe 
the research methods used for the SATMED project and the results section will give a 
detailed analysis of the findings of this study. The terms herbal remedies, traditional herbal 
medicines (THM), and herbal medicines (HMs) will be used interchangeably throughout this 
research. 
 
2.2 Aim of the SATMED Project  
The aim of the SATMED project is to explore the origins, use, and transmission of 
knowledge of traditional herbal medicines used amongst South Asian diasporic communities 
in the UK.  
 
2.3 Objectives of the SATMED Project  
1. Explore the knowledge and use of traditional herbal remedies amongst South Asian 
diasporic communities; describe where the knowledge originates from and how it is 
transmitted.  
2. Investigate where ingredients for herbal medicines are sourced from.  
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3. Obtain insight into the relationship between South Asian people who use herbal 
medicines and their healthcare professionals.  
4. Summarise the types of herbal medicines and plants used within South Asian 
communities; to establish which plant species would be suitable candidates for DNA 
authentication.  
 
2.4 Background Research  
In order to establish why focusing on SA populations for this research is important, the 
background of how migration to the UK first started will be considered. Then the types of 
HMs and traditional medical systems used by SAs will be established to determine the 
origins of HMs, and evidence to support the use of HMs will be explored.  
 
2.4.1 South Asians in the UK  
 The Formation of South Asia   
The first British men went to India as traders as part of the East Indian Company (EIC) in 
search of spices, silk, cotton, ivory and tea. The Indian subcontinent was rich in natural 
resources which Europeans wanted (Kaul, 2011). The EIC began to rule areas of India and 
developed its own armies. After almost a century of oppressive control in India by the EIC 
the Indians rebelled and the British Government rule was established in 1858 (Lambert, 
2014). The two hundred years of British rule in India came to an end in 1947 after which 
India, which was once bigger than Europe, was partitioned into independent states. The main 
body was left as India while the eastern and western wings were called Pakistan (Figure 2-1). 
In 1971 East Pakistan was renamed as Bangladesh. After this the three states and Sri Lanka 
collectively formed South Asia, and its people were referred to as South Asians (Healy and 
Aslam, 1989; Clarke et al., 1990; Brown, 2006).  
 
 
 
 
 
Figure 2-1 Map of India Pre and Post Partitioning (adapted from Brown, 2006) 
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 Migration of South Asians to the UK 
Migration from South Asia started early in the 19th century when SAs first moved to 
countries such as Mauritius, British Guiana, and Trinidad (Clarke et al., 1990). By the late 
20th century SAs had become widely spread across Europe, Africa, Asia, America, and the 
Middle East (Brown, 2006). Reasons for migration may have been forced (e.g. contracts of 
indenture or refugees), or free willed - the migration of traders, entrepreneurs, labourers, and 
professionals. Service in the British army took men from India across the world and as 
transport links improved, migration became easier so people emigrated to seek new 
opportunities.  
During the partitioning of India in 1947 there was large-scale immigration to the UK from 
India and Pakistan due to the violence and unrest. This first mass migration can be broadly 
divided into religious groups as Sikhs from India and Muslims from East and West Pakistan. 
These immigrants clustered in inner city areas of London, Manchester and the West 
Midlands, working in factories, with little or no education and qualifications (Hanif and 
Karamat, 2009). The influx continued until restrictions were set by the Commonwealth 
Immigrants Act of 1962 (Healy and Aslam, 1989).  
During the British reign in India between 1858 and 1947 many Indians were educated or 
trained and taken to other countries to work in British colonies. Indians were used to work in 
clerical, manual labour and farming roles. Thirty two thousand Indians were taken to 
Southeast Africa under indentured labour contracts to build the Uganda railway networks 
(Kasozi et al., 1994). When East African Governments created polices to prevent British 
passport holders from working, many Asians who had settled there were left unemployed 
(Healy and Aslam, 1989). On the 4th August 1972 the president of Uganda, Idi Amin, 
declared that all Asians would be expelled from Uganda within ninety days. At the time of 
expulsion there were seventy five thousand Asians living in Uganda. Many held British 
passports so were able to immigrate to the UK (Kasozi et al., 1994). These immigrants were 
mostly of Gujarati origin and they settled around Leicester and London; they were better 
educated and many had successful businesses (Hanif and Karamat, 2009). According to 
Healy and Aslam (1989) the main types of Asians found in the UK can be categorised as 
Punjabi, Gujarati, Pakistani, Bangladeshi, and those East African Asians usually of Punjabi 
or Gujarati origin from Kenya, Uganda, Tanzania and to a lesser extent Malawi or Zambia. 
The SA population in the UK can be described as being heterogeneous due to the variety of 
religions, cultures, languages, social and economic backgrounds (Gill and Lloyd, 2009; 
Hanif and Karamat, 2009).   
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Diaspora comes from the Greek word (διασπορά) which means to disperse, scatter or spread. 
Brown (2006) uses the word diaspora to refer to groups of people with a common ethnicity 
who have left their original homeland but retained a cultural kinship. Although South Asia 
includes India, Pakistan, Bangladesh, Nepal and Sri Lanka, when referring to SA diasporic 
communities in this study it will focus on Indian, Pakistani and Bangladeshi communities as 
agreed by most official and research bodies (Khunti et al., 2009; Office for National 
Statistics, 2012).  
 
 UK Census Statistics  
The 1991 Census was the first to account for ethnic minorities in the UK (Ballard, 2004). 
The SA ethnic minority encompassed Indians, Pakistanis and Bangladeshis. Of the total 
population 5.5% was identified as ethnic minority of which half was of SA origin (Brown, 
2006). The total SA population in the UK has continued to rise from 3.9% in 2001 to 5.3% in 
2011; Figure 2-2 illustrates the changes in SA ethnic groups in the UK between 2001 and 
2011 (Office for National Statistics, 2012).  
 
 
 
 
 
 
 
 
The Census data reveals that SAs live in all areas of the UK, clustering in certain areas 
reflecting migration patterns (Figure 2-3). For example, there is a high concentration of 
Indians and Bangladeshis residing in Greater London as well as the East and West Midlands; 
while, Pakistanis can be found predominantly in West Yorkshire, Manchester and the 
Midlands (Gill and Lloyd, 2009; Hanif and Karamat, 2009).  
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Figure 2-2 South Asian Ethnic Groups in the UK 2001 – 2011 (adapted from Office for National Statistics, 
2012) 
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2.4.2 South Asian Traditional Medicine  
South Asian countries have a heritage of traditional herbal medicine; Ayurveda, Siddha and 
Unani are systems of traditional medicine (TM) native to SAs. Ayurveda is one of India’s 
most well-known systems of TM which has hundreds of formulations; it was first 
documented in the Rig Veda around 1500 BC. Siddha is said to be the oldest system of 
medicine known, dating back over ten thousand years; it is another branch of traditional 
Indian medicine originating from South India. A newer concept was introduced around 1025 
AD, by the Muslim herbalist Ibn Sina (more commonly known in the West as Avicenna), 
who took his inspiration from Greek and Islamic medicines to create Unani (Lone et al., 
2012; Ansari and Satish, 2013). 
 
 Ayurveda  
Ayurveda translates as ‘the knowledge of life’ and is the holistic approach to traditional 
Indian herbal medicine; encompassing the use of HMs, breathing techniques, meditation, 
yoga and exercise as a complete system of managing health and preventing disease 
(Williamson, 2002). Ayurveda is believed to have originated from the Hindu God, Lord 
Brahma, known as the creator of the universe (Nerkar, 2007). It is thought to be one of the 
oldest systems of TM, which was developed more than five-thousand years ago; when the 
wise men known as ‘rishis’, were thought to have retreated to the Himalayas to meditate to 
gain divine knowledge from Lord Brahma, about how to tackle diseases (Nerkar, 2007). 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-3 Distribution of Indian, Pakistani, and Bangladeshi Communities in the UK (adapted from 
Office for National Statistics, Census 2011) 
Indian          Pakistani        Bangladeshi  
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Their enlightenment was transcribed into Vedas which are Hindu scriptures, still referred to 
today. There are four Vedas in Hinduism; Rigveda, Yajurveda, Samveda and Atharvaveda 
which contain herbal remedies and cures for diseases. 
The principles of Ayurveda originate from the first of the four scriptures known as the 
Rigveda.  The Rigveda describes how the universe is made from five elements known as the 
Pancha Mehabhutas; space (Aksha), air (Vayu), fire (Teja), water (Aap) and earth (Prithi). In 
different combinations these elements make three forces: vata, pitta and kapha, which 
compose the human body and are known as the tridosha (Patwardhan et al., 2005). 
Williamson (2002) recognised that modern science has been able to interpret the three 
components of the tridosha as different systems within the body. Vata is equivalent to the 
central nervous system which regulates breathing, heart rate, and movement. Pitta represents 
the endocrine system and is involved in thermogenesis, digestion, and energy production. 
While the kapha corresponds to the immune system, providing protection to the body and 
wound healing. Disease occurs when components of the tridosha become imbalanced. For 
instance altered metabolism due to pitta imbalance links to thyroid gland malfunction 
(Godagama, 2001; Williamson, 2002; Patwardhan et al., 2005). 
Ayurveda focuses on maintaining good health and making the body more resistant to illness 
and disease; equal importance is also given to the treatment of disease (Vishnuprasad et al., 
2013). Ayurvedic practice takes into consideration individual differences and the treatment is 
tailored (Godagama, 2001). Ayurvedic medicinal plants have already provided the Western 
world with several active molecules for treating an array of conditions including: curcumins 
for inflammation, and guggulsterone for hyperlipidaemia (Patwardhan, 2000). 
Approximately six hundred plants are described in the Ayurvedic Matria Medica (Dash and 
Kashyap, 1980). Ayurvedic medicinal plants are attached to five key aspects; identification 
(ensuring the correct species is used is of paramount importance), cultivation, harvest, 
storage and usage; these factors can ultimately affect the activity, effect, and potency of the 
remedy (Godagama, 2001). The distinctive details outlining the selection and use of plants in 
Ayurveda ensures the correct plants are selected for the appropriate use; an innate system for 
controlling production of herbal remedies.   
Within Ayurveda, plants are formulated into polyherbal mixtures known as ‘rasayana’. A 
common Ayurvedic mixture is Chyawanprash, believed to replenish the bodies’ nutrients, 
containing a combination of over forty natural herbs including: amla (Indian gooseberry), 
cinnamon, clove, turmeric, asparagus and beetroot; according to Dabur Research Foundation 
(1991), the market leader of Chyawanprash sales, this blend of herbs which has been used 
for over two and a half thousand years, has antioxidant properties and helps strengthen the 
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immune system. Triphala is another common rasayana, consisting of three fruits: amla 
(Phyllanthus emblica L. Indian gooseberry), beleric (Terminalia bellirica (Gaertn.) Roxb 
bastard myrobalan), and harad (Terminalia chebula Retx. black myrobalan). This 
formulation has been used to treat numerous ailments including digestive problems, 
constipation, diabetes, hypercholesterolemia, hypertension, and cardiovascular disease 
(Ponnusankar et al., 2011). 
In the sixteenth century during the colonization of India by the British, the traditional form 
of medicine was deemed backward and inferior and was gradually succeeded by Western 
medicine (Dash and Kashyap, 1980). Modern Western medicine was not accessible to all, it 
was expensive and difficult for those in rural areas to access; hence, in remote villages 
Ayurvedic traditions continued to thrive. Traditional doctors preserved the practices of 
prescribing and dispensing HMs. In 1980 the National Congress of India decided Ayurveda 
should be regulated just like Western medicine so institutes for training Ayurvedic 
practitioners were introduced (Godagama, 2001). In the late 1980’s Ayurvedic remedies 
were being used in Western countries.  In India, Ayurveda remains as the system for primary 
health care, and interest across the world is growing (Sharm et al., 2007; Lallanila, 2015). 
Yumi et al. (2008) suggest the reason why Ayurveda is becoming more popular in Western 
communities is due to the increased rates of immigration of Asians from India. This is 
supported by Sandhu and Heinrich (2005) who also found that immigrants brought their 
traditional forms of herbal medicine with them. 
 
 Siddha  
Siddha is another branch of traditional Indian medicine which is believed to have originated 
more than ten thousand years ago. The Siddha scriptures are written in Tamil; hence, are 
predominantly used by people of Tamil origin (Krishnamurthy and Mouli, 1984). One of the 
distinctions made between Ayurveda and Siddha is that, Ayurveda is generally used more by 
people from the north of India and Kerala, while Siddha remains prevalent amongst those 
further South in Tamil Nadu (Zysk, 2008). Siddha healers still play an important role in rural 
health care (Pandikumar et al., 2011). 
Legend has it that Siddha was created by the Hindu God, Lord Shiva, who passed the 
knowledge of medicine to the saints known as Siddhars. There were eighteen Siddhars - men 
who had achieved supernatural abilities, which enabled them to heal the sick, through their 
spirituality and meditation. These saints were believed to be able to cure any illness by 
utilising their divine knowledge to produce medicines from plants. Siddha takes into account 
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the individuals’ disease; considering the persons symptoms, age, gender and environmental 
factors to produce a holistic treatment. The tongue, eyes, pulse, and urine are all assessed to 
determine the type of imbalance and to formulate the appropriate treatment (AYUSH, 2012). 
There are several similarities between Ayurveda and Siddha. For example, the five elements 
which create the body: earth, water, fire, air and space which must be balanced. The concept 
of the three humours (Tamil: tiritocam, Sanskrit: tridosha) representing the wind (vata), bile 
(pitta) and phlegm (kapha) are also the same (Godagama, 2001; Zysk, 2008). The majority 
of the plants are used for similar conditions; some of the common examples include ginger 
for digestive complaints, tulsi for skin conditions, and garlic as an antibacterial 
(Chellappandian et al., 2012). The key differences recognised are that Siddha relies heavily 
on astrology to decide the appropriate treatment regime. The formulation process of 
medicines is deemed highly significant for example: the part of the plant used, the direction 
the sun penetrates the plant and the harvesting are all carefully regulated by the Siddha 
practitioners; deviations are believed to distort the effectiveness of treatment (Kumar et al., 
2013). Ultimately both Ayurveda and Siddha provide a holistic system of healthcare; 
providing a path for life, promoting resilience to disease, and treatment for illness.  
Siddha remains the primary health care regime for the majority of South Indians in Tamil 
Nadu; and is also practiced in Sri Lanka, Singapore and Malaysia (Chellappandian et al., 
2012). Although modern medicine may be available across India, these systems of TM 
continue to thrive. Historical, cultural, and ecological factors could all contribute to the 
continued use of TM not only in India, but around the world (Kunwar et al., 2010; 
Pandikumar et al., 2011).   
 
 Unani  
Unani is a newer form of TM, in contrast to Ayurveda and Siddha. Adopted by the Arabs, 
from the teachings of the ancient Greek and Roman philosopher-physicians Hippocrates and 
Galen. Having emerged over two thousand years ago (Lone et al., 2012), it incorporates 
traditional herbal remedies from several countries, including: India, China, Egypt, Persia, 
and many other Middle Eastern countries (AYUSH, 2012). The system was introduced to 
India by the Arabs, and used predominately by Muslims who lived there (Zysk, 2008). 
During the British rule, as with all the other forms of TM, Unani was deemed inferior and 
the availability of Western medicines surpassed the Unani system of healthcare.  
According to Unani principles, disease occurs as a natural process. The system is based on 
Hippocrates’ Humoral Theory; this suggests there are four humours in the body – phlegm 
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(balgham), blood (dam), yellow bile (safra) and black bile (sauda). Every individual has 
their own unique humoral constitution; therefore, treatment has to be formulated specifically 
once the correct diagnosis is made. Pulse (nubz) measurement is the most common method 
for diagnosis, as well as examination of urine and stools (AYUSH, 2012). Unani recognises 
that social, economic, political, and environmental factors can affect an individual’s health; 
reinforcing the importance of health promotion through adequate education, lifestyle and 
behavioural modifications (Husain et al., 2010; Lone et al., 2012). Unani offers a variety of 
ways of treating disease; regimental therapy, one of the most popular methods of treatment, 
includes: massage, exercise, diuretics and emesis, to rid the body of impurities. Diet therapy 
involves controlling food intake, food should be clean and fresh to prevent disease onset. 
Pharmacotherapy entails the use of naturally occurring medicines, and surgery - physically 
correcting abnormalities (AYUSH, 2012; Lone et al., 2012). 
One of the most common products used in Unani is black cumin (Nigella sativa L. English: 
small fennel, black seed, Sanskrit: kala jeera, Arabic: Habbatul barak). Seeds from the plant 
which is native to the Middle East and Southwest Asia are believed to be the remedy for all 
ailments (Tariq, 2008; Ansari and Satish, 2013).  As defined by Islamic beliefs, it is said the 
Prophet Mohammed described the healing powers of black seed, as being able to cure any 
disease but death (Ansari and Satish, 2013). It is used for numerous health problems 
including: headache, cough, asthma, pain, rheumatism, diabetes, and many other conditions 
(Gali-Muhtasib et al., 2006; Tariq, 2008). The anti-inflammatory, anti-cancer, antibacterial, 
antifungal, and analgesic effects are being widely investigated by researchers (Al-Ghamdi, 
2001). Thymoquinone is one of the active compounds known to have several health benefits, 
including analgesic and anti-inflammatory effects (Gali-Muhtasib et al., 2006; Hosseinzadeh 
et al., 2007). Pharmacological and toxicological investigations have shown that some of the 
active compounds extracted have hepatoprotective and nephroprotective effects (Ali and 
Blunden, 2003). The seeds can be eaten whole, the oil extracts can be applied to the skin or 
mixed with other ingredients to formulate a herbal concoction. The versatility, availability, 
and religious significance attached to this aromatic seed means it is often consumed daily, 
especially by the Muslim population (Ansari and Satish, 2013).  
Like the other forms of traditional medicine discussed, Unani medicines have been used for 
centuries without real scientific validation. More research into the HMs recommended by 
Unani is required to investigate the safety and efficacy of this traditional medical system. 
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2.4.3 Evidence To Support the Use of Traditional Herbal Medicines  
Traditional plant based remedies may be preferred to synthetic alternatives as they have been 
considered to be relatively safer, with better therapeutic effects, less side effects, more 
affordable, and easily obtainable (Ayyanar and Ignacimuthu, 2011). Hatfield (2007) states, 
“Man’s use of plants may be viewed as a long standing clinical trial; remedies that have 
stood the test of time are likely to be worth further investigation.”  Although there may not 
be much scientific evidence to prove the efficacy of HMs, some researchers claim the fact 
that they have been used for so long can be used to validate their use (Pandikumar et al., 
2011). Despite the long standing use of HMs, a shift towards evidence based medicine, and 
scientific validation is prompting more research into HMs. Two commonly used examples 
which have now been researched extensively are turmeric and garlic. Turmeric (Curcuma 
longa L., Indian name: haldi) is commonly known as a spice, colorant and food preservative, 
which has several proposed medicinal benefits. It is said to have antioxidant, anticancer, 
antimicrobial and anti-inflammatory effects (Colalto, 2010). Curcumin, identified as the 
yellow pigment in turmeric, is a compound found in the rhizome of the plant; which is a 
therapeutically active component in turmeric responsible for its versatile medicinal 
properties (Sikora et al., 2010). Chemotherapeutic agents inhibit the hyperproliferation of 
cells, which develop into cancer. Synthetic drugs are often expensive, difficult to synthesise 
and have multiple side effects. On the other hand, curcumin extracted from turmeric is 
cheap, widely available, and is believed to kill tumour cells as it interferes with several cell 
signalling pathways that cause cell death by apoptosis and necrosis (Ravindran, et al., 2009; 
Sikora et al., 2010).  
Garlic (Allium sativum L., Indian name: lasan) is another popular ingredient used in many 
herbal formulations; which is believed to have antibacterial, anti-platelet, and anti-
hypertensive effects.  The therapeutically active components recognised in garlic are allicin 
and alliin (Colalto, 2010; Garodia, 2006). A review by Tovar and Petzel (2009) analysed the 
efficacy of garlic for treating dyslipidaemia, and its action in reducing high cholesterol by 
inhibiting the enzyme involved in cholesterol synthesis; 3-hydroxyl-3-methylglutaryl-
coenzyme-A-reductase. Garlic is effective at reducing low density lipids and triglycerides 
which contribute to high cholesterol; accordingly the benefits of reduced cholesterol 
correlate to reduced risk of stroke and heart disease. The antibacterial action of garlic was 
also observed in the West by the renowned scientist Louis Pasteur in 1858, who noted that 
bacteria died when they were exposed to garlic; crushed garlic juice was also used during the 
Second World War in wounds to prevent infections (Taylor, 2007; Arora and Kaur, 1999; 
Williamson, 2002).  The mode of action is believed to be due to the active molecules, allicin 
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and alliin which interfere with thiol groups on bacterial and fungal enzymes, affecting 
essential metabolism leading to cell death, thus eradicating the organism (Williamson, 2002). 
There are numerous HMs which are getting recognition for their pharmacological effects in 
the Western world.  Dentists commonly recommend cloves (Eugenia caryophylatta Thunb., 
Indian name: long) to their patients for toothaches. The dried flower buds have powerful 
anaesthetic, analgesic, antiseptic, antimicrobial and anti-emetic effects (Chevallier, 2007). 
Eugenol (4-allyl-2-methoxyphenol) has been identified as the active substance responsible 
for many of the medicinal benefits of cloves. The culinary use of cloves is not only to add a 
spicy aromatic flavour, but traditionally it was added to prevent food spoilage and to aid 
digestion (Trajano et al., 2010). Another product which is being recognised for its cosmetic 
value is neem (Azadirachta indica A.Juss.); commercial soaps, shampoos, face washes, 
creams and lotions are now readily available. The neem tree is native to South Asia, and can 
grow up to thirty five meters tall; all parts of the tree can be used including the seeds, leaves 
and bark. It has been described as a pharmacy in its own right due to the many health 
benefits associated with it (Chevallier, 2007), including: antibacterial, antifungal, anti-
inflammatory, anti-diabetic, antipruritic, anti-cancer and a blood purifying properties (Kumar 
et al., 2006; Boursier et al., 2011; Pandikumar et al., 2011).  
The Foundation for Revitalisation of Local Health Traditions (FRLHT) in Bangalore, India, 
has established various projects across India to document the use of traditional HMs. One of 
the key priorities is to build a bridge between the traditional use and knowledge of HMs and 
modern scientific advances. By engaging in clinical research the FRLHT aims to establish 
clinical theories to support traditional use of HMs. By working with local communities, 
farmers, traditional healers, schools and educational institutes they have tried to preserve 
cultural heritage, cultivate sustainable resources, and provide an evidence base for traditional 
Ayurvedic practices (FRLHT, 2015).  
 
2.4.4 Ethnopharmacological Research in the UK 
Ethnopharmacology is “the scientific study of ethnic groups and their use of drugs” (Johnson 
and Sargent, 1996). Ethnopharmacological research involves a multi-disciplinary approach 
whereby botany, chemistry, pharmacognosy, pharmacology and other disciplines are 
considered to document traditional knowledge and use of medicinal plants (King, 1992; 
Patwardhan, 2005; Heinrich et al., 2006). The research methods used are diverse and tailored 
to the objectives of the investigation (Elisabetsky and Etkin, 2009). Plant material may be 
collected, identified and examined by botanists and other scientists while social science 
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inquires may be conducted to explore the medicinal ethnography (Elisabetsky and Etkin, 
2009; Mukherjee et al., 2010). By combining methodologies from several disciplines such as 
social and natural science the objective of ethnopharmacological research which sets out to 
explore and understand traditional systems of medicine can be attained (Elisabetsky and 
Etkin, 2009).   
There is a vast amount of ethnopharmacological research which has explored the use of 
traditional HMs by people around the world (Chhetri, 1994; Thring and Weitz, 2006; Malla 
and Chhetri, 2009; Kunwar et al., 2010; Ayyanar and Ignacimuthu, 2011; Bhatia et al., 
2014). Pieroni et al. (2010) claims that most ethnobotanical research is conducted in exotic 
places and that a gradual shift towards exploring what is going on in ‘back yards and urban 
environments’ will occur. They go on to say that ethnobotanists began to explore the use of 
plants by migrant populations in the late 1990s in North America; this was driven by an 
increasing interest in the use and perception of traditional HMs. In the UK, surveys to 
explore the use of HMs have been conducted (Ipsos MORI, 2008; Mintel, 2009); however, 
there is limited research into the use of HMs by SA communities in the UK (Bhopal, 1986a; 
Sandhu and Heinrich, 2005; Pieroni and Torry, 2007; Pieroni et al., 2010). 
Bhopal (1986a) conducted interviews with 65 Asian participants in Glasgow to explore the 
role of TM in an Asian community. He discovered that the knowledge of HMs amongst 
participants was high, but HMs only had a modest role in participants’ healthcare. 
Participants did not feel it was necessary to disclose information about their use of HMs to 
their HCPs; so Bhopal explored HCPs views of HMs too. He offered general practitioners 
(n=33) and healthcare workers (n=10) the opportunity to complete a questionnaire about 
Asian patients’ use of HMs. The results revealed that HCPs awareness of Asian HMs was 
‘extremely low’ and HCPs were unaware of their patients’ use of HMs. As the research was 
conducted on a small Asian community in Glasgow the results are not representative of SAs 
in the UK; in addition, as the research was conducted in 1986 the results are now dated.  
Sandhu and Heinrich (2005) explored the knowledge and use of HMs amongst a Sikh 
Punjabi community in London, by conducting semi-structured interviews with 84 
participants. They documented the use of numerous HMs by the research participants and 
uncovered how participants managed minor ailments. As this research was focused on a 
specific religious (Sikh) and cultural group (Punjabi) the results are not representative of 
SAs; the authors do highlight that there is an urgent need to investigate the use of HMs 
amongst other ethnic groups in the UK.  
The study by Pieroni and Torry (2007) focused specifically on Kashmiri, Gujarati, and 
English participants medical perception of five ‘herbal drugs’ (cinnamon, cloves, garlic, 
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ginger, and mint). A questionnaire was completed by 274 participants who were asked to 
state the perceived medicinal properties and uses of the products listed. They found a 
difference in traditional knowledge amongst the ethnic groups; whereby, Kashmiri 
participants had widespread knowledge of the herbal drugs listed while it was less prevalent 
amongst Gujarati and especially English participants. 
Pieroni et al. (2010) conducted interviews (n=37) and focus groups (n=42) with Bengalis in 
Bradford to explore their use of traditional HMs. They recorded approximately 150 herbal 
preparations recalled by participants, and identified that many of them were still commonly 
used in the UK. Pieroni et al. (2010) found that middle-aged and older participants were 
more accurately able to recall HMs than younger participants; moreover, younger 
generations seemed to prefer CWM over traditional HMs. The results of this research 
indicate that HMs are still commonly used by Bangladeshi migrant communities in the UK. 
The current research on SA communities’ use of HMs in the UK is limited; but, it has 
provided a basis for conducting this research. Some of the concepts explored by other 
researchers will be further investigated in this study, to help gain a better understanding 
about the current use of HMs by SAs in the UK.        
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2.5 Methodology  
2.5.1 Questionnaire Design  
A questionnaire to meet the aims and objectives of the SATMED project was designed; to 
explore the current use of HMs amongst SA diasporic communities in the UK. Several draft 
copies of the questionnaire were piloted; Malhotra and Birks (2006) refer to pilot studies as, 
‘‘testing the questionnaire on a small sample of respondents for the purpose of improving 
the questionnaire by identifying and eliminating potential problems.’’ Amendments made to 
the questionnaire included: reducing the length of the survey without compromising the 
quality of the data, removing a question which used images of HMs which was ambiguous, 
and rewording some questions (Appendix 1). After which a more refined and tailored 
questionnaire was produced to meet the objectives of the research (Appendix 3). A 
participant information leaflet (PIL) was provided to participants to inform them about the 
purpose of the research (Appendix 4). 
Initially the questionnaire was designed for participants to complete themselves; however, 
after conducting a pilot study the researcher believed it was more appropriate to administer 
the questionnaire personally. Several reasons for changing the way the questionnaire was 
conducted included: incomplete questionnaires, participants dropping out part-way, illegible 
handwriting, and feedback from participants who stated the survey was too long to write 
answers to despite having great knowledge of HMs. To ensure no bias was introduced from 
the researcher when asking the questions, thorough training from Professor Mark Johnson 
was attained; the training enabled the researcher to develop skills to keep participants 
engaged and affirmed how to ask the questions. Although this process was time consuming 
for the researcher the benefits outweighed the drawbacks. Advantages of the researcher 
administering the questionnaires included: the chance to build rapport with the participants – 
gaining trust and better responses to questions, a higher response rate, more complete 
questionnaires returned, and clarification of questions therefore less invalid responses 
(Dornyei and Taguchi 2010).  Furthermore, as the researcher was fluent in Punjabi, Hindi 
and Urdu it was easier to engage participants who could not understand, read or write 
English. 
A mixture of open and closed (quantitative and qualitative) questions were used in this 
survey. One of the reasons for using quantitative questions was so the data obtained could be 
statistically analysed; enabling the quantification of data and comparisons to be made. While 
the qualitative questions obtained richer, more in-depth knowledge of the individual 
participants’ perception regarding the objectives of the study (Levin et al., 2008). The 
questionnaire took on average ten to twenty minutes to complete.   
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2.5.2 The Target Research Population  
The participant inclusion criteria for this research stated participants must be over eighteen 
years of age (so they could consent for their own participation without the need for parental 
consent), and from a South Asian (SA) background (i.e. Indian, Pakistani, or Bangladeshi) 
(Office for National Statistics, 2012). There is no existing database which permits 
randomised or systematic identification of a suitable population of SA origin (i.e. the 
sampling frame); therefore, an opportunity sampling technique was used. For this reason 
there was no pre-defined target of gender or age group to survey. Malhotra and Birks (2006) 
say opportunity sampling involves, ‘‘being in the right place at the right time.’’  The 
sampling method used followed established practice in other similar studies whereby the 
target research population was directly approached in anticipation of recruiting more 
participants (Sandhu and Heinrich, 2005; Thring and Weitz, 2006; Pieroni et al., 2010). 
Participants were reassured that all responses would remain anonymous (as no personal 
identifiable data was taken), and confidential. All the responses were kept in the possession 
of the primary researcher with no unauthorised access.  
A unique aspect of this study was that it focused on SA populations as a whole; whereas, 
most other studies focused on single ethnic or religious groups (Sandhu and Heinrich, 2005; 
Jennings, 2014; Pieroni et al., 2010).  
 
2.5.3 Ethical Approval  
De Montfort University (DMU) ethical approval was obtained before the questionnaires 
were distributed (Appendix 1). The questionnaire and PIL (Appendix 3 & 4) were reviewed 
by the DMU ethics committee, who gave feedback and some minor suggestions. Instead of 
using the phrase ‘side-effects’ they recommended using a more neutral statement such as 
‘unwanted’ or ‘unexpected’ effects. The ethics committee also commented on the length of 
the survey, which after the first pilot study was shortened; as some questions were removed 
or merged together.   
 
2.5.4 Questionnaire Distribution  
In total two hundred questionnaires were conducted across several locations in Birmingham 
and Leicester (one hundred in each city); two cities the primary researcher knew well (Table 
2-1). The Census statistics suggested that Birmingham and Leicester would provide a 
reliable base for the field work as 7% of the population of England are now of SA origin; 
hence, the data would have wider applicability (Office for National Statistics, 2012). 
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Statistics revealed that over 30% of the residents in Birmingham are from an ethnic minority 
group. The SA communities of interest in Birmingham have increased from 17.9% in 2001 
to 22.5% in 2011 (Office for National Statistics, 2012).The demographic profile of Leicester, 
in 2007, revealed that approximately 40% of Leicester’s population were from an ethnic 
minority background (Leicester City Council, 2007).  The 2011 Census suggests that the 
minority population of Leicester has risen to 54.9%, 35.8% of SA background (Office for 
National Statistics, 2012).   
Table 2-1 Summary of Where Questionnaires Were Distributed 
Date: Location: Number: 
September 2013 
Sachkand Nanak Dham International – multicultural 
temple in Birmingham  
22 
September 2013 
Gheeta Bhavan Mandir Handsworth – Hindu temple in 
Birmingham   
14 
October 2013 
Apna Ghar – Asian Community Centre and Day Care 
Centre in Birmingham 
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October 2013 Shakti – Asian Day Centre in Birmingham 14 
November 2013 
Apna Ghar – Asian Community Centre and Day Care 
Centre in Birmingham 
13 
February 2014 De Montfort University Campus – Leicester  23 
May 2014 East West Community Project Day Centre – Leicester  11 
June 2014 Santosh Day Care – Leicester  10 
June 2014 Belgrave Neighbourhood Centre – Leicester  10 
October 2014 De Montfort University Campus – Leicester  21 
November 2014 De Montfort University Campus – Leicester  34 
 
2.5.5 Questionnaire Analysis 
The Statistical Package for the Social Sciences (SPSS) software, version 21, was used to 
input the quantitative data from the questionnaires and analyse the results. SPSS has multiple 
advantages over other analytical software including: the range of statistical techniques which 
enable exploration of relationships between variables (e.g. T-tests and analysis of variance 
test). In addition, significant differences between variables can be tested and cross-
tabulations can also be created (Pallant, 2007).  The software enables data to be coded; thus, 
allowing both quantitative and qualitative responses to be analysed. Microsoft Excel 2010 
was used to create the graphical representations. The number (n) of participants or responses 
will be referenced throughout the results.  
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2.6 Results and Discussion  
This section will summarise the results of the SATMED questionnaire. The survey was split 
into four segments: the first section explored participants’ demographics, the second looked 
at the use of traditional herbal remedies, the third at the use of prescription medication, and 
finally the treatment of minor ailments. Although, two hundred surveys were conducted 
across several locations in Birmingham and Leicester, eight were discarded as they were 
either incomplete or the participants did not come under the SA inclusion criteria, leaving a 
total of one hundred and ninety two surveys for analysis.  
 
2.6.1 Sample Description  
This section was designed to determine participants’ age, gender, ethnicity, religion, and 
occupation. In addition, participants were asked where they currently lived, were born, and 
where their parents were born to establish migration patterns and links between their 
knowledge of herbal medicines (HMs) and their heritage. A total of 192 questionnaires were 
used in this analysis.  
 
 Gender and Age Profile of Participants  
The sample was comprised of 69% (n=132) female and 31% (n=60) male participants. As an 
opportunity sampling technique was employed, there was no method of screening or 
selecting the research sample to ensure an equal number of female and male participants 
were selected. One of the reasons for having more female respondents was due to the 
locations where the research was conducted; in the community and day centres visited in 
both Birmingham and Leicester it was observed that there was always a disproportionately 
larger number of females in comparison to males. Bailey (1994) suggested the gender of the 
researcher may affect participants’ willingness to take part in research, saying SA male 
participants may not be as responsive to a female researcher. As there were fewer 
opportunities to approach male participants it is difficult to say whether or not the gender of 
the researcher affected the recruitment process.   
There was a mixture of participants from the different age groups defined; as illustrated in 
Figure 2-4 which summarises the participants’ age and gender profiles. A larger number of 
participants (n=59) were in the 61 years plus age range; this could be explained by the 
locations selected to target SA participants (i.e. day centres, community centres, and 
religious institutes) which were predominately used by older SA cohorts. In order to explore 
the younger generations’ knowledge and use of traditional HMs places where younger SA 
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participants congregated were also identified; for example, the De Montfort University 
campus and library. There is much debate on how to classify age groups as young, middle 
aged, and elderly (WHO, 2010). For the purpose of this study those under 30 years will be 
referred to as young participants, middle age will include 31 to 60 year olds, and those over 
61 years will be classed as older or elderly participants as identified by the Department of 
Health (2001). 
  
 
 
 
 
 
 
 
 Participants’ Ethnicity  
The 2011 Census results confirm the largest SA ethnic group in the UK are the Indians, 
followed by Pakistanis and a significantly smaller number of Bangladeshis (Office for 
National Statistics, 2012); this was also evident in this research sample (Figure 2-5). There 
were 73% Indian, 19% Pakistani, and 3% Bangladeshi participants. Questionnaires were 
distributed in areas where a variety of South Asians (SAs) could be found (e.g. SA 
community centres and the university campus). It should be noted that there was a large 
number of participants who would describe their ethnicity as Indian even though their 
families now reside in Pakistan and Bangladesh. 
In addition, several participants wanted to add 
the option of Asian British; however, it was 
explained to participants that their place of birth 
would be where they can express their 
nationality; but ethnicity was to determine their 
racial ancestry (Prabhat, 2010). Prabhat (2010) 
defines a person’s ethnicity as being linked to 
their traditional and cultural heritage, language, 
rituals, behavioural and religious characteristics.  
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Figure 2-5 SATMED Participants’ Ethnicity  
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 Participants’ Place of Birth 
Figure 2-6 represents the birth place of participants and their parents; it highlights that 44% 
(n=84) of participants were born in the UK, 27% (n=52) in India, 17% (n=33) in Africa 
(Uganda, Kenya, and Tanzania), 10% (n=20) in Pakistan, and 2% (n=3) in other countries 
which included France, Germany, and Saudi Arabia. The majority of participants born in the 
UK were in the young age group (n=73); while those born in India (n=46), Africa (n=29), 
and Pakistan (n=15) were predominately in the middle age or older age group.  
More than half of the participants’ parents (55%, n=107) were born in India; despite this 
many of these participants families are now settled in Pakistan and Bangladesh but they still 
call themselves Indian as their parents were born in India before the partitioning into 
independent states (Healy and Aslam, 1989; Brown, 2006). 
 
 
 
 
 
 
 
This information can be used to determine whether participants are first or second generation 
citizens in the UK. The term first generation could refer to citizens born in a country or those 
who were born in a foreign country and moved to take residence in another (Moffett, 2015). 
For the purpose of this analysis, first generation immigrants will be used to describe those 
participants born in a foreign country but now living in the UK. From the total sample 
population 108 participants can be identified as being first generation immigrants as they 
were born outside of the UK. Nine participants stated both parents were born in the UK, 
making these participants first generation citizens or natives to the country of birth. Second 
generation refers to people who are born in the country of relocation (i.e. the UK) with one 
or both parents born abroad (Moffett, 2015). There were 75 participants who were second 
generation citizens as they were born in the UK, but one or both parents were born 
elsewhere. Many of the participants’ parents were born in South Asia and may be 
responsible for transmitting valuable knowledge of THM to future generations.  
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 Participants’ First Language Spoken 
The primary language spoken by 
50% (n=97) of participants was 
English (Figure 2-7). Followed by a 
quarter of participants who said their 
first language was Punjabi; this 
included people from India and 
Pakistan as prior to the partitioning 
of India, Punjabi was the main 
language spoken in the North. In the 
UK, Punjabi is the third most popular 
language spoken, followed by Urdu, 
Bengali, and then Gujarati (Office 
for National Statistics, 2012). In this study, Gujarati was the third most common primary 
language spoken and often these participants did not speak any other language. Other first 
languages spoken included Mirpuri and Tamil. Participants were also asked if they spoke 
other languages too. Many of those who spoke English as a first language also spoke 
Punjabi, Hindi, Urdu, and Gujarati. Other languages participants were fluent in included: 
Swahili, French, German, and Dutch. 
 
 Participants’ Religion 
There were a fairly even number of participants from the three main SA religions: Hinduism 
(34%, n=64), Sikhism (26%, n=50), and Islam (36%, n=70) (Healy and Aslam, 1989). There 
was a small fraction of participants who said 
they were Christian and their parents were 
originally from South India; this is where 
Christianity is most common in India. The 
option of ‘No Religion’ was only selected by 
2% (n=4) of participants (Figure 2-8). Some 
religions have a strong affiliation with herbal 
medicines (HMs); for example the Tulsi plant 
represents a goddess in Hinduism (Miller and 
Miller, 2003). By determining participants’ 
religion the link between religion and transfer 
of knowledge of HMs can be explored.   
50%
25%
15%
4%
3% 3%
Participants' First Language
English
Punjabi
Gujarati
Urdu
Hindi
Other
Figure 2-7 SATMED Participants' First Language  
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 Participants’ Qualifications 
Figure 2-9 represents the highest levels of qualifications attained by participants organised 
according to the various age groups. The majority of participants who selected ‘no 
qualification’ were first generation immigrants (n=50) and in the 61 years plus age range 
(n=42). Many participants who had some qualifications from India or Pakistan were 
considered to be equivalent to UK GCSEs; hence, a number of participants (n=10) in the 51-
60 and 61+ age group had GCSEs. A-levels were the highest qualification attained for the 
majority of participants in the 20 or under and 21-30 years age range (n=69); 93% (n=64) of 
participants doing A-levels were currently enrolled on an undergraduate degree programme 
(e.g. pharmacy, nursing, psychology, business information technology, or accounting). 
Apprenticeships were more common amongst the middle aged population (n=14). Hanif and 
Karamat (2009) highlighted that many of the first SA immigrants had little or no 
qualifications; this is also evident from the results of this survey. On the other hand, some 
first generation immigrants with degrees may have come to the UK in search of professional 
job opportunities. Most of the degrees obtained by SA participants were professional 
degrees. Masters and PhD qualifications were also attained by a small proportion of 
participants.  
 
 Participants’ Occupational Status 
Participants’ occupations were summarised into the following categories: student, employed, 
unemployed, retired, or housewife. Students formed 38% (n=73) of the research population, 
followed by 27% (n=52) of participants who had retired.  The employed population which 
comprised 24% (n=46) of participants worked in professional roles such as healthcare 
(doctors, pharmacists, nurses, and carers), finance (accounts) construction (surveyors), 
management (company directors and managers), and law (solicitors). Very few participants 
0
5
10
15
20
25
30
35
40
45
20 or under21-30 years31-40 years41-50 years51-60 years 61 years +
N
u
m
b
er
 o
f 
p
a
rt
ic
ip
a
n
ts
Age range 
Participants' Age Range & Highest Level of Qualification 
No Qualification
GCSEs or equivalent
A-levels or
equivalent
Apprenticeship
Degree or above
Figure 2-9 SATMED Participants' Age Range & Highest Level of Qualification 
36 
Sukvinder Kaur Bhamra 
worked in low or unskilled and trade jobs such as sales, or admin.  5% (n=10) of participants 
were considered to be unemployed for various reasons such as redundancy, disability, or 
cultural and language barriers which participants felt inhibited them from working. When 
middle aged SA women were asked about their occupation 11 participants (6%) said their 
job role was a “housewife”. As this is not a paid occupation it was not included in the 
employed section instead it was given its own category. 
 
 Summary of the Research Participants 
The research sample was composed of a diverse range of SA participants. There were more 
female than male participants from a variety of age groups, ethnic origins, religions, and 
cultural groups. Although the questionnaires were conducted around several locations in 
Birmingham and Leicester, 
participants living across the UK took 
part in this questionnaire (Figure 2-
10); this was because the temples 
where the research was conducted 
had devotees from around the country 
coming to worship. In addition, the 
students at DMU were also from 
different parts of the UK. Participants 
from all over Birmingham, Coventry, 
Derby, Dudley, Leicester, Liverpool, 
London (i.e. Croydon, Hounslow, 
Ilford, Slough, Southall, Surrey, and 
Wembley), Loughborough, Milton 
Keynes, Northampton, Nottingham, 
Rotherham, Walsall, and 
Wolverhampton took part in this 
research (Figure 2-10). Due to the 
number of participants living across 
the UK it means the results can be 
generalised to SAs in the UK, rather 
than just SA communities in the two 
cities where the questionnaires were 
conducted.  
Figure 2-10 Map Highlighting Where Participants Lived in 
the UK  
Adapted from http://www.map-of-uk.com/map.htm (Date accessed: 12/08/2015). 
Locations participants were from in the UK. 
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2.6.2 The Use of Traditional Herbal Remedies  
Question 1: Do you use any herbs, plants, or spices to make homemade herbal remedies 
for your health? If YES, what do you use and why? 
The words herbs, plants, and spices were used to prompt participants to think about the 
different types of HMs they used. Two thirds of participants (66%, n=126) said they did use 
HMs to supplement their health and to treat various conditions. There was a vast range of 
HMs participants listed, including: ajwain (carom seeds) for digestion, ginger for nausea and 
coughs, aloe vera for eczema, cardamom as a mouth freshener or to aid digestion, mint for 
indigestion, fennel for coughs and constipation, and cloves for toothache. The numerous uses 
of turmeric recorded by participants included its use in treating coughs and colds, wound 
healing, as an antiseptic, anti-inflammatory, and its immune boosting properties.  Honey and 
lemon was not only used for coughs and sore throats but also as a face mask to remove 
pimples and lighten the skin. Several products to control diabetes were identified such as 
curry leaf, fenugreek, karela, and tulsi. HMs to help reduce blood pressure (e.g. garlic) and 
cholesterol (e.g. cinnamon) were noted. Other conditions which participants claimed to treat 
with HMs included: healthy hair growth by using egg and yoghurt or henna, blocked sinuses 
opened with menthol or eucalyptus oil, and tea tree oil for spots and scars. Pieroni et al. 
(2010) highlight that very little is known about the use of homemade herbal medicines 
amongst migrant populations. The results of this question uncover that SA migrant 
communities in the UK commonly use a diverse range of HMs. The herbal products 
identified by participants have been summarised in Appendix 5. The 34% of participants 
(n=66) who said they did not use any herbal remedies were asked to move on to question 6 
as the following questions were about participants’ personal use of HMs.   
For the following questions 2-5, the results are only for the 126 people who said they did use herbal 
remedies in question 1. 
Question 2: Where do you get the ingredients for your herbal remedies from? 
This question was asked to explore how ingredients for 
HMs were sourced, and to determine whether or not 
ingredients for HMs could be bought in the UK. This 
question allowed for multiple responses as often people 
get their ingredients from a variety of different places.  
Figure 2-11 illustrates the different ways participants 
obtained the ingredients for their HMs. From the 
analysis of the results, 21 participants said they got the 
Family/ 
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Grow your 
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Ingredients for Herbal 
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Figure 2-11 Where Ingredients for Herbal 
Remedies Were Sourced 
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ingredients from their ‘family/friends’. Participants mentioned family members grew some 
products so shared them, or parents and grandparents gave HMs if ever unwell as reasons for 
getting products from family and friends. Tulsi, ajwain, aloe vera, curry plant, mint, and 
coriander were identified as plants commonly grown by participants (n=23). A small number 
of participants (n=4) revealed they visited Ayurvedic practitioners and clinics for HMs. 
Three of the participants who selected the ‘other’ option, disclosed that they got their HMs 
from ‘Baba Ramdev’ they did not class this as an Ayurvedic clinic/ practitioner as there was 
a strong religious affiliation. Ramdev studied Sanskrit and yoga before he began teaching 
others; he became famous when his yoga sessions were aired on Indian television channels 
across the world. He established the Divya Yog Mandir which was supported by a 
pharmaceutical company (Divya Pharmacy), which formulated and sold Ramdev’s HMs, all 
based on traditional Ayurvedic remedies (Divya Yog Mandir, 2015). These HMs are 
manufactured in India and sold around the world; evidently they are available in the UK with 
Ramdev centres open across the UK and several participants claimed to be using them. The 
remaining six participants who selected the ‘other’ option said they got their HMS from: the 
pharmacy (n=2), Holland and Barrett, The Body Shop, and Forever Aloe Vera 
representatives. 
Participants (n=27) also stated they got their ingredients from ‘abroad’ this included 
countries such as Africa, India, and Pakistan. Raw ingredients including ajwain, shilajeet, 
neem, tulsi, and turmeric; as well as commercial products such as chyawanprash, churan, 
and amrat dhara were commonly imported from India and Pakistan. Participant 67 said, 
‘‘when my family comes from Pakistan or Saudi Arabia they bring us some neem leaves,’’ 
while participant 108 stated, ‘‘I buy my herbs fresh in India, let them dry and grind them, 
then bring them back to the UK.’’ Despite the widespread availability of turmeric in the UK, 
several respondents mentioned that their families back in India and Pakistan grew their own 
turmeric; which they believed was better quality and more effective as highlighted by 
participant 162, ‘‘you can tell in the colour and taste of the turmeric it is much better from 
Pakistan.’’ Pieroni et al. (2010) also found participants in their study imported ingredients 
for HMs from abroad if they were not available in the UK; but, mentioned that many 
ingredients were now available in Bangladeshi shops or larger supermarkets. 
The most common place to get ingredients for HMs, selected by 101 participants, was local 
supermarkets. To explore the availability of ingredients in the UK participants were asked to 
specify whether they got their products from Asian supermarkets, Western chain 
supermarkets (e.g. Asda, Tesco or other Western shops) or both. Figure 2-12 exemplifies that 
a similar number of participants said they got their ingredients from either Asian shops only 
(n=35) or both Asian and chain supermarkets (n=36). 
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Just over half of respondents (51%, n=18) who specified ‘Asian shops only’ were over 61 
years old. Specific Asian shops where the ingredients were bought from were mentioned for 
example in South Birmingham ‘Metha’ and in Leicester the ‘Kelani’ store. There could be a 
variety of reasons why older participants preferred only to visit Asian shops; for instance, 
they know the stores which stock the ingredients they want, and are able to communicate 
with people better in their own language. Language barriers could be a key factor in 
explaining why elderly SAs prefer to shop in Asian supermarkets. The Census 2011 
highlights that the majority of the 2.4% of the population of Birmingham who cannot speak 
English are from a SA background (Birmingham City Council, 2013). Other participants 
from the various age groups who claimed to only get their ingredients from Asian 
supermarkets said they were familiar with the shops and trusted the quality of the products, 
and commented on the price of the products; participant 131 said, ‘‘I prefer the Asian shops 
because they are cheaper.’’ Participants made references to the past when products such as 
gor (jaggery), black seed, and churan were ordered from abroad when family and friends 
went to visit, as they were only available in their native countries; but, now the products 
were readily available in the Asian shops in the UK.  
The two respondents who stated ‘supermarket only’ said this as they claimed they did not 
have Asian shops nearby, so relied on whatever was available in their local area. Finally, 
those who stated ‘both Asian and chain supermarkets’ commented on how ethnic ingredients 
were now available in Western chain supermarkets too; so went wherever was convenient. 
The large supermarkets are now catering for the needs of migrant communities by stocking 
ethnic ingredients (Retail Think Tank, 2013). As identified by the participants in this 
research, ingredients which were once only available from SA countries are now becoming 
more easily accessible from their local supermarkets; this could suggest a change in the way 
ingredients for traditional herbal remedies are sourced. 
Asian shops only Chain supermarkets only Both Asian and chain
supermarkets
Asian or Western Supermarkets
Figure 2-12 Where Ingredients for Herbal Remedies Were Bought From  
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During the research period a satellite project to investigate the availability of traditional SA 
HMs in Leicester was explored in collaboration with Professor Adrian Slater, Dr. Caroline 
Howard, Dr. Tamsyn Thring and Dr. Ketan Ruparelia. A variety of herbal products were 
collected from several supermarkets and SA shops around Leicester and Birmingham. The 
sample inventory comprised a range of products including raw ingredients (e.g. fresh karela, 
ginger and turmeric), seeds, powdered and dried products, as well as preformulated herbal 
remedies (e.g. turmeric capsules, tulsi tablets, and Chyawanprash). While collecting samples 
it became apparent that the products mentioned by the participants in this research were 
readily available.  
Based on work by Seethapathy et al. (2015) and Kumar et al. (2015) the research team 
explored the applications of DNA authentication on the herbal remedies collected. The study 
by Seethapathy et al. (2015) looked at authentication of medicinal plant laxatives Cassia L., 
Senna Mill., and Chamaecrista Moench. After collecting market samples of dried leaf, fruit, 
and bark material from shops across several locations in South India, they discovered the 
adulteration of species amongst the samples; leading them to raise concerns about the species 
of medicinal plants available in the Indian herbal market. Similar work by Kumar et al. 
(2015) also suggests there is a problem of species adulteration and substitution amongst the 
Indian herbal market. DNA authentication work on the herbal remedies collected in 
Birmingham and Leicester correctly revealed the species of the fresh samples collected. 
While other formulations collected such as tablets, capsules, dried turmeric root and neem 
leaves were not so easy to authenticate. Work to complete this study is still in progress.  
One of the observations highlighted was the lack of information about the ingredients of 
products on the labels of some of the commercial formulations brought. Some products had 
very little information about the ingredients while others had none at all. Furthermore, 
several products which had passed their sell by date and others which had their expiry dates 
changed by hand were bought. This raises concerns about the quality of herbal remedies 
available in the UK and suggests further research in required. 
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Question 3: What form of herbal remedies do you use? 
Participants were given several options to select the types of herbal formulations they used 
(Figure 2-13). The most common types of herbal formulations used included: fresh herbs 
(e.g. mint, coriander, and fenugreek), dry powders (e.g. turmeric, cinnamon, black pepper, 
black salt, hing, and churan), and seeds (e.g. fennel, rye, mustard, black seed, and ajwain). 
Participants mentioned that as some ingredients were not readily available in the UK, they 
would import dried material from countries such as India and Pakistan; tulsi, turmeric and 
neem leaves were commonly mentioned as being imported to the UK. Liquid formulations 
used included: oils (e.g. olive, almond, coconut, sunflower, and mustard oil), syrups for 
coughs, and juices for diabetes (e.g. karela, and carrot juice). Tablets and capsules such as 
ginseng, Echinacea, senna, green tea, acai berry, and primrose oil were often bought from 
places such as Holland and Barrett, pharmacies, and other health shops. Ayurvedic and 
Chinese traditional herbal tablets for digestion (e.g. Triphala and churan), diabetes and 
weight loss were bought from India, Ramdev centres (both in the UK and abroad), and 
Chinese herbal shops. One of the participants who selected the ‘Other’ option described a 
sap which is harvested from the mountains in India known as Shilajeet used to improve 
blood circulation, good for people who have had a stroke, and has many other health benefits 
associated (Wilson et al., 2011).   
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Question 4: After using herbal remedies do you notice any unwanted effects? If YES 
please state.  
Of the 126 participants who stated they did use herbal remedies, 87% (n=110) said they did 
not experience any unwanted effects after taking HMs; while 13% (n=16) claimed they had. 
Generally, participants commented on how HMs were natural and so safer to use, with no 
side-effects. Ideologies that HMs were designed by God to help people heal themselves 
naturally were mentioned by participants in this survey. The notion that people think HMs 
are natural and therefore safe has been documented by many other researchers too (Newall et 
al., 1996; Ipsos MORI, 2008). The Medicines and Healthcare Regulatory Agency (MHRA) 
commissioned an investigation into the public’s perceptions of herbal medicines in 2008; the 
report revealed that just one in ten participants were aware that some HMs have side effects 
(Ipsos MORI, 2008).  
The unwanted effects reported by participants are summarised in Table 2-2. Some of the 
effects noted can be classed as minor as they are intermittent effects; for example excessive 
gas or wind produced by some herbals (participant 61) or a sore throat caused by the 
consumption of ginger (participant 72). Participant 42 claimed that adverse effects could be 
easily managed with the correct knowledge and gave the example of how the effects from 
‘garam’ things can be counteracted by taking some orange juice, which has an opposite 
effect. On the other hand, some adverse effects mentioned were more serious and potentially 
life threatening, as reported by participant 116, who reported fresh blood in his stools after 
consuming HMs.    
Defining the concept of garam and bhye: 
The term ‘garam’ when translated into English literally means hot. Garam is a concept used 
by SAs to classify ingredients which warm up the body. In Ayurvedic and other traditional 
medical systems the term describes substances which heat the blood or warm the body 
temperature. Participants identified ingredients such as: ajwain, cumin, cloves, cinnamon, 
coconut, cardamoms, dates, garlic, ginger, karela, peanuts, and turmeric as being garam. 
According to the research participants, when garam ingredients are consumed in excess the 
side-effects of an overheated internal system can include: nose bleeds, dizziness, 
palpitations, sweating, itching, and gastric disturbances (e.g. diarrhoea or acid reflux). 
Nevertheless, the importance of consuming garam foods in proportion was highlighted for 
keeping the body healthy, and was useful for treating conditions such as arthritis and 
diabetes. Some garam foods should be avoided during pregnancy due to the risk of a 
miscarriage; for example, mangos and papaya during the first few months, while tulsi should 
be avoided throughout the entire pregnancy (Winston and Maimes, 2007). During the 
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distribution of the questionnaire several participants made reference to Western medicines as 
being garam. This may be because the side-effects from CWM are similar to those 
experienced after consuming garam substances, or because some of the active ingredients 
fall into the same category as other garam substances. Participant 2 claimed, ‘‘paracetamol 
is garam and I cannot take too much, as if I do I start itching, especially in my head!’’ 
Itching is a documented side-effect caused by paracetamol (Joint Formulary Committee, 
2014).   
There is no straight forward translation for the term ‘bhye’. In contrast to garam ingredients 
which cause heat, bhye ingredients have the opposite effects; so Bhopal (1986b) refers to 
them as ‘cold’ substances. It is a term used to describe an internal imbalance, to which there 
is no equivalent term in Western medicine. Symptoms of bhye can include: nausea, feeling 
bloated, excessive gas production, increased salivation, and mucus production. Substances 
participants identified as being bhye include: rice, pulses, potatoes, carrots, turnips, melon, 
lemon, oranges, okra, and cauliflower. Once again it was highlighted by the research 
participants that these ingredients are vital for a well-balanced internal system but deficiency 
or excess can cause adverse effects. 
Table 2-2 Unwanted Effects Experienced After Using Herbal Remedies   
Participant 
Number: 
Unwanted Effects From Herbal Remedies Reported by Participants: 
20 
‘‘Too much of certain ingredients can cause side effects for example 
when I have pure honey and turmeric mixed together for a sore throat it 
gives a painful burning sensation.’’ 
22 
‘‘Dushanda used for high temperatures gives me phlegm- because it is 
bhye.’’ 
23 ‘‘Some types of masalas give me diarrhoea, as they are garam.’’ 
29 ‘‘Mustard oil causes sickness/ allergy.’’ 
40 
‘‘Too much neem can cause dizziness (feel faint and dizzy) so to 
counteract this side-effect have some ghee with it.’’ 
42 
‘‘If I have too much garam food like ginger or garlic, I drink some 
orange juice because it is bhye so will balance the imbalance.’’ 
47 ‘‘Taking too much ajwain makes me dizzy.’’ 
61 
‘‘Some ingredients cause wind.’’ 
‘‘Discolouring of teeth, e.g. haldi causes teeth to look yellow.’’ 
65 
‘‘Karela juice is great for diabetes but it should not be too taken too 
often as it is strong and it can affect the liver.’’ 
66 ‘‘Too much honey is bad for blood pressure.’’ 
70 
‘‘I was getting hot flushes when taking saunf, ajwain and ginger 
mixture; because they are garam they warm the blood so they can cause 
hot flushes.’’ 
72 
‘‘Too much adrak (ginger) causes irritation to the throat (throat feels 
like it is ulcerated)’’ 
73 
‘‘Haldi caused stomach ache as it is garam in excess caused side-effects 
so had to stop it for a while.’’ 
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82 ‘‘Too much aloe vera can cause diarrhoea’ 
105 
‘‘Too much ginger powder (ganthora) which was used for cramps 
affected my stomach ulcer, as it is so garam.’’ 
113 ‘‘Garlic gives me burps.’’ 
116 
‘‘I got very bad diarrhoea and fresh blood in my stools after taking 
some Baba Ramdev medicines while in India. I felt like I was going to 
die and it was very scary. I called the Ramdev hospital where I was 
being treated for my diabetes and the herbal doctor just said stop taking 
the medicine immediately, which I did. After that experience I would 
never trust that medicine again, I do not know what could have 
happened.’’ 
‘‘Feels very hot (body temperature) when has cinnamon, as it is 
garam.’’ 
 
From the analysis of the survey it should be noted that the definition of unwanted effects or 
side-effects may be different amongst SA and Western communities. During the distribution 
of the questionnaire it was obvious that some effects caused by the consumption of HMs 
were not accepted as side-effects. For example, if a remedy consumed for a headache caused 
GI disturbances (e.g. excessive belching, diarrhoea, or flatulence) it was believed the body 
was excreting the excess waste products from the body to resolve the ailment. Sometimes the 
undesirable effects were thought to be part of the process of recovery (Pole, 2008). In 
addition, there are differences in diagnosis, treatment, and side-effect profiles between 
cultures. This can be exemplified in the diagnosis and acceptance of various health 
conditions, such as mental health problems. Traditionally in SA communities the cause of 
mental health problems may have been due to black magic/ witchcraft/ evil spirits, or the 
will of God due to previous sins and bad deeds (Time to Change, 2010). The theories behind 
the cause of mental health and method of treatment are different in SA and Western cultures.   
This highlights that traditional and Western systems may perceive and treat illnesses in 
diverse ways. Due diligence is required when conducting research in SA populations as 
concepts can easily be misinterpreted. Whilst conducting the surveys the researcher was 
always mindful of such differences and asked the participants to explain concepts fully.  
 
 
 
 
 
 
Table 2-2 Unwanted Effects Experienced After Using Herbal Remedies Continued… 
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Question 5: Where did you learn about herbal remedies? 
Participants who said they used herbal 
remedies for their health, were then asked 
where they had gained this knowledge 
from (i.e. family, friends, GP, 
Pharmacist, educational institute, or 
other); 80% (n=101) of participants 
stated, ‘from their family’ (Figure 2-14). 
Knowledge of HMs was gained from 
both male and female family members.  
Participant 29 mentioned her grandfather 
was an Ayurvedic practitioner and 
participant 87 said her father was an 
Ayurvedic practitioner. However, most 
participants made reference to their 
mums as being the main source of learning about HMs. The transmission of knowledge of 
HMs has been passed on by word of mouth throughout history, from one generation to the 
next (Chhetri, 1994; Thring and Weitz, 2006; Bhatia et al., 2014). This reinforces the key 
role that family play in passing on this valuable knowledge. 
Throughout the SATMED questionnaire any references to family and friends is combined in 
the option ‘family/ friends’; this is because in SA cultures friends are often referred to as 
family, as are neighbours and people from the same village. The distinction between family 
and friends is not always the same as in Western cultures. However, for the purpose of this 
question, to establish exactly where participants learnt about HMs, the option was split into 
individual components i.e. family or friends instead of family and friends. Just three 
participants (2%) specified that they had learnt about HMs from their friends. One 
participant (1%) said she learnt about HMs from her school in India, as it was part of the 
curriculum. The option of GP or Pharmacist was not selected by any of the respondents.  
Participants who selected ‘other’ as their option (17%, n=21) for this question, said they 
learnt about HMs from a variety of places such as: the television (in particular the Asian 
channels such as Astha which airs Baba Ramdev remedies, and ZeeTV), radio, internet (e.g. 
Facebook, Twitter, and YouTube), herbal shops (e.g. Holland and Barrett), traditional 
healers, and from their religion (two participants spoke about the value of black seed in 
Islam). There was some discussion amongst participants about how the media was 
introducing them to HMs. Several participants claimed while using social media websites 
80%
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Figure 2-14 Where Participants Learnt About Herbal 
Remedies 
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and applications, such as Facebook and Twitter, the adverts which pop up are often about 
HMs. Usually HMs for hair and weight loss were advertised; however, this had led the 
participants to look into other HMs of interest. Participants 120 and 123 explained that they 
often researched on the internet for natural remedies. As did participant 165 who said she 
often watched YouTube videos to see how to make various herbal facemasks for her acne. 
Kanthe (2010) suggests the media can have a significant role in influencing peoples’ 
decision to try herbal products; this was true for some of the participants in this study. 
The results from this question have revealed that the principle route of transmission of 
knowledge of HMs is from family. The traditional knowledge of HMs has often been passed 
on from parents and grandparents. Each family may have their own formulation, dosage, and 
duration of treatment which has been optimised through generations of traditional use 
(Bhamra, 2011).  However, with advances in technology, popularity of social media, and the 
ease of access to a vast array of information, the way people are learning about HMs is 
changing (Hegg, 2013).  
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The following questions are inclusive of all 192 participants responses. 
Question 6: Is herbal medicine part of your traditional family & cultural background?  
SA countries are rich sources of natural remedies and are renowned for their long standing 
use of HMs (Bhatia et al., 2014). Pieroni et al. (2010) claims that HMs are embedded in the 
cultural heritage of SAs and is a representation of identity of migrant communities. This 
question was asked to determine the current status of such traditions amongst SA populations 
in the UK, and to determine whether or not the knowledge of HMs is being passed onto 
generations born in the UK. WHO (2008) states that in some Asian and African countries 
more than 80% of the population still depends on traditional HMs for their primary health 
care. In this study the majority of participants are first generation immigrants (n=108) or 
second generation citizens (n=75) in the UK; therefore, it is assumed that HMs will be part 
of their traditional family background. The significant majority of participants in this 
research (85%, n=163) said HMs were part of their heritage; this suggests that SA 
communities in the UK are aware of the traditional use of HMs, regardless of whether or not 
they use HMs themselves (Figure 2-15). 
 
 
 
 
 
Only 15% (n=29) of participants said HMs were not part of their traditional family 
background. Analysis of the results revealed that most of the participants who stated HMs 
were not part of their traditional family and cultural background were in the young age group 
(n=15, of which 12 participants were second generation citizens), born in the UK (n=16), 
with at least one or both parents also born in the UK. As only a small number of participants 
claimed HMs were not part of their traditional family background, claims such as a loss of 
transmission of knowledge to SAs in the UK cannot be made; although, during data 
collection one participants did suggest that this was the case. Participant 39 commented on 
how Westernised her own children had become that they did not even let her use HMs which 
she knew worked, they only used CWM and never considered the use of HMs despite it 
being part of their heritage. It was also noted that two participants claimed their families only 
ever used CWM; thus, they were not aware of traditional or cultural practices of HMs.  
0
20
40
60
80
100
120
140
No Yes
N
u
m
b
er
 o
f 
P
a
rt
ic
ip
a
n
ts
Do Participants Use Herbal Medicines
Traditional and Personal Use Of Herbal Medicines 
Yes-Herbal
Medicines Are Part
of Traditional
Background
No- Herbal
Medicines Are Not
Part of Traditional
Background
Figure 2-15 Participants Personal Use of Herbal Medicines and Traditional Heritage 
48 
Sukvinder Kaur Bhamra 
Question 7: How often do you use herbal medicines? 
This question adopts a modification of the Likert scale to determine the frequency of use of 
HMs. Initially, the questionnaire was designed with the options: very frequently, frequently, 
occasionally, rarely and never; however, after review these options were changed to daily, 
weekly, monthly, when required, and never, to better determine the use of HMs.  
Participants were asked how often they used HMs to determine how frequently they were 
used by the research sample (Figure 2-16). The majority of participants (48%, n=92) claimed 
to use herbal remedies ‘when required’. Remedies such as: cardamom pods for nausea, 
cloves for toothache, honey and lemon for coughs, and aloe vera for skin conditions were 
commonly used when required. 
The 26% of participants (n=50) 
who stated they used herbal 
remedies ‘daily’ mentioned 
taking substances such as 
cinnamon to lower cholesterol, 
ajwain for digestion, masala tea 
and turmeric milk for general 
health and wellbeing. Out of these 
50 participant who used herbal 
remedies daily just over half 
(56%, n=28) were elderly 
participants. The few participants 
(3%, n=5) who claimed to use 
herbal remedies ‘weekly’ made 
reference to not taking too much 
of various ingredients as they are 
garam so should only be 
consumed in moderation; karela 
for diabetes and some masalas were amongst those that should be consumed in moderation.  
Despite 66 participants claiming they did not use any HMs for themselves in the first 
question, only 44 participants said they ‘never’ used herbal remedies in this question. This 
implies the 22 participants who selected alternative options may have later realised that they 
did sometimes use HMs. This would suggest that more of the research participants do 
actually use HMs than first thought.  
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The following question was divided into two parts; the first section (a) asks participants to 
list any herbal remedies, products, or ingredients they know which have medicinal benefits; 
while the second section (b) focuses specifically on medicinal plants. 
 
Question 8A: List as many herbal remedies, products or ingredients you know of… 
The aim of this question was to explore participants’ knowledge of HMs. The first draft of 
the questionnaire asked participants to list ‘herbal remedies’ they knew of; however, after 
reviewing the feedback from the pilot study the terms ‘herbal remedies, products or 
ingredients’ were used to stimulate participants to think about different HMs they knew of. 
The refined wording in the question acted as a prompt which permitted for a wider range of 
responses, without influencing participants’ answers (Harris and Brown, 2010).   
Participants were asked to list as many products as they could think of which were good for 
their health or had medicinal values, even if they did not personally use them. The results 
exemplify a vast range of herbal remedies known and used by the research sample 
(Appendix 5). Figure 2-17 represents the number of items recalled by participants; this 
includes the individual ingredients which may be used to formulate a herbal remedy and 
commercial products. Only 7% (n=13) of the research population were unable to list any 
herbal products in this question. The mean (M) number of responses per participant was 
seven. The highest number of products recalled was by participant 16 who listed thirty 
products.  
The most popular product mentioned by 57% (n=109) of participants was turmeric. Other 
frequently mentioned items included: ginger, ajwain, fennel, cinnamon, garlic, aloe vera, 
clove, tulsi, black pepper, neem, and black seed. Various nuts (e.g. almonds and walnuts), 
teas (e.g. green tea, nettle tea, and masala tea), and oils (e.g. olive, mustard, eucalyptus, 
sesame, castor, sunflower, and fish oil), were also mentioned (Appendix 5).   
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Question 8B: What plants do you know that have medicinal benefits? 
Part B of the question asked participants to specifically name any plants which had 
medicinal benefits; Figure 2-18 represents the number of plants recalled by participants. The 
majority of participants (24%, n=46) recalled at least one medicinal plant (M = 2), the 
maximum number of plants listed by one participant was twelve. Aloe vera was the most 
frequently mentioned plant by 41% (n=80) of participants, followed by mint (28%, n=54) 
and tulsi (23%, n=44). Participants said they used aloe vera for skin conditions (e.g. eczema, 
itchy skin, burns, and skin irritation), diabetes, and arthritis. The gel contained in the fleshy 
leaves of the aloe vera plant has been associated with anti-inflammatory and wound healing 
effects which have been linked to the mannose-6-phosphate sugar component (Davis et al., 
1994). Other traditional uses of aloe vera include its use in treating tooth aches, aiding the 
recovery of mouth ulcers, stomach and duodenal ulcers, irritable bowel syndrome, and its 
immune boosting effects (Chevallier, 2007) 
Various fruits (e.g. amla, cranberry, dates, oranges, and figs), vegetables (e.g. broccoli, 
carrots, and karela), and herbs (e.g. basil, coriander, fenugreek, rosemary, and parsley) were 
documented. Other products such as ajwain, cannabis, cinnamon, chillies, curry leaves, 
dandelion, fennel, ginger, neem, nettles, rose, spinach, and turmeric were also cited by 
participants (Appendix 5). Despite having successfully named multiple herbal products in 
part A, 21% (n=30) of participants failed to name any plants with medicinal benefits in this 
section. This could have been because participants did not want to repeat themselves from 
part A as they had already listed numerous products; or because participants did not know of 
any medicinal plants, as suggested by participant 8 who listed nine herbal remedies in part A 
but said he could not name any plants. Some participants (2%, n=4) were able to recall more 
products when they were asked specifically about plants with medicinal benefits in 
comparison to section A of this question. The ways people use plants is dynamic (Heinrich et 
al., 2006); the range of plants recalled by participants illustrates that they had a considerable 
wealth of knowledge of medicinal plants (Appendix 5).  
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Question 9: Do you know any herbal remedies or products which can be used for the 
following conditions? 
In this question participants were presented with seven health conditions a mixture of minor 
and serious health problems (i.e. arthritis, cough, diabetes, headache, indigestion, itchy skin, 
and wounds) and asked to state any HMs they knew of which could be used to treat or 
manage the conditions. The rationale for selecting these conditions is because they are 
amongst some of the most popular health problems people seek treatment for in the UK 
(PAGB, 2009). Conditions such as cough, headache, indigestion and skin disorders are 
amongst the top ten ailments treated over the counter (OTC) and may be considered as minor 
health problems (PAGB, 2009; Pharmacy Research UK, 2014). Arthritis affects around 10 
million people in the UK (NHS, 2014). Research into arthritis and ethnic minority groups in 
the UK has found that some forms of arthritis appear to be more common and more severe in 
SA ethnic groups (Samanta et al., 1992; Samanta et al., 2005). It is estimated that 3.3 million 
people in the UK have diabetes (Diabetes UK, 2015); SAs in the UK are up to six times 
more likely to have diabetes than the Caucasian population (Khunti et al., 2009). These 
health problems can have a serious impact on peoples’ lives; despite this little is known 
about how the conditions are managed by SA populations (Khunti et al., 2009). By 
investigating participants knowledge of HMs used for these conditions a better 
understanding of alternative therapies used for these health problems can be assessed.   
The majority of participants (86%, n=165) were able to list treatments for one or more of the 
conditions (Figure 2-19); just 8% (n=15) of participants listed a remedy for each of the seven 
conditions. Of the total population surveyed, 14% (n=27) were unable to state herbal 
remedies for any of the conditions listed. Figure 2-19 represents whether or not participants 
stated a response for each of the health conditions. It is evident that more participants were 
able to recall remedies for conditions 
such as a cough (n=151), indigestion 
(n=127), and wounds (n=98) in 
comparison to arthritis (n=65), diabetes 
(n=68), and headache (n=63). As cough, 
indigestion, and skin conditions are 
amongst the top ten conditions treated 
OTC in the UK (PAGB, 2009); this 
could explain why more participants 
knew of HMs to treat them in 
comparison to the other conditions.   
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Figure 2-20 represents HMs stated by participants for each condition organised according to 
the age ranges - young, middle aged and older; it illustrates that for conditions such as itchy 
skin there was a similar number of responses from young, middle aged and older participants 
(n=25, 26, 26 respectively). For conditions such as cough and wounds there were more 
responses from younger participants than the other age groups. While, conditions such as 
arthritis and diabetes there were more responses from the middle aged and older participants 
in comparison to the younger participants. Although arthritis and diabetes can affect people 
of all ages (Arthritis Research UK, 2013a; Diabetes UK, 2015), middle aged and older 
participants appeared to have better knowledge of how to treat and manage them with HMs 
in comparison to younger participants.    
Ginger was mentioned for its use in arthritis (n=9); due to its anti-inflammatory action which 
can help with the pain and loss of mobility caused by the condition (Grzanna et al., 2005). 
The notion that ginger is garam and thus improves circulation was frequently documented. It 
could be eaten in its raw form, soaked in water over night and the liquid taken in the 
morning, infused in tea, or incorporated into daily meals. Ginger powder, tablets, beverages, 
and many other formulations are now readily available and there is a vast amount of 
literature which supports the medicinal claims associated with its use (Polunin and Robbins, 
1992; Pharmaceutical Press, 2013). Ali et al. (2008) say the anti-inflammatory effects of 
ginger have been known for centuries; although, evidence was only made available when 
research conducted identified the active components in ginger and claimed they worked like 
non-steroidal anti-inflammatory drugs (NSAIDs); moreover, ginger avoids the side-effects 
caused by NSAIDs. Ginger is known to contain a mixture of biologically active compounds 
which work in different ways to reduce inflammation; i.e. some compounds have an 
inhibitory effect on the production of inflammatory cytokines, while others inhibit the 
proliferation of inflammatory cells (Ali et al., 2008; Bartels et al., 2015). Fenugreek was 
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another popular remedy recommended for arthritis (n=10); the fresh or dried leaves could be 
incorporated in cooking or infused in tea, the seeds could be ground and blended with other 
herbs, or soaked overnight in water and drank the next morning. Massaging the affected 
joints with various oils was also recommended, including: black seed oil, flax seed oil, and 
garlic oil - made by infusing cloves of garlic in olive or mustard oil. There was a clear 
warning to avoid sour or acidic foods such as yoghurt, oranges, and lemons as they were 
believed to make the condition worse. Participant 62 claimed, ‘‘lemon is very bad for 
arthritis, anything acidic should be avoided.’’ However, there is no evidence to suggest 
cutting these substances out of the diet helps with arthritis; if anything they are an important 
source of nutrients so should be consumed as part of a balanced diet (Arthritis Research UK, 
2013b).  
For the treatment of coughs there were several common herbal remedies suggested; 50% 
(n=76) of participants listed honey as being useful to sooth a cough of which half (n=38) 
recommended taking it with lemon. While others suggested combining honey with black 
pepper, ginger, brandy, cinnamon, or turmeric. Honey is made up of a mixture of compounds 
which give it anti-inflammatory, anti-bacterial, and antioxidant effects which explain why it 
has been used in traditional medicine for coughs (Oduwole et al., 2014). Liquorish, mint, 
tulsi, fennel, black seed, banaksha, and salt water gargles were also listed as being used for a 
cough. Banaksha (Viola odorata L., sweet violet) has traditionally been used to treat cough, 
catarrh, fever, headache and pain, hence its popularity for relieving the symptoms of coughs 
and colds (Bhatia et al., 2014).    
For diabetes it was well known that there was no cure for the condition but blood glucose 
(BG) levels could be managed and kept in control by the consumption of HMs. Of the 68 
participants who listed a herbal remedy for diabetes, 56% (n=38) mentioned the 
hypoglycaemic properties of karela (Momordica charantia L.). Participant 107 claimed, 
‘‘karela is good for diabetes as bitter things can be used to counteract the sugar.’’ Fresh 
karelas are widely available in the UK and can be consumed as a curry, juiced, or soaked 
overnight in water. Various commercial karela formulations are also available, including: dry 
powder, concentrated juice, and tablets. There is an abundance of research conducted on the 
use of karela in diabetes around the world (Baxter, 2008; Pandey et al., 2011; Lone et al., 
2012). There are several proposed methods which can explain the hypoglycaemic effects of 
karela; it is believed to reduce glucose absorption, increase glucose uptake in liver cells, and 
improve insulin secretion (Jayasooriya et al., 2000). Fenugreek (Trigonella foenum-graecum 
L.) was mentioned by 16% (n=11) of participants who highlighted the anti-diabetic 
properties were best obtained by soaking the seeds in water over night, or consuming the 
leaves regularly as part of the diet. Studies have shown that fenugreek can stimulate glucose 
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uptake into cells and plays a part in activating the insulin secretion signalling pathway; thus, 
helping reduce BG levels and improving insulin response in diabetics (Vijaykumar et al., 
2005; Chevallier, 2007). Other products described by participants for diabetes included: tulsi 
infused in water or tea, turmeric with milk, ginger mixed with cinnamon and honey, honey to 
substitute other sugars, figs soaked in milk overnight, gram flour chapattis instead of wheat 
flour, okra as a curry or soaked in water over night, amla, cinnamon, chick peas, curry 
leaves, olives, grapefruit, and neem.  
Just 63 participants (33%) said they knew of HMs which could be used to treat a headache. 
The first response from many participants was often ‘paracetamol’ but participants were 
reminded that this research was focused on HMs, so these responses were disregarded. 
Herbal remedies to treat a headache included: massage the head with oil (olive, almond, 
coconut, or mustard oil), drink plenty of water, masala tea, mint tea, ginger tea, ginger 
infused in water, holy water, honey in hot water, ajwain seeds chewed or infused in water or 
tea, millet flour compress on forehead, menthol rubbed onto forehead, steam inhalation with 
menthol crystals, cloves warmed and the fumes released inhaled, and black pepper chewed 
or infused in tea. Participant 85 claimed, ‘‘you do not get headache if your digestion is ok.’’ 
This point was also highlighted by several other participants and an Ayurvedic practitioner 
(Dr. Pankanj Chansarkar, Kerala), who described the anatomy and explained the causes of a 
headache. Dr. Chansarkar was introduced to the researcher during a field trip to Kerala in 
April 2014, where he explained how according to Ayurveda the build-up of gasses (digestive 
impurities) in the alimentary canal feedback and signal pain receptors which are recognised 
as a headache. According to Dr. Chansarkar a headache is a sign that there is insufficient 
clearing of the digestive tract. He recommended a digestive aid (Triphala- a mixture of amla, 
beleric and harad) to help clear the gastro-intestinal tract in order to eliminate the headache.  
Ajwain is a bitter tasting, aromatic seed that is rich in essential oils which contain thymol.  It 
is commonly used in cooking to add flavour and has numerous health benefits; it is a popular 
digestive aid which can help with gastro-intestinal ailments (i.e. flatulence, diarrhoea, and 
indigestion) and provides anti-spasmodic, laxative, and pain relief effects (Bairwa et al., 
2012). It appears many of the research participants in this study who treated headaches with 
a digestive aid were aware of this traditional knowledge which is not well documented.  
Indigestion is a common ailment which causes a discomfort in the upper abdomen, often 
associated with a bloated sensation, nausea and excessive belching. It was uncovered that SA 
communities in this research used the term ‘gas’ to describe these symptoms. The 
pathophysiology is the same; participants had a clear understanding of what indigestion was 
and how to treat it. Indigestion may be experienced due to eating ‘heavy’ meals (large 
portions, high fat or fried foods), stress, medication, or because of poor metabolism. From 
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the results (Figure 2-19) it is clearly a condition many of the participants have knowledge of 
how to treat; 66% of participants (n=127) surveyed stated one or more herbal remedies to 
treat indigestion. Remedies including: ajwain, black salt, cardamom, fennel, lemon water, 
mint, milk, hing, and churan were recommended for treating indigestion. Churan (also 
known as churna) is a digestive powder composed of several ingredients including ginger, 
cumin, ajwain, rock salt, black pepper, fenugreek, hing, and fennel; although, different 
manufacturers may have their own recipes (Chaudhury and Rafei, 2001).  
There are a variety of commercial products available for itchy skin which are based on HMs. 
Most of the products recommended by participants for itchy skin were topical preparations 
such as the sap from the aloe vera plant rubbed onto the skin (mentioned  by 35% of 
respondents, n=27), oils (almond, coconut, mustard, and olive oil) and pastes (turmeric with 
yoghurt or olive oil, crushed garlic, onion juice, or a mixture of  honey and cinnamon). A 
large number of participants (40%, n=31) suggested using an oil to stop the itching as it 
would moisturise the skin and reduce the dryness, which makes the itch-scratch cycle worse 
(Yosipovitch and Hundley, 2004). Other remedies were formulated to be ingested to provide 
systemic relief from the itching such as: turmeric in milk several times a week, dried neem 
leaves mixed with honey to make small balls taken daily, neem leaves infused in warm water 
or tea.  
The final condition participants were asked to detail a herbal remedy for was wounds; 98 
participants (51%) stated a remedy they knew of which could be used for wounds. A 
considerable number of participants (77%, n=75) listed the benefits of turmeric for aiding 
wound healing. There were several methods of preparation and administration noted. Some 
participants claimed turmeric should be made in to a drink by warming with milk and 
drinking it every night; some recommended adding black pepper, clarified butter (ghee) or 
olive oil. While others preferred to use a topical formulation to give a local effect by making 
a paste with oil (e.g. olive oil or mustard oil), ghee, or water. The medicinal value of 
turmeric is undergoing extensive investigation. It has antimicrobial and anti-inflammatory 
action which may explain its traditional use in wound healing. The antimicrobial function 
prevents bacterial proliferation when the skins defences have been breached; while the anti-
inflammatory action will help the wound heal quicker (Colalto, 2010). Various other topical 
and internal preparations were also recommended for wounds including: the use of neem, 
honey, aloe vera and some even suggested rubbing salt directly into a wound to stop it 
bleeding.  
 
A list of the herbal remedies documented by participants can be found in Appendix 5. 
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Participants’ Knowledge of Herbal Medicines  
Participants’ knowledge of HMs was measured by calculating the total number of ‘items’ 
recalled; this included any ingredients, products or remedies participants mentioned 
throughout the entire survey. Each response was given a value of one and this was added up 
to give the total number of items recalled, if an item was mentioned several times it was only 
counted once. 
Figure 2-21 illustrates the total number of items recalled increased as more questions were 
asked in comparison to Figure 2-17, which just looked at participants responses from 
question 8A. The proportion of participants who did not state any herbal products reduced 
from 7% (n=13) to 5% (n=10); while, those who recalled twenty or more items increased 
from 3% (n= 6) to 10% (n=19). The reason for an increased number of items recalled could 
be due to the prompts given, i.e. asking participants’ to identify medicinal plants or products 
for specific health conditions (Harris and Brown, 2010); or even because participants had 
more time to think about herbal remedies as the questionnaire progressed. Question eight 
alone would not be sufficient to judge the participants knowledge of HMs; but, by having 
additional sections and questions a better indication of knowledge can be assessed.   
The results demonstrate that there was a great wealth of knowledge of HMs amongst the 
research sample. There are various parametric techniques which can be used to explore the 
relationships between variables in this data. For example, a t-test can be used when there are 
two defined groups in a variable; i.e. it can be used to explore the relationship between the 
difference in knowledge across male and female participants. While analysis of variance 
(ANOVA) techniques can be employed when there are two or more groups within a variable; 
i.e. to determine the difference in knowledge across the different age groups (Pallant, 2007).  
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Independent sample t-test 
An independent sample t-test can be used to determine if there is a statistically significant 
difference between two variables. It can be used to explore the differences in the mean 
number of responses between male and female respondents. Table 2-3 identifies the number 
of male and female participants (N), and summarises the mean (M) number of items recalled 
for each group, along with the standard deviation (SD). The mean number of responses per 
female participant was 11 (SD = 7.01), and for male participants M = 7 (SD = 6.18). From 
this it can be concluded that the male participants recalled fewer items but there was less 
variance in their results.  
Table 2-3 T-test Group Statistics 
Gender N Mean number or responses Standard Deviation 
Male 60 7 6.18 
Female 132 11 7.01 
 
 Table 2-4 Independent Samples T-test  
The first part of Table 2-4 indicates the ‘Levene's Test for Equality of Variances’ which tests 
whether the variation for the two groups is the same. If the significance probability (Sig) 
value (P) is greater than 0.05 then results from ‘equal variances assumed’ should be used; 
whereas a lower Sig value indicates results from ‘equal variances not assumed’ should be 
used. In this instance the Sig value is 0.131, as this is larger than the standard of 0.05, equal 
variances can be assumed (Pallant, 2007). The Sig. (2-tailed) result is then used to see if 
there is a significant difference between the two groups (i.e. male and female participants), if 
this value is equal to or less than 0.05 it suggests there is a significant difference between the 
means of the two genders, whereas a higher value would suggest there is no significant 
difference. Table 2-4 shows that the Sig (2-tailed) value p = 0.001, this is lower than the 
Independent Samples Test 
 
Levene's Test 
for Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. (2-
tailed) 
Mean 
Difference 
Standard 
Error 
Difference 
95% 
Confidence 
Interval of the 
Difference 
Lower Upper 
Equal 
variances 
assumed 
2.297 0.131 
3.386 190 0.001 3.565 1.053 1.488 5.642 
Equal 
variances not 
assumed 
3.550 128 0.001 3.565 1.004 1.578 5.552 
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standard 0.05; therefore, this indicates there is a significant difference between the mean 
number of items recalled by male and female participants (Pallant, 2007; Petrovics, 2012).   
Effect size statistics can then be used to provide an insight into the strength of the association 
to show that the results have not just occurred due to chance, as well as highlighting the 
statistical significance (Pallant, 2007; Petrovics, 2012). Eta squared is one way of calculating 
the effect size statistic. The eta squared value can range from 0 to 1 and can be interpreted in 
the following way: 0.01 is a small effect, 0.06 is a moderate effect, and 0.14 is a large effect 
(Cohen, 1988). The following formula is used to calculate eta squared: 
Eta squared  =  ________t2_______             
    t2 + (N12 + N2 - 2) 
 
Eta squared  =  ________3.3862_______             
    3.3862 + (60 + 132 - 2)  = 0.06 
The eta squared value of 0.06 suggests there is a moderate association, that this is a 
significant finding and not just because of chance. In summary, the results from of the t-test 
and eta square confirm there is a difference in knowledge between the two genders; female 
participants had more knowledge of HMs in comparison to male participants. This is 
supported by the Mintel Report (2009), which claims women have more knowledge of HMs, 
thus they use them more than men. Furthermore, Ernst (2000) also states that women of all 
ages use HMs more frequently than men. Male participants in this investigation claimed they 
did not take any HMs for their health (in question 1), but later revealed they did take HMs 
given to them by their grandparents, mother or wife (question 6). This supports the nurturing 
role females have been associated with throughout history (Ehrenreich and English, 1973; 
Hegg, 2013). The traditional role for SA women was as the house keeper; which involved 
cooking and looking after their husband and children once they started their own families 
(Samanta, 1999; Chaudhury and Rafei, 2001). As women were the ones who have 
traditionally been the main cooks in the home they were best equipped with the knowledge 
of how to use food as medicines (Jennings, 2014). This nursing and caring role women have 
been traditionally associated with is evidently still common amongst SA communities in the 
UK; where female participants appear to have more knowledge of HMs than males.  
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Analysis of Variance  
An Analysis of Variance (ANOVA) tests the hypothesis that the means of two or more 
variables are equal (Minitab Inc, 2014). It compares the variance between the groups, 
enabling conclusions to be made regarding variations among results (Pallant, 2007). A one-
way ANOVA can be used to compare the variance between groups in an independent 
variable; for example; how knowledge (dependent variable) varies with age (independent 
variable). The Null hypothesis would be that knowledge is equal despite age; while the 
Alternative hypothesis would be that there is a difference in knowledge between the age 
groups. Table 2-5 summarises the mean number of responses given by each age group, with 
the standard deviation, standard error, and 95% confidence intervals for the mean.  
 
Table 2-5 ANOVA Summary of Participants Age and Mean Number of Herbal Medicines Recalled  
Age N Mean 
Standard 
Deviation 
Standard 
Error 
95% Confidence Interval 
for Mean 
Lower 
Bound 
Upper 
Bound 
20 or under 43 6 6.121 0.933 4.77 8.54 
21 - 30 years 47 8 5.207 0.760 6.88 9.93 
31 - 40 years 10 12 5.633 1.781 8.77 16.83 
41 - 50 years 12 13 11.156 3.220 6.50 20.67 
51 - 60 years 21 13 7.423 1.620 9.62 16.38 
61 years + 59 12 6.346 0.826 10.55 13.86 
Total 192 10 6.945 0.501 9.25 11.22 
Table 2-5 identifies that the mean number of responses increases with age. A potential 
reason for the slightly lower mean for the 61+ age group is because during data collection it 
was noted that some of the older participants were reluctant to share their knowledge or take 
HMs at the same time as taking Western medicines. As reflected by participant 125, ‘I do not 
want to tell anyone about any herbal remedies as if something goes wrong people will blame 
me. I have so much knowledge about herbal remedies but I am scared to share it, in this 
country people do not want to know!’ In addition, many of the participants in the 61+ age 
group took prescription medicines for various health conditions such as diabetes and 
cardiovascular disease, and commented on how they had stopped using HMs. This was 
mentioned by several participants including participant 112 who claimed, ‘I do not take any 
herbal remedies, I only take the doctors medicines because I have to,’ and participant 115 
who said, ‘‘I do not really use much herbal remedies now, I just take my prescription 
medicines.’’  
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Table 2-6 ANOVA Summary of Variance between Participants Age and Number of Responses  
 
Sum of 
Squares 
Degrees of 
freedom 
Mean Square F Sig. 
Between Groups 1299.291 5 259.858 
6.108 0.00003 Within Groups 7913.163 186 42.544 
Total 9212.453 191 - 
 
Table 2-6 represents the results of the ANOVA test which shows the sum of squares, which 
is a measure of variation or deviation from the mean, and degrees of freedom (Minitab Inc, 
2014). If the Sig value is less than or equal to 0.05 there is a significant difference among the 
mean scores of the dependent variable. The sig value indicated in Table 2-6 is 0.00003; 
consequently this shows there is a significant difference in the mean results.  
The F test represents the variance between the groups divided by the variance within each 
group. A significant F ratio would suggest there is more variability between the groups, due 
to the independent variable (i.e. the total knowledge) than there is within the group. If the F 
value is around 1 we can assume the null hypothesis is correct (Pallant, 2007). Table 2-6 
identified that the F value is 6.108 thus the null hypothesis, that there are no significant 
differences in number of responses between the different age groups, needs to be rejected; 
while, the Alternative hypothesis, that there is a difference in knowledge between the age 
groups, can be accepted. 
To calculate the effect size the following formula can be used: 
Eta squared = Sum of squares between groups    = 1299.291 
        Total sum of squares  9212.453      = 0.14 
The one-way between-groups ANOVA was conducted to explore the impact of age on total 
knowledge (i.e. the number of herbal remedies participants recalled). The results show there 
was a statistically significant difference as p < 0.05 and F test results show: p = 0.0003, F = 
6.108. The effect size calculated using Eta squared, was 0.14 indicating a large effect; 
reinforcing a statistically significant result, that knowledge was different across the various 
age groups (Pallant, 2007). The results of the ANOVA test suggest there is a difference in 
knowledge of HMs amongst the different age groups. Although, the knowledge of HMs is 
transmitted to younger SA generations in the UK, as exemplified by their responses 
throughout this investigation, the older participants still had more knowledge of HMs. This is 
supported by Pieroni et al. (2010) who also found that middle-aged and older Bangladeshi 
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participants in their research had better knowledge of traditional HMs than younger 
participants.  
2.6.3 The Use of Prescription Medication  
This section of the questionnaire set out to investigate whether or not participants took 
prescribed CWM alongside HMs. Participants were asked what CWM they were prescribed 
by their doctor, nurse, pharmacist or other HCPs, to explore the safety of consuming HMs, 
and the potential interactions between HMs and CWM. Participants were asked whether or 
not they shared information about their use of HMs with their HCPs, to gain insight into the 
relationship between SA patients and their HCPs. In addition, the side-effects reported from 
CWM and HMs were compared.  
 
Question 10 A: Do you take any regular prescribed medicines? 
   10 B: If Yes, and you are happy to say please state what medicines you take. 
All of the research participants (n=192) were asked whether or not they took any regular 
prescribed medicines; of which more than half of the population (55%, n=106) stated they 
did. This included the treatment for a range of health problems including: pain relief, asthma, 
diabetes, cardiovascular disease, topical treatments for skin conditions, and vitamins to 
supplement deficiencies (Table 2-7). The 45% (n=86) of participants who said they did not 
take any prescription medication were asked to move on to question 13 as the following 
questions were specifically for those who did take prescription medication. 
The following questions in this section represent the responses for 106 participants who took 
prescription medication. 
Figure 2-22 illustrates the age profile of participants who took regular prescribed medication; 
it identifies that more than half (n=57) of the 106 participants who took prescribed 
medication were in the 61 years plus 
age group. Despite this, participants 
from all of the other age groups also 
took prescription medicines. 
Participants were asked to list their 
medication, if they did not want to 
disclose this information they were 
asked to move on to the next question. 
Some of the older participants or 
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13%
5%
4%
14%
54%
Age of Participants Who Took 
Prescription Medication 
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Figure 2-22 Age Profile of Participants Who Took Regular 
Prescribed Medication 
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those who did not speak fluent English, could not name the specific medicines, but knew the 
conditions they were being treated for. Table 2-7 summarises the medical conditions and 
medicines listed by participants. The results revealed that participants were taking 
medication for a vast range of health conditions; the most common conditions mentioned 
were hypertension (n=47), diabetes (n=36), and high cholesterol (n=25). Other common 
health problems included thyroid disorders, asthma, and allergies. The types of CWM taken 
can be categorised by age groups; medicines such as the contraceptive pill, acne treatments, 
and iron supplements were common in younger females (aged less than 20 to 30 years). The 
few young males who said they took regular prescribed medication used inhalers for asthma. 
Medicines for arthritis, hypertension, diabetes, and other chronic conditions were generally 
mentioned by the latter half of the middle aged group (51-60 years) and elderly age group 
(61 years plus). Vitamins, topical preparations for skin conditions, thyroid disorder 
medication, and asthma treatments were mentioned by both genders and all age ranges.  
Table 2-7 Summary of Prescription Medicines Taken by Participants 
Medical Conditions: Conventional Western Medicines Taken: 
Cardiovascular disorders 
e.g. Angina, 
Hypertension, & 
Hypercholesterolemia 
Aspirin, Clopidogrel, Warfarin, 
Furosemide, Spironolactone,  
Amlodipine, Felodipine, Bendroflumethiazide, Ramapril, 
Losartan, Telmisartan, Atenolol, Bisoprolol, Propranolol, 
Atorvastatin, Simvastatin, Rosuvastatin, Ezetimibe. 
Diabetes 
Metformin, Gliclazide, Pioglitazone,  
Insulin injections, Byetta injection.  
Epilepsy Keppra – Lamotrigine.  
Gastro-intestinal disorders Lansoprazole, Omeprazole, Mebeverine, Senna.  
Pain relief 
Paracetamol, Gabapentin, Codeine, Co-dydramol, 
Morphine,  
Ibuprofen, Naproxen. 
Pulmonary disorders 
e.g. Asthma & 
emphysema 
Steroid inhalers (seretide and clenil), Salbutamol, 
Tiotropium, Montelukast tablets. 
Anti-depressants 
& mood stabilisers 
Amitriptyline, Citalopram, Fluoxetine, Mirtazipine, 
Venlaflaxine. 
Skin conditions Duac acne gel, Creams for eczema (steroid and emollients). 
Thyroid disorders Carbimazole, Levothyroxine (thyroxine). 
Miscellaneous  
Anti-histamines (Cetirizine, Loratadine), Contraceptive 
pills, Methotrexate, Pyridoxamine, Quinine, Vitamins, 
Folic acid. 
 
The simultaneous use of HMs and CWM can have serious consequences; by asking 
participants what HMs and prescription medicines they took, the information could be used 
to identify any potential interactions. At the time of conducting the surveys the researcher 
63 
Sukvinder Kaur Bhamra 
did not intend on identifying interactions and making participants aware; there was a 
disclaimer to inform participants to speak to their HCPs if they had any queries about their 
medication, which the DMU ethics committee advised the researcher to include. By looking 
at the list of CWM and HMs participants consumed, a range of adverse effects and potential 
interactions can be identified.  
Fugh-Berman (2000) says, ‘‘concurrent use of herbs may mimic, magnify, or oppose the 
effect of drugs.’’ Williamson et al. (2013) identifies an interaction when the effect of a drug 
is changed by the presence of another substance; this includes herbal medicines and food. 
HMs can alter the drugs pharmacokinetics by affecting the drugs absorption, distribution, 
metabolism and elimination. Cytochrome (CYP) P450 are a group of enzymes which 
metabolise a variety of substrates and have an important role in drug metabolism; the rate of 
enzyme activity can be affected by numerous herbal products. Some products may increase 
the rate of metabolism (enzyme inducers), rendering the drug ineffective at sub-therapeutic 
levels if metabolised too fast; alternatively if the drug is metabolised slower than anticipated, 
it can accumulate and cause toxicity. Tovar and Petzel (2009) claim, ‘‘Garlic is safe when 
used in dietary amounts’’; however, consumption at higher doses and stronger 
concentrations for medicinal purposes may be associated with underlying risks especially if 
used simultaneously with other drugs. Garlic has an enzyme inducing effect; therefore, it can 
reduce the effectiveness of drugs metabolised by CYP 3A4 (Spurgeon, 2000; Foster et al., 
2001). Ponnusankar et al. (2011) investigated the effects of Triphala, a popular Ayurvedic 
mixture with multiple health benefits, on the CYP 450 enzyme; they found the three 
components of Triphala (amla, beleric and harad) caused inhibition of the enzyme; thus, 
reducing drug metabolism.  
Other interactions can be caused by HMs if they affect the drugs pharmacodynamics by 
imitating or inhibiting a drugs mode of action (Chavez et al., 2006). One of the most 
frequently mentioned herbal ingredients was ginger, cited 179 times during the surveys. Its 
use as an anti-emetic, digestive aid, anti-inflammatory, analgesic, and for coughs and colds 
was commonly identified by participants. Ginger can have hypoglycaemic effects; hence, if 
consumed with other anti-diabetic medicines the risks associated with low blood glucose 
(BG) levels may be fatal (Newall et al., 1996). Fenugreek, karela, garlic, turmeric, tulsi and 
aloe vera were also identified by participants as being used in diabetes to lower BG. 
Researchers who have explored the hypoglycaemic properties of fenugreek have found it to 
be a very powerful anti-diabetic agent due to the actives: gonelline, nicotinic acid and 
coumarin found in the defatted portion of the seed (Pandey et al., 2011). A significant 
reduction in BG levels caused by taking HMs could lead to poor diabetic control, 
interactions with medication, and serious health risks for the patient (Sethi et al., 2004).  
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Cloves have been traditionally used as digestive aids and for toothache, due to their 
carminative and analgesic effects. With a high eugonel content, which inhibits platelet 
aggregation, interactions between conventional anti-platelets (aspirin and clopidogrel) and 
anti-coagulants (warfarin) have been identified (Pharmaceutical Press, 2013). This is also 
true for many other herbals including:  garlic, ginger, hing, fenugreek and turmeric which 
can increase blood clotting time (Newall et al., 1996; Spurgeon, 2000). People are at an 
increased risk of haemorrhage due to the dual blood thinning effect of combining CWM with 
HMs (Heck et al., 2005).  
Liquorice was often used by participants to treat coughs and upper respiratory tract 
congestion. Large quantities and long term ingestion has been associated with hypokalaemia 
and hypertension (Lin et al., 2003; Chevallier, 2007). Due to its stimulant and fluid retention 
properties liquorice has been known to increase blood pressure, rendering anti-hypertensive 
medicines less effective (Williamson et al., 2013).  If taken with prescription diuretics (e.g. 
Bendroflumethiazide or Furosemide), which are known to be associated with hypokalaemia, 
potassium levels may fall below optimum levels. Hypokalaemia is usually asymptomatic so 
people may not be aware of the consequences; however, sometimes it may present as 
symptoms of weakness, muscle cramp, constipation and palpitations (Lederer and Batuman, 
2014). Without the correct knowledge, this may not be identified or treated appropriately.  
The incidence of interaction with CWM and HMs is not fully known; Williamson et al. 
(2013) highlight that despite this many HCPs openly admit they lack knowledge in this area. 
The insufficient reporting of interactions and adverse effects may be due to inadequate 
training or a lack of knowledge of how to report them. Interactions between HMs and CWM 
may exist; but, if people do not tell their doctors and pharmacists they will not be able to 
intervene. Alternatively, people may not be aware there is an interaction or adverse effect as 
they do not always present with symptoms.  
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Question 11: Do you tell your (a) doctor and (b) pharmacist what herbal remedies you 
use?  
Figure 2-23 illustrates the responses of whether or not the participants who took regular 
prescribed medication told their doctor and/or pharmacist about their use of HMs. Of the 106 
participants who did take regular prescribed medication, 13% of participants (n=14) did not 
consume any HMs, so they answered ‘not applicable’. Just 18% of participants (n=19) said 
they did tell their doctor, and only 5% (n=5) told their pharmacist about herbal remedies they 
took alongside their prescription medicines. A significant proportion of participants (69%, 
n=73) revealed they did not tell their doctor and even more (82%, n=87) declared they did 
not tell their pharmacist. Similar findings were illustrated by a study conducted by Bhopal 
(1986a), who found participants did not tell their doctor about herbal remedies as they felt it 
was a separate matter. Results from the Ipsos MORI report (2008) revealed that 20% of 
respondents in their survey did not think there was any need to inform their general 
practitioner (GP) about HMs they used; while 56% felt it was important to tell their GP. 
Table 2-8 summarises the reasons why participants in this study did not tell their doctor or 
pharmacist about their use of HMs. 
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Table 2-8 Participants Reasons for Not Telling Healthcare Professionals about Their Personal Use of 
Herbal Medicines 
Participant 
Number:  
Reasons For Not Telling Healthcare Professionals About Personal 
Use of Herbal Medicines:  
67 
‘‘I do not tell the doctor about herbal medicines as doctors do not 
believe you if you tell them they are good.’’ 
73 
‘‘I do not tell the doctor or pharmacist about herbal remedies as the 
doctor says why are you coming to us if you want to try different 
medicines.’’ 
77 
‘‘I do not tell the doctor about herbal remedies taken as he is not 
bothered.’’ 
105 ‘‘My doctor has said she would not advise mixing herbal medicines.’’ 
109 ‘‘I do not tell my pharmacist as I never see one.’’ 
111 
“I do not tell the GP about herbal medicines I take as he might say do 
not take it.” 
113 
‘‘The doctors do not believe in herbal remedies so why should I tell them 
what I use!’’ 
117 
‘‘Doctor refuses the use of herbal medicines and says do not take them 
without our guidance.’’ 
124 ‘‘Too scared to tell the doctor about any herbal medicines taken.’’ 
138 
‘‘I rarely get to see my GP and do not ever see or speak to a pharmacist 
when I go to collect my medicines.’’ 
156 
‘‘I do not tell my doctor or pharmacist about herbal medicines used as 
they do not recommend it.’’ 
Several crucial reasons for not telling the doctor or pharmacist about personal use of HMs 
were identified. From the participants’ responses (Table 2-8) it appears that participants 
thought HCPs lacked interest in HMs and were not concerned if they were consumed, as 
stated by participants 67, 77, and 113. If HCPs are not interested in their patients’ use of 
HMs, then patients will feel reluctant to share this information with them (Staines, 2011). 
HCPs need to be broad-minded and approachable so that patients feel comfortable talking to 
them about their use of HMs (Newall et al., 1996; Vickers, 2000). Participants in this study 
claimed they would be advised to stop using HMs if they told their HCPs, as exemplified by 
the comments from participants 73, 117, and 156. An example of how taking HMs can affect 
patients’ compliance with CWM and why HCPs may tell patients not to take HMs was 
demonstrated by Vohra (2015) who detailed the conversation between a pharmacist and a SA 
patient during a Medicines Use Review (MUR). During the MUR the patient explained to 
the pharmacist that he wanted to stop taking his antidepressant as he was taking a traditional 
Ayurvedic remedy instead; the pharmacist said, ‘Conventional medicine has been clinically 
trialled and is proven to be effective; Ayurvedic preparations are unstandardised and have 
not gone through rigorous patient trials. They also have the potential to interact and 
potentially reduce the effectiveness of prescribed medicines.’’ There are several reasons why 
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HCPs may tell their patients to stop taking HMs including: the risk of herb-drug interactions, 
adverse effects, reduced compliance with conventional therapy if patients take HMs, and 
most importantly the lack of scientific evidence to support the safety and efficacy of HMs 
(Fugh-Berman and Ernst, 2001; Edwards et al., 2012); this concept has been explored further 
in chapter 3.   
Evidently there was a fear of telling HCPs about HMs consumed as they may be regarded as 
inferior to CWM; as exemplified by participant 124 who said she was, ‘‘Too scared to tell 
the doctor about any herbal medicines taken.’’ Also participant 39 claimed, “My son is a 
doctor and will not let me take anything herbal, as he says they are all rubbish, even if I 
know it is good for me.” Dash and Kashyap (1980) documented that traditional medicine was 
considered to be substandard in comparison to Western medicine. Participants in this study 
revealed their anxiety of being treated differently or not treated at all if they exposed their 
use of HMs to their HCPs. While conducting the questionnaire with participant 2 she said, 
“The doctor might refuse my treatment if he knew I was taking herbal medicines!” Similarly 
participant 73 said, “The doctor says why are you coming to us if you want to try different 
medicines.” Language and cultural barriers which prevented participants from sharing 
information about their use of HMs with the HCPs were also identified by participants. 
Participant 122 was diagnosed with end stage liver cancer, and she revealed how the terrible 
effects of chemotherapy were relieved by the consumption of HMs, but she did not tell her 
consultants as she could not speak any English. Some concepts may be difficult to explain to 
Western HCPs; for example, there is no translation for bhye in English and so it is very 
difficult to explain this condition to Western HCPs. In turn, this may make people feel like 
HCPs do not understand their healthcare requirements. This was also reported by participants 
in the study conducted by Pieroni et al. (2010), which revealed that communication problems 
between Bangladeshis and HCPs in the UK prevented patients from using CWM 
appropriately. 
An interesting point raised by participants 109 and 138 was that they hardly saw their doctor 
or pharmacist and that is why they did not tell them about their use of HMs; they went on to 
say if they did see their HCPs, they would mention it. Participants mentioned that they got 
their prescriptions delivered so did not have any contact with their doctor or pharmacist. The 
increased popularity of repeat prescription services which are designed to save time for the 
patient, doctors surgeries, and pharmacies may not be entirely beneficial to patients if it 
means they do not get to see their HCPs. Ultimately, healthcare is a complex issue especially 
when combining different cultures and traditions. The results from this question have 
provided clear examples of why people do not tell their HCPs about the simultaneous use of 
HMs with CWM. Newall et al., (1996) claim that HMs are becoming more popular and 
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therefore HCPs should be aware of  alternative therapies; in addition, patients should feel 
comfortable speaking to their HCPs about their use of HMs without feeling like they are 
being judged.   
 
Question 12 A: Do you notice any unwanted effects from your prescription medicines? 
   12 B: If Yes, what do you normally do to relieve the symptoms? 
From the 106 participants who took prescription medication, 43% (n=46) disclosed they had 
experienced unwanted effects from their medicines (Figure 2-24). Participant 85 claimed, 
‘‘Doctors tablets always give me side-effects.’’ This was supported by participant 87 who 
said, ‘‘When you take Western medicines expect more side-effects and tablets to follow.’’ 
Effects such as nausea, diarrhoea, indigestion, cramp, insomnia and back pain were reported 
by participants; more serious problems such as diabetes and hypertension induced by 
medication were also noted (Table 2-9). For the relief of the side-effects the majority of 
participants (54%, n=57) revealed they would go back to see their doctor. Participant 29 
stated, ‘‘For side-effects from a tablet the doctor just gives another tablet.’’ 31% (n=33) of 
participants who experienced unwanted effects said they would do nothing, while 15% 
(n=16) would try a herbal remedy. There was some mention of CWM being ‘garam’ thus 
causing many of the side-effects associated. 
Participants were asked if they experienced any unwanted effects from their prescription 
medicines to compare the results to a previous question which asked if they experienced any 
unwanted effects from the consumption of HMs. Figure 2-24 shows a higher proportion of 
participants said they experienced side-effects from CWM (43%, n=46), than from HMs 
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(13%, n=16). A survey by Abbot et al. (1996) on users of HMs found that just 8% (n=32) of 
participants said they experienced adverse effects, and none of the effects were serious. 
Similarly the participants in this study who said they experienced unwanted effected from 
HMs, most of the effects reported were minor (Question 4, Table 2-2). In contrast, more 
serious side-effects caused by CWM were noted, such as: palpitations, cramps, nerve 
damage, and thiazide induced hyperglycaemia leading to diabetes (Table 2-9). Some of the 
side-effects reported for HMs and CWM were similar, both were associated with the concept 
of being ‘garam’ (i.e. warming the blood and acting as a stimulant); consequently, side-
effects such as indigestion and nose bleeds were reported. Generally, fewer side-effects were 
reported by participants taking HMs; the belief that HMs are natural and safe, so do not have 
any side-effects was noted by participants including participant 85 who claimed, ‘‘Herbal 
medicines have less side effects and are safer’’ similar views have been documented in 
numerous other studies too (Ipsos MORI, 2008; Mintel, 2009; Ravindran et al., 2009).  
Table 2-9 Side Effects from Prescription Medicines 
Participant 
Number: 
Side-effects Reported: 
2 Bendroflumethiazide induced diabetes (told by diabetic nurse she should 
not have been taking it as it can induce diabetes if you’re already at high 
risk). 
Paracetamol causes itching.  
23 Tablets caused constipation, went back to the GP who gave senna.  
32 Simvastatin stopped was causing cramps, headache, insomnia and back 
pain. 
40 Bloated.  
41 Diagnosed with high blood pressure after taking naproxen long term.  
54 Weight gain caused by medication.  
71 “If I get any side-effects from doctors’ medicines I just do not take them 
for a while, Son is a Doctor so makes sure its ok to stop medicines.”  
85 Side effects with tablets doctor gives (metformin for diabetes), so has 
had doses reduced from one to half a tablet twice daily. Did try and stop 
taking the tablets but nurse said tablets must be taken for diabetes. 
87 “Supposed to be on fifteen tablets daily, for high blood pressure and 
diabetes but so many side-effects I have stopped them all and feel much 
better. When you take Western medicines expect more side-effects and 
tablets to follow.” 
100 Nausea from taking contraceptive pill. 
111 Got diarrhoea from her medicines, went back to the GP who changed the 
tablet for an alternative.  
124 Bad reaction to diclofenac, had to go back to see the doctor. 
130 Palpitations caused by medicines. 
144 Unpleasant stomach ache from the contraceptive pill so went back to GP 
who gave an alternative pill, still has the stomach ache but not been back 
again.  
153 Hair was falling out with salbutamol inhalers so went to GP who gave a 
different inhaler.  
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CWM have a substantial amount of clinical data and evidence to support their use. All the 
side-effects experienced during and after clinical trials are reported (pharmacovigilance); 
consequently warnings are issued in a patient information leaflet, so patients are aware of 
side-effects associated with their medication. On the other hand, it could be argued that 
because HMs do not have the same level of clinical evidence to support their use, their side-
effects are not recorded and therefore not as well known. This research has documented 
some of the side-effects associated with the consumption of HMs, and defined concepts such 
as ‘garam’ and ‘bhye’ which may help people recognise and identify adverse effects from 
HMs. 
In summary of this section about the use of HMs alongside CWM, it can be noted that 
people will try a variety of remedies (traditional, conventional, or both) to supplement, 
maintain, and treat their health. There are barriers which prevent people from talking to 
HCPs about their use of HMs; for example, language and cultural differences which make 
explaining traditional concepts to Western HCPs difficult. Such issues need to be addressed 
to improve relationships between the ethnically diverse population and HCPs. The lack of 
HCPs’ knowledge and understanding of HMs could be tackled by providing more training 
and raising awareness of the issues identified (Newall et al., 1996). There is a clear 
difference in the incidence of side-effects between HMs and CWM; whereby HMs have 
fewer and less serious side-effects in comparison to CWM. The results from this analysis 
have given an insight into some of the potential adverse effects and risks of taking HMs and 
CWM together. Valuable research like this could help raise awareness of the issues 
identified and promote the safe and effective use of both HMs and CWM.   
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The following section contains results from all 192 participants surveyed. 
2.6.4 Treatment of Minor Health Problems  
Minor ailments are considered to be conditions such as allergies, coughs, colds, backache, 
toothache, headaches and migraines, indigestion, and skin problems; in most cases people 
manage these conditions through self-care using over-the-counter (OTC) products (PAGB, 
2009). The treatment of minor ailments is costing the NHS £2 billion per year (PAGB, 
2009); hence, Government initiatives to promote self-care for minor health problems are 
encouraging people to manage their own health (Local Government Association, 2013). The 
use of HMs is becoming more popular for minor and even more serious health problems, but 
the extent of which HMs are used to treat minor ailments remains unknown (Newall et al., 
1996; Barnes, 2003). The final section of the questionnaire was designed to gain insight into 
how SA populations in the UK are managing their minor ailments, and to see where 
participants go for advice. Moreover, it was an opportunity to explore participants overall 
opinions on the efficacy of HMs in comparison to CWM.  
 
Question 13: Do you use herbal remedies for minor health problems before seeking 
medical help?   
Participants were asked if they used herbal remedies before seeking medical help for minor 
health problems such as a cold or headache. A substantially large proportion of the research 
population (72%, n=139) claimed they did, while just 28% (n=52) said they did not. The first 
question of the survey began by asking whether or not any homemade herbal remedies were 
used to supplement participants’ health, to which 66% (n=126) of participants said ‘yes’. 
Question 13 is structured slightly differently but shows more participants claimed to use 
herbal remedies by the end of the survey. This could be because as the questionnaire 
progressed it reminded participants of HMs they were familiar with. Consequently, when 
asked the question of whether or not they used herbal remedies for minor health problems 
more people said yes by the end of the survey.  
Participants were then asked what they would do in the event of a minor illness and who they 
would seek advice from. A ranking order style of question was used for question 14 and 15 
to determine in which order participants would take what action. This was to allow 
participants to decide which action was most appropriate for them.  
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Question 14: In which order would you consider the following treatments for a minor 
illness: 
Participants were asked what they would do for a minor illness such as a sore throat or 
headache, they were given four options: not consider taking any treatment, self-medication 
using herbal products, self-medication using over the counter (OTC) products from the 
pharmacy, or consult their doctor for advice and medication. They were then asked to rank 
the options one to four in the order they would consider the actions (i.e. one being the first 
option and four the last). Figure 2-25 demonstrates the ranking of each of the options by the 
different age groups. The first choice for 44% (n=84) of participants was to self-medicate 
using HMs; this was the most popular first choice for many of the elderly respondents (n=37) 
who may have more experience and trust in HMs. Similar work conducted by Bhopal 
(1986a) found participants were more likely to take ‘Asian’ herbal remedies than CWM for 
conditions such as abdominal discomfort, diarrhoea, toothache and earache. Likewise, 
research by Sandhu and Heinrich (2005) which looked at the use of Sikh HMs uncovered 
38% (n=32) of their participants said the first option for treating a minor illness for was by 
self-medicating with HMs. Other options considered first for minor ailments in this research 
included: not taking any treatment by 39% (n=75) of participants, followed by 8% (n=15) 
who would go to the pharmacy for an OTC product, and 9% (n=17) who would see their 
doctor.  
Participants who said they would not take any treatment for a minor illness (as the first 
option) commented on the nature of the condition; stating that if it was a minor ailment it 
would resolve itself without the need for treatment. The Mintel Report (2009) also found that 
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‘a do nothing’ approach was prominent in the UK, where “six in ten adults would wait for 
the ailment to run its course” rather than taking any treatment or seeking advice. It should 
also be noted that the elderly research population in this study were the least likely to leave a 
minor illness without being treated. Often the older participants were taking several 
prescription medicines for various long term health problems so preferred to seek medical 
help from their doctor, rather than do nothing for a minor ailment; as delaying treatment 
could have serious consequences.    
The younger age group of participants (under 20-30 years) were more likely to treat a minor 
illness with an OTC medicine from the pharmacy as their 2nd or 3rd option, than the other age 
groups.  In general, to summarise the ranking order of the four possibilities: the first option 
for most participants was to self-medicate using herbal products (44%, n=84), the second 
selection was to self-medicate using OTC products from the pharmacy (38%, n=73), the 
third choice was to consult the doctor for advice and medication (46%, n=88), and the final 
option was to not consider taking any treatment (43%, n=83). 
 
Question 15: Who are you most likely to seek advice from for minor health problems? 
The vast majority of participants (82%, n=157) said they would turn to their family and 
friends as the first port of call for advice for minor ailments (Figure 2-26); a pharmacist was 
the second option for 43% (n=83) of participants, followed by seeing a doctor as the third 
option (46%, n=88) and the last option for most participants was consulting a herbal 
practitioner (83%, n=160).  
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The General Pharmaceutical council (GPhC) claims that pharmacies are a key source of 
information and advice for people which can be easily accessed (GPhC, 2015). Community 
pharmacists should be the first port of call for minor ailments, before seeking advice from 
doctors (Local Government Association, 2013). Participants in this study who said they 
would seek the advice from their pharmacist (8%, n=15) before the other options 
acknowledged the pharmacies were easy to access, and a product could be quickly bought 
without delay. However, the results of this investigation suggest a slightly higher proportion 
of participants would rather see their GP (9%, n=17) first than a pharmacist for advice for a 
minor illness. This was also demonstrated in work conducted by Hammond et al. (2004) who 
found that despite pharmacists having an increasing role in managing minor ailments people 
continued to see their GP. Similarly the Mintel report (2009) claims the doctor remains the 
first port of call for seven out of ten adults seeking medical advice. Sandhu and Heinrich 
(2005), found the majority of participants (58%, n=49) in their research said they would seek 
medical advice from their HCPs, either their own GP (29%), a family friend who was a GP 
(9%) or pharmacist (20%) as the first option for minor ailments. A survey conducted on 
behalf of the GPhC found that nine in ten people said they trusted the health advice from 
their pharmacist, although there was greater trust for their doctors; of those who preferred to 
seek advice from their GP many claimed it was a habit and that they did not even think to go 
the pharmacy (GPhC, 2015). Some of the reasons why people choose to see their GP over 
pharmacists were identified by research conducted by the PAGB (2009), including: the cost 
of buying OTC medication in comparison to a free prescription for those who are eligible, 
people feeling extra cautious when treating children, patients seeking reassurance from their 
GP, and people lacking knowledge about the pharmacists roles. Participants in this research 
who took regular prescribed medication (n=12) said they preferred to see their GP as their 
first option, because the doctor was aware of their current health condition so could provide 
better advice than a pharmacist who does not know them; in addition, they did not want to 
risk taking HMs in case of any adverse effects or interactions.   
With the increasing popularity of HMs (Newall et al., 1996; Mintel, 2009), it would suggest 
there would be more demand for trained herbal practitioners (Chevallier, 2007). However, 
the sample surveyed was not interested in seeking the advice of herbal practitioners for 
minor health problems. This may be due to a lack of awareness of how to access traditional 
herbal practitioners in the UK, or the cost associated; as conveyed by participant 82 who 
said, ‘‘I cannot afford herbal medicines they are too expensive to see a practitioner, Western 
medicine is free and easy to access here.’’ This view was shared by several other 
participants too. The cost of HMs could be a key factor in determining participants’ choice 
of treatment, which may also contribute to the changing attitudes and use of HMs and CWM. 
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Before the National Health Service (NHS) was established in 1948, it was very expensive to 
see a doctor and buy the prescribed medicines. The NHS introduced free healthcare to 
everyone, and this saw a shift from seeing the pharmacist for medicines for minor health 
problems to going to see the doctor (Royal Pharmaceutical Society, 2011). If people are 
entitled to free NHS treatment and medicines it appears they would opt for this instead of 
having to pay for alternative treatments; as Participant 126 stated, “Why do you want to use 
herbal medicines when the doctor looks after you and you get everything free here?” 
Johnson et al. (1983) and Bhopal (1986a) identified that SA communities would rather see 
Western HCPs than a traditional practitioner in the UK; this has also been highlighted from 
the results of this investigation.  
 
Question 16: Would you prefer to use traditional herbal remedies over conventional 
Western medicines for minor health problems? 
This question was designed to explore participants’ perceptions of what they preferred to 
take for minor health problems; 79% of participants (n=152) said they would prefer to use 
HMs for minor ailments. Pieroni et al. (2010) also found the majority of their Bangladeshi 
participants claimed they would prefer to use traditional medicines over Western medicines.  
In this study there were some comments which suggested participants were willing to try 
alternative treatments but had reservations because of their lack of knowledge, and evidence 
based research to prove their safety and efficacy. As highlighted by participants 114 and 179 
who said, “I would prefer to use more herbal remedies if I had the knowledge” and 
participant 132 who claimed, ‘‘if there was more evidence on the safety of herbal remedies I 
would prefer to use them over Western medicines.’’ Two young female participants 
mentioned that their parents (who were all born in the UK) only used CWM which meant 
they did not use or have any knowledge of HMs; they went on to say they would prefer to 
use HMs if they had better knowledge. Some participants remained uninterested in trying 
HMs, as exemplified by participant 188 who declared, ‘‘there is not much evidence on 
effectiveness of herbal medicines, it might just be a placebo effect.’’ This view was also 
shared by participant 191 who revealed he would rather take a prescription medicine than 
use any HMs. Several participants commented on the duration of action of HMs in 
comparison to CWM; conveying they would prefer to use HMs if they were as efficient as 
CWM, as mentioned by participant 143 who said, ‘‘I would prefer to use herbal remedies for 
minor health problems if they worked as fast as Western medicines.’’ 
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In discussions amongst participants, while the surveys were being conducted, there was 
some debate about how much evidence has guided the use of HMs, which have been used for 
longer than CWM. Participants spoke about their grandparents and parents giving them HMs 
from a young age, which worked, but there was no clinical evidence to support their use. 
These findings suggests evidence based medicine has become very important in guiding 
peoples decisions; similar conclusions have been proposed by many researchers including 
Evans (2008) and Pole (2008). The range of resources available to help people make an 
informed decision about their healthcare has become easier to access, and these have 
reinforced the ideas of using medicines which have been clinically approved.  
Question 17 & 18: Which do you think are more effective for treating minor (Question 
18) serious/ long term health conditions (Herbal or Western Medicines)?  
The final two questions aimed to get an 
insight into which system of medicine 
participants believed was more 
‘effective’ for treating minor and 
serious health conditions. Minor 
ailments included short term health 
problems such as a cough, cold, 
headache or indigestion; whereas, 
serious illnesses included chronic 
conditions like hypertension or 
diabetes etc. Figure 2-27 shows a clear 
distinction between the perceived 
effectiveness of HMs and CWM for 
minor or serious conditions. Most 
participants (65%, n=125) believed 
HMs were more effective than CWM for minor health problems. Comments about HMs 
being natural and therefore safer with less side-effects were noted; as well as the long 
standing use of herbal remedies amongst participants’ families. Although, some participants 
had their reservations and expressed their concerns of the insufficient evidence to support the 
use of HMs; for example, Participant 160 claimed, ‘‘the effectiveness of herbal remedies can 
only be determined if they are well established.’’ While others mentioned their lack of 
knowledge and experience with using HMs so felt they could not comment on the efficacy of 
HMS, as they had only ever used CWM. 
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When participants were asked which type of medicines they thought were more effective for 
more serious health problems, 93% (n=179) of participants were in agreement that CWM 
were more effective than HMs. This is supported by findings by Bhopal (1986a) who 
discovered Asian communities preferred to use Western medicines over traditional herbal 
remedies; and Johnson et al. (1983) who found that Asians in the West Midlands did not 
perceive traditional HMs to be superior to CWM, in fact they felt conventional medicines 
were better. Participants in this research who suffered from long term serious health 
problems such as diabetes and cardiovascular disorders made reference to feeling obliged to 
take their prescription medicines; due to fears of what their doctor would say if they did not 
comply and the health consequences of not taking their medicines. Others expressed their 
trust in CWM due to the rigorous clinical testing and evidence to prove their safety and 
efficacy.   
Despite the mass consensus, a small fraction of participants (7%, n=13) believed that HMs 
were more effective than CWM even for long term serious health problems. This included 
participant 122 with end stage liver cancer who said her chemotherapy treatment was making 
her worse and it was the HMs she was taking that were keeping her strong. Wachtel-Galor 
and Benzie (2011) found the use of HMs increased in patients with terminal illnesses such as 
cancer. Some participants in this research sample who were in favour of HMs for minor and 
serious conditions made references to how valuable HMs were and noted that some CWM 
were based on traditional HMs. Equipped with the right knowledge, these participants 
believed they could manage their own health without the need for CWM; they believed that 
natural remedies were intended to be used to treat illnesses and were safer with fewer 
adverse effects. Similar results have been observed by other researcher who have looked into 
the perceived safety and efficacy of HMs and also found that people think HMs are natural 
and so safer (Ipsos MORI, 2008; Mintel, 2009; Jennings, 2014). 
There is a clear division in opinions as to which form of treatment is more effective for 
minor and serious health problems. Most participants felt HMs were effective for minor 
ailments while CWM were more effective for serious conditions. The results highlight that 
the research participants had a great wealth of knowledge of HMs which has been passed on 
through the generations. The use of HMs amongst SA communities in the UK remains 
prominent and it can be concluded that participants use both HMs and CWM to treat, 
manage, and maintain their health.  
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2.7 South Asian Traditional Medicines Project Summary  
This research set out to explore the origins, use and transmission of knowledge of HMs 
amongst SA diasporic communities in the UK. Two hundred surveys were conducted across 
several locations in Birmingham and Leicester of which 96% (n=192) were used in this 
analysis. Although the research was conducted in two cities participants from across the UK 
took part in this questionnaire; hence, the results can be generalised to SAs in the UK. The 
research sample was composed of people from different age groups, ethnicities, and 
religions. The methods used to conduct this research enabled the aims and objectives to be 
successfully achieved. As the questionnaires were all administered by the primary researcher 
the importance of remaining impartial and not influencing participants responses was 
imperative; the skills obtained while doing this have been highly valuable.  
One of the key findings of this investigation was that 66% (n=126) of participants claimed to 
use HMs to supplement their health; this increased to 72% (n=139) of participants who said 
they used HMs for minor ailments, by the end of the survey. Participants from all of the 
different age, religious, and ethnic groups claimed to use HMs. Unlike the Ipsos MORI 
report (2008) which claimed the use of HMs was more popular with people educated to 
degree level or above, the use of HMs amongst this research population was not affected by 
their academic status; participants with no qualifications and those with degrees or above all 
claimed to use HMs. A difference in the use of HMs for minor ailments was seen between 
male and female participants; whereby, more female participants (78%, n=103) than male 
(60%, n=36) said they used HMs for minor ailments. This is supported by the results of the 
Ipsos MORI report (2008) which found 41% of female compared to 29% male participants 
claimed to have used HMs. The Mintel report (2009) also highlights that women are more 
likely to use HMs than men; in addition, Ernst (2000) claims women generally use HMs 
more than men. When participants were asked if they preferred to use HMs or CWM for 
minor ailments the vast majority of participants (79%, n=152) said they would prefer to use 
HMs; several participants did comment on their lack of knowledge of HMs which prevented 
them from using HMs. HMs were considered to be more effective than CWM for minor 
ailments by 65% of participants (n=125); whereas, for more serious health problems CWM 
were deemed more effective by 93% of participants (n=179). Just 7% of participants (n=13) 
believed HMs were more effective than CWM for serious illnesses. These results signify that 
both HMs and CWM have an important role in the management of participants’ health.  
The variety of HMs participants used to prevent, treat and maintain their health included: 
ginger for nausea and colds, fennel for digestion, lemon to lighten the skin and remove scars, 
karela for diabetes, and cinnamon to reduce high cholesterol. The use of fresh or dried fruits, 
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vegetables and herbs, oils, teas, seeds, syrups, creams, and gels were recorded by 
participants. The most popular item recalled by 109 participants (57%) was turmeric; its 
immune boosting properties, antibacterial effects for wound healing, and anti-inflammatory 
action in arthritis were frequently documented by participants. Several formulations of how 
to take turmeric were noted, the most popular method (cited 45 times) for consuming 
turmeric orally was to mix a spoon of turmeric in warm milk (with the optional addition of 
butter or oil, and black pepper). Even though turmeric has been used to treat numerous health 
conditions long before written records were created, some of the health benefits of turmeric 
are now being extensively investigated by researchers (Ravindran, et al., 2009; Sikora et al., 
2010). Some of the valuable knowledge of traditional HMs from participants has been 
documented and summarised in Appendix 5.    
Participants’ knowledge of HMs was assessed by calculating the number of different herbal 
remedies, products or ingredients they recalled throughout the questionnaire. Just 5% (n=10) 
of participants were unable to list any herbal products; the average number of products 
recalled per person was ten, while the highest number of items recalled by one participant 
was thirty six. This data highlighted participants wealth of knowledge of HMs. Results of the 
independent sample t-test revealed there was a significant difference (p=0.001, 2-tailed) in 
the knowledge of HMs between male and female participants; the mean (M) number of 
responses per female participant was 11 (SD = 7.01), while for males M= 7 (SD = 6.18). 
Throughout history, across different cultures around the world, women have been given the 
responsibility of the families’ health and prosperity (Ehrenreich and English, 1973; 
Chaudhury and Rafei, 2001; Hegg, 2013); this could be one of the reasons why women have 
more knowledge of HMs than men. The Mintel report (2009) also claims that females have 
more knowledge of HMs in comparison to males. A comparison of age and knowledge of 
HMs was conducted using an ANOVA test (one-way between-groups); it uncovered a 
statistically significant (p = 0.0003) difference in knowledge between the different age 
groups, suggesting older participants had more knowledge of HMs than younger participants. 
Despite this participants from all age groups did have an awareness of the potential uses of 
many different HMs.  
The availability of SA ingredients to formulate HMs and commercial HMs is increasing in 
the UK, making it easier to obtain and use traditional remedies; as portrayed by participants 
in this study. Asian and Western chain supermarkets, health stores, and online retailers are 
trying to cater for the needs of migrant communities, in the UK, by stocking ethnic 
ingredients (Retail Think Tank, 2013). However, some herbal products were identified as 
being difficult to source in the UK; therefore, participants claimed they had to obtain their 
ingredients from other places such as the internet or abroad. An example of a plant which 
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was difficult to cultivate in the UK was Tulsi (O. tenuiflorum L.). Participants mentioned 
how dried Tulsi leaves were imported to the UK from India and Africa; or culinary basil (O. 
basilicum L.) was used as a substitute as this was the closest alternative participants could 
find in the UK. The import and use of HMs from foreign countries has its own risks, such as 
accidental or deliberate species substitution or adulteration (Pharmaceutical Press, 2013). As 
identified in the studies by Seethapathy et al. (2015) and Kumar et al. (2015) who identified 
that the Indian herbal medicines market is affected by species substitution and adulteration. 
The applications of DNA barcoding and authentication of herbal medicines in the UK is 
limited, this research will contribute some important information to this discipline.  
The significant majority of participants (85%, n=163) said that HMs were part of their 
traditional family and cultural heritage. It was uncovered that the family remains the primary 
source for transmitting traditional knowledge of HMs, as 80% (n=101) of participants 
claimed to have learnt about HMs from their family. In addition, 82% (n=157) of 
participants said they would seek advice from their family first for minor ailments; this 
signifies the importance of the family support network which has a vital role in transmitting 
traditional knowledge of HMs (Chhetri, 1994). Bhatia et al. (2014) recognises that 
knowledge of HMs has developed through age old experience and has been orally 
transmitted from one generation to another; hence, if the knowledge of HMs is not 
communicated with younger generations or documented, there is a risk of it being forgotten. 
This research has documented some of this important traditional knowledge. Despite the 
family being the most common way of learning about HMs, some participants (20%, n=25) 
claimed to have learnt about HMs from their religion, school, friends, the television, radio, 
internet and social media (Facebook, Twitter and YouTube); these results identified diverse 
ways of learning about HMs.  
When participants were asked if they took any regular prescribed medication, 55% of 
participants (n=106) claimed to take prescription medication for a variety of health 
conditions such as: asthma, arthritis, cardiovascular disease, diabetes, and thyroid disorders. 
Participants who consumed HMs alongside their CWM were then asked if they shared this 
information with their HCPs; 69% (n=73) revealed they did not tell their doctor, while 82% 
(n=87) said they did not tell their pharmacist. Some participants feared they would be treated 
differently or not at all if their HCPs knew they were taking HMs at the same time as CWM. 
A few participants commented on language and cultural barriers which prevented them from 
sharing information about their use of HMs with their HCPs; concepts such as garam and 
bhye which do not exist in Western medicine were difficult to explain to HCPs. Heuschkel et 
al. (2002) revealed that just 24% of patients in their survey initiated conversations with their 
doctors about HMs; similarly, Bhopal (1986a) found participants did not think it was 
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important to tell their HCPs about their use of HMs. During the analysis of the data, several 
potential interactions between HMs participants used and CWM participants were prescribed 
were identified. If participants do not tell their HCPs about their use of HMs it could affect 
their pharmaceutical care (Pharmaceutical Press, 2013). A crucial discovery of this research 
is that a large number of SA participants do not tell their HCPs about their use of HMs; 
reasons why they did not share this information were also documented. HCPs perspectives 
will be considered in the following chapter (Chapter 3).  
The wide spread use of HMs in developing Asian countries where herbals may be more 
affordable in comparison to conventional medicines is well known (WHO, 2008); however, 
in the UK where conventional medicines are often free (i.e. for patients over 60 years old, or 
people with certain conditions such as diabetes or epilepsy) (PSNC, 2015) HMs may actually 
be a more expensive alternative. This was identified by some participants in this research 
who were not interested in using HMs as they received free NHS treatment. It was clear that 
some participants in this study consumed HMs alongside their prescribed CWM; 78% 
(n=83) of participants who took prescribed medicines claimed to use HMs intermittently or 
regularly to supplement their health, treat an ailment, or to counteract side-effects from 
CWM. When considering the side-effect profiles of CWM and HMs, significantly more 
participants said they experienced side-effects from CWM (43%, n=46) than from HMs 
(13%, n=16). Participants commented on HMs being natural, safer and with fewer side-
effects, this view has been documented in many other studies too (Ipsos MORI, 2008; 
Mintel, 2009; Ravindran et al., 2009).  Pole (2008) argues that herbals are not safe because 
they are natural; they are safe because in Ayurveda after the correct diagnosis, the right herbs 
can be prescribed. This reiterates the importance of having the knowledge to be able to use 
HMs safely, which some participants in this study felt they lacked. Participants believed if 
more literature and evidence based research was available to help educate them about HMs it 
might encourage them to try alternative remedies.   
Traditional knowledge of HMs has been created via trial and error and has been perfected 
over time, unlike conventional medicines which have been studiously researched. One issue 
identified by participants in this study was that the safety and efficacy of HMs has rarely 
been demonstrated using modern scientific investigations. An evidence-based approach to 
this issue needs to be employed in order to provide validation for remedies which have been 
used throughout history (Pole, 2008). Similarly, Evans (2008) explores how evidence based 
medicine has become influential in decision making; modernisation of HMs could be the 
way to integrate the two individual systems. Xie (2001) claims traditional medicine contains 
some valuable elements but there are parts which are no longer applicable and so suggests 
the need for scientific research to decide which elements to keep.  
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Similar research to this investigation was conducted by Bhopal (1986a) who explored the 
relationship between traditional and Western medicine in an Asian community in Scotland. 
This research was on a much smaller scale, it was limited to an Asian community in 
Glasgow, and is now very dated. Since then there have not been many other 
ethnopharmacological surveys to explore the current use of HMs in SA communities, in the 
UK (Pieroni et al, 2007; Pieroni et al, 2010). The results from this questionnaire have 
provided a detailed insight into the current use of HMs amongst SA diasporic communities, 
in the UK. The use of traditional herbal remedies and ethnobotanical research play an 
important role in scientific developments (Malla and Chhetri, 2009); therefore, it is 
imperative to record this knowledge. It has been suggested that ethnic people have immense 
knowledge of HMs which they inherit and pass on from generation to generation, through 
oral conservations; however, there is a risk of losing this knowledge if not documented 
(Chhetri, 1994; Thring and Weitz, 2006; Bhatia et al., 2014). The results of this 
questionnaire have enabled some of this precious information to be recorded.  
The analysis of the results has revealed several areas which require further investigation; for 
instance, the identification and authentication of herbal products to ensure the correct species 
are used in HMs, and HCPs’ views and opinions of HMs. These concepts will be explored 
further in the following chapters.   
  
83 
Sukvinder Kaur Bhamra 
3.0 Chapter 3 –  
Healthcare Professionals’ Views of 
Traditional Herbal Medicines   
 
3.1 Introduction 
The South Asian Traditional Medicines (SATMED) questionnaire (Chapter 2) revealed some 
interesting findings about South Asian (SA) people in the United Kingdom (UK) taking 
traditional herbal medicines (THM) and whether or not they shared this information with 
their medical doctor or pharmacist, i.e. their healthcare professionals (HCPs). A key 
discovery was that the vast majority of participants did not tell their HCPs of herbal 
medicines (HMs) they consumed at the same time as taking prescription medicines; 69% 
(n=73) of participants who were taking conventional Western medicines (CWM) as well as 
HMs said they did not tell their doctor, while 82% (n=87) did not tell their pharmacist. 
Various reasons for not telling their HCPs about the concurrent use of HMs and CWM were 
uncovered, such as: a fear of being treated differently, not being treated at all, and being 
labelled as ‘backwards’ or uneducated. The SATMED questionnaire was able to extract 
some valuable information about the current use of HMs amongst diasporic SA communities 
in the UK; and to establish participants’ views of safety, efficacy, and side-effects caused by 
HMs and CWM.  
Further to this investigation, the primary researcher was intrigued at looking into what HCPs 
thought of THM and their experiences with HMs. By asking HCPs to share their opinions on 
the safety and efficacy of HMs, and their knowledge of interactions and adverse incidents 
from combining HMs with CWM, both patients and practitioners perspectives could be 
assessed. It was anticipated that this study would reveal information about HCPs personal 
and professional views of HMs, something which has not been greatly explored in the UK 
before (Freymann et al., 2006). There is extensive research available on HCPs in the United 
States (US) and other European countries but limited information from the UK (Berman et 
al., 1998; Smith, 2011). Hence, this research will help to contribute to the lack of 
information on UK based HCPs use and opinions of HMs.  
The use of social media in communicating, networking, and even health promotion is 
expanding (Thackeray et al., 2012). Mediums such as Facebook and Twitter were considered 
as an innovative way to raise awareness of this research and to distribute the questionnaire. 
The use of social media in conducting social research is being recognised as a valuable tool 
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for data collection (Wilson et al., 2012), and was used to get HCPs across the UK involved 
in this study. 
 
3.2 Aim of the Healthcare Professionals Survey    
The aim of this investigation is to explore healthcare professionals’ personal and 
professional opinions and experiences of traditional herbal medicines.  
 
3.3 Objectives of the Healthcare Professionals Survey 
1. Explore healthcare professionals’ personal use and knowledge of traditional herbal 
medicines. 
2. Investigate healthcare professionals’ professional experiences of patients taking herbal 
medicines. 
3. Look into the impact of combining traditional and Western medical systems. 
4. Uncover healthcare professionals’ professional opinions on the safety and efficacy of 
herbal medicines.  
 
3.4 Background to the Research  
By reviewing the current literature available around this topic it will help to explain the 
importance of this study (i.e. supporting the need to conduct and document this research). A 
definition of what a healthcare professional (HCP) is will describe the criteria for the 
research population. Exploring the current education standards for UK HCPs to study 
complementary and alternative medicines (CAM) will give an insight into how HCPs are 
prepared to manage patients using alternative therapies. The relationship between HCPs and 
their patients and the implications of combining HMs and CWM will be considered. The use 
of social media to conduct scientific research will also be examined.  
The terms THM and HMs will be used interchangeably. 
 
3.4.1 Definition of a Healthcare Professional  
The International Labour Office (ILO) created a standard definition of occupations called the 
International Standard Classification of Occupations (ISCO). The latest version was revised 
in 2008 (ISCO-08). The objectives of the ISCO-08 were to standardise and organise 
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occupations so they are universally recognised. The ISCO-08 definition for health 
professionals is: “Health professionals study, advise on or provide preventive, curative, 
rehabilitative and promotional health services based on an extensive body of theoretical and 
factual knowledge in diagnosis and treatment of disease and other health problems. They 
may conduct research on human disorders and illnesses and ways of treating them, and 
supervise other workers’’ (International Labour Office, 2012; WHO, 2014). The list 
includes: medical doctors (from all disciplines including general practitioners to specialist 
physicians), nurses, midwives, paramedics, dentists, pharmacists, environmental and health 
professionals, physiotherapists, dieticians, nutritionists, audiologists, speech therapists, 
optometrists, podiatrists, occupational therapists, and traditional and complementary 
medicine professionals.   
In the UK the National Health Service Reform and Health Care Professionals Act 2002 has 
outlined that HCPs are those regulated by bodies such as the General Medical Council, 
General Dental Council, General Optical Council, General Osteopathic Council, General 
Chiropractic Council, General Pharmaceutical Council, and the Nursing and Midwifery 
Council (National Health Service, 2002). In August 2012 The Health and Care Professions 
Council (HCPC) was created to regulate several professions, including: arts therapists, 
biomedical scientists, chiropodists/ podiatrists, clinical scientists, dieticians, hearing aid 
dispensers, occupational therapists, operating department practitioners, orthoptists, 
paramedics, physiotherapists, practitioner psychologists, prosthetists and orthotists, 
radiographers, social workers in England, and speech and language therapists (Health and 
Care Professions Council, n.d.). 
According to UK standards HCPs will be regulated by a professional body; however, the 
ISCO-08 does not specify such details, it just standardises what occupations are classed as 
being HCPs. From this is can be concluded that the term ‘healthcare professional’ is a very 
broad term and refers to someone who is involved in diagnosing, treating, caring or 
rehabilitating, and reviewing patients health. HCPs have a vital role in health promotion and 
a duty of care to their patients, meaning they must be able to advise patients about various 
issues appropriately. As the popularity of HMs increases Western HCPs must have some 
insight into HMs to ensure patients are cared for properly (Zhang et al., 2012).  
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3.4.2 Academic Training in Complementary and Alternative Medicines  
Complementary and Alternative Medicines (CAM) is a very broad term which covers over 
700 types of therapies (Kayne, 2002) including: diet and exercise, reflexology, massage, 
relaxation techniques, and HMs. As CAM is becoming more popular in the UK, and more 
people are experimenting with holistic treatments they are becoming more professionalized 
(Clarke et al., 2014). The House of Lords report (2000) highlighted that conventional HCPs 
should be familiar with CAM therapies, including the potential uses and risks. Some CAM 
therapies are already accepted and widely incorporated as part of conventional Western 
medicine systems such as acupuncture, chiropractic and osteopathy; these are well regulated 
by the Acts of Parliament and are now included in the NHS and NICE guidelines (Clarke et 
al., 2004; Cant et al., 2012). Other forms of CAM such as HMs are becoming a focus for 
regulation; but, the extent of which this knowledge of CAM is taught to undergraduate HCPs 
remains to be discovered. While searching the literature for information about the education 
of HMs content in medical and pharmacy courses in the UK, it proved difficult to assess how 
much information was transmitted to undergraduate students about HMs. Subject guides, 
course and module information from numerous schools were examined with no possibility of 
determining what future HCPs were taught about HMs. In addition, any research on 
undergraduate courses in the UK looked at CAM as a whole and did not distinguish between 
the different elements such as physical or biological therapies.  
Regulatory bodies such as the General Medical Council (GMC) which regulates doctors, 
General Dental Council (GDC) which regulates dentists, the Nursing and Midwifery Council 
(NMC) which regulates nurses and midwives, and the General Pharmaceutical Council 
(GPhC) which regulates pharmacists all have a role in setting standards for education of 
undergraduate students (i.e. the future HCPs). The GMC (2009) updated its guidelines for 
undergraduate medical education in Tomorrow’s Doctors for application from 2011-2012, 
these are the current guidelines in place. One of the objectives under ‘prescribe drugs safely, 
effectively and economically’ states courses must, “Demonstrate awareness that many 
patients use complementary and alternative therapies, and awareness of the existence and 
range of these therapies, why patients use them, and how this might affect other types of 
treatment that patients are receiving.” The GPhC standards for the initial education and 
training of pharmacists called ‘Future Pharmacists’ updated in May 2011, has a single 
statement ‘complementary therapies’ in the indicative syllabus under section A1.1 ‘How 
Medicines Work’. The GMC, NMC, and GPhC have set very broad statements which 
institutes must include in their syllabi (GMC, 2009; NMC, 2010; GPhC, 2011); unlike the 
GDC which does not have any requirements for undergraduate dentistry students to learn 
about complementary therapies (GDC, 2015). Although some regulatory bodies do state 
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some CAM education needs to be included in the teaching syllabi the requirements are very 
broad and need to clarify the extent of coverage which is adequate for HCPs. The House of 
Lords Report (2000) claims the current level of CAM education is too uneven.  
Many researchers around the world have tried to explore the extent of CAM education. In 
the US the majority of medical schools now offer courses on alternative medicine (Eisenberg 
et al., 1998). Wetzel et al. (1998) contacted 125 medical schools in the US to establish the 
provisions for CAM education, of the schools that replied, 64% (n=80) reported offering 
elective courses in CAM; although, the content and styles of teaching was variable. An 
online survey conducted by Ho et al. (2013) explored evidence based medicine (EBM) and 
CAM teaching in UK medical schools; 95 students replied representing 25 different medical 
schools, of which 54% said they had received lectures on CAM in their core courses. In 
Europe CAM education is part of the regular curriculum in 40% of medical schools and 72% 
of health science departments (Barberis et al., 2001; Vagra et al., 2006). Research by Smith 
(2011) investigated the views and practices of UK medical schools inclusion or exclusion of 
CAM in undergraduate medical courses; Smith (2011) found that all of the respondents to 
the survey (18 out of 31 medical schools in the UK) said CAM was included in their syllabus 
in some way. Institutes claimed the study of HMs was available as a special study module 
which students could select, while others claimed that CAM was formally taught. The extent 
of teaching ranged from a single lecture, student centred learning (coursework), 
presentations, and several mixed methods of coverage throughout the course. The amount of 
coverage a single lecture can divulge on CAM is questionable. The decision to include CAM 
in the academic syllabus may be influenced by several factors including: concerns of safety 
and efficacy, lack of research in the area, resources, and funding (Wetzel et al., 1998). The 
main reason for including CAM in undergraduate courses appears to be due to requirements 
by regulatory bodies such as the GMC and GPhC. However, there appears to be several 
reasons why this topic is not covered in great detail. Smith (2011) discloses various reasons 
for not focusing more on CAM in undergraduate medicine degrees in the UK, including: lack 
of interest by students, not enough students interested means running the course is not 
sustainable, lack of staff interest, no space in the syllabus or teaching programme as it is 
already stretched, and limited funding and resources to cover the content. Smith (2011) 
claims there was a consensus for staff to want to focus on evidence based medicine rather 
than CAM.  
Pokladnikova and Lie (2008) looked at the attitudes of first and third year pharmacy students 
in the Czech Republic and found that 83% (n=231) were interested in learning about CAM 
and between 78-91% of students supported CAM education as part of their curriculum. 
Similarly in the UK Freymann et al. (2006) explored the knowledge and use of CAM in 
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undergraduate pharmacy students in The School of Pharmacy, University of London. They 
uncovered students were taught about CAM in the second year of the undergraduate course; 
however, it was still significantly less than the level of CAM education in other European 
countries. Students strongly agreed that HCPs should be aware of natural remedies. 
Inevitably, most HCPs will come into contact with patients who are interested in or using 
HMs; therefore, some provisions for educating future HCPs need to be in place 
(Pokladnikova and Lie, 2008; Smith, 2011; Ho et al., 2013).   
 
3.4.3 The Relationship between Healthcare Professionals and their 
Patients  
The SATMED questionnaire results revealed that participants taking HMs were not always 
willing to share this information with their HCPs; several reasons such as, a fear of being 
deemed backwards or treated differently were mentioned by participants. More importantly, 
factors such as language and cultural barriers were evidently affecting relationships between 
SA participants and their HCPs. Participants stated that their doctors did not understand 
them, and they found it difficult to communicate information about their health problems to 
Western HCPs as they were not familiar with the conditions. This was also uncovered by 
research by Eisenberg et al. (2001) who found participants did not disclose their use of HMs 
to practitioners because they felt like HCPs ‘would not understand’. This highlights the 
importance of having an awareness of cultural diversity; this is also part of GMC (2009) 
requirements in the Tomorrow’s Doctors guide which states that, “students should have 
acquired respect for patients and colleagues that encompasses, without prejudice, diversity 
of background and opportunity, language, culture and way of life.” Dogra et al. (2005) claim 
the importance of teaching cultural diversity needs to be developed further to ensure future 
HCPs can deal with the multicultural patient population. 
The Ipsos MORI survey ‘public perceptions of herbal medicines’ was carried out on behalf 
of the Medicines and Healthcare products Regulatory Agency (MHRA) in 2008. The two 
strands of their investigation involved the qualitative exploration of people’s views of HMs 
(the use, benefits, and risks) and a quantitative survey of the general public’s use and 
attitudes towards HMs. The quantitative section involved face-to-face interviews with 2,032 
adults in the UK; the results revealed that 35% of the survey population had used HMs. The 
majority of respondents were aware that there were risks associated with using HMs 
concurrently with CWM; thus, 56% of participant thought it was important to tell their 
doctor about HMs they were using, when they went to see their doctor. In addition, they 
found Asian and black and minority ethnic (BME) groups were the least likely to tell their 
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doctor about the use of HMs, and the most likely to believe it was ok to take the two forms 
of medicine together. Although pharmacists are ‘drug specialists’ and are in an ideal position 
to monitor and support the safe use of HMs it was clear people trusted doctors more in the 
Ipsos MORI survey, which concluded that participants trusted their doctors for advice on 
HMs more than pharmacists. The SATMED results also identified that more participants told 
their doctor (31%, n=19) rather than pharmacist (18%, n=5) about their use of HMs.  
Negative attitudes of HCPs could affect the relationship with patients as they may not feel 
comfortable talking about their use of HMs (Robinson and McGrail 2004; Staines, 2011). 
This was echoed by participants of the SATMED questionnaire who felt that Western HCPs 
did not approve of their use of HMs. It is clear that patients may feel reluctant to talk to 
HCPs about their use of HMs if HCPs attitude towards HMs is disapproving. Awodele et al. 
(2012) revealed that in Nigeria 40.7% (n=122) of doctors would discourage their patients 
from taking HMs, various reasons such as: lack of traditional healer education and scientific 
research on HMs were noted as reasons for not promoting the use of HMs by HCPs in 
Nigeria. Robinson and McGrail (2004) found that patients did not disclose their use of CAM 
to HCPs as they were worried practitioners would be prejudice towards them and their 
negative responses would persuade them against using CAM.  
A study into the use of CAM in children and young adults with inflammatory bowel disease 
(IBD) revealed that only 24% of patients using CAM had informed their doctor that they 
were doing so (Heuschkel et al., 2002). Studies into the use of CAM in children with cancer 
claim a substantial proportion of children use alternative therapies and the use of these 
therapies is often not discussed with their HCPs (Sawyer et al., 1994). Eisenberg et al. (2001) 
found that 60% (n=304) of participants claimed they did not tell the doctor about alternative 
therapies they used as the doctor never asked. Research conducted by the Drug and 
Therapeutics Bulletin (DTB, 2010) found that 77.3% (n=127) of HCPs surveyed claimed 
they were worried that patients would take HMs and not tell them (DTB, 2010). If patients 
do not want to talk to their HCPs about their use of HMs, should the responsibility of asking 
lie with the HCPs? Heuschkel et al. (2002) found that just 8% of doctors had initiated a 
discussion about CAM with their patients. Similar surveys conducted in Australia found that 
patients did not reveal their use of CAM as their practitioners never asked (Xue et al., 2007). 
The study by the DTB uncovered that only 12.9% (n=21) of HCPs in their survey said they 
‘always’ asked their patients if they took any HMs, 27% (n=44) said they asked ‘on most 
occasions’ while just 8.6% (n=14) said they ‘never’ asked about patients use of HMs (DTB, 
2010).  
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People have been using HMs since before written records were created; the knowledge of 
medicinal plants has been passed on through generations and has had a key role in 
preventing and curing diseases. Inevitably, people cannot be told not to take HMs just 
because they lack clinical evidence, and people will not stop just because ‘the doctor said 
so’. With the migration of people from around the world, they have brought with them their 
own medicines and remedies to the UK, something which HCPs should be aware of and 
have some insight into (Dogra et al., 2005). There are risks and benefits of consuming HMs 
which HCPs need to recognise, especially if their patients are consuming products which 
they consider to be natural and therefore safe (Ipsos MORI, 2008). HCPs are at the forefront 
of primary care and need to be well equipped with the correct knowledge and training on 
HMs. It is not feasible for HCPs to advise patients about HMs if the background knowledge 
is lacking (Pokladnikova and Lie, 2008). 
 
3.4.4 Taking Herbal Medicines alongside Western Medicines 
There may be several reasons why people try or use HMs in addition to CWM, including: the 
traditional use of HMs passed through generations, dissatisfaction with CWM, a desire to 
take control of their own health by making their own decisions, and curiosity to try natural 
and holistic therapies (Doel and Segrott 2003; Clarke et al., 2004). Furthermore, people may 
use HMs when CWM do not appear to be working, or to treat and manage the side effects of 
CWM; this is commonly seen in cancer patients having chemotherapy and radiotherapy 
(Sawyer et al., 1994; Ernst and Cassileth, 1998). In developing countries the high cost of 
pharmaceutical medicines, hospitals and medical facilities means the use of HMs is popular, 
as they may be a cheaper alternative (WHO, 2000). However, in the UK where medicines 
and treatment is often free on the National Health Service (NHS) taking HMs may actually 
be more expensive. During the SATMED questionnaires distribution there were mixed views 
about taking HMs with regards to the financial cost; some participants said they were not 
interested in using HMs as they had to pay for them but got their prescription medicines for 
free. While others mentioned it was expensive to buy ingredients for HMs in the UK but it 
was cheaper to bring them back from countries like India and Pakistan. The import of HMs 
from foreign countries leads to further risks such as contamination, adulteration, and 
misidentification of species (Chapter 4).  
HCPs views of combining THM with CWM are more likely to be determined by evidence 
based research and clinical guidelines, rather than the test of time (Heinrich, 2015). Awodele 
et al. (2012) disclosed that 41% (n = 123) of respondents in their survey to explore doctors 
view of THM, thought THM were effective for treating chronic conditions; although, none 
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of the doctors believed that THM alone could treat a patient. A comparison of UK and 
German general practitioners (GPs) attitudes towards CAM was done by Schmidt et al. 
(2002); they found GPs from both countries generally had a positive attitude towards CAM, 
although the Germans were more positive. GPs from the UK commonly referred patients for 
acupuncture, osteopathy and chiropractic treatment; while, significantly more German GPs 
referred their patients to herbal medicines. In the UK there is limited research to explore 
what HCPs think about combining HMs with CWM; this is an area which needs to be 
investigated further.  
There is a growing concern of serious interactions occurring between HMs and prescribed or 
over-the-counter CWM (Vickers et al., 2006). Smallwood (2005) says there is a risk of 
people not taking their CWM correctly or as prescribed if they use HMs. Vickers et al. 
(2006) found participants did not think it was important to tell their doctors about their use of 
HMs as they did not think they interacted or affected one another. The Ipsos MORI report 
(2008) revealed that 66% of participants thought it was safe to take HMs at the same time as 
CWM. The notion that HMs are natural and therefore safe misleads people to think HMs are 
safe and free from deleterious effects (Howells, 1996; Staines, 2011). Eisenberg et al. (1998) 
claim 60-70% of CAM users do not discuss it with their doctors, meaning patients will not 
get the opportunity to learn about the potential risks and interactions of combining HMs and 
CWM (Schmidt et al., 2002; Graham et al., 2008). If HCPs are not aware that their patients 
are taking HMs alongside CWM they will not be able to intervene, or identify potential 
adverse effects and interactions (Heinrich, 2015). Furthermore, it may affect the appropriate 
pharmaceutical care plan from being implemented which may cause further complications to 
the patients’ health (Ramsay et al., 2005).  
 
 Potential Herb-Drug Interactions  
Polypharmacy is the term used to describe the simultaneous consumption of several 
medicines by one person (Duerden et al., 2013). Multiple medicines may need to be taken to 
control or treat health problems, in which case there is always the possibility for drug 
interactions to occur. The definition of a drug interaction is, “when the effects of one drug 
are changed by the presence of another drug, herbal medicine, food, drink or by some 
environmental chemical agent,” (Baxter, 2008). Dureden et al. (2013) highlights that 
polypharmacy can be harmful due to the increased risk of adverse drug reactions (ADRs), 
and impaired medication adherence if prescribed too many medicines. For CWM before any 
drug is licensed for use it undergoes rigorous testing, providing evidence for its clinical use. 
Details of potential drug interactions are also documented in several sources such as the 
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British National Formulary (BNF) and Stockley’s Drug Interactions, which HCPs have 
access to. Various studies have found between 20-33% of the population use some form of 
CAM either alone or in addition to CWM (Freymann et al., 2006). Polypharmacy with CWM 
alone can be hazardous; but, by adding HMs it could further complicate the consequences. A 
herb-drug interaction is when the effect of a drug is altered by herbal products. Herb-drug 
interactions are based on the same principles of pharmacokinetics (i.e. affect the absorption, 
distribution, metabolism, or elimination) and pharmacodynamics (i.e. drugs effects are 
mimicked or antagonised) as with conventional drug interactions (Chavez et al., 2006).  
Cytochrome (CYP) P450 are a group of enzymes which metabolise a variety of substrates 
and have an important role in drug metabolism. Enzyme-inducing herbals render drugs 
ineffective at sub-therapeutic levels as they are metabolised too fast. Alternatively when 
herbal products inhibit or reduce the rate of enzyme activity drugs will be metabolised 
slower than anticipated; this can cause the drug to accumulate and cause toxicity. Drug 
accumulation can be a serious problem especially for drugs with a narrow therapeutic range, 
such as digoxin (Colalto, 2010). One of the most well-known herbal products which affects 
the CYP 3A4 isoenzyme, is St John’s Wort (SJW) (Hypericum perforatum  L.); it acts as an 
enzyme inducer which reduces the plasma concentration of certain drugs including 
carbamazepine (anti-epileptic), ciclosporin (immunosuppressant), statins and oral 
contraceptives (Komoroski et al., 2005; Graham et al., 2008). Hyperforin one of the active 
constituents in SJW induces P-glycoproteins in the intestinal wall reduces drug absorption. 
Furthermore, if taken with Selective Serotonin Re-uptake Inhibitors (SSRIs) a type of 
antidepressant such as citalopram or sertraline, it can cause serotonin syndrome; where the 
levels of serotonin become so high in the body that it can have fatal consequences (Chavez et 
al., 2006; Williamson et al., 2013).  
Fugh-Berman and Ernst, (2001) conducted a systematic review to explore the interactions 
between herbs and conventional drugs. They found that warfarin, a coumarin anti-coagulant, 
had the most interactions. Products such as garlic, gingko, ginseng, and even excessive 
consumption of green leafy vegetables can alter the anti-coagulant effects of warfarin 
(Chevallier, 2007). The mechanisms of how such interactions occur are not always 
understood or clinically significant; sometimes isolated reports of an interaction are the only 
indication of a potential interaction (Williamson et al., 2013). Warfarin is commonly 
initiated in patients who may have an increased risk of blood clotting, a history of a heart 
attack or stroke, or with prosthetic heart valves. It prevents the blood from clotting by 
inhibiting the conversion of hepatic vitamin K-dependent factors which reduce the amount of 
prothrombin produced; thus, reduces the rate of coagulation (Chavez et al., 2006). Foods 
which are high in vitamin K such as: cranberry juice, raisins, kiwi fruit, soya beans, 
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blackberries, blueberries, broccoli, and kale should be avoided by people taking warfarin 
(Fay, 2009). Despite being part of a healthy diet such products could affect the dose of 
warfarin required to have a therapeutic effect.  
It is very difficult to establish interactions between HMs and CWM as they are not 
frequently reported (Chavez et al., 2006). This may be because people who use HMs and 
HCPs lack the knowledge of herb-drug interactions (Vickers et al., 2006; Staines, 2011). In 
addition, if HCPs are not aware of patients taking HMs they cannot intervene or identify 
potential interactions (Heinrich, 2015). Communication between patients and their HCPs 
about HMs is vital to be able to identify potential herb-drug interactions and adverse effects 
from HMs (Vickers et al., 2006). The incidence of interactions between HMs and CWM is 
not fully known, and currently there is no way of establishing potential problems or clinical 
outcomes (Williamson et al., 2013). The main way of monitoring the safety of HMs is via 
the MHRA, which set up the yellow card scheme (Barnes, 2003; MHRA, 2014a). 
Publications such as Stockley’s Herbal Medicines Interactions (Williamson et al., 2013) and 
Phytopharmacy – An Evidence Based Guide To Herbal Medicinal Products (Edwards et al., 
2015) could be essential in educating HCPs about potential herb-drug interactions; however, 
unlike the BNF and Stockley’s Drug Interactions such texts are not readily available for 
HCPs to access.    
 
3.4.5 Using Social Media to Conduct Scientific Research  
The internet was made available to the public in 1991 with the introduction of the World 
Wide Web (WWW), which revolutionised how people learn, share information, and 
communicate (Vance et al., 2009). In the year 2000 just 26.8% of the UK population had 
access to the internet, in 2014 this had increased to 89.9% (Internet Live Stats, n.d). The 
launch of social media websites and applications such as Facebook, LinkedIn, Twitter, and 
YouTube have increased the ease and speed of communication; social media may be used 
for social, leisure, or professional communications. An Ofcom report in 2013 estimated that 
82% of the UK population aged over 16 had access to the internet, of which 53% used social 
media websites (Ofcom, 2013). For researchers this presents exciting opportunities to 
conduct research as it can be used as a valuable tool to identify and recruit participants 
(Beninger et al., 2014); which can lead to a snowball sample for exploratory work (Bhutta, 
2012). With the rise in popularity and access to social media, Murphy et al. (2013) claim that 
researchers should look into new ways to engage respondents and capitalise on this evolving 
phenomenon.  
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State public health departments have also adopted the use of social media to share 
information and health promotion updates with the public (Thakeray et al., 2012), they have 
used Facebook and Twitter as a way of communicating with the general public and YouTube 
channels to help promote health awareness. The NHS UK has over 87 thousand followers on 
Twitter, while the Department of Health UK have over 161 thousand followers (Twitter, 
2015); the followers were comprised of a mixture of HCPs and the general public. A study 
by Valdez et al. (2014) explored the benefits and challenges of recruiting for research studies 
related to consumer health information technology using Facebook. The study was 
composed of two phases which aimed to recruit specific populations: the first targeted a 
particular ethnic group (Filipino-American) and the second focused on type two diabetics. 
They posted messages on target groups and pages, and also sent private messages to 
administrators and people within the groups to recruit them for their research. They found 
that using social media structures such as Facebook was good for small samples providing 
qualitative data; but not so good for large samples for quantitative research. On the other 
hand, Bhutta (2012) used her personal Facebook networks and obtained over 4000 
completed surveys for her research within one month. Valdez et al. (2014) highlight the 
importance of creating trust and transparency to successfully recruit participants.  
There are several advantages of conducting research using social media; it is a fast and 
efficient way of spreading a message, and getting instant feedback and replies (Sutton, 
2010). Traditional methods of recruiting a sample can be time consuming and costly (Valdez 
et al., 2014). By using social media a large research sample can be recruited from different 
regions and even countries, allowing cross-cultural perspectives to be explored (Woodfield 
et al., 2013). It provides anonymity for participants who may not wish to disclose their 
personal details or identity, as they do not necessarily have to have any contact with the 
researchers (Beninger et al., 2014). In addition, as there is no facilitator present it eliminates 
the effects of researcher bias and may also give participants the freedom to express their 
views more open and honestly. It is cheaper than traditional research methods which may 
require printing and postage costs; in some cases it may even be free to set up an online 
survey. Once the research method, e.g. survey or focus group, is established it is easy to 
distribute the link to the survey and data can be collected quickly (Vance et al., 2009). There 
is an increasing number of people who have remote access to social media via multiple 
channels, e.g. smart mobile phones, netbooks, laptops, and tablets (Ofcom, 2013); therefore, 
online surveys can be completed quickly and instantly whilst on the go. Finally, as the data is 
collected electronically it reduces the risks of data input errors and is easier to analyse and 
store (Woodfield et al., 2013). 
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In spite of all the benefits of using social media to conduct research, there are also some 
disadvantages including: poor response rate, incomplete surveys, and the lack of control of 
the research population (i.e. cannot be sure of who is participating). This could be a 
particular problem if a specific research population is required but people who do not fall 
within the inclusion criteria participate. As the research is conducted without any face-to-
face contact it may be difficult to keep participants engaged throughout the entire process. If 
participants do not understand a question there is no way of clarifying it, which may lead to 
unanswered questions or participants dropping out. The initial cost of some online research 
tools may be expensive, for example the basic survey on SurveyMonkey, an online survey 
development software, is free; however, this only enables a maximum of ten multiple choice 
questions and one hundred responses. In order to create a full survey where respondents can 
also write comments and unlimited responses can be collected it can cost from £229 per year 
(SurveyMonkey, 2014). Considering that just over 50% of British adults use social media it 
would mean a significant portion of potential participants are not included in the research 
(Woodfield et al., 2013). One of the main drawbacks of this type of research is that because 
it is a fairly new concept it is difficult to apply traditional ethical principles to (Beninger et 
al., 2014).  
The Drug and Therapeutics Bulletin (DTB) conducted some research to explore what HCPs 
knew about HMs using online surveys. They emailed 1,157 subscribers to the DTB and had 
a response rate of 14.2% (n=164). The limitations of this research were that they had a low 
response rate, it only targeted HCPs who had subscribed to the DTB, and was limited to 
mainly doctors and clinicians rather than a variety of HCPs; thus, limiting the 
generalisability of the results. Despite this they did uncover some interesting results (DTB, 
2010). 
Using social media to conduct research provides a unique opportunity to engage a diverse 
range of people from around the world in a study, quickly and efficiently. Enabling 
researchers the freedom to explore concepts in an innovative way and people to share their 
thoughts and perspectives on a subject they are interested in (Woodfield et al., 2013). 
Traditional research methods have been tried and tested; their long standing use has been 
refined and guidelines to conduct ethical, safe, reliable and valid data are widely available. 
Conversely, the use of social media for conducting scientific research is a relatively new 
phenomenon; any new research done this was will help to highlight the benefits and 
drawbacks of this research method. Scientists should be willing to move with advances in 
technology instead of sticking to traditional methods (Murphy et al., 2013).  
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3.5 Methodology  
The following section details the research methods used to conduct this study; describing the 
design of the questionnaire, the participant inclusion criteria, how the survey was distributed, 
the ethical approval process, and how anonymity and confidentiality were maintained.  
 
3.5.1 Questionnaire Design 
In order to explore HCPs opinions and knowledge of HMs a questionnaire to meet the aims 
and objectives of this investigation was constructed (Appendix 6); with a combination of 
open and closed questions to obtain both quantitative and qualitative data. It was designed to 
be an online, self-completion questionnaire, giving participants the flexibility to complete the 
survey in their own time (Moore, 2000). An introductory statement was created to advise 
participants on the purpose of the research and inclusion criteria (Appendix 7). Brent (2014) 
claims the more questions you ask the less time participants spend on each question. It was 
important to keep the questionnaire concise as it was anticipated that participants may be 
deterred from a lengthy survey. For this reason there were only twenty questions split into 
four sections, estimated to be completed within 10-15 minutes. The first section set out to 
explore participants’ personal use of HMs: looking into the traditional use of HMs amongst 
families and cultural backgrounds, and HCPs knowledge of HMs for specific ailments. The 
second section focused on patients’ use of HMs, whereby HCPs experience of adverse 
effects and interactions caused by HMs were investigated. The third section looked at the 
HCPs’ professional opinions of THM; exploring their perceptions of safety and efficacy of 
HMs, and opinions on the level of education on alternative therapies during their 
professional training. The final section was designed to evaluate the population 
demographics, exploring ethnic origins, gender, and occupations.  
 
3.5.2 Participant Inclusion Criteria  
The definition of a HCP was explored in section 3.4.1 (p84). After considering the 
definitions of a HCP and receiving feedback from the De Montfort University (DMU) Ethics 
committee (Appendix 2A) it was concluded that the term healthcare professionals (HCPs) 
would be used to refer to those who currently have or previously had interactions with 
patients dealing with any aspect of patient care. This could include: doctors, consultants, 
surgeons, nurses, dentists, pharmacists, optometrists, and physiotherapists, herbal medicine 
practitioners, etc.  
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The principal requirement for the participant inclusion criteria was that participants had to be 
a HCP from the UK or having some experience of working in the UK; this was so the results 
could be generalised to UK HCPs. Undergraduate students currently completing degrees or 
courses were not directly invited to participate, if the students had training placements or 
contact with patients their responses were used for the analysis (e.g. pre-registration 
pharmacists or optometrists or students with clinical placements). There were no other 
defined parameters for the research sample (i.e. gender, age, or occupation), as this was an 
exploratory survey to investigate the general perceptions of HCPs on HMs.  
 
3.5.3 Distribution of the Questionnaire  
Initially, it was intended that the questionnaire would be posted to HCPs, mainly doctors’ 
surgeries and pharmacies around Birmingham and Leicester (the same cities where the 
SATMED questionnaires were conducted). However, this raised some doubt about the 
ethical approval required to send questionnaires to doctors who were contracted with the 
NHS (see section 3.5.4, p98). Also, the cost of printing and posting the questionnaires, the 
time consuming process, and low response rate associated with postal questionnaires were 
outweighing the benefits of conducting the research.  
The concept of using SurveyMonkey (an online survey software) and distributing it via 
social media was discussed amongst the research team and was considered to be a better 
alternative; as it avoided the cost of printing and posting the questionnaires. As the 
questionnaire was published online, distribution was not limited to two cities (Birmingham 
and Leicester); instead participants from across the UK were able to complete the survey. It 
was anticipated to be a quicker and easier way of distributing the survey to the target 
audience. The survey was available online for one year from 12th May 2014 -12th May 2015; 
this gave participants the freedom to complete the survey at their own leisure.    
The link to the online survey was emailed to friends and colleagues by the research team, 
participants were then asked to forward the email to other HCPs they knew. The link was 
circulated around Lloyds Pharmacy stores around the West Midlands with the approval of 
the area and regional managers. In addition, it was posted onto the researchers’ personal 
Facebook and Twitter accounts, where friends who were HCPs were asked to complete the 
survey and share the link on their own profiles too. The link was re-tweeted (shared) by 
various HCPs and organisations on Twitter including The Guardian Healthcare. The 
distribution method used led to a snowball sampling technique being adopted as the survey 
was passed on from person to person.     
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3.5.4 The Ethical Debate  
To satisfy the De Montfort University (DMU) ethical guidelines, any changes to the original 
PhD proposal which required ethical approval needed to be declared to the DMU ethics 
committee and approved before the amendments were imposed. An amendment form was 
completed and submitted for review (Appendix 2A). The ethics committee highlighted 
several points which needed to be addressed (Appendix 2B). The main concern was the 
requirement of the National Health Service Research and Development (NHS R&D) 
approval for the study as it was going to explore the views of HCPs who worked for the 
NHS.  
Contact was made with the NHS R&D team at Leicester City Clinical Commissioning Group 
(CCG), who initially said the University ethical approval was sufficient for the online 
distribution of the questionnaires. If the questionnaires were to be posted to doctors surgeries 
then approval from local CCGs would need to be obtained. The ethical approval for the 
project was debated amongst the Leicester CCG as there were no guidelines for online 
surveys with HCPs. Governance Arrangements for Research Ethics Committees (GAfREC), 
published by the UK Health Departments in May 2011 states, “Research Ethics Committee 
(REC) review is not normally required for research involving NHS or social care staff 
recruited as research participants by virtue of their professional role,” (NHS Health 
Research Authority, n.d.). As the online surveys were to be completed by HCPs in their 
personal time some said NHS ethical approval was not required.  
Several correspondences later it was decided that the NHS R&D and Site Specific 
Information (SSI) forms needed to be completed via the Integrated Research Application 
System (IRAS) as the team at the Leicester CCG were collectively unsure about how to treat 
online surveys. SSI forms detail what activities will happen in precise locations and separate 
forms are required for each CCG; however, as the survey was distributed online the locality 
of the HCPs could not be forecasted. Despite this it was agreed to complete the process to 
ensure the study was conducted ethically. The time consuming application process was 
completed and ethical approval for the study was granted by the Leicester City CCG which 
provides the Primary Care R&D Service across Leicester, Leicestershire and Rutland 
(Appendix 2C). 
Beninger et al. (2014) identifies the difficulties of applying traditional ethical principles to 
newly developing methods such as online and social media research. Due to the limited 
guidance available it proved to be a challenge; but one where valuable lessons were learnt.  
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3.5.5 Anonymity and Confidentiality  
As no personal identifiable data was obtained participants anonymity was ensured 
throughout the process. The demographic data obtained at the end of the questionnaire was 
designed to evaluate the types of HCPs who were completing the questionnaire, their age, 
place of birth and ethnic background. No personal contact details were taken and there was 
no way of tracing where responses had come from.  
The survey was designed and published online via SurveyMonkey. It was a password 
protected website which only the primary researcher had access to, ensuring all responses 
were kept confidential. By having all the data password protected the researcher ensured 
there was no unauthorised access. 
 
3.5.6 Analysis of the Questionnaires 
The SurveyMonkey software created graphs for quantitative questions, and enabled the 
results to be exported; summarising them into a portable document format (pdf) or 
PowerPoint presentation. Although this software enabled the data to be summarised it did 
not allow cross comparisons or correlations to be made. For this reason the results were then 
manually imported into the Statistical Package for the Social Sciences (SPSS) software 
(version 21), where they were analysed. 
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3.6 Results and Discussion  
A total of 112 respondents attempted the questionnaire, of which 93 were completed. Of the 
total number of participants who started the questionnaire, 19 withdrew at different stages; 
11 participants stopped after question 3, 3 participants left after question 4, 1 stopped after 
question 9, and the other 3 participants left out the ‘about you’ section. It was contemplated 
to discard the incomplete surveys; however, this would mean losing some valuable data. For 
this reason all responses were included in the analysis and the number (n) of respondents for 
each question has been highlighted.  
 
3.6.1 Sample Description  
The ‘about you’ section of the questionnaire was designed to get some background 
information about the research participants. As 19 participants withdrew by this stage of the 
survey, these results are from the 93 participants who completed the entire questionnaire.  
 
Age and Gender Profiles 
Figure 3-1 summarises the age and gender profile of the research sample: 57% (n=53) were 
female and 43% (n=40) were male participants. Most of the participants (n=33) were in the 
21-30 years age group; nevertheless, there was a range of participants representing the other 
age groups too. The two participants in the ‘20 years or under’ age group where both 
optometry students who had clinical placements; thus, their responses were included in this 
analysis.  
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Figure 3-1 Healthcare Professionals' Age and Gender Profiles 
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Ethnic Origins  
The two main ethnic groups participants identified with were White-British (39%, n=36) and 
Asian/ Asian British-Indian (38%, n=35). Figure 3-2 identifies the proportion of participants 
from each ethnic background. The 7% (n=6) of participants who selected other claimed to be 
White-Italian, White-American, White-other, White-mixed, mixed White-British with Black-
Caribbean, and Turkish.  
 
Figure 3-2 Healthcare Professionals' Ethnic Origins 
 
Birthplace & Religion 
The majority of participants (81%, n=75) were born in the UK, 8% (n=7) were born in India, 
5% (n=5) in Africa and the remaining 6% (n=6) who selected ‘other’ said they were born in 
Albania, Australia, Ireland, Poland, or the USA. Some religions have a strong affiliation with 
HMs; for example black seed (Nigella sativa L.) is claimed to be the cure for all diseases but 
death according to Islamic beliefs (Ansari and Satish, 2013), while Tulsi (Ocimum 
tenuiflorum L.)  represents a goddess in Hinduism (Miller and Miller, 2003). There was a 
range of participants from each of the religious options presented; 25% Christian, 20% 
Hindu, 11% Sikh, 10% Muslim, 4% other (other religions listed included Buddhist, Jain, 
Jewish, and Humanist), while 30% (n=28) of participants claimed to have ‘No Religion’. 
Participants were asked about their birthplace and religion to see if any correlation between 
their knowledge and use of THM was influenced by their background (this will be explored 
later in the results section). 
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Highest Qualification 
There was a vast array of qualification listed by participants, including: GCSEs, A-Levels, 
diploma, bachelor’s degree, postgraduate/ clinical diplomas, Bachelor of Dental Surgery 
(BDS), Fellowship of the Royal College of Surgeons (FRCS), Doctor of Medicine (MD), 
Masters, Master of Science (MSc), Master of Philosophy (MPhil), Master of Pharmacy 
(MPharm), Doctor of Pharmacy  (PharmD), Member of the Royal College of Psychiatrists 
(MRCPsych), Bachelor of Medicine and/or Surgery (MBBS), Member of the 
Royal College of Obstetricians and Gynaecologists (MRCOG), Member of the Royal 
College of General Practitioners MRCGP, Doctor of Philosophy (PhD), and post-doctorate 
(All Acronyms, 2015). A large number of participants (46%, n=43) had a Masters Level or 
equivalent qualification (Figure 3-3). Several pharmacists who had either an MPharm or 
bachelor’s degree in pharmacy stated their highest level of qualification was their post-
graduate/clinical diplomas. Two participants selected the ‘other’ option, of which one stated 
‘professional’ and the other ‘Fellow of the Society of Biology.’ The high level of 
qualifications participants have reflects the types of jobs they have, and the range of HCPs 
who completed this survey.   
 
 
 
 
 
 
 
Figure 3-3 Healthcare Professionals' Qualifications 
 
Job Role: 
Over 42 different occupations were listed by participants. Table 3-1 outlines the different job 
roles participants stated. It would not have been possible to recruit the variety of HCPs if 
traditional research methods such as postal questionnaires were used. If the surveys were 
posted to pharmacies and GP surgeries the responses would have been limited to community 
pharmacists, general practitioners, and practice nurses. Due to the survey being published 
online, it was easier to forward the link to a diverse range of HCPs. 
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 Table 3-1 Summary of Healthcare Professionals’ Occupations 
Key: (n = the number of participants identified under each profession). 
Do you currently work/ have worked in the UK? 
This question was added due to concerns over the survey spreading internationally on social 
media, as the link was being rapidly circulated. Although the introductory paragraph before 
starting the questionnaire clearly stated ‘for UK healthcare professionals’ there was a risk of 
respondents not acknowledging this. As this question was added at a later date just 20 (22%) 
participants who completed the surveys responded; all of whom did confirm they currently 
did or had worked in the UK.   
   
Academics: 
Medical 
doctors: 
Nurses: Pharmacy: Other HCPs: 
Biophysicist 
(1) 
Anaesthesia 
registrar (1) 
Hospital nurse 
(2) 
Community 
Pharmacist 
Manager (9) 
CBT therapist 
(1)  
Lecturer (1) 
Consultant 
physician (2) 
Nurse 
consultant (1) 
Clinical / Chief 
/ Lead/ 
specialist  
Pharmacists 
(6) 
Dentist (2) 
PhD 
fellowship (2) 
General 
practitioner (8) 
Practice nurse 
(1) 
Hospital 
Pharmacist (3) 
Deputy chair 
BMA (1) 
Professor (3) 
Non consultant 
carer grade 
psychiatrist (1) 
 
Non-
Pharmacist 
manager  (1)  
Independent 
public health 
specialist (1) 
Senior lecturer 
(1) 
Foundation 
year 1 doctor 
(1) 
 
Pharmacist 
(23)  
Optometrist (1)  
Optometry 
student (2)  
Clinical 
research 
consultant (1) 
Specialist 
registrar in 
Obstetrics and 
gynaecology 
(1) 
 
Pharmacy 
technician (1) 
Renal 
specialist 
dietician (1) 
Researcher (2)   
Pharmacy staff 
(1) 
Speech and 
language 
therapist (1) 
    
Pre-
registration 
Pharmacist (2) 
Various/ 
unspecified (4) 
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3.6.2 Healthcare Professionals’ Personal Use of Herbal Medicines   
Questions 1-4 were designed to explore HCPs personal knowledge and use of HMs. The first 
three questions were answered by 112 participants who attempted the questionnaire; after 
which 11 participants withdrew.  
 
Question 1: Is traditional herbal medicine part of your family/ cultural background? 
Of the total population who completed this question 45% (n=50) said HMs were part of their 
family/ cultural background; while, 55% (n=62) said it was not. The demographics of the 
participants indicated they were from a range of ethnic backgrounds, religions, and countries. 
A comparison of participants’ ethnic origins and whether or not they said HMs were part of 
their family/cultural background revealed some interesting findings (Figure 3-4). More 
participants from the SA ethnicities (i.e. Indian, Pakistani, and Bangladeshi backgrounds) 
claimed the use of HMs was part of their family and cultural background. Whereas, 
participants from Western cultures (i.e. White: British and Irish) stated HMs were not part of 
their family or cultural backgrounds.    
 
Figure 3-4 The Link Between Ethnicity and Traditional Remedies Being Part of Participants’ Cultural 
Background.  
An Analysis of Variance (ANOVA) test was used to see whether or not there was a 
statistically significant difference between ethnicity and the traditional use of HMs by 
participants’ families. The Null hypothesis would be ‘the traditional use of HMs is not linked 
with ethnicity’; while, the Alternative hypothesis would state ‘the traditional use of HMs is 
associated with ethnicity.’ If the significance (Sig) value is less than or equal to 0.05, there is 
a significant difference between the two variables (Pallant, 2007). The results from the 
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ANOVA test gave a Sig value of 0.00 which is lower than 0.05 (Table 3-2); thus, a 
significant difference between the traditional use of HMs and ethnicity can be assumed. For 
this reason the null hypothesis can be rejected and the alternative hypothesis can be accepted, 
as a difference between the traditional use of HMs by families in different ethnic groups was 
statistically significant. Therefore, it can be concluded that the use of THM is associated 
with ethnicity. 
Table 3-2 ANOVA Summary Data for Ethnicity and the Traditional Use of Herbal Remedies 
 
Sum of 
Squares 
df Mean Square F Sig. 
Between 
Groups 
14.034 7 2.005 18.938 0.000 
Within 
Groups 
8.998 85 0.106 
  
Total 23.032 92 
   
  
Question 2: Do you use any plants, herbs or spices for your own health? 
*If ‘Yes’, what do you use and why? 
The Ipsos MORI report (2008) stated those educated to a degree level or above were 
generally more likely to use HMs. From the qualifications listed by this research population 
it is clear participants were highly educated, 68% of participants had qualifications higher 
than a degree. Despite this, a large proportion of participants (62%, n=70) said they did not 
use any HMs for their own health. The 38% (n=42) of participants who did claim to use 
plants, herbs, or spices for their health listed a range of different products (Table 3-3). 
Numerous remedies for coughs and colds were listed including: honey and lemon, turmeric 
in milk, Echinacea, tulsi, ginger, and cinnamon. Mint, ginger, cardamom, and cumin were 
frequently mentioned for improving digestion. Various remedies for skin conditions such as 
aloe vera, turmeric, and neem were noted. For stress, anxiety and mild depression products 
such as St John’s wort, valerian, and passion flower were documented. The most popular 
product mentioned was turmeric, cited by 45% of participants (n=19); its uses as an anti-
inflammatory and antiseptic for skin infections and wound healing, coughs, colds, and 
immune boosting properties were detailed. Other products frequently cited included: ginger, 
cloves, mint, honey, lemon, aloe vera, and herbal sleeping aids. Some products such as fever 
grass, Sorrel Bitter herbs, nettle tea, and bush tea were identified by just a small number of 
participants.  
Similar to the results from question one, SA participants claimed to use HMs more than any 
of the other ethnic groups. The responses from participants of SA origin were compared to 
the other ethnic group participants, and a distinctive difference was seen. Most of the 
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products listed by SA participants included herbs and spices native to Asia such as ajwain, 
cardamom, and tulsi. Whereas products listed by the other ethnic groups were native to 
Western countries for example Agnus castus, camomile, Echinacea, nettles, and valerian. 
The most popular Western herbal product noted was Echinacea (Echinacea angustifolia 
DC.) which is native to North America (Chevallier, 2007). It has a long standing use in 
traditional medicine and has been considered as one of the most important medicinal herbs 
used to treat common cold and infections (Rezaie et al., 2013). Miller (2005) identifies it as 
“one of the top-selling herbs of all time,” as numerous commercial products in different 
pharmaceutical forms are available. The evidence supporting the use for Echinacea, as with 
most other herbal remedies, is variable (Miller, 2005).  
Table 3-3 Summary of the Herbal Remedies Used by Healthcare Professionals 
Participant 
Number: 
Herbal Remedies Used: 
2 Rhodiola for energy. 
3 
Fresh mint in tea to help aid digestion.  
Turmeric Powder for upset stomachs. 
4 Honey, ginger, lemon mixture for dry coughs. 
6 Nettle tea. 
8 Turmeric. 
12 
It's not a part of my normal routine but could use one on recommendation 
depending on the ailment. An example is Turmeric extract for skin 
inflammation 
16 
Turmeric and salt - antiseptic properties. Cinnamon and ginger - digestive 
properties Tulsi - digestion and coughs. Cardamom - digestion, infection. 
Clove -painkiller/tooth pain. Cumin – digestion. 
17 
I use aloe vera from my plant pot for eczema on my hand. I do not like the 
idea of using chemicals found in creams on my hand which I may then use 
to pick up food when eating. In addition, I have tried a number of 
medicinal creams (e.g. steroid creams emollients etc.) which have been 
ineffective so I wanted to try something different. 
20 Ginger-sore throats. Turmeric-sore throats. Echinacea-sore throat. 
21 
Turmeric being the main one. If someone has a cold, Turmeric in milk 
does the trick. 
23 
Tulsi, cinnamon, turmeric, clove, cardamom, aniseed, fennel seeds, 
fenugreek seeds, mint, honey, nutmeg, okra. 
I use the above to treat cough and cold, diarrhoea, abdominal pains, 
acidity, toothache, weight loss, indigestion, lower the blood glucose etc. 
26 Neem tablets and washing products. 
32 Peppermint tea for indigestion. Honey and lemon for colds. 
35 Herbal sleeping tablets on occasion. 
44 
Very rarely. In conjunction with OTC medicines I may have used a small 
amount of ground turmeric in some milk to help with coughs and colds. 
46 
Turmeric for its antiseptic properties, sometimes with a hot chapatti 
(wholegrain wheat flour based) to act as a heated bandage for sprains. A 
mixture of chapatti flour and cold water to form a paste to apply on small 
burns. A mixture of turmeric and honey as a cleansing face mask. 
48 Mint-for upset tummy, Turmeric as antiseptic. 
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49 
Aloe Vera, Cerissie tea, Fever grass, Sorrel Bitter herbs, Ginger, Garlic, 
Bush tea. 
50 Turmeric, Basil. 
51 
I use traditional Chinese herbs for cough related to Aspergillus in my 
lungs. I tell my consultant I do so. The herbs reduce the mucous, infection 
and dramatically reduce coughing spasms. The herbs are specifically 
prescribed for me according to my symptoms. 
53 Valerian- sleep. 
56 Camomile tea for relaxation, witch hazel for antiseptic. 
63 
Local honey for hay fever - works amazingly well! Agnus castus for PMS 
symptoms. I advise patients to try linseed oil for excess GI wind. Some 
patients report benefits from St John's wort for depression/ anxiety; 
passion flower for anxiety/ stress. 
64 
Many. Only daily ones are hawthorn and Ginkgo tinctures for circulatory 
problems. I use natural antiseptics and digestive remedies too. 
70 Senna is used as a primary constipation therapy. 
74 Ajwain for indigestion and headaches, cloves for toothache, turmeric. 
81 Turmeric for infections and skin problems. 
85 Ginger, tulsi, turmeric. 
86 
Ginger, ground roots for sickness and nausea. Fresh turmeric as a hot 
drink for cough and sore throat. Dry turmeric powder soaked into cloths 
for wounds, Clove for toothache. Garlic oil for ear infections. Mint. 
88 
Mentha (calm nerves, eases digestion) lemon, honey, cinnamon (sore 
throat, colds, allergy, immune system), ginger (nausea, immune system), 
coconut oil and water (health being, skin). 
90 
Lots- turmeric, ginger, garlic, cinnamon, cumin, fennel, black pepper, 
honey are the most common that I use here in the UK for various ailments.  
Sandal wood, red sandal wood, turmeric and honey for skin. 
92 Ginger tea for cold. 
97 Ginger for upset stomach. 
101 Turmeric with hot milk for sore throat. 
102 Turmeric, mint, cinnamon, pepper, and ginger. 
105 
Echinacea, to maintain immune system. Turmeric, general wellbeing. Aloe 
Vera skin heath and wound repair. 
108 My mum thinks having turmeric powder with hot milk helps with coughs. 
112 
Turmeric + Ginger. Provides rapid and effective relief in comparison to 
conventional medications. 
There is very little research which has explored UK based HCPs personal use of HMs. 
Generally research focuses on patients’ use of HMs, concurrent use of HMs with CWM, or 
undergraduate students views of HMs (Heuschkel et al., 2002; Freymann et al., 2006; Smith, 
2011). The results from this question reveal there are several factors which may influence 
HCPs decision to use HMs including: traditional use amongst ethnic and family 
backgrounds, perceived safety and  efficacy, and clinical evidence to support the use of 
HMs. It was clear from some participants’ feedback that evidence based medicine was 
crucial in influencing their decision to take HMs; due to the lack of clinical research to 
support the use of HMs, HCPs were often reluctant to use them for their own health. While 
other HCPs revealed the use of HMs has been part of their traditional heritage and the long 
standing use of HMs is sufficient evidence to support their use.   
Table 3-3 Summary of the Herbal Remedies Used by Healthcare Professionals Continued… 
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Question 3: Would you prefer to use traditional herbal remedies over conventional 
Western medicine for minor health problems? E.g. cold/constipation/mild skin irritation? 
The results from this investigation found that 42% (n=47) of participants said they would 
prefer to use HMs for minor health problems rather than CWM. As reflected by participant 
91, a pharmacist, who claimed that, “using nature's remedies rather than synthetic, has fewer 
side effects and many more health benefits.” Several references to HMs being natural and 
therefore safe were noted. In addition, participants claimed the use of HMs had been passed 
on through generations of the family and therefore they had tried them, when recommended 
by a family member. There was no correlation between the preference of using HMs with 
gender, or age; however, similar to previous questions participants from SA ethnic 
backgrounds generally preferred to use HMs for minor health problems more than other 
ethnic groups (Figure 3-5).  
 
Figure 3-5 Healthcare Professionals' Ethnicity and Preference to Use Herbal Remedies for Minor Ailments 
On the other hand, 58% (n=65) of participants claimed they did not prefer to use THM over 
CWM for minor health problem. The participants forming this research group were all HCPs 
who were specialists in various sectors of the healthcare framework. Their practice and 
education is evidence based and their distrust of HMs which lacked scientific validation was 
evident, as demonstrated by: participant 71 who stated, “lack of controlled trial data and 
standardisation of preparations is a crucial weakness in the use of herbal medicines,” and 
participant 100 who said, “to be credible more patient and double blind trials need to take 
place.” Other reasons for not favouring the use HMs for minor health problems included: 
distrust in natural remedies, the effects of HMs being compared to a placebo, suspicion of 
unregulated products, and uncertainty of what the HMs actually were (i.e. adulterated 
species). This was demonstrated by participant 60 who said, “The difficulties with quality 
control (specifically in terms of dosage and active ingredients) make treatments with herbal 
remedies very much a gamble.” 
0
5
10
15
20
25
30
35
White: British/
Irish
Black/ Black
British: African/
Caribbean
Asian/ Asian
British: Indian/
Pakistani/
Bangladeshi
Other
N
u
m
b
er
 o
f 
P
a
rt
ic
ip
a
n
ts
Ethnicity 
Ethnicity and Preference To Use Herbal Remedies For Minor Ailments 
Prefer to
Use Herbal
Remedies
Do Not
Prefer to
Use Herbal
Remedies
109 
Sukvinder Kaur Bhamra 
 Question 4: Can you name any herbal remedies which can be used for the following 
conditions (arthritis, cough, diabetes, and indigestion)?-If so, please state what could be 
used.     (Question 4 was answered by 101 participants) 
The four conditions selected for this question, arthritis, cough, diabetes, and indigestion, 
were also used in the SATMED questionnaire (Chapter 2); therefore, it was decided to use 
the same conditions in this survey. This question was designed to explore HCPs knowledge 
of HMs for common health problems treated in the UK (WHO 2006; PAGB, 2009; Arthritis 
Research UK, 2013a). In addition, similarities and differences between the SATMED 
participants and HCPs knowledge of HMs used for these conditions could be compared. 
Less than half of the participants (46%, n=46) did not state any HMs for the conditions 
listed; these participants either left the question blank or replied with answers such as ‘no,’  
‘not sure,’ or ‘none are useful’.  Research by the DTB found that doctors’ knowledge about 
the clinical aspects of HMs and regulation was poor; of the HCPs who completed their 
survey 36.2% claimed their knowledge of HMs was ‘quiet poor’ while 10.4% said it was 
‘very poor’ (DTB, 2010). The results from this survey could suggest that the 47% of HCPs 
who did not state any HMs in this question lacked the knowledge about the clinical benefits 
of HMs for the conditions stated. On the other hand, it may be argued that just because 
participants did not list any HMs does not mean they lack the knowledge, but instead they 
chose not to reply. 
The remaining 54% (n=55) of participants did attempt to state HMs for the conditions listed: 
31% of the participants stated a HM for just one condition, 15% for two conditions, 24%  for 
three conditions and 30% were able to recall a remedy for all four conditions (Table 3-4). 
Figure 3-6 illustrates the number of participants who recalled a herbal remedy for each of the 
conditions; cough (n=37) and indigestion (n=41) had more responses in comparison to 
arthritis (n=30) and diabetes (n=28). Cough and indigestion are amongst the top ten most 
common minor ailments treated by doctors and over-the-counter by pharmacists in the UK 
(PAGB, 2009), which could explain why more HCPs knew about HMs for these conditions 
in comparison to arthritis and diabetes.   
 
 
 
 
 
 
Figure 3-6 Healthcare Professionals' Who Recalled a Herbal Remedy/Remedies for the Conditions Listed   
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Table 3-4 Summary of Herbal Remedies for Arthritis, Cough, Diabetes, and Indigestion 
Arthritis Cough Diabetes Indigestion 
Apple cider vinegar 
(2) 
Basil  Aloe vera (2) 
Ajwain/ 
Trachyspermum 
ammi (3) 
Avocado with 
Soybean  
Black pepper (2) 
Black pepper in honey  
Bilberry extract 
(2) 
Anise tea 
Aniseed (3) 
Black Currant Oil Cardamom  
Bitter gourd 
/karela (11) 
Cabbage core 
(contains pepsin)  
Boswellia (3) Coltsfoot  Black seed  Cardamom  
Bromelain Echinacea  
Cinnamon (6)  
Camomile 
Chondroitin  
 
Garlic (2) Fenugreek (4) Cloves  
Cod liver oil (2) Ginger (4) Garlic Cold milk  
Commiphora Jeevan San Jeevan (an 
Indian herbal remedy) 
Green tea Corn flour paste  
Devils claw (4) Liquorice (2)  Ginger Fennel (8)  
Eucalyptus oil  
Honey (2) 
Honey in warm milk  
Honey in hot water 
with/without lemon (8) 
Honey, lemon &ginger 
Honey & lemon/ black 
pepper 
Gurmar  Ginger (6)  
Fenugreek seeds  Mallow   Okra (2) 
Haajmola/ trifla 
churan (2) 
Garlic  Pineapple juice  Sweet potatoes  
Liquorice and 
coriander  
Ginger (4) Poppy Tulsi (basil) Milk thistle  
Glucosamine (5) Squill  Turmeric  Mint (5) 
Rosehip (2) Tea   
Peppermint (1) 
Peppermint oil  
Peppermint tea 
(3) 
Sesame seed oil  Thyme (3)  
Plantain and 
green bananas for 
ulcers  
Tulsi  Tulsi (2)  Senna 
Turmeric (6) 
Turmeric (10) 
Turmeric powder in 
milk   
 Suva (Dill seeds) 
Willow bark = 
aspirin/salicylates 
(3) 
  Turmeric 
Wintergreen 
(topically)  
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Arthritis Research UK (2012) revealed that approximately 10 million people seek advice 
from their GP about arthritis; it is a condition which can affect all ages. Arthritis Research 
UK (2012) have acknowledged that sufferers will be tempted to try alternative therapies and 
have created a report based on randomised controlled trials which have tested the 
effectiveness and safety of some common HMs used for rheumatoid and osteoarthritis. It has 
summarised the safety and efficacy of several products including: fish oil, borage seed oil, 
evening primrose oil, Cat’s claw, and flaxseed oil for rheumatoid arthritis; Indian 
frankincense, ginger, Devil’s claw, willow bark, glucosamine, and chondroitin for 
osteoarthritis. Each product was given an efficacy score between 1-5 depending on the 
reported improvement in pain, movement, and general wellbeing; 1 correlated to no or very 
little evidence, while 5 represented data where there was consistent evidence across several 
studies. A traffic light system was used to code the safety profile, green represented minor/ 
infrequent side-effects reported, amber signified commonly reported side-effects (even 
minor ones) or more serious effects, and red illustrated serious side effects reported. The full 
report is available for the general public to access to help make more informed decisions 
about herbal remedies to help with their condition (Arthritis Research UK, 2012). The most 
common HMs documented for arthritis by participants in this survey were: turmeric, 
glucosamine, ginger, Devils’ claw, cod liver oil, rosehip, apple cider vinegar, and willow 
bark (Table 3-4). Many of these remedies were similar to those listed in the Arthritis 
Research UK (2012) report ‘Complementary and alternative medicines for the treatment of 
rheumatoid arthritis, osteoarthritis and fibromyalgia.’ Several remedies such as turmeric, 
ginger, and sesame seed oil were similar to responses listed by the SATMED survey 
participants. The key difference noted was that the participants in this survey mentioned 
products such as glucosamine, rosehip, Boswellia and willow bark, which none of the 
SATMED participants identified. Boswellia (also known as Indian frankincense, Boswellia 
serrate Roxb. ex Colebr.) is famous for its use in the traditional Indian medical system of 
Ayurveda (Siddiqui, 2011). The resin from the trees has an anti-inflammatory action as it is 
rich in  mono/di/tri-terpenes and pentacyclic triterpenic acids i.e. β-boswellic acid which 
inhibit pro-inflammatory enzymes (Sontakke et al., 2007).  
Research by the Royal Pharmaceutical Society (2014) found that common ailments such as 
coughs and colds cost the NHS £1.1 billion a year, when patients are treated by their GPs or 
Accident and Emergency. The HMs mentioned for cough included turmeric, tulsi, honey 
(with or without lemon, black pepper, ginger, in hot water), and liquorice. HMs such as 
poppy, squill, coltsfoot, mallow, and thyme were mentioned specifically by White-British/ 
Irish participants. Mallow (Marshmallow, Althaea officinalis L.) is a traditional European 
herb; that has demulcent properties which help sooth a cough (Chevallier, 2007).  In January 
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2014 a new product was introduced by Omega Pharma called Bronchostop, a cough syrup 
which combines Marshmallow root and thyme extracts (Buttercup Bronchostop, 2014). It is 
marketed as a traditional herbal medicine as the evidence for its efficacy was based on its 
traditional use. The development, marketing, and success of new HMs suggests consumers 
are interested in trying natural remedies; as implied by the sales figures of Bronchostop 
which were reported to the value of £4.36 million since being launched in 2014 (OTC 
bulletin, February 2015). Those participants who did not support the use of HMs for the 
treatment of cough made references to HMs having a placebo effect or not having any effect 
on treating a cough at all, like participant 62 who claimed that, “none are useful (neither are 
any conventional medicines),” while, participant 51 stated she only used medicines “on 
prescription from my practitioner” for a cough.  
For indigestion peppermint, fennel, mint, aniseed, and ajwain were the most popular HMs 
mentioned.  Participant 85 listed senna as being useful for indigestion; however, it is licensed 
for use as a stimulant laxative for constipation, which can cause abdominal cramping as a 
side-effect, making indigestion feel worse (Chevallier, 2007). Although there is no evidence 
to support the use of senna for indigestion it may be something the participant tried and 
found useful.  
WHO (2006) estimated that in 2000, 171 million people around the world had diabetes and 
they predicted it would more than double by 2030 to 366 million people; however, in 2014 
an estimated 422 million adults were living with diabetes (WHO, 2016). There are currently 
3.3 million people diagnosed with diabetes in the UK, a condition which can affect any age, 
cannot be cured, and in most cases requires medical treatment (Diabetes UK, 2015). 
Diabetes can have serious health consequences if not managed correctly. The most popular 
HMs mentioned for diabetes were karela, cinnamon, fenugreek, aloe vera, and okra. Other 
products listed by the HCPs included bilberry, black seed, sweet potato, and gurmar. Gurmar 
(Gymnema Sylvestre (Retz.) R. Br. ex Sm.) in Hindi translates to ‘destroyer of sugar’ and it 
has been used traditionally to treat diabetes and symptoms associated with diabetes such as 
urinary frequency (Saneja et al., 2010).  
Many similarities between the products/ HMs recalled in this survey and the SATMED 
questionnaire were noted; i.e. turmeric, ginger, tulsi, garlic, mint, and aniseed were 
mentioned frequently by participants in both surveys. Whereas, products such as rosehip, 
Marshmallow, willow bark and Devil’s claw were only identified by participants in the 
HCPs survey. Unlike the SATMED questionnaire which was for SA participants only, this 
survey was open to participants from all ethnicities which has enabled more varied responses 
to be collected. Participants from the non SA ethnic groups listed more Western herbals such 
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as coltsfoot (Tussilago farfara L.) and nettles (Urtica diocia L.) which are native to Europe 
(Chevallier, 2007). A difference in knowledge of HMs was also identified between the ethnic 
groups, as more SA participants (n=28) were able to list HMs for the conditions than White 
British/ Irish participants (n=13); this suggests that SA HCPs had more knowledge of HMs 
for the conditions listed compared to HCPs from other ethnicities. 
Overall the results from question 4 have revealed a diverse range of HMs for arthritis, cough, 
diabetes, and indigestion known by the HCPs (Table 3-4), exemplifying the wealth of 
knowledge HCPs possess. 
 
3.6.3 Patients’ Use of Herbal Medicines  
This section of the survey tried to establish whether or not patients reported their use of HMs 
to their HCPs, how often HCPs came across patients using THM, and HCPs experience and 
knowledge of adverse effects and interaction caused by the consumption of HMs. This 
analysis represents the results of 98 participants who completed this section.  
 
Question 5: Do you currently have contact with patients? 
This question was added shortly after the survey was launched; as after reviewing the initial 
responses it was decided to assess whether or not HCPs were actually dealing with patients. 
This was to determine how many of the respondents were actively practicing their 
profession. As the question was added later, 11 participants had missed the question. Of 
those who did complete the question 91% (n=79) said they were in contact with patients, 
while just 9% (n=8) were not. Participants who were not in contact with patients were 
generally working in academia, research, or retired; they completed the survey based on their 
previous experience while working with patients. In addition, some HCPs no longer had 
regular contact with patients but were involved in different aspects of patient care for 
example superintendent pharmacists responsible for the overall management of professional 
services across pharmacies. 
 
Question 6: Do your patients tell you about any herbal medicines they use? 
As many as 52% of patients in the UK have tried some form of complementary therapy at 
some point, with HMs reported as the most common form used (Posadzki et al., 2012). One 
third of HCPs (33%, n=32) who answered this question said their patients did not tell them 
114 
Sukvinder Kaur Bhamra 
about any HMs they used. A small number of participants (2%, n=2) selected the ‘not 
applicable’ option as they did not have contact with patients, so could not answer the 
question. Newall et al. (1996) claims that doctors are becoming increasingly aware of their 
patients’ use of HMs. This is supported by the results of this survey which revealed that 65% 
(n=64) of HCPs said their patients did tell them about their use of HMs. Practitioners of 
CWM have not always accepted the use of HMs; however, there appears to be a change in 
the attitude of Western HCPs to complementary therapies (Vickers, 2000). In order to build 
trust with patients, so patients feel comfortable telling HCPs about their use of HMs, HCPs 
must keep an open mind and be approachable (GMC, 2009).  
Vickers (1994) identified that there is an increasing use of complementary therapies across 
Europe, and doctors should routinely include questions about complementary therapies when 
taking a patients history. Upon reflection of this survey, a question about whether or not 
HCPs asked patients about their use of HMs should have been included; to see if HCPs were 
proactive in finding out about their patients’ use of HMs. Heuschkel et al. (2002) looked at 
the use of HMs in children and young adults with inflammatory bowel disease and found that 
just 8% of doctors initiated a discussion about CAM. If patients do not tell their HCPs about 
their use of HMs it can have serious consequences, such as patients delaying seeking medical 
attention which could exacerbate their condition (Pharmaceutical Press, 2013). HCPs should 
be encouraged to routinely ask patients about their use of HMs (Heuschkel et al., 2002).  
 
Question 7: How often do you come across patients who take herbal medicines alongside 
their prescription medicines? 
When the initial version of the questionnaire was submitted for review to the DMU ethics 
committee this question was created using the likert scale: ‘Very Frequently, Frequently, 
Occasionally, Rarely, Never.’ The ethics panel review of the questionnaire led them to ask, 
‘how frequently is frequently?’ They suggested modifying the scale to justify the frequency 
of reporting; thus the terms ‘Daily, Weekly, Monthly, Annually, and Never’ were used.  
Figure 3-7 reveals that most HCPs did come across patients who were using HMs alongside 
their prescription medication. Very few HCPs (3%, n=3) claimed they met patients who told 
them about their use of HMs daily (this would be equal to the ‘very frequent’ option on the 
original likert scale).The majority of HCPs (35%, n=34) said patients reported their use of 
HMs ‘monthly’, an equal proportion (22%, n=22) selected ‘weekly’ or ‘annually’. Those 
HCPs who disclosed that patients never reported their use of HMs (17%, n=17), most 
worked in academia or research, some were pharmacists in managerial or office based roles 
(i.e. chief or clinical research pharmacists), optometry students, and a dentist.  
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Figure 3-7 Frequency of Patients Reporting their Use of Herbal Medicines to HCPs 
De Smet et al. (1997) claim patients may feel reluctant to tell their HCPs about their use of 
HMs; this was also observed in the results from the SATMED questionnaire, where 
participants did not want to tell their HCPs about their use of THM. The SATMED 
questionnaire participants revealed they were scared of being treated differently or judged by 
their HCPs. HCPs have the opportunity to build a relationship and trust with their patients. 
During consultations if patients feel they can trust their HCP they may feel more inclined to 
disclose their use of HMs. Patients may not think that reporting their use of HMs is 
important, due to the common misconception that, ‘herbal remedies are natural and therefore 
safe’ (Ipsos MORI, 2008; Shaw et al., 2012). In some situations, such as before surgery, it is 
vital for HCPs to know whether or not patients take HMs as there could be complications if 
not disclosed (Ang-Lee et al., 2001). Overall, the results from this question suggest that more 
HCPs claimed that they were informed about their patients’ use of HMs than those who were 
not.  
 
Question 8: Have you encountered any adverse effects caused by the consumption of 
herbal medicines? 
Adverse effects from HMs could be anything from a minor side-effect, such as local 
irritation from using witch hazel for skin conditions, to life threatening reactions like cancer 
or hepatotoxicity caused by comfrey (Pharmaceutical Press, 2013); 31% (n=30) of HCPs in 
this survey claimed to have encountered an adverse drug reaction (ADR) associated with 
HMs (Table 3-5). An example of a serious herbal-ADR caused by the consumption of garlic 
supplements was identified by participant 15, an anaesthetic registrar, whereby the patient 
had impaired blood coagulation which caused severe blood loss during surgery. It has been 
suggested that garlic can have an anti-platelet effect similar to that of low-dose aspirin; 
therefore, if taken with other blood thinning drugs there is an increased risk of bleeding 
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(Williamson et al., 2013). Participant 22 (a medicines information pharmacist) recalled a 
patient with deranged liver functions after taking Kava kava (Piper methysticum G.Frost.); a 
product which is now prohibited in the UK and many other countries due to the fatal 
hepatotoxic effects associated with its use (Mann and Andrews, 2007). In 2006, 79 reports of 
liver damage associated with the use of Kava were reported to the MHRA (Pharmaceutical 
Press, 2013), which eventually led to it being banned in the UK. 
There are several well documented adverse effects caused by the consumption of HMs, 
including: heartburn caused by peppermint, hypoglycaemia caused by karela or fenugreek, 
and renal failure or cancer caused by Aristolochia species (Newall et al., 1996; Shaw, 2010). 
Although peppermint is considered to be a HM it is one of the few products prescribed by 
UK HCPs for abdominal colic or irritable bowel syndrome (BNF July, 2015). As it is 
regulated and its efficacy has been clinically tested, the ADRs associated with its use are 
well known i.e. as it’s an irritant it can cause hypersensitivity reactions such as headache, 
bradycardia, and muscle tremor (Pharmaceutical Press, 2013). However, with most other 
HMs there is limited knowledge and information available on the ADRs associated with their 
use, making it imperative to conduct more research on the safety and efficacy of HMs. 
Shaw (2010) claims that adverse effects from HMs may be due to the unregulated use of 
HMs, poor quality of herbals, adulterated or contaminated herbs, or the wrong or 
misidentified herbs being used. Participant 59 also listed several reasons why patients may 
experience adverse effects after consuming HMs, such as “contaminated products due to 
poor quality controls” and “adverse synergistic effects with existing prescription drugs.” 
Several references to ADRs caused by Chinese herbal medicines which contain steroid 
contamination were also noted by participants 49, 72 and 109. 
Pharmacovigilance involves monitoring drug safety and adverse effects. WHO (2015) 
defines pharmacovigilance as, “science and activities relating to the detection, assessment, 
understanding, and prevention of adverse effects or any other drug-related problem.” It 
begins during clinical trials and continues once the drug is available on the market (Sarker et 
al., 2015). Although, it is focused on conventional medicines the same principles can be 
applied to HMs (Barnes, 2003). The Medicines and Healthcare products Regulatory Agency 
(MHRA) established the ‘yellow card scheme’ (YCS) to monitor the safety of all healthcare 
products in the UK, including HMs (MHRA, 2014a). Until 1996 the YCS only collected 
ADR information on licensed HMs; however, in October 1996 this was changed to include 
all HMs (Mann and Andrews, 2007). Shaw et al. (2012) claims that as the use of HMs has 
increased, the reports of adverse effects should have also risen; despite this, the number of 
reports remains low (Barnes, 2003). This was also found in the results of this survey 
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whereby 69% (n=68) of HCPs said they had not come across any adverse effects caused by 
the consumption of HMs. In 2001, 70 reports of herbal-ADRs were received by the MHRA, 
this formed just 0.4% of the total number or reports received in 2001 (Mann and Andrews, 
2007). The latest MHRA Annual Report and Accounts 2014/15 reveals that 14,836 ADRs 
were reported, a 12.5% increase in the last three years; however, it does not specify the 
number of herbal-ADRs reported (MHRA, 2014b). The Herbal Medicines Advisory 
Committee Annual Reports 2014 identified that 51 reports of ADRs from herbal medicinal 
products (excluding food, cosmetics, and homeopathic products) were received via the YCS 
in 2014 (MHRA, 2014c).  
Unlike CWM which have undergone clinical trials and extensive research to document their 
safety and efficacy profiles, often the only evidence for the safety and efficacy of HMs is 
their long standing use throughout history (De Smet et al., 1997). Traditional knowledge of 
HMs is not well documented, let alone the adverse effects which may be associated. In 
addition, peoples’ lack of knowledge of the adverse effects caused by HMs could have an 
important role in the severe underreporting of adverse reactions caused by HMs. Educating 
the public about potential herbal-ADRs caused by HMs could help people use them safely 
and reinforce the importance of reporting via the YCS (Pharmaceutical Press, 2013). The 
need to improve pharmacovigilance of HMs to ensure people use them safely is of 
paramount importance (Barnes et al., 1998).  
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Table 3-5 Adverse Effects Encountered From Patients Taking Herbal Medicines 
Participant 
Number: 
Adverse Effects From Taking Traditional Herbal Remedies: 
2 
Loose stools, digestive problems, nausea, dizziness, raised liver 
enzymes. 
15 
Impaired coagulation leading to excess blood loss at surgery - patient 
taking garlic supplements. 
Excess liquorice consumption has been reported to cause malignant 
hypertension. 
20 Hypoglycaemia with karela. 
22 
Deranged liver function with Kava kava. 
Collapse with multi-constituent product.  
Organ failure in baby from unidentified Asian medicine ....to name a 
few. 
33 
When I worked in Oncology there were a number of occasions when 
ladies being treated with trastuzumab for breast cancer asked about 
whether there was a problem if they were taking a herbal product. The 
answer was always possibly and in one case the patient taking 
Hypericum had her dose delayed until she had stopped taking it. 
36 Renal impairment. 
44 
A number of years ago, i was informed by a colleague of a patient who 
had been admitted with liver impairment thought to be caused by an 
Indian herbal remedy. 
49 Only Chinese herbal medicines that have potent steroids in. 
56 
Not so much herbal but a patient using green vegetable juices for 
cancer; but, also taking warfarin and ended up with nose bleeds. 
57 Digestion issues. 
59 
Many adverse reactions due to:  
a) contaminated products due to poor quality controls 
b) deliberately adulterated products to give an effect 
c) adverse synergistic effects with existing prescription drugs 
d) side effects of herbal medicines. 
60 
Malignant Neuroleptic Syndrome. 
Serotonergic Syndrome.  
61 Liver damage due to use of TCM herbal remedy for eczema. 
62 
Many side effects have been described in literature and in MHRA 
warnings. 
72 
Renal failure after use of an aphrodisiac steroids in skin cream leading 
to skin thinning. 
75 
Severe GI bleed resulting in prolonged ICU admission, herbal medicine 
was for memory (not exactly sure as it has been some time since) but 
was not gingko. 
79 Use of garlic. 
82 
Unsure whether traditional remedies were the causative item but 
dramatic increase in blood pressure for heart failure patient when 
taking both traditional and Western medicines , but this was about 10 
years ago. 
100 Urticaria. 
109 
Many years ago a patient taking a Chinese tea remedy which had 
steroids in it. 
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Question 9: Are you aware of any interactions between herbal medicines and 
conventional Western medicines? 
Over a third of participants (37%, n=36) said they did not know of any interactions between 
HMs and CWM; while, the majority of participants (63%, n=62) said they were aware of 
interactions. Those participants who said they knew of interactions between HMs and CWM, 
56% (n=55) named at least one interaction (Table 3-6). The most common herbal product 
known to interact, described by 37% (n=33) of participants, was St Johns Wort (SJW). SJW 
is one of the most well-known herbal remedies which has been used to treat mild depression, 
anxiety, sleep disorder, seasonal affective disorder, toothache, pain, gastritis, stomach ulcers, 
and aid local wound healing (Chevallier, 2007). Due to the numerous interactions with 
CWM it has been extensively researched. There are several active constituents in SJW 
responsible for its diverse medical uses including flavonoids, hypericin, and hyperforin 
(Williamson et al., 2013). SJW is known to affect a number of the cytochrome (CYP) P450 
enzymes which accounts for the range of interactions associated with it. It has an enzyme 
inducing effect on the CYP 3A4, CYP 219 and CYP 2E1 isoenzymes. The role of these 
isoenzymes on drug distribution and metabolism is speeded up rendering other drugs less or 
ineffective; this causes SJW to interact with drugs such as anti-epileptics (carbamazepine 
and phenytoin), contraceptive pills, ciclosporin, theophylline, antidepressants – monoamine 
oxidase inhibitors (MAOIs) and selective serotonin reuptake inhibitors (SSRIs), and warfarin 
(Henderson et al., 2002; Williamson et al., 2013). SJW can also affect the transporter protein 
P-glycoprotein, which has an essential role in drug absorption from the intestine, and 
distribution, acting as a drug efflux pump (Gurley et al., 2008). One of the main drugs 
affected by this mechanism is digoxin, a drug which has a narrow therapeutic index; 
therefore, small variations in blood concentrations can lead to toxicity or a sub therapeutic 
dose (Currie et al., 2011). There are several studies which demonstrate that the induction of 
the P-glycoprotein in the intestine by SJW leads to reduced absorption of digoxin (Hennessy 
et al., 2002); hence reducing the concentration of digoxin in the blood rendering the drug 
ineffective. Other drugs affected by this include ciclosporin and fexofenadine (Gurley et al., 
2008).  
Participants also mentioned the interactions between warfarin and several herbal remedies 
such as ginseng, gingko, garlic, and cranberry juice. It has been reported that these 
substances can impair platelet aggregation, therefore effect blood coagulation. The 
International Normalised Ratio (INR) is a measure of the blood coagulation, which should be 
between 2-3 depending on the condition for which warfarin is initiated (BNF, 2015). A high 
INR means the blood is thinner so takes longer to clot, increasing the risk of bleeding; while 
a low INR means the blood clots too quickly. As these HMs reduce platelet aggregation, if 
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taken with warfarin they can also increase the risk of bleeding. One study claimed that 
ginseng reduced the effectiveness of warfarin; however, the pharmacological mechanism 
remains unclear (Yuan et al., 2004). Reports that cranberry juice inhibited the metabolism of 
warfarin therefore reducing its clearance from the body and increasing its effects were 
documented by the Committee of Safety of Medicines /MHRA when several incidents of 
increased INR and bleeding were reported (CSM/MHRA 2003). A study in the UK which 
looked at the pharmaceutical care plans of 631 patients in an outpatient anticoagulant clinic 
found that 170 patients were using some form of HM at the same time as taking warfarin; of 
these patients 58% were taking something which could potentially interact with warfarin. 
The authors concluded that by taking a full drug history from patients, potential interactions 
between HMs and warfarin could be avoided (Ramsay et al., 2005). Fugh-Berman and Ernst 
(2001) say those taking anticoagulants especially coumarins should generally be advised to 
avoid taking any HMs. 
As the practice of polypharmacy, whereby multiple drugs are consumed concurrently is 
becoming more common (Edwards et al., 2012), the risk of interactions between HMs and 
CWM needs to be considered. Furthermore, HCPs need to be more aware about potential 
interactions which could affect their patients’ health. Although there are some valuable texts 
which summarise herb-drug interactions published (e.g. Stockley’s Herbal Medicines 
Interactions - Williamson et al., 2013), such books are not readily available to HCPs. As 
identified by participants 20, 59, and 67 there are a variety of sources available to determine 
herb-drug interactions; however due to the lack of research on many HMs there may be 
limited evidence available to inform and guide HCPs.  
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Table 3-6 Interactions between Herbal and Conventional Western Medicines Identified by Healthcare 
Professionals 
Participant 
Number: 
Interactions between Traditional Herbal Medicines and  
Conventional Western Medicines: 
2 
St John's wort with contraceptives and anti-depressants (SSRI's and 
MAOI's).  
Dan shen with anticoagulants. 
10 
St John's wort interacts with many drugs as it is a cytochrome P450 3AE 
inducer; for example, oral contraceptives, warfarin, and simvastatin. 
12 
I'm aware of a lot of interactions between herbal medicines and P-
glycoprotein and cytochrome enzymes, which can in turn affect drugs 
that are dependent on them. St John's wort is an example of a herbal 
medicine that can produce such interactions. 
15 
Too many to list- St. John's wort & SSRIs can cause serotonin syndrome. 
Garlic, ginkgo & ginseng in combination with fish oil can cause 
impaired coagulation /blood pressure. 
16 St. John's wort and warfarin. 
17 
While working as a medicines information pharmacist in secondary 
care, I formulated a table of interactions between warfarin and a large 
variety of herbal/traditional compounds. 
18 
St. John's Wort and various other medications, including some anti-
retrovirals. 
20 I refer to Stockley-particularly for St. John's wort. 
22 INR changes Enzyme induction Additive side effects. 
24 St. John's wort. 
25 St John's wort interacts with CYP450 liver metabolised drugs. 
26 St. John's wort and warfarin. 
30 
Ginseng known to interact as well as St. John's wort with antiretrovirals 
for HIV. 
Aloe vera reduces drug absorption of many drugs Maca can interact as 
it’s an enzyme inducer. 
32 
St John's wort and a plethora of Western medicines.  
Some questions about the use of antioxidants alongside chemotherapy or 
targeted therapies.  
Plenty of theoretical interactions e.g. aloe vera juice speeding up the GI 
tract and possibly causing a reduction in absorbed medications. 
34 St. John's wort. 
36 Hepatic enzyme inhibition. 
40 Cranberry juice and warfarin. 
42 St John’s wort is widely documented. 
48 St. John's wort with levongesterel. 
53 St John’s wort and P450 interactions. 
56 
Many potential interactions between St John's wort and various 
medications.  
Also concern with many herbal remedies for renal patients as most 
herbal remedies filtered via kidneys e.g. liquorice/nettle etc. 
57 The usual ones given by the MHRA, NIH, etc. 
58 SSRI and evening primrose. 
59 
Yes, well documented in the literature, e.g. 
http://www.ncbi.nlm.nih.gov/pubmed/10953464 
http://www.sciencedirect.com/science/article/pii/S0024320505012452 
http://archinte.jamanetwork.com/article.aspx?articleid=522673 
http://www.sciencedirect.com/science/article/pii/S1043661810000915 
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and many more. 
60 St John's Wort with SSRI, MAO-I and neuroleptics. 
61 
Enzyme induction e.g. Contraceptive pill failure due to use of St John's 
wort.  
Especially  CYP450 - warfarin potentiation 
62 Many have been described in the literature. 
63 
St John's wort interacts with lots of things e.g. warfarin, tyramine 
containing foods. Gingko biloba with warfarin. 
Ginseng with aspirin, clopidogrel, and warfarin. 
64 
I would always check for known or possible interactions and be very 
careful with things like warfarin. 
65 Too many to describe. 
66 
St John's Wort interacts with many medicines. There are too many other 
interactions to list here. See standard pharmacology and 
pharmacognosy texts. 
67 
I have a book on the subject. Herb-Drug interactions in oncology by 
Cassileth, Yeung and Gubili, Memorial Sloan-Kettering Cancer Centre 
People's Medical Publishing House, Shelton Connecticut. 
68 St John’s wort. 
69 St John's wort interacts with many drugs, e.g. warfarin. 
70 The basics like St John’s wort as an enzyme inducer etc. 
71 
St John's wort interacts with many conventional pharmaceuticals, 
including statins, beta blockers and antiretroviral drugs. 
72 St John’s wort and anticoagulants. 
73 
But only through the literature. It is always difficult to relate cause and 
effect in individual cases. 
74 
Garlic and anti-coagulants. 
St John’s wort and many medicines. 
75 St. John's wort, Echinacea, gingko, garlic, red yeast rice. 
77 Mainly the pill. 
79 St John’s Wort especially. 
81 St John’s Wort. 
82 Depends if St John’s wort is classed as traditional or not! 
84 St John’s wort and warfarin. 
87 St John’s wort etc. 
88 
Ginseng and blood pressure medications. 
Warfarin and high consumption of green vegetables (iron content). 
90 Saint John’s wort and various hormonal medications. 
92 St. John's wort and warfarin. 
93 Some augment the actions of oestrogen in HRT. 
100 Need to avoid with some anti-hypertensive medicines. 
103 
St John's Wort and antidepressants. 
Ginkgo Biloba with various drugs 
104 St John’s wort can interfere with Western antidepressants. 
110 St John's Wort, Black Cohosh, EPO/GLA, Saw palmetto. 
111 St John’s Wort interacts with contraceptive pill. 
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3.6.4 Professional Opinions of Herbal Medicines   
The final part of the questionnaire aimed to investigate HCPs professional opinions on the 
safety and efficacy of HMs. The literature search around this topic revealed that there was 
limited information available about how much information is passed on to undergraduate 
HCPs during their courses (Smith, 2011); for this reason participants were asked whether or 
not they received sufficient education on HMs during their training. This section was 
completed by 96 participants. 
 
Question 10: Do you think the use of plants, herbs and spices is effective to prevent or 
treat various health conditions? 
Two thirds of the participants (66%, n=63) said they thought HMs were effective. 
Participants commented on how the long standing use of HMs throughout history was an 
important factor in determining the efficacy of HMs; as demonstrated by participant 42 (a 
pharmacist) who stated, “Pharmacy is generally sceptical about the use of traditional herbal 
medicines because of lack of scientific studies but, in my opinion, traditional herbal 
medicines can be very effective in non-Western countries where there is a tradition for this. 
If something has been used for centuries and works then it works.” In addition, participant 
36 (a consultant physician) claimed, “I am sure that there is some evidence of benefit (even if 
placebo effect) for some herbal medicines - but I do not see them as a replacement for 
conventional medicine.” Despite the limited evidence to support the health claims associated 
with HMs the transmission of this knowledge throughout time has been used an indicator for 
the efficacy of HMs.  
The remaining third of participants (34%, n=33) who did not think HMs were effective or 
any better than a placebo, made comments regarding the lack of evidence to prove the 
efficacy of HMs. The emphasis on the lack of reliable scientific evidence to support the use 
of HMs, was illustrated by participant 62 who said, “If you look at NCCAM's herbs at a 
glance (http://nccam.nih.gov/health/herbsataglance.htm) you will see that there is not a 
single herbal preparation for which there is good evidence for efficacy, even according to 
this pro- CAM organisation. They originated in a time when anecdote rather than proper 
testing sufficed; there is no excuse for pharmacies selling things that are either unproven or 
disproved.”  
Although there were mixed reviews about the effectiveness of HMs, some participants 
suggested that HMs were used to supplement CWM, especially in patients with cancer and 
HIV. Participant 63 (a GP) said, “Western medicine alone is not enough to treat someone 
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holistically. Additional approaches are required, including herbal medicines and 
complementary therapies e.g. art therapy, hypnotherapy. Many issues are stress related or 
exacerbated by stress and these unfortunately are not dealt with adequately.” This is 
supported by findings from Awodele et al. (2012) who uncovered that 41% (n=123) of 
participants in their survey of Nigerian HCPs thought that HMs were effective for chronic 
conditions; although none thought that HMs alone could be used to treat a patient. 
Subscribers to the DTB were asked to complete a survey about HMs, of the 164 respondents 
who were asked if they thought HMs were helpful: 22.2% (n=36) said ‘rarely or never’ 
while 75.3% (n=122) said HMs were helpful ‘in some circumstances’ (DTB, 2010).  
It is well known that many of the HMs used are based on their traditional reputation rather 
than clinical evidence (Newall et al., 1996). In addition, many HMs may be used in their 
crude form, rather than in pharmaceutical formulations making it difficult to determine the 
safety and efficacy of HMs due to the vast range of formulations and irregular doses. The 
emphasis on evidence based medicines requires validated scientific evidence including 
randomised controlled trials which prove the efficacy of drugs; however, this information is 
not available for most HMs (Pharmaceutical Press, 2013). More research on HMs is now 
being conducted to validate the efficacy of HMs. For example, the wealth of literature 
available on SJW which has provided useful evidence to support the traditional health claims 
associated with its use. The vast amount of information available on SJW has even led some 
people to question whether it is still considered a HM or a CWM as stated by participant 82, 
“depends if St John’s wort is classed as traditional or not!”  
The results for question 10 demonstrate the different views HCPs had regarding the efficacy 
of HMs. A larger number of participants agreed that HMs were effective for some health 
conditions; however, there were still some reservations regarding the perceived efficacy of 
HMs due to the lack of clinical data to support their use. 
 
Question 11: Do you think the use of plants, herbs and spices is safe? 
One of the reasons for the popularity of HMs is the belief that they are natural and therefore 
safe (Shaw et al., 2012); similar views were shared by 58% (n=56) of participants in this 
survey who thought HMs were safe. Participant 42 (a pharmacist) who agreed HMs were 
safe stated, “conventional Western medicines are just as harmful as traditional herbal 
medicines if used improperly and in excess.” On the other hand, 42% (n=40) of HCPs did 
not agree that HMs were safe. Some participants stated that HMs may be more dangerous 
than CWM due to the lack of evidence to support their use. Various reasons participants felt 
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HMs were not safe included the lack of clinical evidence to support their use, the lack of 
regulation of HMs, and problems of quality and contamination. Several participants 
commented on the need for proper regulation to be able to determine the safety of HMs. 
Participant 36 (a consultant physician) said, “Whilst only a small amount of harms are 
caused - I cannot call them safe because in some instances they are not. I think that all in all 
more regulation is needed and then I would consider the patient's views in taking a cautious 
approach to use of herbal remedies in some conditions,” and participant 44 (a pharmacist) 
who noted, “Traditional herbal medicines need to be regulated better, I have seen recent 
reports of hazardous contaminants.” 
An interesting statement was made by participant 15 (an anaesthesia registrar) who claimed, 
“It's more complex than whether they're safe or not - it depends on the dose, what other 
medication the patient is on & the interaction between them (if any). Often, herbal products 
have inconsistent concentrations between batches & therefore the true dose is never known. 
There have been instances of additives not listed on packaging also being included in the 
product - I feel generally these products are an unknown quantity because the contents, 
concentration & production methods are subject to much lower standards of scrutiny than 
tablets. They are drugs just as much as tablets are, the 'herbal' label lulls people into 
thinking there are no possible side effects - this is not true, nor is it safe.” This reiterates that 
there are numerous factors which can affect the safety of HMs including: the dose (high 
doses may cause toxicity), co-morbidities (taking HMs while taking CWM increases the risk 
of interactions), time of use (before surgery could impair blood coagulation or cause 
complications, during pregnancy or lactation could affect the baby), adulteration (the wrong 
species selected), or contamination (heavy metals or other active constituents) (Upton and 
Romm, 2012). Furthermore, participant 59 stated, “For most conditions, herbal medicine is 
unnecessary, ineffective and the risk of interactions with pharmaceutical drugs too high to 
recommend using them for any condition. Contamination (accidental, natural and 
deliberate) means their safety will always be in question.” 
Some herbal products are now prohibited or have restricted use in the UK due to the safety 
concerns associated with them. The MHRA document ‘Banned and restricted herbal 
ingredients’ updated in December 2014, lists all the products which are subject to 
restrictions in the UK. It includes completely restricted products such as aristolochia, Kava-
kava, and aconite (Aconitum species) traditionally used for poison arrows. Other products 
which can only be prescribed by a registered doctor or dentist include: foxglove (Digitalis 
purpurea L.) and opium (Papaver somniferum L.). Some products can only be purchased 
from a registered pharmacy under the supervision of a pharmacist such as, Mistletoe berry 
(Viscum album L.) and Belladonna (Atropa belladonna L.) (MHRA, 2014d). Before 
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concerns of the risks, adverse effects, and fatalities were recognised some of these products 
were widely available; but, over time as more reports documented the risks associated with 
them, they were withdrawn from the market.     
All drugs which have a marketing authorisation have to undergo extensive research to 
validate the risks and benefits of treatment; whereas, HMs may be consumed without any 
clinical research to support their use. The fact that HMs have been used for hundreds of 
years does not suggest they are safe (Barnes et al., 1998). Herbal products known to cause 
adverse effects or which may be harmful can be avoided; however, this information may not 
always be known and the long term implications remain to be uncovered. The risks of herb-
drug interactions can affect the efficacy of conventional medicines which may threaten the 
pharmaceutical care of patients (Pharmaceutical Press, 2013). Participants in this survey also 
made reference to the fact that HMs were harmful as their patients were more reluctant to 
take CWM if they were taking HMs, making health problems worse and more difficult to 
manage once they had exacerbated. There were several concerns raised over the safety of 
HMs; nevertheless, with better information sharing between patients and their HCPs, 
reporting of ADRs, and more research on HMs the safety profiles for herbal products can be 
better understood.    
 
Question 12: Would you ever recommend herbal medicines to your patients? 
Various reasons for not recommending HMs to patients were identified by 65% (n=62) of 
participants, including: participant 51 (an independent public health specialist) who said he 
would not recommend HMs, “Because of the antipathy and overabundance of perceived 
problems related to herbal remedies by the medical profession,” participant 56 (a dietician) 
who claimed there was, “Not enough evidence to support the use of herbal medicines and 
potential interactions with Western medicines,” and participant 69 (a doctor) who stated, “It 
all depends on the evidence base! Great damage is done when people take alternative 
medicine instead of medicine proven to work.” The Mintel Report (2009) claims that doctors 
and pharmacists may be uncomfortable referring patients to herbalism due to the lack of 
regulation, this was also observed within this research sample whereby HCPs said that the 
lack of regulation was one of the main reasons for not recommending HMs. This is further 
supported by the findings of the DTB survey of HMs which found that 84% (n=138) of 
HCPs surveyed did not think HMs were well regulated (DTB, 2010).  
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Some of the other reasons participants in this study refused to recommend HMs to patients 
included: 
Participant 16 (clinical pharmacist), “Difficult to quantify, as each case would vary in view 
of co-morbidities and individuals.”  
Participant 22 (medicines information pharmacist), “As a healthcare professional 
recommendations on treatment should be evidence based...evidence for efficacy and safety of 
herbal remedies is lacking, therefore I would not recommend herbal remedies.” 
Participant 32 (senior pharmacist), “There are not enough large comparable clinical trials 
into herbal medicines to warrant advising patients to use them instead of Western medicines. 
There is insufficient data for mixing herbal medicines and Western medicines, much of the 
advice provided to my patients if they state they want to use herbs as well as Western 
medicine is based on limited data and theory.” 
Participant 77 (GP), “I work on evidence based medicine principles and therefore unless 
trial evidence available I could not in good faith recommend them.”  
Participant 84 (pharmacist), “I do not recommend herbal remedies due to concerns over 
interactions with conventional medication. I think they could play a role in 
prevention/treatment of health conditions but there is variable quality between preparations 
which again means I do not feel I can recommend them. I do not see the harm in someone 
not taking a conventional medication trying herbal remedies.” 
According to the GPhC standards of conduct, ethics, and performance, pharmacist are not 
allowed to recommend any remedy where they have any reason to doubt the safety or quality 
(Rees et al., 2014). In addition, pharmacists should only offer advice on HMs if they have 
had suitable training or knowledge. Some participants who said they would not recommend 
HMs went on to say they would recommend HMs if they had better knowledge of HMs; like 
participant 11 (a pharmacist) who claimed, “I would recommend herbal remedies to patients 
if my knowledge on it was sufficient. As I do not know much about it and how it works to 
treat different conditions, I cannot really recommend it.” Similarly to the findings of this 
research, Koh et al. (2003) found that many pharmacists like doctors did not believe they had 
the basic knowledge about HMs to be able to recommend them safely.  
Other participants who said they would recommend HMs if there was more evidence to 
support their use such as participant 69 (a doctor) who said, “Herbal remedies are fine, but I 
will only prescribe them when I have evidence that they work better than conventional 
therapy and that they are safe to use within the context of the pharmaceutical regimens the 
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patient is already on.” Furthermore, participant 106 (a pharmacist) claimed, “The biggest 
problem with traditional herbal remedies is lack of information. The most common query I 
get regarding herbal products is "Is this safe with my other medication?" While there are 
very good books around (e.g. Stockley's Herbal Medicines Interactions) and advice (e.g. 
from the NPA) the books are rarely available in the average pharmacy and a phone enquiry 
cannot always give the immediate response that a customer may want. As a result it is 
frequently necessary to err on the side of caution and say that I cannot recommend it as I do 
not have sufficient information on the product.”  
Just 35% (n=34) of participants said they would recommend HMs to their patients. The types 
of herbal remedies participants said they would recommend are summarised in Table 3-7. 
The most common herbal remedies participants said they would recommend included 
turmeric for various ailments such as cough, sore throat, skin conditions, and wound healing. 
Honey and lemon for coughs and colds, and evening primrose oil for low mood. Some of the 
reasons participants said they would recommend HMs to their patients included:  
Participant 12 (pharmacist), “The use of herbal medicines is safe if used in context of other 
co-administered drugs and with full knowledge of the effects of the herb.” 
Participant 20 (clinical pharmacist/ senior lecturer), “Alongside allopathic medicines 
provided the patient consults the pharmacist - I think the patients’ faith in day to day 
traditional herbs and spices also helps them psychologically.” 
Participant 27 (optometrist student), “Because it will most probably be preservative free 
meaning less adverse reactions from patients. Most likely to have less side effects. More 
positive effects then negative even if used long term. Herbal medicines are sustainable.” 
Participant 70 (pharmacist/ researcher), “If they are effective and safe, why not?”  
Participant 88 (pharmacist), “Because it is safer, effective and with less side effect than 
conventional medicine.”  
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Table 3-7 Herbal Remedies Healthcare Professionals Would Recommend To Their Patients  
Participant 
Number: 
Herbal Remedies Healthcare Professionals Would Recommend:  
2 
Turmeric for digestive complaints.  
Rhodiola for energy. 
Saw Palmetto for Libido. 
3 
Using ginger in tea or in foods to help with sickness. 
Green tea to help with digestion and due to anti- oxidant properties. 
6 Tea bags for dry eyes.  
18 Peppermint products for IBS.  
21 Turmeric as it works for me!  
23 
For minor ailments such as cough and cold: honey and liquorice, honey 
and lemon.  
For Indigestion: fennel seeds, mint, aniseed. 
26 
Aloe vera creams, neem soap-is effective for patients who have skin 
conditions such as eczema.  
46 
Very simple remedies which I have tried and tested, mainly those 
involving turmeric and honey as previously stated. 
47 For examples garlic against infections.  
49 Yam for arthritis. 
63 
Passion flower for stress. 
Agnus castus for PMS/ cycle regulation. 
Saw palmetto for prostate (BP) related lower urinary tract symptoms. 
64 For mood - St. John's wort or evening primrose oil.  
68 
Black cohosh. 
Evening primrose oil 
Saw palmetto.  
73 
Of course most elements and biological substances have active 
ingredients and while all are bad for you in excess- even water - many 
have been synthesised, including the first manufactured drug aspirin 
(from salicylic acid, originally from tree bark). In fact when herbal 
remedies are proved in scientific trials to have beneficial effect they are 
absorbed in mainstream medicine. What is left is usually of minor or no 
value, based on placebo effect and encouraging pseudoscience. 
74 Honey and lemon is much better than cough syrups.  
81 Peppermint for digestive issues.  
82 Echinacea proven remedy anything that I have the evidence for.  
91 
Typically, for constipation- figs, prunes and pears. Natural constipation 
relief with the added benefit of all other associated nutrients. 
103 Prevention as part of balanced diet.  
108 
I’ve recommended using cider vinegar to help with arthritis as I’ve seen 
that it helped my mum. 
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Howard et al. (2001) found that in their survey of 70 pharmacists, 53% claimed to use 
dietary supplements themselves, they later went on to conclude that personal use correlated 
to an increased likelihood of making a recommendation to a patient. This can also be seen 
from the results of this investigation; participants who used HMs were generally more 
inclined to recommend them to their patients (Figure 3-8). Newall et al. (1996) say that 
HCPs need to be aware of the suitability of herbal remedies, even if HCPs do not use HMs 
themselves or believe they are effective they should still have some awareness about HMs as 
their patients may be using them. 
Heuschkel et al. (2002) found that one of the reasons respondents in their survey, about the 
use of CAM in patients with IBD, said they would use complementary therapies was if they 
were recommended by a doctor. The results from this survey suggest that some HCPs would 
recommend HMs, while others may have their reservations. Generally, the reasons for not 
recommending HMs were due to concerns of potential interactions with CWM, reduced 
compliance with prescribed medication, lack of evidence to support the use of HMs (i.e. 
limited safety and efficacy data), and HCPs personal lack of knowledge of HMs. Participants 
who were happy to recommend HMs had positive attitudes towards HMs, and often had tried 
HMs themselves. If there was better evidence to support the use of HMs and HCPs were 
more competent many said they would recommend HMs to their patients.  
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Question 13: Did you receive any information about herbal medicines during your 
professional training? 
As the literature available on how much information is passed on to undergraduate HCPs 
was limited this question was designed to try and establish whether or not HCPs in the UK 
had received any training on HMs. Over a third of participants (35%, n= 34) said they did 
receive some information on HMs while undertaking their professional training. This was 
exemplified by participant 33 (a senior lecturer in law, ethics and pharmacy practice) who 
said, “When I trained (in the 1970's) there was a large amount of pharmacognosy taught 
and that did cover materials of plant origin but not herbal remedies specifically.”  
However, a large number of participants (65%, n=62) said they did not receive any 
information about HMs during their training. HCPs are at the frontline of patient care so 
need to be competent in giving advice and treating patients appropriately especially if they 
may be taking HMs. If HCPs are not adequately trained it could affect patient care, increase 
the risk of interactions with CWM, and adverse effects may go undetected.  
 
Question 14: Do you think enough training is provided to you about herbal medicines? 
The results from this question revealed that the vast majority of participants (74%, n=71) 
said they did not think enough information was provided to them on HMs. Participant 67 (a 
professor emeritus of surgery and medical humanities) stated, “Our students should be 
taught that there are no metaphysical difference in biological activity between herbal and 
pharmaceuticals.” Koh et al. (2003) conducted over 400 surveys on pharmacists in 
Singapore to find out about their use, knowledge and attitudes towards CAM; they found that 
90.5% (n=380) felt not enough information on CAM was provided during their training.  
Although regulatory bodies such as the GMC and GPhC do require undergraduate students 
to be informed about CAM, they do not specify the content. As the brief is often so broad 
(i.e. the GPhC standards for education states ‘complementary therapies’) this leaves schools 
open to decide what they think is suitable to meet the requirements (GPhC, 2011). Research 
by Smith (2011) found that in some medical schools, in the UK, a single lecture was deemed 
sufficient. It may be useful for regulatory bodies to clarify the extent to which CAM should 
be taught to students (Smith, 2011) to better prepare future HCPs to deal with patients taking 
HMs.  
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Some participants in this study (26%, n=25) said they thought enough training was provided; 
for example, participant 85 (a pharmacist) who stated, “I know about herbal medicines as I 
studied pharmacognosy during my bachelor’s degree in India”; however, this participant did 
her pharmacy degree in India where training on HMs is commonly included in the 
curriculum. Furthermore, Participant 61 (a GP) who said he did not receive any information 
on THM while training, nor did he think enough training was provided then went on to say, 
“It’s difficult to see how further training in a totally different method of medicine, using 
preparations with significantly varying concentrations of active ingredients and unregulated 
or tested by MHRA could be fitted in to an already overloaded curriculum.” The comments 
made by participant 61 suggest that the intensive training programmes HCPs endure are 
already straining; similar responses were also seen by Smith (2011). When Smith (2011) 
contacted UK medical schools to investigate the extent of inclusion of CAM education in 
undergraduate courses it was revealed that schools felt there was a lack of interest from staff 
and students in CAM, limited funding, and most importantly the programmes were already 
congested. Newall et al. (1996) claims that, “a pharmacist should be able to advise the 
consumer on the rational and safe use of all medicines; thus, a pharmacist should be fully 
informed about the quality, safety, and efficacy of herbal medicines.” However, if this vital 
information is not transmitted to HCPs while they are training it would be difficult for them 
to gain this knowledge. Research conducted by the DTB (2010) explored how well informed 
HCPs felt that doctors were about HMs; 75.5% felt doctors were ‘poorly informed’ about 
HMs, while only 21.5% felt that doctors were ‘well informed’.  
As the popularity of HMs increases, more high quality research to support the use of HMs is 
required. Vickers (2000) claims that research on CAM is being conducted worldwide 
reflecting the growing awareness of the use of HMs. This will enable HCPs to be educated 
about HMs with reliable evidence based guidelines, an issue which was raised by many 
participants in this investigation. Regulatory bodies should make requirements for CAM 
education clearer so HCPs are equipped with the knowledge to deal with HMs queries 
competently. Educating future HCPs and providing continual professional development 
(CPD) programmes to encompass HMs will help HCPs make better informed decisions 
about HMs.    
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Question 15: Any other comments: 
The final question gave participants the opportunity to share any comments and feedback. 
Table 3-8 summarises the remarks made by participants. Most of the comments were 
generally about the structure and content of the survey. Some participants, such as 
participant 22, were very engaged with the questionnaire and had several points they wanted 
to highlight. There were concerns that just participants who used or had knowledge about 
HMs would complete the survey giving biased results; however, the comments suggest 
participants with a range of opinions completed the survey, not just people who are in favour 
of HMs.    
 
Table 3-8 General Comments from Healthcare Professionals  
Participant 
Number: 
General Comments: 
2 Very nice survey, number 10 - it depends what health conditions.... 
12 
In line with question 12, more information is needed rather than an 
outright rejection by healthcare practitioners.  
16 All the best with the project!  
22 
Your survey does not give the opportunity to say that I am happy for 
patient's to take alternative remedies as long as they are safe, of good 
quality and do not interact with other drugs. I am aware of the beneficial 
effects (may be placebo) of the patient being empowered by being in 
control of their own therapy. Taking alternative remedies should not 
stop a patient reporting the condition/side effect that they are treating to 
their clinician. Very little information is available on South Asian 
alternative remedies. Have great concerns about quality of products 
available. 
30 
Use of herbal medicines is common amongst people living with HIV. 
This might be an area to investigate in the future. 
43 
Difficult to answer some questions which are closed questions and 
therefore black and white. 
49 Would love to hear more.  
50 Lot of potential. Needs research.  
64 
I am in mental health and do not prescribe so limited experience of 
patients' prescription medicines for things other than depression and 
pain. 
66 
What matters is not what people think, but what the evidence says. So 
there is no yes or no answer for question 10 and 11. 
81 
Would have been nice to have a list of herbal medicines plants spices to 
help channel thoughts with regards to answers in survey. 
90 
It would be nice if various traditional medicines could be included in 
Western medicine however it is very difficult and not practical. 
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3.7 Healthcare Professionals Survey Summary  
The HCPs survey was published online using the SurveyMonkey software, and distributed 
via social media (Facebook and Twitter), which enabled a range of HCPs from across the 
UK to participate. In total 112 surveys were attempted with participants dropping out at 
various stages; although 93 surveys were completed, responses for incomplete surveys were 
also used in the analysis to avoid losing some valuable data. This research has provided a 
unique insight into HCPs personal and professional opinions of HMs. As there is limited 
research into UK based HCPs views of HMs the results from this study can be used to 
contribute to this discipline.  
The use of social media to conduct scientific research has only gained attention in the last 
few years (Sarker et al., 2015), and proved to be highly valuable while conducting this 
research. By using social media to distribute the link to this survey it enabled HCPs from 
across the UK to be contacted to participate in this research. A range of different HCPs 
comprised this research population, instead of being limited to a single group of HCPs which 
would have been the case if postal questionnaires were used. As the survey was published 
online via SurveyMonkey it was easy to create, modify, and track the progress of the 
questionnaire. Other benefits of conducting this research using social media included the fast 
and efficient distribution of the survey, lots of responses were collected in a short period of 
time, and it was cheaper than printing and posting the questionnaires. The disadvantages of 
using social media while conducting this research included the lack of control of who was 
sharing the link, who was completing the questionnaire, and participants dropping out 
partway through. If the surveys were conducted face to face the process could have been 
regulated better with fewer participants dropping out or missing questions (Moore, 2000). 
The main issue was the lack of control over who was completing the questionnaire. One 
completed survey raised concerns about whether or not the participant was a HCP from the 
UK. In the introductory statement before the questionnaire there was great emphasis on ‘UK 
based HCPs’. When the link for the survey was posted on Twitter and Facebook it was also 
emphasised: “If you are a UK based healthcare professional please take a few minutes to 
complete this survey.” For this reason later a question was added at the end of the survey to 
determine whether or not participants did or had worked in the UK, to try and overcome the 
issue of HCPs from outside of the UK being included in the analysis. Finally, one of the 
most time consuming parts of this investigation was the ethical approval process, as the use 
of social media and online surveys is a relatively new way of conducting research there were 
no guidelines for ethical approval (Beninger et al., 2014). Uncertainty amongst internal 
(DMU) and external (NHS) ethics committees meant the ethical review process was lengthy 
and complicated. Despite some of the drawbacks encountered during this study, the results 
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suggest it has been a very useful way of conducting research. HCPs from across the UK, the 
researcher would not have ordinarily come into contact with were able to take part. 
Responses from a variety of different HCPs representing various professions, age groups, 
and ethnicities were able to contribute their knowledge and opinions. As the survey was 
available online it enabled participants the freedom to complete it at their own leisure and 
pass it on to other HCPs they knew.  
The HCPs that formed this survey population were from a range of professions including 
pharmacy, medicine, dentistry, optometry, research and academia. Participants from various 
ethnic groups completed the survey, making it possible to compare ethnic differences 
between knowledge and use of HMs. Just under half of the participants (45%, n=50) said the 
use of HMs was part of their traditional family and cultural background. There was a 
statistically significant association between the traditional use of HMs and ethnicity. SA 
ethnic groups were more likely to say HMs were part of their family and cultural background 
than any of the other ethnic groups; while White British/ Irish participants were more likely 
to claim that HMs were not part of their traditional heritage. Over a third of participants 
(38%, n=42) said they used HMs themselves, these participants documented a large 
assortment of HMs they knew of or used. The most common products recalled by 
participants included turmeric, ginger, mint, honey, lemon, and Echinacea. Participants 
(53%, n=54) mentioned a wide range of HMs they knew of, for the four conditions listed: 
arthritis, cough, diabetes, and indigestion. In comparison to the findings from the SATMED 
questionnaire a more diverse range of herbal products were known and documented by the 
HCPs in this survey; products native to Asia (e.g. ajwain and tulsi) and Western countries 
(e.g. camomile and Echinacea) were mentioned. The diversity of products mentioned by 
HCPs could be because the questionnaire was open to all ethnic groups, and not restricted to 
just SA participants like the SATMED questionnaire. The results from this analysis revealed 
that HCPs who completed this survey had variable knowledge of HMs; some participants 
had extensive insight into a broad range of HMs, while others had limited knowledge. A 
difference in knowledge of HMs between ethnic groups was also identified, as more SA 
HCPs recalled HMs in comparison to White British/Irish HCPs. This knowledge difference 
could be linked to the traditional heritage of HMs amongst SA cultures which SA 
participants referred to in both this survey and the SATMED questionnaire. From the 
comments of several participants it was evident they were keen to learn more about HMs if 
there was evidence to support the claims associated with the use of HMs. 
When HCPs in this study were asked if their patients told them about their use of HMs 65% 
(n=64) said they did. However, when participants from the SATMED questionnaire were 
asked whether or not they told their doctor or pharmacist about their use of HMs, 69% 
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(n=73) said they did not tell their doctor while 82% (n=87) did not tell their pharmacist. This 
is supported by the findings of several studies which have found patients do not always tell 
their HCPs about their use of HMs. Giveon et al. (2004) found that 44.7% of participants did 
not tell their doctor about their use of HMs, whilst 11% did but only rarely. Results from the 
Ipsos MORI report (2008) on public perceptions of HMs found that 56% of participants felt 
it was important to tell their doctor about their use of HMs; interestingly they found that 
Asian and Black minority ethnic groups were less likely to disclose information about their 
use of HMs to their doctors (Ipsos MORI, 2008). The qualitative results from the SATMED 
questionnaire revealed that SA participants did not want to tell their HCPs about their use of 
HMs as they were afraid of being treated differently or not treated at all. The high rates of 
under reporting the use of HMs by patients may be influenced by several factors, of which 
ethnicity may be one (Williamson et al., 2013; Ipsos MORI, 2008); this could explain why 
the results for not reporting the use of HMs to HCPs was so high in the SATMED survey. 
The HCPs in this survey revealed that their patients informed them about their use of HMs 
fairly frequently. The importance of accepting and understanding cultural differences is vital 
for HCPs to be able to build rapport with their patients; as Staines (2011) highlighted, that 
negative attitudes of HCPs towards alternative therapies could be detrimental to the 
relationship with their patients. Building trust will help patients feel at ease when disclosing 
information about their use of HMs to their HCPs; this is vital for providing appropriate care 
for patients, identifying adverse drug reactions (ADRs) and interactions with HMs. 
Numerous herbal ADRs were noted by 31% (n=30) of participants. Some ADRs identified 
were considered to be minor effects (e.g. local irritation caused by using tea tree oil); 
whereas, others were more fatal and sometimes life threatening (e.g. hypoglycaemia caused 
by karela, or deranged liver functions caused by Kava kava). As people using HMs often 
‘self-prescribe’ the risks associated with ADRs may not be known; Barnes et al. (1998) 
found that those who experienced ADRs (minor or serious) from HMs were less likely to see 
their GP than if it was an ADR caused by CWM. Although efforts to improve herbal 
pharmacovigilance have been implemented (i.e. the yellow card scheme has been extended 
to include herbal ADRs), herbal ADRs are still underreported and go unmonitored (Barnes, 
2003). This reinforces the importance of HCPs being competent in recognising and reporting 
incidents associated with HMs.  
The most common herb-drug interaction reported by 33 participants in this research involved 
SJW. SJW was the third best-selling herbal remedy in the UK in 2013 (Ministry of Foreign 
Affairs, 2014). Its traditional use for mild depression and anxiety has become so popular its 
status as a traditional herbal remedy has been questioned. It is one of the few HMs for which 
there is extensive research and clinical evidence to support the traditional health claims 
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associated. It could be due to the wealth of literature available for SJW that makes it so well 
known to HCPs. The most common CWM which participants identified as being affected by 
HMs was warfarin. Many participants described HMs which could potentially affect the 
efficacy of warfarin including garlic, gingko, SJW, and cranberry juice. Polypharmacy with 
CWM is common practice in patients with multiple health conditions; combining HMs into 
the mixture could increase the risk of ADRs and interactions (Edwards et al., 2012). Due to 
the unknown risk of herb-drug interactions some HCPs believe it is best to avoid taking HMs 
alongside CWM (Fugh-Berman and Ernst, 2001). Almost two thirds of participants (63%, 
n=62) in this survey were aware of herb-drug interactions and documented some of their 
knowledge. The 37% (n=36) of participants who said they were not aware of interactions 
between HMs and CWM highlighted the importance of educating HCPs about the potential 
risks associated with consuming HMs alongside CWM.  
Despite the range of ADRs and herb-drug interactions documented by the research 
participants their views on the safety and efficacy of HMs were mixed; 66% (n=63) of 
participants thought HMs were effective for treating and preventing various health 
conditions, and 58%, (n=56) said they were safe. Some participants felt the long standing use 
of HMs throughout history was sufficient evidence to support the use of HMs, while others 
made reference to the lack of evidence based medicine and scientific validation of HMs. The 
42% (n=40) of participants who said they did not think HMs were safe and the 34% (n=33) 
who did not think they were effective felt the lack of clinical evidence for HMs meant they 
could not make an informed decision to determine the safety and efficacy of HMs. In 
addition, without randomised clinical trials to prove the efficacy of HMs many HCPs felt 
reluctant to recommend HMs to patients. Nevertheless, it was observed that those HCPs who 
had personally tried or used HMs were more likely to recommend them to their patients. 
Vickers (2000) suggested that recent advances in research have provided some good 
evidence to support the use of some complementary therapies; in addition, more research is 
being conducted around the world to provide evidence to support the use of CAM. Funding 
to support research has also been increased, although it still lags behind other areas of 
research and is still fairly restricted (Vicker, 2000; Cant et al., 2012).    
The significant majority of participants (65%, n=62) claimed they were not given any 
information on HMs during their professional training; while, even more participants (74%, 
n=71) believed that not enough training was provided on HMs. These results have given an 
insight into what HCPs in the UK think about the current level of education on HMs 
provided to them. The analysis reveals that HCPs are not satisfied with the existing level of 
training they receive on HMs, and many felt incompetent giving advice about HMs to their 
patients. Although regulatory bodies such as the GMC and GPhC do set standards which 
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require schools to include some information about CAM there is no defined syllabus; and in 
some cases a single lecture was deemed sufficient to meet the standards set by regulatory 
bodies (Smith, 2011). Very little high quality research on CAM exists (House of Lords, 
2000), this could be a key reason as to why it is not extensively taught in undergraduate 
courses. More money is being invested in exploring the risks and benefits of CAM, and high 
quality research is being conducted worldwide (Vicker, 2000); this will provide better 
resources to educated HCPs so they can make informed decisions about HMs. Several 
participants expressed their interest in learning about HMs, especially if there was scientific 
evidence to support their use.   
There are some very useful texts to help HCPs learn about HMs, such as Stockley’s Herbal 
Medicines Interactions (Williamson et al., 2013) and Phytopharmacy – An Evidence Based 
Guide To Herbal Medicinal Products (Edwards et al., 2015); however they are not readily 
available to all HCPs. The British National Formulary (BNF) is a vital resource for HCPs 
and is available to all doctors and pharmacists and many other HCPs. The BNF July 2015 
edition explains why information on HMs is not included in the BNF; it states, “while it 
would be useful to have information about herbal medicines in the BNF, in order to provide 
reliable and authoritative information on homeopathic or herbal medicines, it would be 
necessary to set up a parallel structure with specific expertise in complementary medicine. It 
would be very difficult to achieve this and to include all the information in the BNF.” Having 
access to texts which would help HCPs make informed decisions about the safety and 
efficacy of HMs will help improve HCPs knowledge of HMs, relationships with patients, 
and increase HCPs confidence in advising patients about the use of HMs (Pokladnikova and 
Lie, 2008).  
As the popularity of HMs continues to grow (Zhang et al., 2012), and HMs become more 
integrated into Western healthcare (Vickers, 2000), the importance of HCPs being aware of 
the risks and benefits of consuming HMs alone or in conjunction with CWM will become 
more important. In order to ensure patients are receiving the correct pharmacological care it 
is vital for HCPs to deduce their patients’ use of HMs; a concept which needs to be 
reinforced to HCPs in the UK. Changes to the regulation of HMs and more clinical research 
are providing evidence based support for the safety and efficacy of HMs. Furthermore, better 
training and education on HMs for future HCPs means they will be equipped with the 
knowledge to identify potential ADRs and interactions, and advise patients on the safe use of 
HMs. There are very few studies which have explored UK based HCPs views on CAM 
(Smith, 2011), and little research actually focuses on just HMs. The results from this 
investigation have enabled an insight into HCPs personal use and professional views of HMs 
to be uncovered; providing valuable data for future research. 
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4.0 Chapter 4 – The Tulsi Project 
4.1 Introduction 
The Tulsi Project was developed after considering the results from the main South Asian 
Traditional Medicines (SATMED) questionnaire (Chapter 2); which explored the current use 
of traditional herbal medicines (THM) by South Asian (SA) diasporic communities, in the 
United Kingdom (UK). DNA authentication projects conducted by colleagues at De 
Montfort University (Chapter 2, section 2.6.2, p37) and other researchers have highlighted 
how DNA barcoding has been used to identify adulterant and substitute species in herbal 
medicines (Howard et al., 2009; Kumar, 2015; Seethapathy, 2015) have inspired this 
research. 
Tulsi (Holy basil, O. tenuiflorum L.) was identified as one of the most popular herbal 
ingredients used and known by the SATMED participants. This plant stood out from all of 
the other common herbal products identified such as ginger (Zingiber Officinale Roscoe) and 
turmeric (Curcuma longa L.) for several reasons. Firstly, the numerous health benefits 
associated with tulsi ranged from minor skin ailments to long term health problems like 
asthma and diabetes (Chapter 2, Section 2.6.2, p37). When participants were asked if they 
grew any plants for medicinal purposes, tulsi was one of the main plants, after mint, which 
was grown; tulsi seeds were commonly brought to the UK from Africa and India. In 
addition, when participants revealed what products they imported to the UK from abroad it 
was commonly dried tulsi leaves or seeds; with reference to the poor growth conditions and 
low survival rates of the plant in the UK. The religious significance of tulsi was also noted as 
participants referred to the value of the plant for Hindus. 
After considering all the information collected, it was evident that participants grew their 
own tulsi plants, imported material from abroad (Africa and India), and bought commercial 
products from suppliers in the UK, online, and abroad. A variety of different tulsi plants 
were recognised by participants, with frequent references made to Raam, Shyam (Krishna), 
and Vana tulsi. Raam and Shyam tulsi are varieties of O. tenuiflorum which is native to Asia; 
whilst some authors claim Vana tulsi is O. gratissimum L. (Joshi et al., 2012). As 
participants revealed that they grew plants from seeds they acquired from abroad, an interest 
in the species of tulsi plants grown in the UK developed; the applications of DNA analysis 
for species authentication to identify tulsi species were then explored.  
DNA barcoding is a relatively new technique that can be used to discriminate between 
different plant species, and identify any contaminants or adulterants. The literature around 
this topic is ever expanding and it is anticipated that the results from this investigation will 
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have a novel contribution. A range of tulsi samples were collected which were subjected to 
DNA analysis to determine their species. Samples were collected from research participants 
(community samples), as well as commercial samples, and authenticated species for the 
identification process. This research involved a multi-disciplinary approach by combining 
social science research methods with molecular techniques.  
 
4.2 Aim of the Tulsi Project   
The aim is to investigate the cultural and commercial value of tulsi, Ocimum tenuiflorum, 
amongst diasporic South Asian communities in the UK; and to authenticate tulsi samples 
using DNA-based analytical techniques. 
 
4.3 Objectives of the Tulsi Project   
1. Explore the cultural and commercial values associated with tulsi, in South Asian 
communities in the UK. 
2. Collect a range of tulsi products and perform DNA analyses in order to: classify species, 
identify genetic variations, and isolate adulterant species.  
 
4.4 Background to the Research  
This section will give an insight into the origins, cultural values, medicinal uses, and 
botanical identity of tulsi; in order to establish the importance of this research. An 
explanation of the traditional and new research methods used for medicinal plant 
identification will highlight the potential applications of DNA barcoding. 
 
4.4.1 Origins of Tulsi  
Tulsi is native to tropical Asia, it grows wild in warm regions. It has been used in South 
Asia, China, the Middle East, Africa and Australia for centuries (Maimes, 2004). With the 
migration of people, the plant has become available around the world, and varieties are even 
grown in the UK. As the tulsi plant travelled West, it became known to Christians as "holy" 
basil as is reflected in its Latin binomial, O. sanctum L. (now referred to as O. tenuiflorum 
L.). The scared plant was given as a gift in the annual celebration of the birth of St. Basil, as 
people gave it the status as a ‘gift from Christ’ (Miller and Miller, 2003).  
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Tulsi is used in various traditional medical systems including: Ayurveda, Siddha, and Unani. 
Ayurvedic scriptures refer to tulsi as one of the main pillars of herbal medicine, first 
mentioned in the Rig Veda around 1500 BC. It is widely incorporated in traditional Indian 
cuisine, cosmetics, herbal remedies and religious ceremonies (poojas). The whole plant can 
be used, seeds, roots, leaves, flowers and even the stem (Prakash and Gupta, 2005). The 
woody stem is often used to make tulsi beads, worn as necklaces or bracelets believed to 
provide physical protection, and even made into rosaries for spiritual protection (Miller and 
Miller, 2003). Daily use of tulsi is believed to help maintain balance of the chakras, energy 
centres of the body (Winston and Maimes, 2007). 
Tulsi is one of the most sacred plants on the Indian subcontinent, as it represents a Hindu 
goddess, Virinda Tulsi. Legend has it that Virinda was married to a demon called Jalandhar 
who was destroying the world. Due to Virinda’s purity and devotion to God her evil husband 
was immortal. The only way to kill Jalandhar was if his wife’s purity was tarnished. Lord 
Krishna disguised himself as Virinda’s husband and tainted Virinda’s purity; which led to 
the death of Jalandhar. Virinda felt she had been betrayed by the Gods and threw herself onto 
her husband’s burning pyre, to relieve herself from the shame of cheating on her husband. 
From this it is said her soul was transformed 
into the tulsi plant and Lord Krishna vowed 
to marry her to take away the shame. 
Hence, every year the wedding anniversary, 
Tulsi Vivah, is celebrated by Hindus around 
the world (Figure 4-1). It is Virinda Tulsi’s 
purity and devotion to God which makes 
Hindus believe the plant is so pure and 
sacred; thus the plant is incorporated in 
religious ceremonies, used as religious 
offerings (Prasad), and added to the 
burning pyre of the deceased where it is 
believed to aid the passage to heaven 
(Shatri Ramnik Dev, 2013). Tulsi plants are 
supposedly kept in every Hindu temple and 
most households where it is thought to be a 
blessing if the plant grows (Wagner, 2010).   
 
Figure 4-1 Tulsi Wedding at Shree Laxmi Narayan 
Temple, Birmingham  
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4.4.2 Medicinal Benefits of Tulsi 
The ‘elixir of life,’ tulsi is known as a rasayana, a herb with life prolonging and rejuvenating 
properties, which helps prevent and cure diseases (Miller and Miller, 2003). Tulsi is 
considered one of the most powerful herbs as it is used for treating a vast array of medical 
disorders; including conditions which affect the skin, the cardiovascular, endocrine, 
respiratory, and central nervous system (Winston and Maimes, 2007). Traditionally tulsi has 
been used to treat asthma, bronchitis, diabetes, diarrhoea, eye disorders (chronic 
conjunctivitis, cataracts, and glaucoma), fever, insect bites, snake bites, malaria, and a 
variety of skin diseases. Tulsi is also known to have antibacterial, antifungal, antiviral, 
antidiabetic, anticancer, antifertility, anti-inflammatory, adaptogenic, analgesic, 
cardioprotective, and hepatoprotective properties (Prakash and Gupta, 2005; Philip and Unni, 
2011; Singh et al., 2012). Different parts of the tulsi plant including the seeds, roots, stems, 
and leaves are known to possess therapeutic properties and are used to formulate herbal 
remedies (Prakash and Gupta, 2005). There are various ways to consume tulsi in order to 
reap the medicinal benefits. Fresh or dried tulsi leaves can be eaten, used in cooking, infused 
in tea, hot water, or bath water. A variety of commercial tulsi products are also available 
including: capsules, creams, juices, oils, shampoos, soaps, tablets, teas, and tonics. 
Human and animal studies have suggested tulsi can be useful for diabetes as it has been 
found to alter glucose regulation via several pathways (Chattopadhyay, 1993; Vats et al., 
2002; Prakash and Gupta, 2005). Agrawal et al. (1996) administered 2.5g of tulsi leaves to 
type 2 diabetic patients for sixty days and observed a decrease in fasting and post-prandial 
blood glucose. Tulsi has been shown to reduce blood glucose levels, and increase glycogen 
stores and insulin levels in the body (Joshi et al., 2012). Traditionally tulsi is believed to 
have been used as a contraceptive and to improve libido. The literature available on the 
antifertility and abortive effects of tulsi are dated (Khanna et al., 1986), but precaution in 
pregnant women are still taken (Prakash and Gupta, 2005). Studies in female rats found a 
reduction in implantation, full term pregnancies and a reduced litter size after the 
administration of tulsi (Vohra et al., 1969; Khanna et al., 1986). Animal studies suggest tulsi 
can temporarily reduce sperm count and sperm motility (Ahmed et al., 2002), and increase 
libido (Pande and Pathak, 2009). Hence, in India tulsi has traditionally been used as a male 
contraceptive (Sethi et al., 2010). Research even documents the powerful antibacterial 
effects of tulsi in treating the sexually transmitted disease, gonorrhoea, caused by Neisseria 
gonorrhoea which is sensitive to extracts of O. tenuiflorum; Shokeen et al. (2005) refer to it 
as being as  good as penicillin and ciprofloxacin.  
 
143 
Sukvinder Kaur Bhamra 
4.4.3 Active Compounds in Tulsi 
The chemical composition of tulsi is complex and can vary between different cultivars 
(Rahman et al., 2011). The quantities of chemicals found in plants can be affected by the 
growing conditions, stage of harvesting (young or mature plant), processing and 
manufacturing stages, and storage conditions (Pattanayak et al., 2010). Tulsi plants contain a 
variety of saponins, flavonoids, triterpenoids, tannins and essentials oils; including, eugenol, 
methyl eugenol, eugenic acid, urosolic acid, carvacrol, linalool, limatrol, caryophyllene, and 
methy chavicol (Pattanayak et al., 2010; Rahman et al., 2011). 
Tulsi leaves contain the phenolic compounds eugenol and methyl eugenol which form part of 
the plants’ essential oil content. Eugenol is responsible for the spicy aromatic fragrance 
produced by the plant, as well as some of the associated health benefits. Eugenol has 
antiseptic, anaesthetic, antibacterial, antifungal, and antioxidant effects. Quantitative 
variations have been seen in the composition of essential oils in tulsi plants grown in 
different parts of India, different seasons of harvesting and growing conditions (Prakash and 
Gupta, 2005). 
 
4.4.4 Precautions with Tulsi 
Traditionally tulsi is avoided in pregnant women as it has been known to cause miscarriage 
and was used to induce abortion. Ursolic acid, one of the major constituents found in the 
leaves, is believed to have antifertility effects (Prakash and Gupta, 2005). Batta and 
Santhakumari (1970) demonstrated the antifertility affects in mice by administering a dose of 
200mg/kg of tulsi in a benzene vehicle to pregnant mice. Animal studies have shown the 
antifertility effects but the results remain dated and inconclusive (Gardner and McGuffin, 
2013). Tulsi was traditionally considered to be a male contraceptive (Sethi et al., 2010) and 
has been associated with reducing sperm count and motility (Khanan et al., 1986; Ahmed et 
al., 2002); therefore, it should be avoided if trying to conceive. 
Some herbal remedies require fresh tulsi leaves to be chewed in order to obtain the medicinal 
effects. The plant contains natural mercury, which may be harmful to the teeth if the leaves 
are chewed and in prolonged contact with the mouth (Joshi et al., 2012). This can be avoided 
by swallowing the leaves whole with water or drinking infusions. If the plant is grown in 
areas where there are high levels of chromium contaminating the soil (i.e. from industrial 
leaks, fertilisers, and pesticides) it can have severe consequences as chromium can damage 
the liver and kidneys (Rai et al., 2004). 
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Singh et al. (2001) revealed the fixed oil of tulsi at a dose of 3ml/kg prolonged blood clotting 
time; they claimed the effect was because the oil prevented platelet aggregation. The blood 
thinning properties of tulsi have been compared to that of aspirin; therefore, people taking 
anti-platelets (e.g. aspirin and clopidogrel) and anticoagulants (e.g. warfarin) should 
consume tulsi with great caution (Singh et al., 2001). Winston and Maimes (2007) highlight 
that tulsi enhances cytochrome CYP450 enzyme activity. This can increase elimination of 
drugs rendering them less useful or ineffective. However, the American Herbal Products 
Association released an updated botanical safety handbook in 2013 which stated there were 
no drug interactions or adverse effects identified for tulsi (Gardner and McGuffin, 2013).   
 
4.4.5 Botanical Identity of Tulsi  
Typical characteristics of the Lamiaceae family include a 
square stem, opposite and decussate leaves, with numerous 
oil glands which secrete aromatic oils giving the plants 
distinct odours (Paton et al., 2005; Schmiderer et al., 2008). 
Part of the Lamiaceae family is the Ocimum genus, which 
has around thirty species (Paton, 1992). Alongside the 
traditional culinary basil (O. bascilium L.), tulsi (O. 
tenuiflorum L.) is the Indian alternative, commonly 
referred to as Holy basil; as reflected in its former Latin 
binomial O. sanctum L. which translates to sacred or the 
incomparable one. The word basil is likely to have 
originated from the Greek word Basileus which means kingly or royal. Some may refer to 
tulsi as the ‘King of Herbs’ however due to the Hindu association of the plant with the 
goddess Virinda Tulsi others call it the ‘Queen of herbs’ (Miller and Miller, 2003).   
Tulsi can be described as a highly branched herb or shrub which can grow up to a meter tall, 
from the tiny round, dark brown, odourless but pungent tasting seed (Joshi et al., 2012). The 
bright green to dark purple, aromatic leaves are classically arranged in an opposite 
formation, with an oval-oblong shape similar to that of mint leaves. The square stem is hairy, 
purple to brown coloured, and woody in appearance; while the flowers can range in colour 
from white, yellow, and purple (WHO, 2002b).  
There are a variety of different types of tulsi available (Figure 4-2). According to Ayurvedic 
scriptures the most common types being Raam tulsi, and Shyam also referred to as Krishna 
tulsi. Botanists classify these two types as O. tenuiflorum; and the less common type is Vana 
Kingdom: Plantae  
Division: Magnoliophyta  
Class: Magnoliopsida  
Order: Lamiales  
Family: Lamiaceae  
Genus: Ocimum  
Species: O. tenuiflorum  
Botanical name: O. tenuiflorum 
Synonyms: O. sanctum  
(Hiran, 2009) 
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tulsi (O. gratissimum) which is commonly known as African basil (Joshi et al., 2012). 
Although the plants are characteristically different, they may all be referred to and kept as 
tulsi (Maimes, 2004).  
 
 
 
 
 
 
 
 
 
 Microscopic Characteristics of Tulsi 
WHO (2002) describes tulsi leaves as having a layer of small, quadrangular cells on the 
lower epidermis, trichomes of 2-6 cells, including short glandular trichomes, and diacytic 
stomata located on both the upper and lower epidermis. Similar studies by Datta et al. (2012) 
and Joshi et al. (2012) also recorded several important characteristics of tulsi including: oil 
globules, multicellular and unicellular simple and glandular trichomes (Figure 4-3).  
 
 
 
 
 
 
 
 
 
Figure 4-2 Raam, Shyam, and Vana Tulsi Grown In Bangalore, India  
Figure 4-3 Image of the Lower Epidermis of a Tulsi Leaf at 500x Magnification under a Scanning 
Electron Microscope  
Trichome 
Oil gland 
Stomata 
Taken at De Montfort University by R. Armitage and S. Bhamra.   
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The image (Figure 4-3) reveals a high concentration of trichomes on the lower surface of the 
tulsi leaf. Trichomes often have several functions including: producing and storing essential 
oils and chemicals which may be used to supplement the defence mechanism of the plant, 
and offering protection to the leaf from insects and larvae (Levin, 1973). The structure, 
function, and density of trichomes can be used for taxonomic purposes. Numerous oil glands 
can also be seen in Figure 4-3. The Lamiaceae family has several species which are highly 
aromatic; most of the species produce and store essential oils in specialised epidermal oil 
glands (Schmiderer et al., 2008). The oils produced are distinctive of the species and can be 
used to identify the plants. The oils are composed of a mixture of compounds, which have 
many health benefits. The essential oils produced by tulsi contain the active compound 
eugenol, which has antiseptic and anaesthetic properties (Prakash and Gupta, 2005). The 
scent of the oil deters insects and has been used as a mosquito repellent (Joshi et al., 2012).  
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4.4.6 Methods of Plant Identification 
The European Pharmacopoeia is a standard reference for the quality control of 
medicines (European Directorate for the Quality of Medicines & HealthCare, 2015); it has 
defined morphological and chemical profiles for medicinal plant species. Unlike traditional 
methods of plant authentication (i.e. morphology and chemical analysis) (Chen et al., 2014); 
DNA barcoding is a relatively new technique for plant identification, the applications of 
which are still being explored.  
 
 Morphology 
A dichotomous key is used to sequentially identify parts of the plant to categorise the plants 
family, genus, and species (Jacono, 2009). Morphology encompasses the use of highly 
trained individuals who can identify the plants superficial structures to classify them; it 
includes the macroscopic and microscopic features. The macroscopic features are the 
physical characteristics of the plant such as the colour, size, structure, shape, taste, and 
aroma of the plant (Joshi et al., 2004). The microscopic structures of the plant can be seen 
using powerful microscopes and techniques such as scanning electron microscopy (SEM). 
The morphological features can be affected by the age of the plant, stage of harvesting, 
processing, and storage of the plants (Joshi et al., 2004). A clear example of how age can 
affect the microscopic features can be seen in Figure 4-4; the younger tulsi leaf has more 
trichomes which may help protect the leaf during development, in comparison to the mature 
leaf which has less trichomes.  
 
 
 
 
 
 
SEM is a technique which can be used for examining plant surfaces at high resolution and to 
determine plant species. Electrons from a beam interact with atoms on the surface of the 
sample, producing an image of the surface composition. Previously, plant tissues needed to 
be preserved by dehydration for observation in an electron microscope otherwise the sample 
would be distorted under the high vacuum. Often samples had to be coated with conductive 
Figure 4-4 Image of Young and Mature O. tenuiflorum Leaf under a Scanning Electron Microscope 
Taken at De Montfort University by R. Armitage and S. Bhamra.   
148 
Sukvinder Kaur Bhamra 
material to prevent the accumulation of electrostatic charge, which could reduce the quality 
of the image produced. However, advances in technology mean the fresh sample can be 
analysed under SEM without altering the surface properties (Pathan et al., 2008). The 
technique also allows surface structures to be measured and quantified in three dimensions 
(Talbot and White, 2013).  
 
 Chemical Analysis  
In the early days of botanical identification, the introduction of microscopy was a ground 
breaking and revolutionary technique used to aid the authentication of plants; later, advances 
in technologies promoted the use of spectrophotometry and chromatography (McCutcheon, 
2002). Since then the chemical profile of plants has been used as a valuable tool for 
authentication, quality control, and standardisation of medicinal plants (Joshi et al., 2004). 
Thin layer chromatography (TLC), high performance thin layer chromatography (HPTLC), 
and high performance liquid chromatography (HPLC) are some of the techniques currently 
used for the identification of plants.  
TLC is inexpensive, simple and fast to use; however, the poor reproducibility of results and 
lack of automation are major drawbacks of this technique (Dong, 2013). The refinement of 
HPLC and HPTLC techniques mean they are more precise, can be automated, and the results 
are reproducible (Cziczo, 2004; Dong, 2013). One of the main limitations associated with 
chemical analysis is that the chemical profiles can be affected by the natural variability of 
plants. This can be affected by the growing conditions (regional variations, soil, climate, and 
pests), stage of harvesting, drying, storage (treatment with pesticides and preservatives), and 
processing (McCutcheon, 2002; Joshi et al., 2004; Vlietinck et al., 2009).  
Currently European Pharmacopoeial standards are based on a plants morphology 
(macroscopic and microscopic descriptions), and a combination of chemical analysis 
techniques, for example TLC and HPLC (McCutcheon, 2002; Vlietinck et al., 2009). The 
use of DNA authentication techniques to identify the plants species could also be used 
alongside the current standards (Joshi et al., 2004). The British Pharmacopoeia (2016) has 
recently validated the use of DNA based identification techniques for HMs. 
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 DNA Authentication of Plants 
DNA barcoding is a technique used to identify species based on short regions of DNA (Kress 
et al., 2005). Variations in a defined region of the DNA sequence can discriminate between 
different species, identify contaminants and adulterants (Joshi et al., 2004; De Mattia et al., 
2011).  This novel authentication technique was introduced by Paul Hebert in 2003 (Kress 
and Erickson, 2008). The analogy of a supermarket scanner identifying a product from the 
black and white stripes on the barcode was used to exemplify how this technique can be used 
to identify species by their unique genetic sequence (Kress, 2009).   
To be able to distinguish between species, the target DNA barcode must contain enough 
variability, but, must also have regions of similarity for the universal primers (Rai et al., 
2012). A primer is a short fragment of DNA which is complimentary to the target region of 
DNA. Plant DNA is stored in the mitochondria, nucleus, and chloroplasts. The mitochondrial 
cytochrome c oxidase gene (cox1) is highly conserved in plants; the low level of sequence 
variation renders this region ineffective for authentication (Kress et al., 2005). The internal 
transcribed spacer (ITS) region of the nuclear ribosomal unit is one of the most commonly 
sequenced regions in plants (Kress et al., 2005). It evolves relatively quickly and can be 
useful in determining interspecies and sometimes intraspecies relationships (Cullings and 
Vogler, 1998). The 5.8S rRNA gene evolves slowly, like the other genes for the 18S and 28S 
rRNA; and is often used as an alignment tool due to its location (Figure 4-5). Although, in 
certain groups the ITS region has reduced species level variability so may not be as useful 
(Kress et al., 2005). Several other concerns with the ITS region include: the existence of 
divergent paralogous copies within individuals, development of secondary structures which 
result in poor quality sequencing data, and the inadvertent amplification of endophytic DNA 
in the presence of fungal contamination (Kress et al., 2005). These limitations of the ITS 
region have led to it being rejected as a core component of the plant barcode (Hollingsworth 
et al., 2011).  
 
Figure 4-5 The ITS Regions in the Nuclear Ribosomal RNA Repeat 
Adapted from Cullings and Vogler (1998). ITS – internal transcribed spacer; IGS – Intergenic spacer. ITS-1 is 
located between the 18S and 5.8S ribosomal RNA gene; ITS-2 is located between the 5.8S and 28S ribosomal 
RNA gene. 
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The Consortium for the Barcode of Life (CBOL) have proposed two coding regions from the 
plastid (chloroplast) genome, matK and rbcL, as “core barcodes” for plants, to be used 
alongside other regions (Hollingsworth, 2011). The non-coding chloroplast trnH-psbA 
marker has also been identified as an efficient region for discriminating between species 
(Vassou et al., 2015). Kress et al. (2005) propose the trnH-psbA region is the best plastid 
option for sequencing as it has good priming sites, length, and interspecific variation. In 
addition, as the trnH-psbA region is shorter, it may be useful for damaged or degraded 
samples (Howard, 2010).  
DNA analysis can be used as a stand-alone method or in conjunction with traditional 
methods for the identification of plant species (Chen et al., 2014). DNA barcoding is not 
restricted by the condition of the plant, as with morphological features which can change and 
degrade depending on various harvesting, processing, and storage conditions (McCutcheon, 
2002). It does not require specialist taxonomic knowledge for identification. Unlike chemical 
analysis which can vary between plants harvested at different stages (young or mature) DNA 
analysis is not affected by the age of the plant (Kazi et al., 2013). The genetic composition is 
not affected by environmental factors or physiological conditions (Joshi et al., 2004). The 
amount of plant sample required is very small (from as little as 0.02g of dried or 0.1g of 
fresh plant material), in comparison to other techniques which may require several grams or 
a full plant for identification. DNA can be extracted from fresh, frozen, dried, or preserved 
samples. As the sample of DNA extracted is very small (usually 100µl) it is easy to store, 
compared to bulky plant specimens (Howard, 2010).  
Nevertheless, there are several limitations with using DNA barcoding including: the 
amplification of non-target DNA from contaminants, and problems with primer specificity 
and amplification (Hollingsworth, 2011). Recently the New York State Attorney General 
Eric Schneiderman’s office sent out cease and desist letters to four retailers (GNC, Target, 
Walmart, and Walgreens) to stop the sales of some herbal supplements sold in New York. As 
research commissioned by his office found products were substandard according to the DNA 
testing. They revealed that many of the products (79%) could not be genetically verified or 
found ingredients not listed on the label (Schneiderman, 2015); for example, Echinacea, 
Ginseng, and St John’s Wort products from the various retailers (e.g. Walmart and GNC) 
were found to contain contaminants such as asparagus, rice, grass, wheat, and citrus. 
Schneiderman’s results were questioned as he relied on just one technique for species 
authentication and all the work was conducted in one laboratory. Critics have said that his 
results should have been validated with microscopic or chemical methods, rather than being 
used as a stand-alone method for authentication. A statement released by the Chief Science 
Officer of the American Botanical Council (ABC) Dr Stefan Gafner, and ABC Founder and 
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Executive Director Mark Blumenthal stated, “DNA testing seldom is able to properly 
identify chemically complex herbal extracts as little or no DNA is extracted in many 
commercial extraction processes” (American Botanical Council, 2015). A major drawback 
to the use of molecular techniques is that the plants DNA may be damaged or degraded 
during manufacturing and processing stages; however, to try and overcome this problem, 
primers have been designed to target shorter fragments (Chase et al., 2005). Furthermore, the 
lack of reliable reference barcodes for species identification may be limiting the use of this 
technique. This is one of the key issues identified by this research and the aim is to help 
contribute some new barcodes to the references libraries.   
The process of DNA authentication involves the extraction of DNA, a polymerase chain 
reaction (PCR), gel electrophoresis, and sequencing. After this a DNA sequence is generated 
which can be used to identify and authenticate plant species. The theory behind each stage 
will help to explain how DNA analysis is conducted and what happens during the processes.   
 
 DNA Extraction  
The extraction of DNA from plants (fresh or dried), tablets, capsules, tea bags, and other 
formulations can be done by using various protocols or commercial kits. Initially the sample 
needs to be lysed to disrupt the cell wall, cell membrane, and nuclear membrane to access 
the DNA. This can be done using chemical and physical methods (e.g. manual grinding with 
a pestle and mortar, or sonication). The DNA is then precipitated ensuring the removal of 
molecules such as proteins (i.e. using a protease), polysaccharides and lipids (i.e. using a 
detergent or surfactant), phenols, Ribonucleic acid (RNA) using an RNase and other 
secondary metabolites which may affect the quality of the purified DNA.  
 
 Polymerase Chain Reaction (PCR) 
A PCR needs to be carried out in order to exponentially amplify the target region of the 
DNA. The basic components required for a PCR include the DNA template, primers, DNA 
polymerase, deoxynucleoside triphosphates (dNTPs), and a buffer to maintain optimal 
conditions for the reaction. Once the reaction mixture is created, it is subjected to repeated 
cycles of variable temperatures for denaturing, annealing, and extension of the template 
DNA.  
Primers are small fragments of DNA which act as a starting point for DNA synthesis. The 
PCR amplification requires two primers, which act as templates for sequence amplification 
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in the forward and reverse direction. The free nucleotides (dNTPs): Adenine (A), Cytosine 
(C), Guanine (G), and Thymine (T), are attached to the complimentary sequence of the 
primers template by the DNA polymerase enzyme, which assembles the new DNA strand. 
MyTaq Red Mix (2x) is a ready to use mixture for PCR reactions; it contains the buffer, 
DNA polymerase enzyme (Taq polymerase), dTNPs, MgCl2, enhancers, and stabilisers to 
ensure a robust PCR reaction occurs (Bioline, 2015).   
Once the PCR mixture is created, it is put in to a thermal cycler for the PCR reaction to 
commence.  The temperature is initially raised up to 95ºC to enable the DNA double helix to 
be unwound, by breaking the hydrogen bonds; this exposes the single strands of DNA. The 
reaction temperature is then reduced for the annealing step; where the primers bind to 
specific sites on the single strand of DNA. The temperature is then increased for the final 
step of elongation, where the Taq polymerase synthesises a new complimentary strand of 
DNA by adding the free dNTPs. These cycles are repeated to amplify the template DNA. 
Finally, there is an extension period which ensures the reaction is complete. 
 
 Gel Electrophoresis  
Gel electrophoresis is the process of separating and analysing DNA fragments based on their 
size. An electric current is used to attract the negatively charged DNA fragments towards the 
anode. Shorter molecules move faster; therefore, they migrate further along the gel. A dye 
(e.g. SYBR® Safe) added to the gel enables results to be viewed under ultra-violet (UV) 
light in a transilluminator. A single bright band indicates the PCR has amplified the DNA 
(Figure 4-6). A faint band could indicate a low concentration of DNA in the sample. A 
smeared band could suggest too much DNA in the sample, DNA degradation or 
contamination (Palumbi et al., 2002). Multiple bands formed suggest multiple priming sites 
for the primer on the target DNA (National Diagnostics, 2011); in such cases the bands can 
be cut out and purified for analysis. If no band is seen it could mean the PCR failed, the 
quantity or concentration of the DNA template was insufficient, or the presence of 
contaminants, in such cases the PCR can be repeated after the original DNA sample has been 
cleaned. A DNA ladder can be used to determine the size of a DNA fragment. A positive 
control is a known sample which amplifies and is used to ensure the PCR reaction works; 
while, a negative control (distilled water) is used to ensure there is no contamination during 
the process.  
  
Figure 4-6 Image of a Gel, after PCR Amplification and Gel Electrophoresis of Several 
Ocimum Samples (A-E), Negative and Positive Controls, and a DNA Ladder 
 1        2         3        4        5         6        7         8 
Key: 
1. Negative Control  
2. Positive Control  
3. Sample A 
4. Sample B 
5. Sample C 
6. Sample D 
7. Sample E 
8. DNA Ladder   
Negative control – distilled water; positive control – DNA sample known to amplify; DNA ladder – 
Bioline Easy Ladder 1. 
Size (base pair) 
2000 
1000 
500 
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100 
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 Sequencing 
During the sequencing process a reaction similar to that of the PCR stage is carried out. 
Primers, DNA polymerase, dNTPs and dideoxynucleotides triphosphates (ddNTPS) are 
added to the query sample. The ddNTPS lack the 3 prime hydroxyl group required for 
extension, therefore these act as the terminators of the elongation of the DNA sequence. The 
ddNTPs representing each of the four nucleic acid bases (A, C, G, and T) are labelled with a 
different florescent tag which will help with detection. These ddNTPs attach 
complementarily to the new DNA strands; thus, DNA chains of varying length are produced 
(Figure 4-7).  
Capillary electrophoresis is then used to sort 
the DNA fragments by length. The sample is 
loaded into a capillary tube which contains a 
viscous polyacrylamide gel. An electrical 
current is applied, which pulls the negatively 
charged DNA through the capillary; the 
shorter fragments migrate through the gel 
faster than the larger strands. As the 
fragments emerge at the end of the capillary 
they pass a laser beam, this causes the dye to 
fluoresce. The fluorescence emitted by each 
base is detected by a photocell which then 
relays the information into a computer that 
visualises the data as an electropherogram 
(Wiley, 2012). This creates the genetic 
sequence of the sample.   
 
 Species identification and authentication  
The Consortium for the Barcode of Life (CBOL) is an international initiative which aimed to 
develop DNA barcoding as a global standard for the identification of biological species. 
Genetic reference libraries have been created for sharing DNA sequences, including 
GenBank and the Barcode of Life Database (BOLD). These databases allow DNA sequences 
to be shared, managed, analysed, and used for comparisons (De Mattia et al., 2011; CBOL, 
2015). Specimens used to create DNA barcodes still need to be authenticated by a 
taxonomist using the traditional methods of morphology to ensure the correct species is 
being used for the standard. Once a database is set up, fast and reliable identification can 
commence. 
Figure 4-7 DNA Sequencing Summary, from 
Etheridge 2012 
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 DNA Authentication of Ocimum Species  
Several researchers have explored the use of different regions (e.g. nuclear ITS, plastid 
matK, rbcL and trnH-psbA) for DNA barcoding of the Ocimum species. Some have created 
reference sequences which are available on databases such as GenBank, while others have 
used the reference sequences to authenticate fresh, dried and commercial tulsi products.  
Jürges et al. (2009) identified the difficulties of extracting tulsi DNA from multicomponent 
formulations and tried to define markers to distinguish between different Ocimum species. 
The ITS 1 and ITS 2 markers were amplified for eight Ocimum samples, of which five were 
supposedly O. tenuiflorum. Their results identified three of these samples were truly O. 
tenuiflorum while the other two samples had been incorrectly identified and were other 
Ocimum species instead. Their findings were confirmed by microscopic and macroscopic 
characteristics of the samples. One of the challenges Jürges et al. (2009) found was the 
different terminology used in Ayurvedic tradition and scientific botany. Although tulsi is the 
term used for O. tenuiflorum Jürges et al. (2009) claim in different parts of India “tulsi” 
could be used for other Ocimum species or any kind of basil depending on the origins. Their 
use of DNA barcoding to identify tulsi samples in commercial samples had limited success; 
however they were able to produce several reference Ocimum sequences.  
Christina and Annamalai (2014) claim Ocimum species are morphologically very similar to 
one another hence easily misidentified. Consumption of the wrong species could have 
adverse effects or an inappropriate therapeutic effect. To address these issues Christina and 
Annamalai (2014) used DNA barcodes to validate several “Medicinally important Ocimum 
species.” They looked at the efficiency of three barcodes (matK, rbcL and trnH-psbA) to 
identify nine Ocimum species from India. They concluded the markers they used showed a 
high PCR amplification efficiency which enabled the discrimination of the Ocimum species. 
Of the three markers used, they found the trnH-psbA region was ideal for the authentication 
of Ocimum species although it was not able to distinguish between the two varieties of O. 
tenuiflorum - Raam and Krishna tulsi.  
Anbazhagan et al. (2014) collected four morphologically distinct plant samples which were 
identified as being Ocimum species. Using the matK gene for the PCR amplification they 
identified three of the samples were O. tenuiflorum and one was O. basilicum when the 
sequences were compared to sequences in GenBank. Like Christina and Annamalai (2014),   
Anbazhagan et al. (2014) also revealed that the matK region was suitable for DNA barcoding 
of Ocimum species.      
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The British Pharmacopoeia (2016) recently validated the use of DNA barcoding techniques 
for the identification of herbal medicines. They used O. tenuiflorum as an example to 
demonstrate how DNA barcoding could be used authenticate the plant material which may 
be used in herbal medicines. The trnH-psbA region was used to create the reference O. 
tenuiflorum sequence which is now part of the Holy basil monograph in the British 
Pharmacopoeia (2016). 
This research highlights the applications of DNA barcoding techniques for authenticating 
Ocimum species.     
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4.5 Methodology  
A mixed methods approach was used for this research; the use of semi-structured interviews 
and molecular techniques presented a dynamic approach to this multidisciplinary research. 
This section outlines the rationale for the methods used for this investigation.  
 
4.5.1 Interviews with South Asian Communities and Sample Collection 
Interviews are a type of qualitative research method which enables richer, in-depth 
knowledge of the individual participants’ perception regarding the objectives of the study to 
be explored (Gill et al., 2008). A semi-structured interview process was used to collect 
primary data for this research. A mixture of open and closed questions were used during the 
interviews; as open ended questions give participants the opportunity to share as much 
information as they wish, while, closed questions enable quantitative analysis of results.  
During structured interviews the researcher reads out the questions and records the 
respondents answers; they do not allow for deviations from the set questions (Moore, 2000). 
Whereas, semi-structured interviews give the flexibility to ask questions around the topic. If 
participants do not understand the question this type of research method gives the researcher 
the flexibility to explain the question in a way the participant understands. In addition, it 
gives the researcher the opportunity to explore interesting concepts further when they are 
identified (Wisker, 2008). This method allows the researcher to build rapport with 
participants; which in this research made it easier to obtain tulsi samples for molecular 
analysis from participants. Conducting semi-structured interviews may be time consuming 
and expensive, and the results may be difficult to analyse and generalise if no trends are 
observed; but, with the correct training and skills this is a valuable method of obtaining 
unique primary data (Moore, 2000).  
The structure of the interviews was shaped by results from the SATMED questionnaire 
which the researcher was interested in exploring in more detail. The interview questions 
(Appendix 8) were designed to explore the cultural and commercial values of tulsi; a plant 
which many participants in the SATMED questionnaire claimed to use, grow, or import to 
the UK. An interest in establishing the country of origin of tulsi plants was addressed by 
asking participants where their seeds or plants were originally from. Participants were asked 
a range of questions to determine where their knowledge of the plant came from, and what 
they used it for. Participants were given the opportunity to express their views about the use 
of tulsi for religious and medicinal purposes, the growing conditions required, and any other 
special precautions to take with the plant.  
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An opportunity sampling technique was used to recruit participants who were willing to take 
part and give a sample of their tulsi plants. A participant information leaflet (PIL) was given 
to potential participants so they knew what the research was about and what was required of 
them (Appendix 9). Although this technique does not allow a representative sample to be 
selected, it is a fast and efficient way of recruiting a sample (McLeod, 2014). Participants 
were identified through the researchers’ personal contacts; initially, recruiting friends and 
family who kept a tulsi plant, and were willing to participate. Followed by contacting 
participants who agreed to take part; either from previous contact with the researcher (during 
the SATMED questionnaire distribution), via the social media network created (Facebook), 
or by word of mouth from other participants. Posters and leaflets (Appendix 10 & 11) 
designed were used to create awareness of the project and provided contact details of the 
researcher for people interested in taking part. A website (www.dmutulsiproject.webs.com) 
and a Facebook profile (Tulsi Project - https://www.facebook.com/pages/Tulsi-
Project/531956563523250?fref=ts) were also created to raise awareness of the project. The 
participant inclusion criteria for this aspect of the research was very broad; anyone over the 
age of eighteen years old, of SA origin, who had a tulsi plant or any tulsi products, willing to 
take part were accepted. (See Appendix 2D for the ethics proposal for this research).  
Tulsi leaves, seeds, and other samples were collected from participants during the face-to-
face interviews. Several interviews were conducted remotely via telephone; these 
participants were asked to post samples to the researcher. All tulsi samples collected from 
participants were classified as ‘community samples’ and given a code to identify where they 
were collected from (see section 4.5.2).   
 
4.5.2 Collection of Tulsi Samples 
A variety of tulsi samples were collected for molecular analysis. This included samples from 
participants taking part in the interview and any volunteers encountered throughout the 
research period; these samples were labelled as ‘community samples’. Tulsi products (e.g. 
seeds, plants, tablets, capsules, oils, juices, soaps, and shampoos) bought from multiple 
sources in the UK, India and online were identified as ‘commercial samples’. The ‘reference 
specimens’ represent the reference Ocimum samples obtained from botanists and established 
sources; i.e. Professor Peter Nick (Botanical Institute Karlsruhe Institute of Technology, 
Germany), Dr. Eike Reich (Director at CAMAG Laboratory, Switzerland), and The Royal 
Botanic Gardens Kew - DNA bank (samples from Chase M.W and Suddee et al.).  A unique 
code for each sample was issued; a letter for the source/ location (e.g. A = Africa, B = 
Birmingham, C = commercial, G = Germany, I = India, L = London, Li = Leicester, V = 
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reference, etc.), followed by the chronological sample number (Appendix 12). For 
community samples given by participants who took part in the interviews the participant 
identification code was the same as the sample code for their tulsi sample. If multiple 
samples were given by a participant a letter was added to the end of the identification code 
(e.g. participant B15 from Birmingham gave two samples - B15a and B15b). The letter ‘g’ 
after a code was used to represent seed samples which were given from the original plant 
sample (e.g. B07 leaves from a plant and B07g were seeds from the same plant).  
 
4.5.3 Scanning Electron Microscopy of Tulsi Samples 
The Carl Zeiss Evo® HD 15 scanning electron microscope was used to conduct the SEM 
work on the tulsi samples collected, under the supervision of Rachel Armitage (Senior 
Technician and PhD Researcher) and Liz O’Brien (Senior Technician). Several of the 
reference Ocimum samples obtained from Professor Peter Nick were analysed under SEM.  
 
4.5.4 DNA Analysis of Tulsi Samples 
In order to authenticate a plant species the DNA must first be extracted, followed by a PCR 
to amplify the target DNA sequence, and then gel electrophoresis to check the PCR has 
successfully worked. If a positive PCR result is obtained the sample is then sequenced. The 
DNA sequence data can then be used to identify the plant species.  
 
 DNA Extraction 
The Qiagen DNeasy Plant Mini Kit was used to conduct all DNA extractions. The Mini 
Protocol from the DNeasy® Plant Handbook, pages 22-25, was used (Qiagen, 2012).  
 Once samples were selected for DNA extraction the appropriate amount was weighed 
(0.1g of fresh plant material or 0.02g of dried material). The samples were mechanically 
disrupted using a pestle and mortar and then lysed in a TissueLyser (for 1 minute at 30 
Hz) with a tungsten bead in a microcentrifuge tube. For fresh plant samples 400µl of the 
lysis buffer (AP1) and 4µl RNase A (100mg/ml) was added during the maceration in the 
TissueLyser; while for dried samples these were added after. The tubes were then re-
positioned in the TissueLyser and this step was repeated, to ensure equal 
homogenisation.  
 For the cells to be completely lysed the samples were left to incubate at 65ºC for ten 
minutes. 
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 To precipitate the proteins and polysaccharides from the sample 130µl Buffer AP2 was 
added and then incubated on ice for five minutes.  
 Cell debris and precipitates were removed by spinning the samples through a 
QIAshredder column, for two minutes at 14 000 revolutions per minute (rpm).  
 1.5 times the flow through volume of Buffer AP3/E was then added to help the DNA 
bind to the membrane of the DNeasy spin column.  
 The sample was then applied to a DNeasy spin column and centrifuged for one minute at 
8000 rpm. 
 500µl of Buffer AW was added and centrifuged (for one minute at 8000 rpm) and the 
flow through was discarded to remove any contaminants. This was then repeated; 
however, it was centrifuged for two minutes at 14000 rpm to dry the DNeasy membrane.  
 For the final elution of the DNA, 100µl of Buffer AE was left to incubate on the DNeasy 
spin column membrane for five minutes, before being centrifuged for one minute at 8000 
rpm. This was repeated, to leave a final volume of 200µl of pure DNA sample.   
 Once the DNA was extracted 50µl was pipetted into two separate tubes to be stored at 
minus 20ºC and minus 80ºC for preservation. The 100µl left in the original tube was 
used as the working sample of DNA. 
 
 Polymerase Chain Reaction (PCR) 
A master mix containing the MyTaq Red Mix (2x), forward primer, reverse primer, and 
distilled water was made (Table 4-1). 48µl of the master mix was aliquoted into a 0.5ml PCR 
tube, followed by 2 µl of template DNA. A positive control (known DNA sample) and 
negative control (distilled water) were always used to ensure the PCR had worked 
successfully and there was no contamination. 
Table 4-1 PCR mixture with BioLine MyTaq Mixture 
Component: Volume per reaction: 
MyTaq Red Mix 25 µl 
Forward Primer 1 µl 
Reverse Primer 1 µl 
Template DNA 2 µl 
Distilled Water 21 µl 
Total 50 µl 
 
The PCR tubes were then transferred into the Bio-Rad PTC-200 Thermal Cycler for the PCR 
reaction to commence.  
160 
Sukvinder Kaur Bhamra 
Primers and protocols used include:  
rbcL 
rbcL_f (Forward primer) 5’-ATGTCACCACAAACAGAGACTAAAGC-3’ 
rbcL_rev (Reverse primer) 5’-GTAAAATCAAGTCCACCRCG-3’ 
PCR protocol for rbcL: 
Initial denaturation step - 5 minutes at  95°C. Followed by 35 cycles of 30s at 95°C, 20s at 
52°C and 50s at 72°C. Final extension period of 5 minutes at 72°C. 
matK 
3F Kim (Forward primer) 5’-CGTACAGTACTTTTGTGTTTACGAG-3’ 
1R Kim (Reverse primer) 5’-ACCCAGTCCATCTGGAAATCTTGGTTC-3’ 
PCR protocol for matK: 
Initial denaturation step - 5 minutes at 94°C. Followed by 5 cycles of 30s at 94°C, 40s at 
44°C and 40s at 72°C. Then 30 cycles of 30s at 94°C, 40s at 46°C and 40s at 72°C. Final 
extension period of 3 minutes at 72°C. 
ITS 
ITS1 (Forward primer) 5’-TCCGTAGGTGAACCTGCGG-3’ 
ITS4 (Reverse primer) 5’-TCCTCCGCTTATTGATATGC-3’ 
PCR protocol for ITS: 
Initial denaturation step - 7 minutes at 95oC. Followed by 30 cycles of 1 minute at 95oC, 30s 
at 60oC and 1 minute at 72oC. Final extension period - 7 minutes at 72oC. 
 
trnH-psbA 
psbA (Forward primer) 5’-GTTATGCATGAACGTAATGCTC-3’ 
trnH (Reverse primer) 5’-CGCGCATGGTGGATTCACAATCC-3’ 
PCR protocol for trnH-psbA: 
Initial denaturation step - 5min at 95°C. Followed by 35 cycles of 1 minute at 95°C, 30s at 
touchdown temperature* and 1 minute at 72°C. Final extension period of 7 minutes at 72oC.   
*Touchdown temperature begins at 58°C, reduced by 1°C per cycle until 48°C, then 
continued at 48°C for the remainder of the program. 
(Primers and Protocols obtained from Biomolecular Technology Group, A guide to 
molecular techniques, Standard Operating Procedures, 2013) 
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 Gel Electrophoresis 
After the PCR reaction was complete, the samples were loaded (5 µl) on a 1% w/v agarose 
gel (0.5g agarose powder mixed with 50ml 0.5 X TBE* buffer, and 2µl SYBRsafe™ as the 
DNA stain), with TBE buffer for the electrophoresis. The gel electrophoreses was run for 30 
minutes at 90V. An image of the gel was then taken using the Bio-Rad Gel Doc EZ imager 
and the Image LabTM Software. The Bioline Easy Ladder 1 was used to determine the 
molecular weight of the DNA. 
*TBE = Tri-borate-EDTA, made by mixing 10.8g Trise base, 5.5g Boric acid, 0.584g  EDTA 
and 1 litre of distilled water. 
 
 Extraction of Multiple Bands 
When multiple bands were seen on the agarose gel, the Qiagen® QIAquick gel extraction kit 
was used to cut multiple DNA bands from the gel for further analysis. In order to extract the 
DNA from the multiple bands, the gel electrophoresis was repeated with the following 
modifications: up to 50µl of PCR sample was loaded on the gel and it was run for 60-90 
minutes at 90V. An image of the gel was printed to map the bands on the gel. The gel was 
then taken to the UV light box where the individual bands were carefully cut out using a 
blade. The segments were placed in a labelled tube before the protocol for the extraction was 
followed from the QIAquick Spin Handbook, page 25-26 (2006).    
Once the DNA was eluted from the gel, another agarose gel was made to check the DNA had 
been successfully extracted, before sending the samples for sequencing. 5µl of the sample 
was mixed with 2µl of loading buffer before being pipetted onto the gel, which was run for 
30 minutes at 90V. Samples were then sent for sequencing, or a PCR was done to amplify 
the DNA before sending the samples for sequencing. 
 
 DNA Isopropanol Clean Up 
DNA may need to be cleaned in order to remove impurities and contaminants such as 
enzymes, proteins, and cell debris if they are not fully removed during the final stages of the 
DNA extraction. The isopropanol clean up method from the De Montfort University - 
Biomolecular Technology Group, A Guide to Molecular Techniques, Standard Operating 
Procedures, page 6, 2013 was used: 
50µl of the DNA sample was added to 35µl of isopropanol in a 1.5ml microcentrifuge tube. 
The mixture was centrifuged at 15,000 × g for 30 minutes at 4°C. The supernatant was then 
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removed before re-suspending the pellet in 200µl of 70% ethanol. This mixture was then 
centrifuged at 15,000 × g for 10 minutes at room temperature. The supernatant was once 
again removed, and the ethanol was allowed to evaporate (for 20-30 minutes). Finally the 
pellet was re-dissolved in 50µl of elution buffer TE. 
 
 NanoDrop Spectrophotometry 
The NanoDropTM Lite (Thermo Fisher Scientific Inc) was used for quantification of DNA in 
the samples. It is a UV spectrophotometer which uses Light Emitting Diode (LED) 
technology to measure the samples absorbance at 260 and 280 nm. A very small quantity of 
sample (1-2 µl) is required for the analysis. It provides three key readings: concentration 
(ng/µl), A260, and A260/A280 purity ratio. The concentration value reveals the 
concentration of nucleic acid in the sample. The A260 measures the absorbance and should 
have a value between 0.1-1.0, results less than 0.1 are not very reliable. The A260/A280 
purity ratio determines the level of protein contamination; a value of 1.8 is accepted as being 
pure DNA, lower values indicate the presence of proteins, phenols, and other contaminants 
which also absorb at 280nm (Thermo Fisher Scientific Inc, 2012).  
 
 Sequencing  
Samples which gave a positive PCR result (as indicated by the gel electrophoresis) were sent 
for sequencing to an external sequencing company, Macrogen Europe, Amsterdam (The 
Netherlands) who provide Sanger sequencing services. The results from the sequencing 
company provided details of the sequence length, GC%, and also the sequence trace 
(electropherogram). The DNA data obtained were then used for analysis, identification, and 
construction of a reference database.  
 
 Sequence Analysis 
Data was analysed using CLC Main Workbench 6 (CLC bio). This software enabled 
sequence data to be analysed by assembling DNA sequences, trimming sequences, producing 
contigs (i.e. overlapping DNA sequences to produce a consensus sequence), and multiple 
alignments. Default settings were used to produce contigs with an automated vote based 
conflict resolution. If sequences could not be assembled using the default settings, the 
minimum alignment read length was reduced from the default 50 bases to 1 base and the 
alignment stringency was modified from medium to low (as recommended in the CLC user 
manual).   
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The Basic Local Alignment Search Tool (BLAST) was used to input the query DNA 
sequences, for comparisons with reference DNA barcodes from reference databases for 
identification (http://blast.ncbi.nlm.nih.gov). DNA databases such as Genbank 
(http://www.ncbi.nlm.nih.gov/genbank/) and BOLD (http://www.boldsystems.org) were 
used to search for reference Ocimum sequences, which were then compared with query 
sequences in CLC. 
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4.6 Results and Discussion  
4.6.1 Tulsi Project Interview Results  
Semi-structured interviews were designed to collect information about the current use and 
importance of tulsi to individuals who kept the plant. Questions to understand why tulsi was 
kept, where it was originally from, and why it was important to participants helped to reveal 
some interesting information. While the interviews were conducted participants were asked 
for a sample of their tulsi plants, seeds, or any other tulsi products they had. These were then 
subjected to DNA analysis.  
 Sample Description 
An opportunity sampling technique was used to recruit participants. Participants known to 
the researcher who had a tulsi plant were approached and asked if they would take part in 
this research. They were asked to answer some questions during a short interview (Appendix 
8) and provide a sample of their tulsi plant, seeds, or any other tulsi products they had. 
Participation of one contact led to the recruitment of several others, leading to a snowball 
effect. Interviews were conducted with people from several locations across Birmingham, 
Leicester, and London. The awareness of the project raised via the social media Facebook 
page and the website led to people from Australia and Singapore getting in contact to see if 
they could take part and have their samples authenticated. Samples were posted and received 
from Singapore, however due to fungal contamination they were discarded.   
Although twenty six tulsi samples were collected from participants, not everyone was able to 
take part in the interview.  In total thirteen interviews were conducted with the collection of a 
tulsi sample for genetic testing. Most of the interviews were conducted face to face; while, 
some were completed via telephone and samples were then posted to the researcher.  
All participants were of Indian ethnicity and over 30 years old. There were more female 
(77%, n=10) than male (23%, n=3) participants in this survey population (Figure 4-8). One 
participant was of the Sikh faith while all the others were Hindu. Just one participant was 
born in the UK, whereas most of the others were born either in India (n=8) or Africa (n=4). 
All of the participants’ parents were born in India or Africa.  
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 Analysis of the Interviews 
Participants were asked a series of questions to establish where they got their tulsi from, 
what they used it for, and to gather some background information for this research. As a 
semi-structured interview style was used, it gave the researcher the freedom to ask the 
questions in an informal conversational manner. 
 
 Where did you get your Tulsi from? 
Many participants (54%, n=7) claimed to get their tulsi from their family; seeds and plant 
cuttings were often passed on from mothers, grandparents, or aunties. Some participants said 
they got their tulsi from friends (23%, n=3); while others (15%, n=2) said they got their tulsi 
from the temple (mandir), due to the religious affiliation tulsi plants can always be found in 
Hindu temples. One participant claimed she got her tulsi from both friends and family. It is 
common practice to share cuttings and seeds with friends and family. Some participants 
claimed tulsi seeds and dried material from India and Africa were brought to the UK during 
visits to family or via post (Figure 4-9). The migration pattern of people from India to the 
UK and Africa, and then from Africa to the UK can be seen in Figure 4-9; whether or not 
this impacts the species of tulsi found in the UK will be considered later.  
  
 
India 
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Gujarat  
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Figure 4-9 Map of Where Tulsi Samples Were Collected in the UK, and Where Samples Might Have 
Originally Came From  
Durban 
Key: 
 Transfer of tulsi from India  
 Transfer of tulsi from Africa 
Locations in the UK where tulsi 
samples were collected 
The map summarises where participants may have got their tulsi from and where samples were collected in 
the UK. This is based on where participants’ families were in India and Africa and where participants or 
their families lived before migrating to the UK.  
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 Do you have any Tulsi seeds? 
Participants were asked if they had any tulsi seeds to uncover the source of their plants; in 
addition, the researcher was keen to collect seed samples to grow at the university. The vast 
majority of participants (77%, n=10) did have seeds; whereas, the others (n=3) said they got 
their tulsi as a plant or a cutting and did not have any seeds. Some participants claimed the 
original source for their seeds was either India or Africa. Seeds which had been taken from 
India to Africa and then to the UK were also identified by one participant (participant B06); 
she was born and brought up in Uganda but said her mother got her tulsi seeds from her 
grandmother in India, her mother sent her some seeds in the post when she moved to the UK 
where she kept her plant for sixteen years before it died. She now has another plant from a 
friend in Leicester and each year she harvests the seeds and shares them with neighbours, 
friends, family, and the temple.  
 
 Do you grow your own Tulsi?  
This question aimed to establish whether or not people grew their own tulsi plants; as not all 
the samples obtained were fresh plant material. Twelve participants (92%) said they either 
did or had tried to grow a tulsi plant, just one participant said she did not grow her own tulsi; 
participant A14 said, “No I do not grow it personally but my mum and mother-in-law do.” 
Some participants said they had problems propagating the seeds and maintaining a healthy 
plant. While others claimed they tried to grow a tulsi plant but it did not grow very well here 
in the UK. For example participant B102 claimed, “In India it is much easier to grow tulsi, 
but here in the UK it always dries out!” These participants made reference to the size and 
abundance of the tulsi plants their families grew back in India and Africa. Participants 
commented on how the environment and climate in the UK was not suitable for growing 
tulsi. It was also noted that participants claimed Raam tulsi was easier to grow than Shyam 
tulsi. Those who were able to successfully grow their own tulsi plants said they kept it in a 
warm place near a radiator, a window to enable plenty of light to get to the plant, or in a 
porch to mimic a greenhouse. Many participants made reference to how difficult it was to 
keep tulsi; those who were able to grow and maintain the plant were believed to be very 
fortunate.  
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 Are there any special requirements for storing/ growing/ keeping Tulsi? If so what are 
they? 
The significant majority of participants (85%, n=11) claimed there were special growth 
requirements for ensuring the survival of their tulsi plants; such as participant B105 who 
said, “The tulsi plant must be very well respected and cared for. You cannot touch it without 
washing your hands or ladies if it is the time of month.” Participants who were able to grow 
a plant, as well as those who were unable to keep tulsi mentioned several requirements for 
keeping the plant.   
Most importantly participants identified the warm and sunny environment required for tulsi 
to flourish in, which were not ideal in the UK. As the tulsi plant is found predominately in 
the tropics it is accustomed to warm, humid and sunny climates (Grayer, 2001). In the UK, 
often the temperature is not optimal for growth of tulsi and during the winter months there 
are insufficient levels of sunshine. Due to the warm climates in Asia and Africa tulsi grows 
wild almost anywhere the seeds are sown. The minimum temperature tulsi will survive in is 
around 18ºC; hence, in the UK where temperatures often fall below this minimum 
requirement, tulsi must be kept indoors or in a greenhouse with the temperature maintained 
between 18-23 ºC. The use of artificial heating sources such as radiators were used to try and 
keep plants warm, but there was a risk of the plant drying out and dying if kept too close. 
Participants explained how difficult it was to keep their tulsi plants warm enough, in an area 
with plenty of light; a window sill in the kitchen appeared to be the most common place to 
keep tulsi. 
In India and Africa as the climate is well suited for tulsi to thrive it is often grown in the 
centre of the courtyard, as it is supposed to bring the family together and be a blessing. Some 
believe the plant should be kept in the front of the house to welcome the Gods, while others 
say it should be kept in the centre of the home. Participants had different views about where 
the tulsi plant should be kept; but, one thing which was consistent was that it should not be 
moved once placed.  
The small dark brown seeds should be sown around April-May, covered lightly with finely 
sieved compost, and not over watered. In theory, the soil will need some extra nourishment 
as the tulsi begins to flourish, using plant feeds, fertilisers or manure can help the plant grow 
healthier and stronger (Wagner, 2010). However, participants made specific references to not 
using fertilisers, chemicals or even plant feeds as they would not be suitable for the holy 
plant. Participant B02 said, “Tulsi should only be given water as it does not need anything 
else, it would be disrespectful to pour chemicals and fertilisers onto the goddess”.   
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Traditionally the tulsi plant is idolised as a Goddess, Hindus believe extra affection should 
be shown to the plant. Special rituals and prayers (poojas) have been conducted for centuries 
to help the plant thrive. Wagner (2010) describes multiple ways of caring for and worshiping 
the plant, including: chanting the tulsi Mantras, saying the one hundred and eight sacred 
names of tulsi, gently kissing the leaves, and thanking the plant for being with you. During 
the interviews it become apparent that there were several ‘terms and conditions’ attached to 
the successful growth and longevity of the plant. It was noted that the plant should not be 
disturbed in the evening as it sleeps just like humans do, during menstruation women are not 
supposed to touch the plant as this is a time of impurity, the plant should only be watered or 
touched after washing your hands, and the plant should not be moved around as this would 
be classed as being disrespectful to the Goddess. The myth is that tulsi will only grow in 
fortunate people’s homes, ‘‘only the lucky people can grow this plant in their home,’ 
Participant B05.  
 
 What type of Tulsi is this? 
Participants were asked to specify the type of tulsi they had. Some participants did not know 
the type of tulsi they had while others were able to differentiate between the different 
varieties of tulsi they had or knew of. The two main types of tulsi identified by the research 
population were Raam and Shyam tulsi (Figure 4-10). Raam tulsi was described as having 
large bright green leaves; the plant often grew very big and survived the harsh UK climate. 
On the other hand, Shyam tulsi was known to have smaller, darker green leaves and did not 
grow as tall as Raam tulsi. Some participants claimed their Shyam tulsi plants dried out 
during winter but rejuvenated during the summer time, while others said once their plant 
dried out in winter it never grew back. This suggests the Raam tulsi grown by participants 
may be a different species which does not require the same growth conditions as the Shyam 
tulsi. Six of the participants interviewed were not sure about the type of tulsi they had.  
 
 
 
 
 
 
 
 
 
 
Raam Tulsi Shyam Tulsi  
Figure 4-10 Community Raam and Shyam Tulsi Samples Collected During the Interviews  
Photographs of tulsi plants in participants’ homes identified by participants as A –Raam tulsi, B - Shyam tulsi.  
A               B 
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 Can you tell me all the different names Tulsi has: 
With the wide spread use of tulsi across the world there are numerous ways of referring to it. 
This question was asked to be able to get a better understanding of how to refer to tulsi the 
correct way. Participants gave a range of names for tulsi including: tulasi, Virinda, tulsi maa, 
tulsi devi, tulsi rani, Nandani, Laxmi, and sweet basil. Many of the names given to tulsi have 
a religious connotation. The names given symbolise the religious significance for 
participants i.e. ‘maa’ meaning mother, ‘rani’ translating to queen, and ‘devi’ referring to 
goddess. In Hinduism there are 108 names for tulsi; some devote worshipers believe by 
chanting the 108 names to the plant helps to promote its growth and prosperity. Other 
common names for tulsi include: holy basil, monk’s basil, sacred basil, green tulsi, garden 
balsam, solasi, sulasi, sursa, thulasi, tulashi, tjlsi, and Virandra (WHO, 2002b; Joshi et al., 
2012). In the various states of India the plant is referred to in different ways. The incorrect 
term or pronunciation could lead to great confusion; as experienced by the research team 
during field research in India. In areas where Punjabi or Hindi are spoken the word ‘tulsi’ is 
used; however, in South India the term tulsi was not recognised but instead it was known as 
‘thulasi’. 
 
 Do you keep Tulsi in your home? If so why? 
All participants interviewed said they kept tulsi in their home; those who struggled to grow 
the plant said they kept it in their family homes in India and Africa. The main reason of 
keeping tulsi for 92% of participants (n=12) who were Hindus was the religious significance. 
Participants claimed the plants growth and presence in the home symbolised luck and it was 
a blessing to be able to keep it. Participant B15 said, “It is very important if you are Hindu to 
keep tulsi,” while participant B12 claimed, “we keep it in our home for good luck and for 
religious ceremonies.” 
The importance of having tulsi for offerings to God during poojas was mentioned. 
Participant B03 described how her mother used to make her take blessings from the tulsi 
plant kept in the centre of the courtyard, in their home in India, before any exams and 
important events. Just one Sikh participant (B01) who got her tulsi from a Hindu friend said 
she kept the plant for the health benefits associated with it. Participant B01 had diabetes and 
was told to take tulsi leaves in her tea to help reduce her blood glucose levels.  
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 Where did you learn about Tulsi? 
Participants were asked how they had learnt about tulsi to establish where and how this 
traditional knowledge was being transmitted. The religious and medicinal values associated 
with the tulsi plant were evidently passed on through generations, as the family appear to be 
the main source for learning about tulsi, for 62% (n=8) of participants (Figure 4-11). Due to 
the religious significance of the plant for Hindus, religion has also had a key role in 
transmitting the knowledge of the benefits of tulsi for three participants. Participants spoke 
about how the priest (pandit) talked 
about tulsi during religious 
ceremonies to explain the importance 
of the plant which represented the 
goddess Virinda Tulsi. Participants 
also shared their knowledge of what 
the religious significance was and 
what it meant to them. Some 
participants (n=2) claimed to have 
learnt about tulsi from their friends, 
while discussing natural remedies for 
various ailments. Participant B02 
made reference to having learnt 
about tulsi during her education in India.  
Participant B06 talked about her experience with tulsi growing wild in Africa; saying it grew 
in abundance on the sides of the streets and roads; she said her mum always talked about 
how important the plant was and felt like it was not being given the correct respect in the 
wild conditions it was seen in.  
 
 Does Tulsi have a religious purpose in your life? If so what is it? 
As 92% of participants were Hindu, the tulsi plant did have a religious significance for them, 
even for those not actively practicing their religion. The one non-Hindu participant (B01) 
said, ‘I am not Hindu but I still respect the plant as my friend has told me what the plant 
represents.’ Many participants detailed the reasons for worshiping the plant and explained 
why the plant was referred to as a goddess. Participants mentioned how it was used as 
offerings as prasad during prayers.  
The purity of the plant was associated with the numerous healing properties, believed to be 
Gods cure for all diseases. The leaves placed in the mouth of the deceased were believed to 
15%
62%
23%
Where Participants Learnt About Tulsi
Friends
Family
Religion
Figure 4-11 Where Participants Learnt About Tulsi 
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aid the passage to heaven. If the plant grows it is believed to symbolise a blessing and is 
perceived as being lucky. Due to the religious affiliation of the plant every mandir should 
have a tulsi plant; this makes it accessible for everyone to get blessings from the tulsi 
goddess even if they cannot keep a plant at home.  
Many of the participants who kept tulsi for the religious properties were strict vegetarians 
and mentioned how the consumption of meat and alcohol should be avoided in the house 
where tulsi is kept, as it would be disrespectful to the goddess. One participant spoke about 
her friend who kept a plastic tulsi plant in her home so she always had the presence of the 
goddess with her, just like with other religious pictures and statues in her personal mandir.  
 
 What do you use Tulsi for? 
By asking participants what they used tulsi for, the current use amongst SA communities in 
the UK could be established. Many participants (n=9) claimed to keep tulsi just for religious 
purposes. The plant was kept in the home to represent the goddess Virinda Tulsi and used 
during prayers as an offering to the Gods. During a research visit to a commercial tulsi 
supplier in Bangalore, India (April 2014), the problem of tulsi sales and waste were 
highlighted. Hinduism is the main religion in India (Census of India, 2011), with over 80% 
of the population identified as being Hindu. The demand for tulsi plants and leaves to be 
used as offerings to the gods during prayers and religious ceremonies is a big business. 
Therefore, tulsi needs to be quickly and widely available. Once the plants and leaves have 
been used for the religious ceremonies they are usually discarded as waste. Dr Velusamy 
Sundaresan and his researcher team at the Central Institute of Medicinal and Aromatic 
Plants, Bangalore, have tried to explore the possibilities of recycling the vast amounts of 
tulsi which are being wasted; however, progress has been slow and issues with 
authentication have been highlighted (Sundaresan, 2014).  
 
 What are the medicinal benefits of using Tulsi? 
The significant proportion of participants (87%) were aware of the diverse range of health 
conditions for which tulsi could be used. Participant B02 made reference to tulsi being the 
cure to all conditions as it was a God given plant; this opinion was shared by many others 
who were aware of both the religious and medicinal values of the plant. Participants listed 
the use of tulsi for: asthma, chest infections, sore throat, cough, colds and flu, fever, diabetes, 
skin conditions (e.g. eczema and itchy skin), mouth freshener, excessive stomach acid 
production, and period pains.  
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For many of the conditions the most common way to consume tulsi was by infusing it in 
warm water or tea. For conditions such as cough, sore throat, and the use as a mouth 
freshener - one or two leaves could be chewed. For skin conditions participants 
recommended bathing in tulsi infused water or rubbing the leaf directly onto the affected 
area of the skin.  
A small minority of participants (n=2) did not state any medicinal benefits of tulsi as they 
said they did not know any; they said they only knew the religious uses and had never heard 
about it being used as medicine. 
 
 Is there any other information which you think is important/ interesting to know about 
Tulsi? 
Participants were given the opportunity to share any additional information about tulsi. Table 
4-2 outlines the comments participants made, including some of the ‘terms and conditions’ 
to keeping a tulsi plant.  
Table 4-2 Participants Comments about Tulsi 
Participant Comments 
B02  
-The only thing tulsi maa needs is water. No artificial food, chemicals or 
fertilisers are needed. 
-If I have a cough I just take a few leaves and chew them. 
-Keep the tulsi in a warm place; I keep mine near the radiator.  
B03 
-Tulsi mala has 108 beads made from the woody stems of the tulsi plant. It is 
used to help you concentrate when you pray. 
-Tulsi should be kept in the centre of the home. 
B04 
-Do not touch tulsi on a Sunday.  
-If you keep the seeds you must do the plants marriage. 
-Can make holy water blessed with tulsi. 
B05 
-Tulsi represents lord Krishna so I tie a rakhi (cotton thread) on the plant, as I 
do not have any brothers of my own.  
-The plant does not survive in all homes only the lucky people can grow this 
plant in their home. 
-Cannot pick leaves in the evening. 
B06 -Cannot keep it outside as will not grow so have to keep it inside the house. 
L10 
-If a lady is on her period and she touches or waters the tulsi, it will die. 
So do not touch the plant during this time. 
B102 
-It is a very important plant to my family – it is maintained very well and my 
parents nurture their plants. As it has a religious purpose it is very valuable for 
us. 
B105 -It’s a very sacred plant for us; it means you’re very lucky if it grows. 
These comments illustrate the religious significance of tulsi and the traditions associated 
with keeping the plant which are evidently closely followed by communities in the UK at 
present. 
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 Summary of The Interview Results 
The interviews have helped gain a deeper understanding of why tulsi is so important to 
people and why it might be kept in the home. Evidently, a strong religious affiliation for 
Hindus means the plant has a special place in many of the participants’ homes; although, this 
may not be the only reason for keeping tulsi. The numerous health benefits associated with 
tulsi may also be a reason for keeping the plant. Family, friends, and religion all have a role 
in transmitting the knowledge of the uses and benefits of tulsi. The ‘terms and conditions’ 
attached to the prosperous growth of the plant may just be a myth; but, they still have a 
strong precedence amongst SA communities in the UK today. The results have revealed that 
tulsi is culturally, medicinally and commercially an important plant. Several types of tulsi 
samples were collected from participants. As different varieties are available, the importance 
of selecting the correct species will now be explored by looking at the DNA of the plant 
species.        
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4.6.2 DNA Authentication of Tulsi Samples 
The following section details the findings from the DNA analysis. It will describe how 
samples were collected and classified, some of the challenges faced during the study, and the 
achievements of using this novel molecular technique.  
 
 Classification of Tulsi samples 
A total of 111 tulsi samples were collected through the duration of this research (Appendix 
12). The samples collected were categorised as community, commercial, reference, or 
miscellaneous; 26 community samples were collected from participants encountered 
throughout the research period who donated their personal tulsi plants, leaves, or seeds. 
Forty-seven commercial samples included products such as teas, tablets, capsules, soaps, 
shampoos, creams, and oils, these were bought from shops, markets, and online; in the UK 
and abroad. Raw tulsi material ready to be used in commercial products which was obtained 
from Pukka Herbs, was classified in the commercial samples sub-group. Thirty-three 
Ocimum samples obtained from sources where the plants had been authenticated by expert 
botanists formed the ‘reference’ specimens. Six samples which were not identified as 
community, commercial, or reference were labelled as miscellaneous; these samples were 
collected by the researcher from various places while travelling throughout the research 
period.  
Of the total 111 samples collected, 29 samples were excluded from the analysis as the 
quality of DNA of the sample was very poor and in many cases no DNA was isolated during 
the extraction process (Appendix 12). Two of the samples were seeds which failed to 
germinate on numerous occasions; a DNA extraction from the seeds was attempted, but was 
unsuccessful. It is difficult to extract DNA from seeds due to the high level of primary 
(polysaccharides and lipids) and secondary metabolites (e.g. in the case of Lamiaceae, 
caffeic acid and other polyphenols), as well as proteins, which can degrade the quality of the 
DNA (Hassan et al., 2012). These samples did not give a positive PCR result and the lack of 
DNA in the sample was confirmed by results from the NanoDrop analysis. A potential 
reason why DNA was not extracted from the samples could have been due to the types of 
products used, e.g. soap, syrup, capsules, and oils; in which the DNA may have been 
degraded during manufacturing processing.  
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 The plastid matK and rbcL Regions  
The Consortium for the Barcode of Life (CBOL) Plant Working Group, proposed two 
coding regions from the plastid genome – matK and rbcL as ‘‘core barcodes’’ for plants 
(Kress et al., 2005; Chase et al., 2005; Hollingsworth, 2011). Thus, initially the matK and 
rbcL regions were selected for PCR amplification and DNA analysis of the Ocimum 
samples. The first 13 samples collected were a mixture of community and commercial 
samples. The PCR results for these samples were highly variable (Figure 4-12) and did not 
sequence as well as expected (Figure 4-13). Poor sequence data could not be used to search 
the reference DNA database for identification of the species, or to create contigs. The few 
samples which had good quality sequences which could be used for identification were put 
into BLAST; where most of the samples were identified as being similar to one reference O. 
basilicum sequence. No suitable O. tenuiflorum reference sequences were found in the 
database.  
  
Key: 
1. Negative control 
2. Positive control 
3. – 
4. B08 
5. B07 
6. B02 
7. B00 
8. B05 
9. B01 
10. B02a 
11. B03 
12. B04 
13. B07 
14. C20 
15. C08 
The image illustrates the results of the gel electrophoresis of community and commercial tulsi samples 
amplified by the matK and rbcL regions. Negative control – distilled water; positive control – DNA sample 
known to amplify. 
Figure 4-12 Gel Image of matK and rbcL PCR Products 
Sample B06g represents a tulsi sample collected from participant B06 (Appendix 12). 
Figure 4-13 Section of the Electropherogram for the Forward rbcL Sequence for Sample B06g 
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 Reference Ocimum Barcodes  
During the initial background research it was clear that there was a lack of reliable reference 
barcodes to identify the tulsi samples, in the existing DNA databases (GenBank and BOLD). 
This meant reference DNA barcodes for the Ocimum species needed to be created before any 
identification of unknown samples could commence. Thus, authenticated Ocimum plants, 
seeds, leaves, dried material, and DNA were collected to create the reference Ocimum DNA 
sequences. During later stages of this research, in 2014, reference sequences were submitted 
by various sources into GenBank (Appendix 14), these were also used for the identification 
of unknown samples. The reference sequences created throughout this study will also be 
submitted to the GenBank and BOLD databases.  
 
Creating Reference Ocimum barcodes 
A range of authenticated Ocimum samples (n=33) were obtained and used to create the 
reference DNA sequences (Appendix 12 and 13). When a good quality DNA sequence was 
obtained, three reads were ordered (usually, two forward and one reverse read) to produce a 
reliable contig (Figure 4-14). The consensus sequence was analysed to identify any conflicts 
between the three sequences which needed to be resolved before it was used as the reference 
DNA sequence; to compare with other samples and produce a multiple alignment.  
 
 
Full DNA sequences and multiple alignments can be found in Appendix 13. 
The electropherograms of three ITS sequences (one reverse ITS 4 and two forward ITS 1 reads) for reference O. 
tenuiflorum sample G26 from Professor Peter Nick. 
Figure 4-14 Image of a Section of a Contig Produced from Three Electropherograms of ITS Sequences 
from a Reference O. tenuiflorum Sample 
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For some species more than one authenticated specimen was available (i.e. from the 
reference specimens and DNA sequences on GenBank) and the sequences were all identical 
or very similar, a consensus sequence was made (Figure 4-15). Figure 4-15 shows part of a 
multiple alignment created with the DNA sequences of seven different authenticated O. 
tenuiflorum samples showing all the sequences were identical.  
 
The consensus sequence from the authenticated Ocimum samples was then used as the 
reference sequence to compare unknown tulsi samples with (Figure 4-16). Figure 4-16 is a 
multiple alignment of several samples of which the species were unknown, with the O. 
tenuiflorum consensus reference sequence. The alignment identifies some differences 
between the reference and query sequences; the illustration below shows the process 
involved in checking whether or not the base differences are reliable. 
   
The alignment of reference O. tenuiflorum ITS sequences represents four samples (G26, G27, G36 and G37) 
from Professor Peter Nick and three samples (V93, V94 and V99) from Dr. Eike Reich. 
Figure 4-15 Multiple Alignment of Several Authenticated O. tenuiflorum ITS Sequences 
 
 
Differences in bases need to be checked against the 
original sample sequence. From the original 
electropherogram of sample B15b, two peaks can 
be seen at base position 173, where the base 
difference is on the alignment. Therefore, it can be 
concluded that there should be a C instead of a T at 
this base position. 
The multiple alignment represents a reference O. tenuiflorum sequence (a consensus of seven different 
reference samples) aligned with several tulsi samples for which the species were unknown (Oci_unk).  
Key: Oci_unk_ sample identification code_extraction number_ region amplified 
Figure 4-16 Section of a Multiple Alignment of ITS Sequences of Reference O. tenuiflorum Samples Used 
to Identify the Species of Unknown Tulsi Samples 
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From the example shown (Figure 4-16) the base difference at position 173 may be a 
technical error as two peaks can be seen at this position on the original electropherogram of 
the three sequences for sample B15b; or there may really be two different bases at this 
position, suggesting a polymorphism is present in the species. The quality of the 
electropherogram is important in helping to identify how to proceed with the analysis. In this 
instance the T peak seen at position 173 may be a shoulder from the previous T base 
continuing across the electropherogram.    
 
ITS Sequencing of Reference Ocimum Specimen  
Thirty three reference Ocimum specimens were obtained; of which 14 samples were 
successfully amplified with the ITS primers (ITS1 and ITS4) (Table 4-3). The sequence data 
for O. tenuiflorum and O. gratissimum was of high quality and the differences in the 
sequences can be clearly seen (Figure 4-17) along the entire sequence (546 bases), this 
alignment shows 75 base differences which clearly portray the differences between the two 
species (Appendix 13).  
 
A further twelve Ocimum sequences were obtained from GenBank (Appendix 14) for 
comparison with the reference specimens collected. O. gratissimum and O. selloi sequences 
matched the reference sequences from GenBank. However, the reference O. tenuiflorum, O. 
Oci_ten_Ref_7_ITS represents a consensus sequence of seven reference O. tenuiflorum sequences aligned in 
Figure 4-15 with Oci_gra_Ref_G30_768_ITS which represents the ITS sequence of the reference O. 
gratissimum specimen G30.  
Figure 4-17 Multiple Alignment of O. tenuiflorum and O. gratissimum ITS Sequences 
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basilicum, and O. americanum sequences did not align with the sequences for the same 
species from GenBank.  
Upon further investigation of the O. basilicum samples, it was noted that all four of the 
sequences (one reference specimen from Peter Nick and three sequences from GenBank) 
were very different (Figure 4-18); this could be explained by the complex nature of the ITS 
region, natural variance within the Ocimum species, or misidentification of the samples.  
 
Some of the reference Ocimum species did not sequence as well as O. tenuiflorum and O. 
gratissimum with the ITS region. The sequence data was not good enough to produce 
reliable reference DNA barcodes (Figure 4-19). For good practice a combination of forward 
and reverse sequences should be used to produce a contig, the electropherograms in Figure 
4-19 illustrates the problem of obtaining good quality reads in both directions. 
The multiple alignment represents four O. basilicum reference sequences – three sequences from GenBank 
and G34 from Professor Peter Nick.  
Figure 4-18 Multiple Alignment of Several O. basilicum ITS Sequences 
The electropherograms represent poor ITS sequences for three reference Ocimum species (O. africanum, 
O. citridorum, and O. kilimandscharicum). 
Figure 4-19 Electropherograms of Three Reference Ocimum Species with Poor ITS Sequencing Data 
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  trnH-psbA Sequencing of Reference Ocimum Specimen  
Of the 33 reference Ocimum specimens obtained, 25 samples were successfully amplified 
using the trnH-psbA region. As the sequencing results were of high quality for most of the 
reference Ocimum specimen, reliable contigs and consensus sequences were made (Figure 4-
20). Several reference Ocimum DNA sequences were also available on GenBank (Appendix 
14). Reference specimens obtained and sequenced matched with reference DNA sequences 
available on GenBank, included: O. tenuiflorum, O. gratissimum, O. basilicum, O. 
kilimandscharicum, O. africanum, O. americanum, and O. citridorum. Therefore, these 
sequences were aligned with the reference consensus sequences and used to identify 
unknown Ocimum species.  
 
Table 4-3 summarises whether or not a sequence was created for the reference specimens 
using the ITS and trnH-psbA regions. The identification of the samples was confirmed by 
aligning the sequences in a multiple alignment and also by entering the sequence into 
BLAST to compare it with other reference samples.  
Once a consensus sequence was created from the reference specimens these were used to 
identify the species of tulsi samples collected throughout the investigation. All of the 
sequences were also put into BLAST to confirm the identity of the species. Samples which 
did not match 100% with the reference sequences created were identified by their closest 
match to reference sequences on the database.    
The electropherograms represent trnH-psbA sequences for three reference Ocimum species (O. africanum, 
O. citridorum, and O. kilimandscharicum). 
Figure 4-20 Electropherograms of trnH-psbA Sequences of Three Reference Ocimum Species 
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Table 4-3 Reference Ocimum Specimens Sequencing Summary  
Sample  
ID: 
Sample 
source: 
Type of tulsi 
specified: 
 ITS sequence: 
trnH-psbA 
sequence: 
G26 PN O. tenuiflorum / / 
G27 PN O. tenuiflorum / / 
G28 PN O. africanum x / 
G29 PN O. citridorum x / 
G30 PN O. gratissimum / / 
G31 PN O.kilimandscharicum x / 
G32 PN O. gratissimum / / 
G34 PN O. basilicum / / 
G36 PN O. tenuiflorum / / 
G37 PN O. tenuiflorum / / 
G38 PN O. tenuiflorum / / 
G39 PN O. tenuiflorum x / 
C81 Kew O. gratissimum / / 
C82 Kew O. selloi / x 
C84 Kew O. tenuiflorum x / 
C85 Kew O. americanum x / 
V86 CAMAG O. tenuiflorum x / 
V87 CAMAG O. tenuiflorum x / 
V88 CAMAG O. tenuiflorum x / 
V90 CAMAG O. tenuiflorum x / 
V92 CAMAG O. tenuiflorum x / 
V93 CAMAG O. tenuiflorum / / 
V94 CAMAG O. tenuiflorum / / 
V96 CAMAG O. tenuiflorum x / 
V98 CAMAG O. tenuiflorum / / 
V99 CAMAG O. tenuiflorum / / 
Key: PN = Professor Peter Nick (Botanical Institute Karlsruhe Institute of Technology, Germany); Kew = The 
Royal Botanic Gardens Kew - DNA bank; CAMAG = Dr. Eike Reich (CAMAG Laboratory, Switzerland); x = 
No DNA sequence obtained; / = DNA sequence successfully obtained.   
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4.6.2.3.1 Ocimum gratissimum Reference Specimen  
Three O. gratissimum reference specimens were obtained: G30 and G32 from Professor 
Peter Nick (Botanical Institute Karlsruhe Institute of Technology, Germany), and C81 from 
The Royal Botanic Gardens Kew - DNA bank (Chase, M.W.). As all three samples have 
been identified by highly skilled botanists and identified as O. gratissimum, the sequence 
data of all three samples should align closely in a multiple alignment. Two samples G32 and 
C81 aligned together with no differences across 526 bases with the ITS region (Figure 4-21) 
and 336 bases with the trnH-psbA region (Figure 4-22); whereas, sample G30 did not match 
the other two references. The results were confirmed when the DNA samples were amplified 
and sequenced by both the ITS and trnH-psbA regions. To further validate these findings 
reference DNA sequences were obtained from GenBank and used in the analysis. 
 
ITS Sequencing of Ocimum gratissimum Reference Specimen   
Five O. gratissimum reference sequences obtained from GenBank were used to compare 
with the query samples (Figure 4-21). The alignment suggests there are two distinct varieties 
of O. gratissimum (A and B) which have not been differentiated. Across the entire sequence 
length ranging from 393-515 bases, for the ITS sequences, there are 14 bases which 
differentiate the two types of O. gratissimum (Appendix 13). A large number of base 
differences in not commonly seen in a species; but, could be explained by the high 
variability in the ITS region within the Ocimum species. To verify the difference was 
genuine the analysis was repeated using a different primer region (trnH-psbA). 
 
 
  
  
A 
B  
  
The multiple alignment represents several reference O. gratissimum sequences. Samples G30 and G32 from 
Professor Peter Nick, C81 from Kew DNA bank and five sequences from Genbank have been used to create 
this alignment which identifies there are two distinct types of O. gratissimum (A and B). 
Figure 4-21 Section of a Multiple Alignment of Reference O. gratissimum ITS Sequences 
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trnH-psbA Sequencing of Ocimum gratissimum Reference Specimen   
When searching for trnH-psbA reference samples, three O. gratissimum sequences were 
found on GenBank and used to compare the three reference specimens in question (G30, 
G32, and C81). Figure 4-22 highlights that sample G30 (A) has a perfect match with the 
three reference sequences from GenBank; while G32 and C81 (B) still align with each other, 
but are slightly different from the other four sequences. Across the 319 bases in the 
alignment there are just 3 base differences. Although there are not as many base differences 
seen with the trnH-psbA region, in comparison to the ITS region, the differences observed 
were valid. For each of the reference samples, three independent sequences were aligned in a 
contig to ensure a reliable consensus sequence was produced; therefore, the results from this 
investigation are reliable. It can be confirmed the quality of the sequence data for samples 
G32 and C81 was good, with clean single peaks at the base positions where the difference 
were found.  
 
Summary of Ocimum gratissimum Results  
Using both the ITS and trnH-psbA regions two varieties of O. gratissimum were identified; 
these were discriminated by several base differences. Although the ITS region showed 
greater variability between the two varieties, the trnH-psbA sequences were of  high enough 
quality to support these findings. Using two regions has proved to be valuable in this 
investigation, as they have helped to verify the results. This study identifies the possibility of 
having different varieties of the same species; these may be referred to as cryptic or sibling 
species as they are morphologically identical but their genetic barcode may be significantly 
different (Sáez and Lozano, 2005).  
 
  
  
A 
B 
  
  
A 
B 
The multiple alignment represents several reference O. gratissimum sequences. Samples G30 and G32 from 
Professor Peter Nick, C81 from Kew DNA bank and three sequences from Genbank have been used to create 
this alignment which identifies two O. gratissimum subgroups (A and B). 
Figure 4-22 Section of a Multiple Alignment of Reference O. gratissimum trnH-psbA Sequences 
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 Community Tulsi Samples  
A total of 26 community tulsi samples were collected from participants encountered 
throughout the research period. The species for 84% (n=22) of the samples were identified 
using either one or both of the barcoding regions - ITS (n=15) or trnH-psbA (n=22). The 
results have been summarised in Table 4-4 which details the sample identification number, 
where samples were originally obtained from (donor), the donor location, reported country 
of origin, the type of tulsi (i.e. Raam, Shyam or unknown), and the species identification 
after amplification of the ITS and trnH-psbA regions. The different species identified have 
been colour coded to easily identify the species of the tulsi samples collected.  
As previously highlighted there are two varieties of O. tenuiflorum commonly known as 
Raam and Shyam tulsi (Joshi et al., 2012). The results from this analysis revealed that most 
(n=10) of the Shyam tulsi samples collected from the UK and India were O. tenuiflorum; 
however, Raam tulsi (n=8) samples from the UK and Africa were identified as being O. 
gratissimum instead. Just one Raam tulsi sample (B102c) collected in India by participant 
B102 was correctly identified as O. tenuiflorum. One Raam tulsi sample (B04) collected 
from Birmingham which was a cutting passed on from a friend matched closely to O. 
basilicum. These results indicate the species of the tulsi plants are different to what they are 
expected to be (i.e. tulsi should be O. tenuiflorum). Issues with nomenclature were also 
identified by Jürges et al. (2009) who found that tulsi may be used to refer to any type of 
basil rather than a specific species. Whether or not the species of tulsi is important to people 
who keep tulsi is not known, but could be explored further in the future.  
Of the 8 samples which were identified as O. gratissimum, five samples were specifically 
identified as being Raam tulsi by participants. Just one participant B02b thought her tulsi 
was a Shyam tulsi plant but instead it matched with the Raam tulsi samples identity of O. 
gratissimum. These results confirm the findings which suggest that O. gratissimum species 
may be kept as a substitute for O. tenuiflorum in the UK. 
Three samples matched closely to O. basilicum reference sequences from GenBank 
including B04, L11 (the origins of these samples were unknown), and Li80 who noted that 
the sample was a basil collected from a friend‘s garden (Table 4-4). The species for four of 
the samples could not be authenticated. Two of these were seed samples (B12 and B105) 
which failed to germinate, while samples B09 and B101 failed to amplify with the ITS and 
trnH-psbA regions. Interestingly one sample (B03) from India was identified as a Veronica 
species. The seeds were germinated in a petri dish and re-grown in autoclaved soil to rule out 
the possibility of contamination in the soil but the same results were obtained. This could 
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suggest the seeds collected by this participant were not tulsi seeds and may have been 
wrongly identified.  
Table 4-4 Community Tulsi Samples Species Identification Summary 
Partic
ipant 
ID: 
Sampl
e 
ID: 
Tulsi 
originally 
from 
(donor): 
Donor 
Location: 
Reported 
country 
of origin 
of tulsi: 
Type of 
tulsi 
specified: 
Species 
identification –
ITS: 
Species 
identification -
trnH-psbA: 
B01 B01 Friend Birmingham - Unknown O. gratissimum O. gratissimum 
B02 
B02a Friend Birmingham - Raam O. gratissimum O. gratissimum 
B02b Aunty Leicester - Shyam O. gratissimum O. gratissimum 
B03 B03 Mother Amritsar India Unknown 
Veronica 
species 
Veronica 
species 
B04 B04 Friend Birmingham - Raam O. basilicum1 O. basilicum2 
B05 B05 Friend Leicester - Raam O. gratissimum O. gratissimum 
B06 
B06 Friend Leicester - Shyam O. tenuiflorum O. tenuiflorum 
B06g Friend Leicester - Shyam O. tenuiflorum O. tenuiflorum 
B07 
B07 - - - Raam O. gratissimum O. gratissimum 
B07g - - - Raam O. gratissimum O. gratissimum 
B09 B09 
Bought 
from India 
Punjab India Unknown - - 
L10 L10 Cousin   India India Unknown O. tenuiflorum O. tenuiflorum 
L11 L11 - - - Unknown O. basilicum3 O. basilicum4 
B12 B12 Mother India India Unknown - - 
A14 A14 
Mother-
in-law 
Durban, 
South 
Africa 
Africa Unknown O. gratissimum O. gratissimum 
B15 
B15a Temple Birmingham - Raam O. gratissimum O. gratissimum 
B15b Temple Birmingham - Shyam O. tenuiflorum O. tenuiflorum 
Li79 Li79 Mother Leicester - Unknown - O. tenuiflorum 
Li80 Li80 Friend Coventry - Basil - O. basilicum5 
U100 U100 - - USA Unknown - O. tenuiflorum 
B101 B101 - - - Unknown - - 
B102 
B102a Mother Gujarat India Shyam - O. tenuiflorum 
B102b Mother Gujarat India Shyam - O. tenuiflorum 
B102c Mother Gujarat India Raam - O. tenuiflorum 
B102d Mother Gujarat India Unknown - O. tenuiflorum 
B105 B105 Mother India India Unknown - - 
Key: Colour of the text Blue = O. gratissimum; Green = O. tenuiflorum; Red = O. basilicum;  
Black = not identified; Grey = not an Ocimum species; A = Africa; B = Birmingham; L = London; Li = Leicester; 
U = USA. 
1 94% match with reference O. basilicum sequence from Genbank (DQ667240.1) 
2 98% match with reference O. basilicum sequence from Genbank (JQ339256.1) 
3 91% match with reference O. basilicum sequence from Genbank (DQ667240.1) 
4 99% match with reference O. basilicum sequence from Genbank (FR726106.1) 
5 99% match with reference O. basilicum sequence from Genbank (FR726106.1) 
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Species Substitution 
The two main types of tulsi recognised in traditional texts are Raam and Shyam (Krishna) 
tulsi which are considered to be varieties of O. tenuiflorum (Joshi et al., 2012). A number of 
tulsi samples collected from SA communities in the UK and a sample posted from South 
Africa were labelled as Raam tulsi (Appendix 12). Upon identification of the species using 
the reference DNA barcodes, it appeared that Raam tulsi samples matched with the O. 
gratissimum reference sequences instead of O. tenuiflorum. This suggests that the species of 
Raam tulsi plants has been confused and substitution has occurred. Migration of SA 
communities from India to Africa and then to the UK may have affected the transfer of seeds 
and caused confusion of species. O. gratissimum is native to Africa and known to grow 
abundantly even in the wild; whereas, it is difficult to find in India and does not grow as 
well. Due to similar morphological features, it may have been misidentified by people or 
kept as a substitute as the preferred type was not available. Findings from the interviews for 
this research suggest Raam tulsi was easier to germinate and grow in comparison to Shyam 
tulsi, in the UK. The results suggest species substitution has occurred for Raam tulsi which 
appears to be O. gratissimum instead of O. tenuiflorum.  
Although reference specimens G32 and C81 were identified as O. gratissimum they appeared 
to be different to reference G30 (Figure 4-23), which aligned with all the community tulsi 
samples identified as Raam tulsi. From this analysis it can be concluded that two varieties of 
O. gratissimum were identified.  
 
 
 
 
 
 
 
Two community tulsi samples (B04 and L11) matched closely to O. basilicum reference 
sequences instead of O. tenuiflorum. This further supports the results which suggest the 
species of tulsi plants kept in the UK may have been substituted by alternative Ocimum 
species.   
  
O. gratissimum 
B 
O. gratissimum  
A 
  
The multiple alignment represents the two types of reference O. gratissimum sequences (A and B) aligned 
with several community tulsi samples for which the species were unknown (Oci_unk).  
Key: Oci_unk_extraction number_sample identification code_region amplified 
Figure 4-23 Section of a Multiple Alignment of ITS Sequences of Unknown Tulsi Samples with 
Authenticated O. gratissimum Samples A and B 
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 Commercial Tulsi Samples  
A range of commercial products were brought from around the UK, India, and online. In 
total 47 samples including: capsules, creams, soaps, syrups, shampoos, teas, tablets, oils, 
toothpaste, and a tulsi rosary were bought. Raw tulsi material used by Pukka Herbs was also 
included in this collection. Table 4-5 summarises the species identification for the samples 
which were identified using the ITS and trnH-psbA regions. Just 5 commercial samples were 
identified using ITS primers (ITS 1 and ITS 4), while 13 samples were identified with the 
trnH-psbA region (complete list of the commercial products used in this analysis can be 
found in Appendix 12).  
Table 4-5 Commercial Tulsi Samples Species Identification Summary 
Sample  
ID: 
Sample 
source: 
Type/ Species 
of tulsi 
specified: 
Type of Sample 
used for DNA 
extraction: 
Species 
identification –
ITS: 
Species 
identification -
trnH-psbA: 
B00 
Basil plant 
from Tesco 
O. basilicum Fresh leaves O. basilicum O. basilicum 
C08 
Pukka three 
tulsi tea bag 
Species not 
specified. 
Raam, Shyam 
& lemon tulsi 
Dried leaf 
material from 
inside a tea bag 
- O. tenuiflorum 
C13 
Tulsi seeds 
from ebay 
O. tenuiflorum 
(Shyam) 
Seeds – 
germinated. 
DNA extraction 
from leaves  
O. tenuiflorum O. tenuiflorum 
C16 
Akamba 
garden centre 
O. basilicum Fresh leaves O. basilicum O. basilicum 
I44 
Market in Fort 
Kochi, India  
- Dried leaves O. tenuiflorum O. tenuiflorum 
I45 
Phalada Agro 
farm 
O. tenuiflorum Dried leaves - O. tenuiflorum 
I46 
Phalada Agro 
farm 
O. tenuiflorum Dried leaves O. tenuiflorum O. tenuiflorum 
I47 
Phalada Agro 
farm 
O. tenuiflorum Dried leaves - O. tenuiflorum 
I48 
Phalada Agro 
farm 
O. tenuiflorum Dried leaves - O. tenuiflorum 
C73 Pukka Herbs 
Species not 
specified. 
(Raam) 
Dried leaves - O. tenuiflorum 
C74 Pukka Herbs 
Species not 
specified. 
(Raam) 
Dried leaves - O. tenuiflorum 
C76 Pukka Herbs 
Species not 
specified. 
(Shyam) 
Dried leaves - O. tenuiflorum 
C78 Pukka Herbs 
Species not 
specified. 
(lemon Vana) 
Dried leaves - O. basilicum 
 
Despite the samples being subjected to various procedures to try and produce a positive PCR 
result (e.g. a new extraction of the sample, an isopropanol clean up, or diluting the DNA) the 
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species for many (n=34) of the commercial products could not be identified. Jürges et al. 
(2009) also experienced similar problems of extracting tulsi DNA from multicomponent 
formulations. The trnH-psbA region was able to amplify more commercial samples in 
comparison to the ITS region. One of the reasons why the trnH-psbA region might have 
produced better PCR results for the commercial samples is because it is a shorter fragment; 
therefore, making it easier to amplify samples which may have been degraded during the 
manufacturing processes. 
 
 The nuclear ITS Region 
The use of the ITS region for producing DNA barcodes to identify various species has been 
investigated with varying degrees of success (Jürges et al., 2009; Selvaraj et al., 2012); yet 
little is known about its suitability as a barcode for the Ocimum species. This investigation 
explored the suitability of the ITS region as a barcode to differentiate between Ocimum 
species. As little documented data is available, the results from this study can be used to 
contribute to the gap in the literature. 
In this investigation the ITS region provided variable quality sequencing data. Of the total 
111 samples collected, two samples were excluded from the analysis as they were seeds 
which failed to germinate and DNA was not successfully extracted. A further 27 commercial 
samples including: capsules, tablets, shampoos, creams, and soaps were also excluded after 
several attempts to amplify the samples with no success. Hence, 82 samples were included in 
this analysis, of which the ITS region was used to successfully identify 35 (43%) samples 
(Appendix 12); this included the identification of 14 community, 5 commercial, 14 
reference, and 1 miscellaneous sample.  
The ITS region shows a high level of discriminatory power for some species (Li et al., 
2011); this was observed for the O. tenuiflorum and O. gratissimum samples analysed. The 
ITS region is known to be better at discriminating species than some of the plastid regions; 
however, the limitations associated with the ITS region have a key in influencing the use of 
these primers (Hollingsworth et al., 2011). As identified by Kress et al. (2005) the reason the 
ITS region may not sequence as well in some plants is due to the problem of paralogy and 
issues associated with this highly repeated part of the nuclear genome.  
It was observed that samples which were either O. tenuiflorum or O. gratissimum were often 
straight forward to PCR and amplified well; in addition, they produced good quality 
sequencing data for analysis. The PCR worked better on fresh and dried plant material as 
opposed to samples which may have been exposed to manufacturing processes (e.g. 
189 
Sukvinder Kaur Bhamra 
capsules, tablets, and tea bags). For commercial products and other Ocimum species (e.g. O. 
africanum, O. basilicum, O. citridorum, and O. kilimandscharicum) the PCR results were not 
as easily obtained. Samples which failed to produce a single bright band on the gel were then 
subjected to various processes. For example, the PCR was repeated using a lower 
concentration of DNA by diluting the sample (1 in 10), or an isopropanol clean-up of the 
DNA sample was carried out to remove any inhibitors in the sample which maybe inhibiting 
the PCR reaction. Of the 35 samples which gave a positive PCR result with the ITS region, 
54% gave a clear PCR result and a good quality sequence on the first attempt; all the others 
required further optimisation before good quality sequencing data was obtained. Although 
several samples gave a positive PCR reaction result the data could not be used for the 
analysis as the quality of the sequencing data was poor.  
The results from this investigation show that the ITS region could be a potential barcode for 
authenticating some of the Ocimum species (e.g. O. tenuiflorum and O. gratissimum). But 
not all of the Ocimum species were successfully amplified; thus, the use of other barcode 
regions should also be explored.  
 
Problems Encountered with the ITS Region 
Several challenges were encountered while working with the ITS region including: difficulty 
amplifying and sequencing the region, poor quality sequencing data, and fungal 
contamination.   
 
 Multiple Bands 
Several samples displayed multiple bands on 
the gel electrophoresis (Figure 4-24). This 
may indicate the presence of more than one 
species in the DNA sample; i.e. multiple 
species if a mixed sample is used, or 
contamination. The DNA for these samples 
was extracted from a single plant so there 
was no chance of the sample being mixed. A 
DNA ladder was used to estimate the size 
and quantity of the DNA fragments. In 
Figure 4-24, the fragments look very similar; 
Samples with 
multiple bands 
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Figure 4-24 Gel Image of Ocimum Samples with 
Multiple Bands 
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this was investigated further by extracting the DNA from the individual bands, repeating the 
PCR to amplify the DNA, and then sequencing the samples. The DNA sequencing of the 
individual bands revealed that they had the same sequences. This could be due to the 
formation of secondary structures (Kress et al., 2005). 
 
 Poor ITS Sequencing Data 
Some of the Ocimum species did not sequence as well as O. tenuiflorum and O. gratissimum 
with the ITS region. The messy DNA sequences may be due to paralogous gene copies; the 
multiple copies of the ITS region within cells can lead to different variants being 
simultaneously sequenced (Hollingsworth, 2011). This problem can cause the same species 
to be given several different identities depending on different laboratory protocols, and 
chance (Hollingsworth et al., 2011). Poor quality sequencing data may also be caused by the 
formation of secondary structures by the ITS primer which can interfere with the sequencing 
(Kress et al., 2005). In addition, the GC content can also be a factor which can affect the 
quality of the sequence. The GC content is the fraction of Guanine (G) and Cytosine (C) 
nucleotides in the amplicon. GC rich regions can contribute to the formation of secondary 
structures, and often require optimisation (e.g. higher annealing temperatures) before suitable 
amplification can occur (Henke et al., 1997), making sequencing very difficult (Fazekas et 
al., 2010). A high GC content can increase the possibility of mis-priming; thus affecting the 
quality of the sequencing date. The GC content for the Ocimum samples varied between 45-
72%. Some samples with a high GC content did have poor quality sequence data in 
comparison to those with a lower GC content.  
 
 Amplification of Fungal Contamination  
The sequencing results for several samples revealed fungal DNA had been amplified instead 
of the plant DNA. This is a well-known problem with the ITS region, as the fungal ITS 
region is so similar to that in plants it can be unintentionally amplified (Hollingsworth et al., 
2011). Various stages were repeated; for example, a new DNA extraction, an isopropanol 
clean-up of the original DNA sample, another PCR with the original/cleaned/diluted DNA 
sample. Some of the samples eventually gave a plant species; but, some samples still 
appeared to amplify the fungal contamination rather than the plant DNA. For example, 
samples I45 and I49 collected in India were identified as Alternaria alternate (Fr.) Keissl. 
The results for these samples could not be used. 
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4.6.2.6.1 Application of ITS2  
It has been suggested that if the full ITS region is difficult to sequence a portion of it (ITS2) 
may provide a useful alternative (Li et al., 2011). As the ITS2 region is a smaller fragment of 
the ITS region it can reduce the amplification and sequencing problems associated with the 
entire ITS region (Kress et al., 2005; Hollingsworth et al., 2011). Samples which did not give 
good quality results with the full ITS region (ITS1 and ITS4) were then sequenced with the 
ITS2 primer. The ITS2 primer is kept as a universal primer by Macrogen, hence several 
samples were re-sequenced with the ITS2 primer in addition to ITS1 and ITS4 using the 
Macrogen online ordering facility. However, the results were still not as good as expected as 
the sequencing data was poor and could not be used for the analysis.   
 
 The plastid trnH-psbA Region 
The results from this analysis confirm the high level of interspecific variation amongst the 
trnH-psbA region in the Ocimum genus. The region amplified and sequenced samples 
efficiently and produced good quality sequence data. PCR with the trnH-psbA primers was 
conducted with the 82 Ocimum samples (community, commercial, and reference); of which 
the species for 66 samples (80%) were identified including: 21 community, 13 commercial, 
25 reference, and 6 miscellaneous samples. Reactions were conducted personally and by a 
Graduate Champion Research Student (Linnette Sleigh) under supervision. The initial PCR 
and gel electrophoresis results appeared to work more efficiently without the need to clean 
the DNA or repeat the PCR, unlike with the ITS region. In general, most of the samples gave 
good quality sequencing data on the first attempt.   
Some species may have low variability, making it difficult to distinguish between species 
(Newmaster et al., 2007). This was observed with the two types of O. gratissimum (A and 
B), where only 3 base differences were identified by trnH-psbA, over 334 bases; whereas, 
the ITS region identified 21 base differences across 526 bases. If specific primers to 
distinguish between the two types of O. gratissimum species were to be created using the 
trnH-psbA results it would be more difficult, because of how similar the sequences are. 
Similar to results published by Christina and Annamalai (2014) and the British 
Pharmacopoeia (2016), the trnH-psbA region proved to be useful for authenticating the 
Ocimum species in this investigation.  
4.6.3 Scanning Electron Microscopy Results  
Several of the reference Ocimum specimens obtained from Professor Peter Nick (Figure 4-
25) and some community tulsi samples were analysed using SEM (Figure 4-26), to confirm 
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the identity of the samples. The results revealed the unique differences in the surface 
structures of the samples analysed. The Ocimum species are all aromatic plants; hence, oil 
glands which secrete the aromatic oils can be found dispersed across all of the leaves 
(Maimes, 2004). The size and number of oil glands are characteristically different in the 
Ocimum species, and can be used to distinguish between the samples (Suddee et al., 2005).  
Differences in hair structure and density were identified. O. africanum, O. basilicum and O. 
citridorum are described as having hairless leaves (i.e. there are no trichomes on the surface 
of the leaves) (Paton, 2014); this is evident in Figure 4-25 as the surface of the leaves are 
glabrous. On the other hand, O. gratissimum and O. tenuiflorum do have hairs on the upper 
and lower epidermis of the leaves. Differences between the two species can be seen; O. 
gratissimum has a higher density of trichomes covering the entire surface of the leaf in 
comparison to the O. tenuiflorum sample. Although O. tenuiflorum does have trichomes, 
there are fewer of them and they are widely dispersed around the leaf.  
Figure 4-26 shows the differences in surface structures between fresh and dried Raam and 
Shyam samples, collected from participants in the UK. Both tulsi samples have numerous oil 
glands, which are classical characteristics of the Lamiaceae family. However, the Raam tulsi 
sample has more trichomes covering the leaf in comparison to the Shyam tulsi leaf. These 
morphological differences can help distinguish between different species. These SEM 
images confirm the DNA analysis results which found Shyam tulsi was O. tenuiflorum while 
the Raam tulsi samples was O. gratissimum. 
Figure 4-25 SEM Image of Ocimum Species  
SEM images of the lower epidermis of five different Ocimum species (O. africanum, O. basilicum, O. citridorum, 
O. gratissimum, and O. tenuiflorum) taken at De Montfort University by R. Armitage and S. Bhamra.  
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SEM can provide valuable information about the surface structures of different species, 
which can help differentiate between them. All of the images in Figure 4-25 and Figure 4-26 
A + B used fresh leaf samples for the SEM; the surface structures were clear and easier to 
identify in these images. Dried leaf material imaged by SEM (Figure 4-26 C + D) was 
difficult to analyse as the structures had dehydrated it was more difficult to identify them. 
Jacono (2009) observed that when plant material was dried or cut into smaller fragments it 
became difficult to identify the plant from its morphology; this was observed with the dried 
samples used in this investigation. Jacono (2009) claims the most reliable way to identify a 
plant is while it is fresh, either alive in its habitat or having been recently collected; although, 
adulterants may sometimes resemble the same characteristics as a genuine sample (Joshi et 
al., 2004). This illustrates the importance of having highly skilled professionals involved in 
the identification of plants and the use of additional authentication techniques to verify the 
identification of the species.   
  
A = lower epidermis of a fresh Raam tulsi leaf; B = lower epidermis of a fresh Shyam tulsi leaf; C = lower 
epidermis of a dried Raam tulsi leaf; D = lower epidermis of a dried Shyam tulsi leaf, taken at De Montfort 
University by R. Armitage and S. Bhamra. 
Figure 4-26 SEM Comparisons of Raam and Shyam Community Tulsi Samples Collected in the UK 
A    C 
 
 
 
B    D 
194 
Sukvinder Kaur Bhamra 
4.7 Tulsi Project Summary  
4.7.1 The Current Use of Tulsi by South Asian Communities in the UK 
The interview results revealed what tulsi plants were being used for, where tulsi plants, 
products, and seeds were sourced from, and what value the plants had amongst SA 
communities in the UK. In total 13 interviews were conducted which enabled in-depth data 
to be gathered and analysed. Most of the interviews were conducted face-to-face by the 
researcher, although several were done via telephone due to the location. Interviews with 
participants from across Birmingham, Leicester, and London were conducted, with the 
collection of tulsi samples for molecular analysis.  
Two main varieties of tulsi were identified and kept by participants; which were Raam and 
Shyam (Krishna) tulsi. Raam tulsi was described as having large flat, bright green leaves 
which often grew quite tall; whereas, Shyam tulsi had distinctly smaller, darker green to 
purple leaves, and was harder to grow. Of the population surveyed 92% of participants 
(n=12) claimed to grow their own tulsi plants, with varying degrees of success in the UK.  
Reference to how the cold and damp climate in the UK was not ideal for the growth and 
survival of tulsi was noted. Participants who grew their plants from seeds revealed that they 
had got their seeds from family, friends, and religious institutes; both in the UK and abroad - 
from Africa or India. The sharing of seeds and cuttings was common practice amongst the 
SA communities. The different species of tulsi grown and used in the UK may be explained 
by the different migration and settlement patterns of SA communities.  
The knowledge of what the plants were used for and how they should be maintained was 
passed on predominantly by older members of the family (mothers and grandparents), and 
priests and scriptures from the Hindu religion. Due to the representation of the Hindu 
goddess Virinda Tulsi, it was evident that the tulsi plants had a prestigious position within 
Hindu communities. It was observed that the plants were cared for and kept as religious 
figures in specific locations either in the front or centre of the home, and in temples 
(mandirs). Participants believed it was a blessing to be able to keep a tulsi plant in the home. 
The results identified numerous medicinal benefits of tulsi including the use in treating sore 
throat, cough, diabetes, asthma, and skin conditions. 
The findings of this research have explored the current position of the tulsi plant amongst SA 
diasporic communities, in the UK. The range of medicinal, culinary, cultural and religious 
uses of tulsi makes this plant highly valuable. The vast array of commercial products 
available on the market are designed to be easy and convenient for people to utilise the 
health benefits of the plant around the world, even if they do not have access to the plant.  
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4.7.2 Identification of Plant Species  
Traditional methods of plant identification involve the use of morphological features, where 
botanists have looked for particular traits to identify plant families and species. Techniques 
such as Scanning Electron Microscopy (SEM) have been improved to be able to distinguish 
microscopic plant features, without destroying the surface structures (Pathan et al., 2008). 
The SEM images captured during this research were able to illustrate the differences 
between the species; just as Dr Alan Paton had suggested (Paton, 2014). The O. gratissimum 
sample had significantly more trichomes (hair like structures) on the leaf surface in 
comparison to the other Ocimum species; while the smooth, glabrous surface of the O. 
basilicum leaf was seen clearly in the SEM images. Although, when samples were dried it 
was difficult for the lay person to distinguish between the different species; with the correct 
training the results could be better interpreted and understood. SEM images were only taken 
of some of the reference specimens (i.e. O. africanum, O. basilicum, O. citridorum, O. 
gratissimum, and O. tenuiflorum) to explore the differences in surface structures between the 
different species. The results from the SEM analysis were able to support the molecular 
results; i.e. the different surface structures where characteristic of the different species.  
The age of the plant, condition of the sample and manufacturing process can affect the 
characteristics of the samples, making them difficult to identify without the correct 
knowledge (Jacono, 2009). Likewise, chemical analysis is also affected by the natural 
variance in plants, growing conditions, processing, and storage (McCutcheon, 2002). This is 
where DNA analysis provides its unique advantages as it is not affected by the age of the 
plant, condition (e.g. fresh or dried), growth conditions, or manufacturing processes (e.g. 
drying and storage). It is a relatively new technique for plant authentication which requires 
more research, in comparison to the other identification methods which have a long standing 
and reputable use. The results from this investigation have revealed the usefulness of DNA 
analysis and can be used to contribute to this evolving discipline.  
 
4.7.3 The Applications of DNA Barcoding for Medicinal Plant 
Identification 
While conducting background research into Ocimum DNA sequences it became apparent 
that there was a lack of reliable reference Ocimum DNA sequences available in the databases 
such as GenBank and BOLD. Chase et al. (2005) highlighted this as a potential limitation of 
DNA authentication, as there is a lack of DNA barcodes available in the reference databases. 
Before authentication of tulsi samples could commence a reference database needed to be 
created to be able to verify the species. This research has had an important role in collecting 
196 
Sukvinder Kaur Bhamra 
a range of authenticated Ocimum specimens (n=33) from around the world to create 
reference barcodes which will make future authentication faster and reliable; in addition, 
these sequences will be submitted to the GenBank and BOLD databases.   
As recommended by The Consortium for the Barcode of Life (CBOL) Plant Working Group, 
initially the plastid matK and rbcL regions were explored for amplification of DNA samples 
(Kress et al., 2005; Chase et al., 2005). The PCR results were highly variable and the 
sequence data for the few samples which did provide a positive PCR result were very poor. 
From the literature it was clear these regions are highly valuable; however, their use with the 
Ocimum species was limited and required optimisation. When other regions such as the 
nuclear ITS and plastid trnH-psbA were explored amplification and sequencing results were 
much better. The ITS region had limited success as it was only able to amplify and sequence 
some of the Ocimum species (O. tenuiflorum, O. selloi, and O. gratissimum), while the trnH-
psbA region provided better DNA sequencing data for a larger range of species. Of the total 
111 tulsi and Ocimum samples collected during the research period, 82 samples were used 
for the final analysis of which 67 samples (82%) were successfully identified with the 
combination of the ITS and trnH-psbA regions.      
In order for DNA barcoding to work there must be enough variation in the DNA sequence to 
differentiate species from one another (interspecific variation); and a much lower level of 
variation within a species (intraspecific variation) (Lahaye et al., 2008). The intraspecific 
variation is known to be relatively low for both ITS and trnH-psbA (Kress et al., 2005). The 
results from this investigation revealed that the ITS region had higher intraspecific variation 
than the trnH-psbA region, as it was able to identify more base differences in the DNA 
sequence. The ITS region was highly variable but limited due to poor quality sequence data. 
The trnH-psbA region provides a high level of interspecific variation, therefore allowing the 
discrimination of different species (Kress et al., 2005). The results from this study revealed 
that both the ITS and trnH-psbA regions were able to distinguish and identify several 
Ocimum species; nevertheless, more samples (n=66) were identified using the trnH-psbA 
region than the ITS region (n=35). 
Several challenges of using the ITS region were encountered during the investigation, 
including the difficulty amplifying and sequencing samples, the amplification of fungal 
DNA instead of the plants, and poor quality sequence data possibly due to paralogous copies 
of ITS region being present. In cases where the complete ITS region was difficult to amplify 
and sequence the ITS2 region was recommended and tried; but, no improvement in results 
were obtained. The trnH-psbA region worked more efficiently than the ITS region and 
provided higher quality sequence data. Although, there is a risk of low variability within 
197 
Sukvinder Kaur Bhamra 
species, the differences found for the Ocimum species was sufficient to discriminate between 
them. This was also observed by Hollingsworth (2011) who claimed the trnH-psbA region 
had better discriminatory power, and gave more efficient recovery of sequence data 
compared to other primer regions such as matK and rbcL.  
 It has been proposed that a combination of regions should be used for the authentication of 
species (Kress et al., 2005; Li et al., 2011); this was successfully completed in this study and 
the results validated each other.  A multigene approach using different priming regions such 
as the nuclear ribosomal ITS and plastid trnH-psbA regions have been proposed as 
combinations for DNA barcoding (Chase et al., 2005; Kress et al., 2005). This study has 
implemented these proposals and discovered some interesting results. Both regions have had 
varying degrees of success with the Ocimum species. The trnH-psbA region proved to be 
better than the ITS region at sequencing the Ocimum samples, as it was able to authenticate 
more than double the number of samples.  
Reference specimens (n=33) obtained from several sources (Professor Peter Nick - Botanical 
Institute Karlsruhe Institute of Technology, Germany; Dr. Eike Reich - Director at CAMAG 
Laboratory, Switzerland; and The Royal Botanic Gardens Kew - DNA bank) were used to 
create reference DNA sequences to identify the species of samples collected throughout the 
project. A large proportion of the samples collected for analysis (n=67, 82%) were identified 
using the reference DNA barcodes created. Fresh and dried leaf samples were the easiest to 
extract DNA from, amplify and sequence. A total of 26 community samples were collected 
of which 81% (n=21) were identified as an Ocimum species. Commercial products which 
had been processed were often difficult to extract DNA from, as identified by the NanoDrop 
analysis which often showed little or no absorbance at 280nm. This may be due to 
manufacturing processes involved in formulating the products which may have damaged and 
degraded the DNA. Although one of the advantages of DNA analysis is that it is not affected 
by manufacturing processes, the results from this study found that steam treatment and 
drying in extreme temperatures did degrade the DNA of commercial samples collected 
(n=47); making it very difficult and sometimes impossible to extract DNA. But, because the 
trnH-psbA region is a shorter fragment it worked better with commercial samples (i.e. 13 
commercial samples species were identified) where the DNA may have been degraded or 
sheared into smaller fragments, in comparison to a longer region such as the ITS (i.e. 5 
commercial samples species were identified). A large number of the commercial samples 
(72%, n=34) could not be used in the analysis as DNA was not successfully extracted, 
similar problems were also encountered by Jürges et al. (2009) who also struggled to 
authenticate the species of commercial tulsi products.   
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4.7.4 The Key Discoveries of the Tulsi Project  
The cultural and commercial values associated with the tulsi plant can increase the risk of 
adulteration due to the constant and rising demand of the market (Christina and Annamalai, 
2014). The correct identification of tulsi plants is made difficult by the similar morphological 
features of the Ocimum species. Raam and Shyam tulsi samples collected in India looked 
very similar; whereas, samples from the UK were distinctly different. Both Raam and Shyam 
tulsi are supposed to be varieties of O. tenuiflorum; however, the DNA analysis identified 
Raam tulsi samples collected from SA communities in the UK and Africa as O. gratissimum 
instead. According to the results from this investigation, Raam tulsi species have been 
substituted in the UK; but how relevant this is to SA communities remains to be investigated. 
Many of the commercial samples collected did not specify the type of tulsi (i.e. Raam or 
Shyam), except for samples from Pukka Herbs®; the Raam and Shyam tulsi samples from 
Pukka Herbs® did match the O. tenuiflorum references. In addition, Raam and Shyam 
samples collected personally during field work in India were also correctly identified as O. 
tenuiflorum; further supporting the theory of species substitution in the UK. Plant species 
which are difficult to source, expensive, and have limited availability are subject to 
adulteration with products which maybe morphologically similar. Using taxonomically 
correct plants is critical to the safety and efficacy of herbal medicine (WHO, 2002b). 
Adulteration of plants can have fatal consequences; therefore, the importance of selecting the 
correct plant species is of paramount importance, especially when consumed for medicinal 
purposes (Christina and Annamalai, 2014).  
The main reasons for keeping tulsi plants identified by participants in the UK were for 
cultural or religious purposes, in which case the species of the plant may not be as important. 
Different species may have different pharmacological effects; therefore, the species used for 
commercial and medicinal purposes must be properly identified and authenticated. DNA 
analysis has proved to be a technique which can accurately identify and discriminate 
between the Ocimum species. 
The results of this investigation have enabled new reliable reference DNA sequences for the 
Ocimum species to be created and will contribute to the DNA databases currently lacking 
this information (Appendix 13 & 15). This will enable more efficient authentication of 
Ocimum samples to take place. The ITS and trnH-psbA regions have been able to 
successfully authenticate and discriminate several Ocimum species. A range of unknown 
Ocimum samples have been identified, illustrating the usefulness of this technique. 
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5.0 Chapter 5 - Discussion  
5.1 Overview of the Research Outcomes  
The research set out to explore the knowledge and use of traditional herbal remedies 
amongst South Asian (SA) diasporic communities and healthcare professionals (HCPs) in 
the UK. The results of this investigation have provided an insight in to the current use of 
herbal medicines (HMs) by South Asians (SAs), where ingredients for HMs are sourced 
from, how minor ailments are treated, and where the knowledge of HMs originates from and 
is transmitted through generations (Chapter 2). Furthermore, patients’ perspectives of HMs 
(i.e. SA participants taking conventional Western medicines) were compared with the views 
of HCPs in the UK (Chapter 3). SA participants and HCPs views of HMs and some of the 
key finding from this research have been summarised in Figure 5-1. Figure 5-1 highlights 
how the results of these two phases of the research identified the problem of species 
substitution and the need for authentication of HMs; as well as identifying a medicinal plant 
of interest (Tulsi, Ocimum tenuiflorum L.) for DNA analysis. Tulsi was one of the most 
popular medicinal plants mentioned by participants in both strands of the research; the 
religious significance and numerous medicinal benefits associated with the plant make it a 
culturally and commercially valuable plant.  
 
 
 
 
 
 
 
 
 
 
 
Figure 5-1 Venn Diagram of South Asian Participants and Healthcare Professionals views of Herbal 
Medicines and the Connection of the Three Phases of the Study 
The Venn diagram summarises some of the key themes identified and illustrates how the three phases of the 
research (i.e. SATMED Project, HCPs survey, and the Tulsi Project) interlink and led on to the identification 
of  a medicinal plant of interest (i.e. Tulsi) for DNA analysis.    
Key: 
CWM - Conventional Western Medicines 
HMs - Herbal Medicines  
SA - South Asian 
SAs - South Asians  
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The use of DNA barcoding in ethnobotany is relatively new (Newmaster and Ragupathy, 
2010). This research represents the first time where the use of DNA barcoding in 
ethnobotany has been used to explore medicinal plants used by a diverse migrant community 
living in Western urban cities. A mixed methods approach combining social science research 
methods (i.e. questionnaires and interviews) and DNA barcoding techniques were used to 
fulfil the aims and objectives of this study.   
 
5.1.1 Objective 1: Explore the knowledge and use of traditional herbal 
remedies amongst South Asian diasporic communities, in the UK; 
describe where the knowledge originates from. 
While conducting the background research for this investigation, it became apparent that 
there was very little information on the use of traditional HMs by SA communities in the 
UK. Recent ethnopharmacological research has either looked at the general UK populations’ 
perspectives of HMs (Ipsos MORI, 2008; Mintel, 2009), or focused on a specific gender, 
religious or ethnic group (Sandhu and Heinrich, 2005; Jennings, 2014). Hence, evidence of 
the current use of HMs amongst the wider SA population in the UK has been limited. Bhopal 
(1986a) conducted his research on the use of HMs by Asian communities over thirty years 
ago; the results of this study provide an important update on the use of HMs by SAs in the 
UK. The South Asian Traditional Medicines (SATMED) questionnaire was designed and 
administered by the primary researcher (Chapter 2), which enabled the collection of some 
valuable quantitative and qualitative primary data for this study. 
The migration of SAs introduced different religions, traditions, cultures, cuisines, and 
traditional herbal remedies to the UK (Sandhu and Heinrich, 2005); yet little was known 
about the current use of HMs by SAs in the UK, until this research was conducted. Figure 5-
2 illustrates the migration of SA participants to the UK, which may have been direct from 
South Asia (i.e. India, Pakistan, or Bangladesh) or via other parts of the world (e.g. Africa, 
Europe, The Middle East, Malaysia, Sri Lanka, etc.); it also summarises what participants 
brought to the UK with them (e.g. their knowledge and traditions of HMs) and the challenges 
participants faced in the UK (e.g. lack of knowledge of Western medicines, difficulty 
sourcing ingredients for HMs, and cultural/ language barriers).  
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The knowledge of HMs has been passed on orally from generation to generation (Chhetri, 
1994; Hatfield, 2007) and there is a risk of losing this knowledge if it is not documented 
(Thring and Weitz, 2006; Bhattia et al., 2014); this research has enabled some of this 
valuable information to be documented, as the vast range of ingredients, remedies, and 
products participants used for traditional HMs has been summarised (Appendix 5). 
Participants from the SATMED questionnaires (80%, n=101) and Tulsi Project interviews 
(62%, n=8) revealed that family was the primary source for transmitting the knowledge of 
traditional HMs; although, religion, the internet, television, and social media were emerging 
as alternative ways of learning about HMs. Hegg (2013) also identified the way people are 
learning about traditional HMs is changing, due to advances in technology and the popularity 
of social media.  
The SATMED questionnaire revealed that there was a significant difference in knowledge of 
HMs between the genders (i.e. females knew more about HMs than male participants). Ernst 
(2000) claims that women generally use HMs more than men which may explain this 
difference in knowledge. Furthermore, gender differences in knowledge of HMs were also 
found by the Ipsos MORI (2008) and Mintel (2009) reports who claimed females had more 
knowledge of HMs than males.  
Figure 5-2 The Migration of South Asians to the UK - What Migrants Took with Them and Challenges 
They faced in The UK 
Direct migration of 
South Asians to the 
UK  
Migration of South 
Asians around the world  
Migration of South Asians 
from around the world to 
the UK  
The diagram represents the migration pattern of South Asians to the UK which may have been direct from 
South Asia or from other parts of the world where South Asians moved to. It also summarises what migrants 
took from their native country and the challenges they faced in the UK. 
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A significant difference in knowledge of HMs was also identified amongst participants from 
the different age groups in this study (i.e. older participants had more knowledge than 
younger participants). Although younger participants may not have had as much knowledge 
of HMs in comparison to older participants, this may be due to a lack of experience which 
comes with age. Bhopal (1986a) predicted that the use of traditional medicines by young 
SAs would decline in the future as people became more familiar with Western medicines. 
The results of the SATMED survey identified that traditional HMs still play an important 
role in the lives of SAs of all ages in the UK. The results revealed that SAs participants of all 
ages use HMs to supplement and maintain their health, treat minor ailments, and manage 
side-effects caused by conventional Western medicines (CWM). It can be concluded from 
this research that traditional HMs still play an important role amongst SA communities in the 
UK as they are regarded as safe and effective and part of peoples’ traditional heritage.  
The Retail Think Tank (2013) identified that Western supermarkets, health stores, and online 
retailers are now stocking ethnic ingredients to cater for migrant communities. This was 
echoed by participants in this investigation who said ingredients for HMs which in the past 
were personally brought from abroad were now becoming commercially accessible in the 
UK. Participants identified some HMs, ingredients, dried plant material, and seeds (e.g. tulsi) 
which were still personally imported to the UK from abroad, mainly from India, Pakistan, 
and parts of Africa (e.g. Kenya and Uganda). This added to the interest of authentication of 
plant species in HMs which was explored further in Chapter 4 (Objective 3). As tulsi was 
one of the most popular products participants claimed to grow, import, and use for religious 
and medicinal purposes it was selected as the plant to be used for molecular analysis.  
The use of HMs alongside CWM was also explored in the SATMED questionnaire, where 
SA participants (who can also be considered as patients) were asked about whether or not 
they shared the information about their use of HMs with their HCPs; 69% (n=73) of 
participants did not tell their doctor, while even more (82%, n=87) did not tell their 
pharmacist. Various reasons for not sharing information about the use of HMs with HCPs 
were noted including: the fear of being labelled as backwards or old fashioned, treated 
differently or not treated at all, HCPs not understanding problems patients presented with 
(i.e. due to language and cultural barriers), and not seeing their HCPs to be able to tell them. 
Similar results were disclosed by Eisenberg et al. (2001) where participants also reported 
feeling that HCPs did not understand them. Some participants in this study did not think it 
was important to share this information as HMs were regarded as being natural and therefore 
safe; this was also documented in the Ipsos MORI report (2008) where respondents did not 
think HCPs needed to know about their use of HMs. As patients’ perspectives of traditional 
HMs were explored, this led to an interest in exploring the views and opinions of HCPs too. 
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5.1.2 Objective 2: Obtain insight into UK based healthcare 
professionals’ knowledge and opinions of herbal medicines. 
There are several examples of researchers who have looked into undergraduate medical or 
pharmacy students perspectives of HMs in the UK (Freymann et al., 2006; Pokladnikova and 
Lie, 2008; Smith, 2011). Numerous researchers have explored the views of HCPs in other 
countries such as the US, Europe, and Africa (Berman et al., 1998; Smith 2011; Awodele et 
al., 2012); yet, there is no current documented research which has investigated the opinions 
of HCPs in the UK. Research to explore the publics’ perceptions of HMs in the UK 
conducted by Ipsos MORI (2008), on behalf of the Medicines and Healthcare products 
Regulatory Agency (MHRA), excluded HCPs from the research as they feared it would 
distort their results.  
The lack of research into HCPs views of HMs may be restricted by ethical issues around 
recruiting HCPs to participate in research, as experienced during this investigation. 
Nevertheless, this study overcame the ethical concerns raised by the De Montfort University 
Ethics Committee and gained approval from the Leicester City Clinical Commissioning 
Group. This research used social media (i.e. Facebook and Twitter) to recruit participants 
and conduct the surveys online (using SurveyMonkey) to explore HCPs views of HMs.  
Figure 5-1 summarises some of the key concerns HCPs raised about the use of HMs during 
this investigation, such as: the lack of clinical evidence to validate the safety and efficacy of 
HMs, the availability of poor quality HMs, and the lack of regulation of HMs which 
increases the risk of species substitution and adulteration. HCPs claimed that more research 
needs to be done on HMs and that they required more education on HMs before they could 
recommend them to their patients, or help patients make informed decision about HMs.  
The SATMED questionnaire analysis uncovered several barriers which may have affected 
SA participants’ willingness to share information about their use of HMs with their HCPs, 
such as language and cultural barriers; hence, many participants said they did not tell their 
HCPs about HMs they consumed. The Ipsos MORI report (2008) found that Asian and black 
and minority ethnic (BME) groups were less likely to tell their doctor about their use of 
HMs. The HCPs survey encompassed HCPs from all ethnic groups and their views on the 
general patient population not a single ethnic community. When HCPs were asked whether 
or not their patients informed them about their use of HMs 65% (n=64) claimed they did. 
From the finding of this research it is evident that cultural differences can affect the 
relationship between patients and their HCPs. In the Tomorrow’s Doctors (GMC, 2009) 
standards for education guidelines published by the General Medical Council (GMC) for 
undergraduate medical students, it says students should have respect for cultural diversity 
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without prejudice. Hence, if HCPs were informed of alternative therapies different ethnic 
communities used it may help them better understand their patients and provide tailored 
advice and care. 
The House of Lords report (2000) states that HCPs should be familiar with Complementary 
and Alternative Medicines (CAM), which is a broad term which includes hundreds of 
therapies including: acupuncture, reflexology, and HMs. Most regulatory bodies such as the 
GMC or General Pharmaceutical Council (GPhC) which govern HCPs and set standards for 
education of undergraduate courses also state CAM should be taught to students. However, 
Smith (2011) found that the level of CAM education varied significantly amongst medical 
schools in the UK. A large number of HCPs (65%, n=62) in this study claimed they did not 
receive any information about HMs during their professional training, this made them feel 
incompetent in giving advice to patients about the safe and effective use of HMs. The 
education of HCPs on CAM needs to be improved, as Smith (2011) suggests standardising 
the curriculum to ensure HCPs have some knowledge of HMs which patients may be using 
so they are competent to provide appropriate advice. Furthermore, guidance for patients to 
improve concordance with conventional medicine could be created to raise awareness of the 
implications of combining traditional and conventional medicines.  
There was not enough up to date information on UK based HCPs views of HMs prior to this 
investigation being conducted. The results of this research can be used to contribute to this 
discipline where there is a need to improve HCPs knowledge and understanding of HMs 
used by the culturally diverse population in the UK. As the use of HMs continues to grow in 
the UK (Mintel, 2009) it is imperative for HCPs to understand the risks and benefits of 
consuming HMs alone or in conjunction with CWM as they could have a serious impact on 
patients’ health.  
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5.1.3 Objective 3: Use DNA barcoding techniques for the identification 
of herbal medicines and medicinal plants used in South Asian 
communities. 
From the results of the SATMED questionnaire tulsi (O. tenuiflorum L.) was identified as 
the medicinal plant of interest for DNA analysis. The HCPs survey results strengthened the 
purpose of conducting this authentication research, as HCPs highlighted the issue of species 
substitution and the need for more high quality research on HMs. This phase of the research 
was called the Tulsi Project and involved the multi-disciplinary collaboration of social 
science and molecular technology to attain the aims and objectives of the investigation. 
Interviews were conducted to explore the cultural and commercial value of the plant and 
tulsi samples were collected for molecular analysis; in total 111 tulsi samples including 
seeds, fresh and dried plant material, and commercial products (e.g. capsules, DNA extracts, 
oils, soaps, teas, and tablets) were accumulated during the research period.  
The interviews revealed that the tulsi plant holds a prestigious position with Hindu families 
and temples in the UK, due to its religious affiliation with the Hindu goddess, Virinda Tulsi. 
In addition, the numerous health benefits mentioned by participants suggested the medicinal 
values were commonly utilised by participants for diabetes, asthma, respiratory infections, 
coughs and cold, and various skin conditions; these health benefits have been explored by 
many researchers (Miller and Miller, 2003; Prakash and Gupta, 2005; Winston and Maimes, 
2007; Singh et al., 2012). The interviews enabled the collection of samples from participants 
personal tulsi plants (referred to as the community samples). Participants identified their tulsi 
plants as being either the Raam or Shyam varieties and disclosed where the seeds or plants 
were originally obtained from. Some participants claimed the seeds for their tulsi plants kept 
in the UK were either from India or Africa, and were commonly shared amongst family and 
friends. The DNA analysis exposed some interesting findings about the species of the tulsi 
samples collected from participants in the UK.  
A combination of barcode regions should be used for the authentication of species (Li et al., 
2011). The matK and rbcL regions have been referred to as the “core barcodes” for plants 
(Kress et al., 2005; Chase et al., 2005; Hollingsworth, 2011); however, they did not produce 
good quality sequencing data for many of the Ocimum samples in this investigation. The 
nuclear ITS and plastid trnH-psbA regions produced fast, efficient, and unambiguous results 
for several of the Ocimum species (e.g. O. gratissimum and O. tenuiflorum); thus, these 
regions were used to carry out the molecular analysis. Commercial products proved the most 
difficult to extract DNA from; hence, 29 samples were excluded from the analysis. In total 
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the species for 82% (n=67) of the samples analysed were successfully identified using ITS 
and trnH-psbA barcodes.  
In comparison to other methods of medicinal plant authentication (e.g. morphology or 
chemical analysis) DNA barcoding is a relatively new technique which can be used to 
discriminate between species, and identify contaminants and adulterants (Kress et al., 2005; 
De Mattia et al., 2011). It was anticipated that the results of this research may provide a 
novel contribution to this discipline; this was successfully achieved in several ways. Firstly, 
there was a lack of reliable reference DNA sequences for the Ocimum genus in the current 
DNA databases (i.e. GenBank and BOLD); thus, authenticated Ocimum samples were 
obtained and reference DNA sequences were created which will be added to the databases 
for other researchers to use. Secondly, species substitution amongst the community Raam 
tulsi samples collected from participants in the UK was uncovered, as Raam and Shyam 
Tulsi are considered to be varieties of O. tenuiflorum; however, in this investigation Raam 
tulsi samples were identified as O. gratissimum instead. From the analysis of this research it 
was apparent that Raam tulsi samples collected in the UK had been substituted by alternative 
species. A small number of tulsi samples collected had been identified as being O. basilicum 
and several others as an African species (O. gratissimum) which may be linked to the 
migration routes of SAs to the UK (Chapter 4, Figure 4-9).   
The results demonstrate that DNA based techniques are a valuable tool for the authentication 
of medicinal plant species. It can be argued that there is still more work to be done (i.e. to 
create more reference DNA sequences for other medicinal plant species); but, this rapidly 
evolving authentication technique has proved to be very powerful for the identification of 
species, contaminants, and adulterants in this research. 
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5.2 Limitations of the Research  
5.2.1 Research Participants 
 Sample Size 
With just over 3 million SAs living in the UK (Office for National Statistics, 2012) it would 
have been difficult to survey a significant number of participants in the time frame of this 
PhD as a single researcher. In addition, there is no validated or accessible sampling frame 
available for a sample to be drawn from. For these reasons a specific number of participants 
was not pre-determined and an opportunity sampling technique was employed to conduct the 
research. In the original PhD proposal for the SATMED questionnaire it was designed to be 
a self-completion questionnaire; however, after the pilot studies this was changed to be 
administered by the researcher. As this method of distribution was more time consuming it 
was not possible to complete as many questionnaires as anticipated (i.e. approximately three 
to four hundred).  
The HCPs survey was completed online and circulated by participants which meant the 
researcher could not regulate the distribution or completion of the questionnaires. If surveys 
were conducted face to face it could have reduced the number of incomplete questionnaires 
(n=19) (Moore, 2000); however, this would have limited the range of HCPs recruited. As it 
was not possible to track who had received the link, attempted or completed the survey it 
was difficult to determine the potential response rate while the survey was available online. 
Despite the researcher forwarding the link to a large number of personal and professional 
contacts via several different channels (i.e. personal email, Facebook and Twitter accounts, 
Lloyds Pharmacy and Jhoots Pharmacy internal networks, and supervisory teams’ contacts) 
the number of respondents could have been larger as only 112 participants attempted the 
survey.  
For the Tulsi Project 13 interviews were conducted; these interviews provided an in depth 
insight into the topic and enabled very detailed responses to be collected from participants. 
Baker and Edwards (2012) claim the number of participants acceptable for a qualitative 
study could range from one to one hundred depending on the purpose of the research. After 
analysing the results of the 13 participants it was evident that the responses were very 
similar. Theoretical saturation had been reached as no new significant data were identified 
(Seale, 1999); therefore data collection was stopped. Despite the sample size being small it 
was sufficient to meet the objectives of the study (i.e. to determine the cultural values 
associated with the tulsi plant).  
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Generally in all three phases of the research (i.e. SATMED questionnaire, HCPs online 
survey, and Tulsi project interviews) more participants could have been recruited; but, the 
research needed to be conducted in a timely manner and as the aims and objectives of this 
research were successfully achieved the sample size was deemed sufficient.  
 
 Control Group of Participants for The SATMED Questionnaire  
The aim of the SATMED questionnaire was to focus on SA participants, a population for 
which little ethnopharmacological data in the UK exists; other ethnic groups were not 
included in this investigation. However, if a control group of participants (i.e. not from SA 
ethnic backgrounds) were also included in this research comparisons between the use of 
HMs amongst different ethnic groups could have been made. As there was no intervention or 
experimental variables being explored in this study it was not necessary to have a control 
group (Punch, 2014).   
Although the SATMED questionnaire only included SA participants the HCPs survey was 
open to people from all ethnic backgrounds. The HCPs survey analysis did reveal some 
interesting cultural differences in the use of HMs between participants from SA and other 
ethnic groups (Chapter 3). 
 
5.2.2 DNA Analysis of Tulsi Samples 
Before carrying out the DNA analysis it became apparent that there was a lack of reliable 
Ocimum reference DNA sequences for the study. Due to this, reference DNA sequences had 
to be created by first collecting reliable authenticated Ocimum specimens (e.g. seed, plant, 
and DNA samples) and then creating the DNA sequences. This took a significant amount of 
research time as samples for a range of different Ocimum species had to be obtained, seed 
samples needed to be germinated and grown, and then the DNA extraction and sequencing 
had to be done by the primary researcher.  
One of the anticipated objectives of the Tulsi Project was to create a fast and reliable 
polymerase chain reaction (PCR) test to determine the type of Ocimum species (i.e. O. 
basilicum, O. tenuiflorum, or O. gratissimum) of samples; inspired by work conducted by 
Howard et al. (2009) for the identification of Hypericum species. If a PCR test to identify the 
Ocimum species was created it would allow for more samples to be analysed. However, due 
to time constraints and the time taken to collate and create the reference DNA sequences this 
was not possible. In retrospect this leads to further work which could be conducted as a 
result of this research.  
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5.3 Implications of the Research  
Smith (2011) looked at the level of education of CAM amongst medical schools in the UK 
and found that despite it being a requirement of the GMC, the regulatory body which sets 
standards for education, the level of CAM education was highly variable (i.e. from a single 
lecture to student centred learning). A large number of HCPs in this study (74%, n=71) felt 
they did not have enough training on HMs. HCPs revealed that they felt incompetent to give 
patients advice on HMs as they lacked knowledge and said more training was required. If 
educational institutes could be made aware of the issues identified by participants in this 
research, changes to the curriculum could be implemented to improve the level of CAM 
education. This would mean future HCPs are better equipped with the knowledge of HMs to 
help make better clinical decisions and inform patients about the safety and efficacy of HMs. 
HCPs are often required to undertake Continuing Professional Development (CPD) as part of 
their professional practice. After giving a presentation to the Biomolecular Technology 
Group at De Montfort University the potential to create a CPD programme for HCPs was 
discussed with the supervisory team and Gary Trappit (Business Development Manager at 
DMU); this will be considered at a later date. 
Participants in the Tulsi Project revealed that the tulsi plant was kept for various reasons 
including religious and medicinal purposes. Both Raam and Shyam varieties of tulsi were 
kept by people in the UK and collected for molecular analysis. During the DNA analysis of 
tulsi samples collected from participants, it was uncovered that Raam tulsi plants kept in the 
UK were not O. tenuiflorum but were O. gratissimum instead. This leads to several questions 
which the researcher would have liked to explore further including: What are the 
implications of having the wrong species (i.e. medicinally and religious/culturally), and 
whether or not the species of tulsi matters to people who keep it for religious or cultural 
purposes. Questions for a focus group to explore these concepts further were designed 
(Appendix 16). The university ethical approval delayed the process and due to time 
constraints this was not completed. This research has provided the background and resources 
to continue the work in the future. 
One of the desired outcomes of this research was to design a fast and efficient PCR test to 
distinguish between Ocimum species (Howard, 2010). As the starting material were collected 
during this research and the reference DNA sequences were created, this work was 
successfully completed at De Montfort University by a visiting researcher Seethapathy GS 
from the Ashoka Trust for Research in Ecology and the Environment, India (July 2015). This 
will allow for a larger study to authenticate the species of tulsi samples.   
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5.4 Conclusion  
This research has presented the results of the unique integration of ethnopharmacological 
research with DNA analysis something which (to my knowledge) has not been previously 
been done before. The results of this thesis could have important implications for the range 
of disciplines studied. The SA population in the UK is rising (Office for National Statistics, 
2012), now this research has documented evidence which reveals: the knowledge of HMs 
SA people have, types of HMs they use, and where ingredients are sourced from. The results 
demonstrate that traditional HMs are still commonly used by diasporic SA communities in 
the UK. This study enabled both patient and practitioners’ view of HMs to be explored. 
HCPs raised concerns about the safety and efficacy of unregulated HMs which lacked 
reliable clinical evidence, and felt they needed more training on the risks and benefits of 
HMs. Ultimately, if HCPs were better educated about HMs they would be able to deal with 
patients’ queries about HMs competently, ensuring patients received the best 
pharmacological care. The unregulated import of HMs, products, ingredients or seeds, to the 
UK carries risk of species substitution and adulteration which was demonstrated in the Tulsi 
Project. The molecular work conducted highlighted the usefulness of DNA analysis in 
authenticating plant species in HMs, and proved to be valuable technique for fast and 
efficient identification of the Ocimum species.  
The multi-disciplinary approach used to conduct this research has enabled the perspectives 
of SA communities and Western HCPs of HMs in the UK to be explored, as well as the use 
of DNA barcoding in ethnobotany; providing a unique contribution to ethnopharmacology. 
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Appendices  
 
Appendix 1 Research Proposal for Traditional Herbal 
Remedies PhD Project  
*Please refer to the external memory device for the complete SATMED Ethical Proposal  
Appendix 1 contains: 
1. Standard ethics application form for the SATMED project  
2. Ethics proposal- SATMED version 1  
3. Ethical Approval Application, Amendments 
4. Ethics proposal- SATMED version 2  
5. Ethical Approval Amendments – for version 3  
6. Ethics proposal- SATMED version 3 
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Appendix 2 Ethical Approval Communications  
Appendix 2A Ethics Proposal Amendment Form for HCPs 
Questionnaire 
De Montfort University 
Faculty of Health & Life Sciences 
Faculty Research Ethics Committee 
AMENDMENT/EXTENTION APPLICATION FORM 
PLEASE READ SUBMISSION GUIDELINES BEFORE COMPLETING THIS FORM 
Further information and application forms are available at http://www.dmu.ac.uk/research/ethics-and-governance/faculty-
specific-procedures/health-and-life-sciences-ethics-procedures.aspx. 
For further information or advice please contact the Research and Commercial Office, Faculty of Health and Life Sciences, 1.25 
Edith Murphy House, Phone: 0116 2506122 / 0116 2577891 or email: hlsfro@dmu.ac.uk 
 
Amendments may include changes to the terms of the FREC application, the protocol or any other supporting documentation 
for the trial.  Applicants should consider; 
a) Any change in the research proposal 
b) The safety or physical or mental integrity of the subjects of the trial 
c) The scientific value of the trial 
d) The conduct or management of the trial 
e) The quality or safety of any investigational medicinal product used in the trial 
 
1. Applicant name:                                                  2.Postal & email address:  
Sukvinder Kaur Bhamra 
 93 Brooklands Road 
Birmingham 
B28 8LB 
suky_bhamra@hotmail.com 
 
3. Supervisor(s) or co-applicants:              4. Programme (if applicable):                        
Prof Adrian Slater, Prof Mark Johnson,  
Dr. Caroline Howard 
 
 n/a 
 
5. Title of Research Project:               
Investigating the use and identity of traditional herbal remedies amongst South Asian 
communities using biomolecular techniques.   
 
6. Original Approval                    7. Start date for the project                   8.Expected end 
date for the project:  
    Reference number;                                                                               (FREC/RCO 
must be advised 
upon completion) 
 111
3     
 01/10/2012  October 2015 
 
9. Brief description of proposed amendment 
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One of the objectives set in the initial proposal (version 3) was ‘to gain an insight into 
healthcare professionals knowledge and understanding of traditional herbal medicines used 
in South Asian communities in the UK’. A questionnaire and Participant Information Leaflet 
(PIL) has now been created to fulfil this objective.   
The questionnaire has been designed to gain an insight into healthcare professionals’ 
personal and professional opinions of traditional herbal medicines. The term healthcare 
professionals (HCPs) refers to those who have regular clinical contact with patients. The 
main focus for this study will be on General Practitioners (GPs) and pharmacists as they are 
at the frontline of dealing with minor health problems which may be treated with herbal 
medicines. In addition, for the purpose of this exploratory research other HCPs who may 
also have had opportunities to discuss herbal medicines with their patients will also be given 
the chance to participate (i.e. including nurses, dentists and opticians). 
The questionnaire will be administered as a postal questionnaire to GPs and Pharmacists 
across Birmingham and Leicester, whose addresses are readily available in the public 
domain (i.e. directories/ the internet). Hence, the style of the PIL is similar to a cover letter. 
Survey monkey (an online survey software) will also be used to publish the same 
questionnaire online in anticipation of reaching more people and getting a larger response 
rate. An opportunity sampling technique will be employed as healthcare professionals 
known to the research team will be asked to participate and forward the link for the online 
survey to other healthcare professionals to complete.  
 
10. Rationale for the amendment 
Page 6 of the ethics proposal highlighted that separate ethical approval will be sought at a 
later stage depending on the progress of the study. After assessing the progress of the study, 
it is now at a stage where this objective can be explored.  
 
11. Please list each potential ethical issue relating to your study and state how these will 
be addressed: include potential risks to participants and research staff     
  
The Participant Information Leaflet (PIL) has been carefully worded to prevent harm being 
caused to participants. A PIL produced by the GPhC was used as a template to tailor this to 
healthcare professionals. 
Healthcare professionals who use traditional herbal medicines may feel hesitant to share this 
information but anonymity and confidentiality will be assured.   
All postal questionnaires will be returned to De Montfort University and not the researchers 
personal address to ensure personal details of the researcher are kept safe.  
  
239 
Sukvinder Kaur Bhamra 
Appendix 2B HCPs Questionnaire Ethics Review Reply  
Re: Ethical Approval Application – Investigating the use and identity of traditional  herbal 
remedies amongst South Asian communities using biomolecular techniques. (Ref: 1113) 
Reviewers comments: Applicants response: 
I was unable to find any 
information in the 
application paperwork 
about who is included in 
the definition 'healthcare 
professionals' and how 
they will be recruited. 
The proposal doesn't 
seem to have been 
extended from the 
original to include 
details about this section 
of the study - sample 
size, inclusion criteria, 
recruitment methods etc. 
so it is difficult to give an 
ethical opinion on the 
work to be completed. 
This links directly to the 
issue of NHS R&D 
approval. If the research 
is proposing to recruit 
NHS healthcare 
professionals, we might 
expect to gain this. I am 
assuming this is not the 
intention, but 
clarification needs to be 
sought on whether it is 
needed - dependent on 
the sample and the 
means of recruitment. 
We need an update on 
this specific phase of the 
study and clarification of 
whether NHS R&D 
approval is required.  
Clarification of Healthcare Professionals: 
The term healthcare professionals (HCPs) refers to those who have 
regular clinical contact with patients. The main focus for this study will 
be on General Practitioners (GPs) and pharmacists as they are at the 
frontline of dealing with minor health problems which may be treated 
with herbal medicines. In addition, for the purpose of this exploratory 
research other HCPs who may also have had opportunities to discuss 
herbal medicines with their patients will also be given the chance to 
participate (i.e. including nurses, dentists and opticians). 
Not only are we are looking for healthcare professionals who may have 
experience of discussing the use of herbal medicines with patients but 
we also want to know their personal views and opinions of herbal 
medicines.  
Recruitment methods:  
The postal questionnaire will only be sent to GP surgeries and 
pharmacies whose addresses are readily available in the public domain 
(i.e. directories/ the internet). Once the target locations have been 
agreed (with supervisors) we will collate a list of address to post the 
questionnaires to. If ethical approval is granted I will seek advice from 
my supervisor (Prof. Mark Johnson) and DMU staff who have 
experience with this form of questionnaire distribution (e.g. Peter 
Rivers, Sandra Hall etc.). 
 
An online version of the questionnaire which will be published via 
Survey Monkey can be completed by any healthcare professional if 
they are interested in participating.  
 
An opportunity sampling technique will be employed as healthcare 
professionals known to the research team will be asked to participate 
and forward the link for the online survey to other healthcare 
professionals to complete. 
 
Sample size:  
There are no defined parameters for the sample size as this exploratory 
research is an open survey which will be running in the background 
while the main themes of the research are explored. The survey will be 
available online for a year, from the date of publishing the 
questionnaire, as this is the duration of the license we will purchase for 
the online survey software.  
 
Inclusion criteria:  
Participants must be over 18 years old so participants can consent for 
themselves. 
Participants must be a healthcare professional, either practicing or 
retired.  
The healthcare practitioner must have practiced in the UK at some 
point in their career (no specific time period). 
The rationale for posting questionnaires to GP surgeries and 
pharmacists is because these healthcare professionals are the first port 
of call in a community setting (i.e. primary care) who will deal with 
minor ailments which may often be treated with herbal medicines. 
Hence we are most interested in the views and opinions of GPs and 
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pharmacists. 
However, as this is an open survey with the intention to explore 
healthcare professional’s views and opinions of herbal medicines 
anyone who is a healthcare professional and wishes to participate can 
do so. This is so we can get a variety of healthcare professional’s views 
and opinions of herbal medicines.  
 
NHS R&D approval: 
Advice from several colleagues from DMU and external NHS ethics 
advisors has been useful in clarifying whether or not NHS R&D 
approval would be required.  
Including: 
Maggie Barrett - Senior RM&G Facilitator (Leicestershire, 
Northamptonshire & Rutland Comprehensive Local Research 
Network). 
Debbie Wall - Research & Development Manager, NHS Leicester City 
(awaiting a response). 
As we will not be using the NHS to recruit participants or conduct/ host 
the research; we have no sponsors and will not require any patient 
details we would not require NHS ethical approval. I am currently 
working on completing the IRAS forms to get assurance from Debbie 
Wall to clarify this.  
‘Research involving staff as participants REC review is not normally 
required for research involving NHS or social care staff recruited as 
research participants by virtue of their professional role.’ - See more 
at: http://www.hra.nhs.uk/resources/before-you-apply/research-
requiring-nhs-rd-review-but-not-ethical-review/#sthash.QIjBvS5h.dpuf 
Exceptions to the need for REC review  
Subject to any overriding legal requirements, REC review is not 
required for the following types of research:  
-Research limited to the involvement of NHS or social care staff 
recruited as research participants by virtue of their professional role. 
- Research involving use of or access to a care organisation’s premises 
or facilities, but not otherwise involving patients or service users. - See 
more at: http://www.hra.nhs.uk/resources/research-legislation-and-
governance/governance-arrangements-for-research-ethics-
committees/#sthash.LkrVSzts.dpuf 
In relation to ethical 
issues raised, the 
researcher has not 
indicated what they 
would do if a participant 
were to reveal 
dangerous or poor 
practice in this 
questionnaire.  
The questionnaire will be anonymous as we are not asking for any 
personal/ identifiable details (for example registration/ license details 
are not required). If dangerous practices were identified there would be 
no way of identifying the participant so we wouldn’t be able to address 
them even if they were identified. The nature of this questionnaire has 
been designed with the intent of exploring the healthcare professionals’ 
views and experience with herbal medicines, not their professional 
practice. 
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Appendix 2C NHS R&D Approval Letter 
 
 
 
 
 
 
 
06.05.2014 
Study Ref: LCCR 200214 
End Date: 31.03.2015 
Project Status: Approved 
Dear Miss Sukvinder Bhamra 
Re: Investigating the use of traditional herbal remedies 
I am pleased to confirm that Leicester City Clinical Commissioning Group which provides 
the Primary Care R&D Service across Leicester, Leicestershire and Rutland, has received a 
review of this research study via the Coordinated System for gaining NHS Permission (CSP) 
from the Clinical Research Network: East Midlands. This review confirms that the 
appropriate study-wide and local research governance checks have been undertaken and that 
this study complies with the requirements of the Research Governance Framework and 
national legislation. In conjunction with the local discussions the Clinical Research Network: 
East Midlands have had with you regarding participating as a site for this study, I am now 
happy to formally provide assurance for this study to proceed within Leicester City CCG, 
East Leicestershire & Rutland CCG and West Leicestershire CCG. Your research has been 
entered onto our primary care research database. 
This assurance is provided with the following conditions: that no additional costs are 
incurred at the site (s) as a result of this study being undertaken and unmet service support 
costs will be provided by the Clinical Research Network: East Midlands. 
Please reply to this letter confirming the expected start date and duration of the study. As 
part of the Research Governance Framework it is important that the Leicester City CCG 
R&D office is notified as to the outcome of your research. As such the Clinical Research 
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Network: East Midlands will request feedback once the research has finished along with 
details of dissemination of your findings. We may also request brief updates of your progress 
from time to time, dependent on duration of the study. Similarly, if at any time details 
relating to the research project or research team change, the Leicester City CCG R&D office 
must be informed. 
The documents reviewed for assurance are as follows: 
Document Title Version Date REC 
Approval DMU Faculty Research Ethics Committee approval letter N/A 25.06.13 N/A 
Amendment 1 1.0 October 2013 28.11.2013 
Ethics Proposal – SATMED 3.0 N/A 25.06.13 
Participant Information Leaflet – Healthcare Professionals 3.0 October 2013 28.11.2013 
Questionnaire – Healthcare Professionals 3.0 October 2013 28.11.2013 
If you have any further questions regarding this or other primary care research you may wish 
to undertake in the Leicester, Leicestershire and Rutland area, please feel free to contact me 
again, or the Clinical Research Network: East Midlands Primary Care research office. I wish 
you every success with the research. 
Yours sincerely 
Deb Wall 
R&D Manager 
Leicester City CCG 
Tel: 0116 295 1520 
Email: debbie.wall@leicestercityccg.nhs.uk 
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Appendix 2D Ethics Proposal Amendment Form For The Tulsi Project 
DE MONTFORT UNIVERSITY 
APPLICATION FORM FOR RESEARCH ACTIVITY REQUIRING HUMAN 
RESEARCH 
ETHICAL CONSIDERATION OR APPROVAL 
Applicant name:                                                  Postal address and contact details:  
Sukvinder Kaur Bhamra  93 Brooklands Road,  
Hall Green, Birmingham, B28 8LB 
Tel: 07828246920 
Email: p07246383@myemail.dmu.ac.uk 
Supervisor(s) (if applicable):                   Programme (if applicable):                           
n/a  
Prof. Adrian Slater,  
Prof. Mark Johnson,  
Dr. Caroline Howard  
 
 
South Asian traditional Indian herbal 
medicine (SATMED)  
 
Title of Research Project:               
A study to explore the evolving role of tulsi, Ocimum tenuiflorum, within a multicultural 
population, followed by the genetic authentication of samples collected. 
 
Start date for the project:                                  Expected end date for the project:  
                                                        (FREC/RCO must be advised upon 
completion) 
01/10/2012  October 2016 
Brief description of proposed activity and its objectives: 
The tulsi project has emerged as a satellite project, which has developed during the initial 
stages of my PhD. Extensive background research done suggests that this plant (Ocimum 
tenuiflorum) has multiple medicinal benefits, huge cultural significance and would be a great 
starting point to develop my biomolecular analytical skills.  
From this project we anticipate collecting a variety of tulsi samples from participants, 
whether it be tulsi seeds to grow in the growth room, leaves (fresh/dry) or any other tulsi 
product which we can extract DNA from. These will be added to the current traditional 
herbal medicines inventory we have in the university. At the same time as collecting samples 
of tulsi we will ask participants a few questions, a semi-structured interview, about their 
tulsi. Questions will aim to gain an insight into where their tulsi is from, why it is kept, what 
it is used for and any other significant facts about the plant.  
Please see the attached proposal for further information*. 
*Please refer to the external memory device for the complete Tulsi Project Ethical Proposal  
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Ethical issues identified:            How these will be addressed: 
Confidentiality & anonymity.   Responses will be coded with a reference 
number to protect participants’ identity. 
No data will be identifiable once coded and 
analysed. 
Risk of causing distress to 
participants. 
 Wording of questions will be considered 
carefully to prevent any adverse effects on 
participants. 
Informed consent.  A participant information leaflet will be 
provided to all participants prior to the 
interview; this will enlighten participants as to 
what the research is about and enable them to 
give informed consent. 
Participants will have the freedom to withdraw 
at any point during the interview. 
Unauthorised access to data 
collected. 
 Researcher will keep all data collected in a 
lockable cabinet, with restricted access.  
All data on computers and memory sticks will 
be password protected.  
 
 
To which ethical codes of conduct have you referred? These are specific to each 
Faculty/School, if you have a query please ask your supervisor or Faculty REC for 
advice.  
The British Sociological Association has been consulted for ethical guidance in this 
instance.  
http://www.britsoc.co.uk/media/27107/StatementofEthicalPractice.pdf  
 
 
 
 
 
*Please refer to the external memory device for the complete Tulsi Project Ethical 
Proposal 
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Appendix 3 SATMED Questionnaire  
Questionnaire on the Use & Knowledge of Traditional Herbal Medicine 
Q1a. Do you use any herbs, plants or spices to make homemade  
herbal remedies for your health? 
Yes  
  
*If your answer is No please go to question 6 
 
No  
 
Q1b. 
 
If YES, what do you use and why? 
 
....................................................................................................................................................
....................................................................................................................................................
.................................................................................................................................................... 
    
Q2. Where do you get the ingredients for your herbal 
remedies from? 
 
Tick all that apply.  
 
Family/ friends  
Grow your own  
Ayurvedic clinic  
Local supermarket  
Abroad  
Online  
Other  
Please state:........................... 
 
 
Q3. What form of herbal remedies do you use? 
 
Tick all that apply. 
Fresh herbs  
Dry powders  
Seeds  
Tablets  
Liquid formulations  
Creams / Pastes  
  Other  
Please state:……………….. 
    
    
Q4. After using herbal remedies do you notice any unwanted effects? 
 
 
Yes   
No  
 *If YES, please state:  
......................................................................................................................................................
......................................................................................................................................................
...................................................................................................................................................... 
 
Q5. Where did you learn about herbal remedies? Family/ Friends   
GP/ Pharmacist  
Educational institute e.g. school   
Other 
Please state:............................................. 
 
Q6. 
 
Is herbal medicine a part of your traditional 
family & cultural background?  
  
Yes 
No 
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Q7a. How often do you use herbal medicinal products? Daily   
Weekly  
Monthly  
When required  
  
*If your answer is Never, please go to question 8. 
Never*  
    
 
Q7b. 
 
 
What herbal products do you use for medicinal purposes?  
Please state what they are used for: 
 
………………………………………………………………………………………………
………………………………………………………………………………………………
……………………………………………………………………………………………… 
 
Q8a. 
 
List as many herbal remedies, products or ingredients you know of: 
 
..................................................................................................................................................... 
..................................................................................................................................................... 
..................................................................................................................................................... 
………………………………………………………………………………………………..... 
……………………………………………………………………………………….….………
………………………………………………………………………………………………..…
………………………………………………………………………………………………….. 
 
Q8b. What plants do you know that have medicinal benefits? 
Please list the plants and what they are used for.  
 
…………………………………………………………………………………………………..
…………………………………………………………………..………………………………
……………………………………………………………………..………….………………..
……………………….…………………………………………………………………………
………………………………………………………………………..………………………… 
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If you have any concerns regarding any of your medicines please see your doctor or local 
pharmacist. 
Q9. Do you know any herbal remedies or products which can be used for the  
following conditions? 
Condition: Herbal remedy: 
 
Arthritis  
 
 
 
Cough 
 
 
 
Diabetes 
 
 
 
Headache  
 
 
 
Indigestion 
 
 
 
Itchy skin 
 
 
 
Wounds  
 
 
 
Prescription Medicines:  
 
Q 10a. 
 
Do you take any regular prescribed medicines? 
 
Yes 
 
  
*If NO please go to question 13 
No   
 
Q 10b. 
 
If YES, and you are happy to do so please state what medicines you take:  
Otherwise please go to question 11 
..............................................................................................................................................
.............................................................................................................................................. 
  
Q11a. Do you tell your Doctor what herbal remedies you use? Yes  
  No  
    
Q11b. Do you tell your pharmacist what herbal remedies you use? Yes  
  No  
    
    
 
Q 12a. 
 
Do you notice any unwanted effects from your regular medicines? 
 
Yes 
 
No  
    
Q 12b. If YES what do you 
normally do to relieve the 
symptoms? 
Use a herbal medicine  
Get a product over the counter from your pharmacy  
See the doctor for a medicine   
Nothing  
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Minor illness: what would you do?  
Q13. Do you use herbal remedies for minor health problems before seeking 
medical help?   
 
Yes 
No 
   
For question 14 and 15 please rank in the order you are most likely to do first.  
1 being the most likely action you would take followed by 2, 3 and 4 for the least likely.  
 
 
Q14. 
 
In which order would you consider 
the following treatments for  
a minor illness. 
 
E.g. A cold/ sore throat/ migraine  
 
Please rank 1-4 
 
a. Would not consider taking any treatment. 
 
b. Self-medication using herbal products. 
 
c. Self-medication using over the counter  
products from the pharmacy. 
d. Consult your GP for advice and medication. 
 
   
  
 
 
Q15. Who are you most likely to seek advice from for minor health 
problems? 
 
Please rank 1-4  
a. Family/ Friends 
 
b. Pharmacist 
  
c. Doctor 
 
d. Herbal  
practitioner 
 
   
 
Q16. 
 
 
 
 
 
 
 
Would you prefer to use traditional herbal remedies over conventional 
western medicines for minor health problems? 
 
Yes 
No 
Q17. Which do you think are more effective for treating minor health 
conditions? 
Traditional 
herbal remedies 
 
Prescription 
medication 
 
 
 
Q18. Which do you think are more effective for treating serious, 
long term health conditions? 
Traditional 
herbal remedies 
 
Prescription  
medication 
249 
Sukvinder Kaur Bhamra 
 
Thank you for completing this questionnaire 
  
 
  
About you:   
* Gender: Male  
  Female   
    
 
* What is your age range?  20 or under             21-30                 31-40               41-50 
  51-60             61+ 
  
 
  
* What is your ethnic origin?   Asian – Indian  
    Asian – Pakistani   
    Asian- Bangladeshi  
   
Other please state:.............................. 
 
* Place of birth: United Kingdom  
  India   
  Africa  
  Pakistan  
    
Other please state:………….…………. 
 
* Parents place of birth:  Mother……………………………………………….. 
 
Father………………………………………………… 
* What languages are spoken at home?  
 
1st …………………………………………………………………………………………………... 
Other ……………………………………………………………………………………………….. 
 
* 
 
What is your religion? Hindu             Sikh              Muslim             Christian             No religion  
  
Other, please state:.............................................................................................................................. 
 
 
* What is your highest level of qualification?....................................................................................... 
 
* 
 
 
* 
 
What is your job role?……………………………………………………………………………… 
 
 
What is your postcode (first 4 digits) ………………………………………………………………… 
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Appendix 4 SATMED Participant Information Leaflet  
Traditional Herbal Medicine - Participant Information Leaflet 
My name is Sukvinder Kaur Bhamra. I am doing a PhD at De Montfort University in 
traditional herbal medicine. I have a keen interest in traditional herbal medicine as it 
encompasses the use of herbs and spices for medicinal purposes.  
My aim is to explore people’s knowledge and use of traditional herbal remedies and 
to discover how this knowledge has been transmitted through generations. After 
carrying out this research I aim to gain an insight into the variety of herbal products 
available and used within the community.  
 
  
 
 
In order to participate in this research you must be over eighteen years old, you will 
need to complete this questionnaire, which will take no more than fifteen minutes. 
By completing the questionnaire you are consenting for the data to be analysed and 
published as part of my thesis, academic journals and conferences.  
If you wish to withdraw from participation, you may discard your questionnaire 
before handing it back to me. Once you hand in a completed questionnaire there will 
be no way of identifying your responses, so there will be no way of withdrawing 
your answers from the study. As no personal details are required the process ensures 
anonymity.  
All completed questionnaires will remain confidential as no unauthorised person will 
have access to the data.  
If you would like to be part of future research done at the university on traditional 
herbal medicine then please ask to leave your contact details and we may be in touch.  
 
 
I hope you will enjoy this and thank you for participating in my research. 
.................................................................................................................................................... 
For further information please do not hesitate to contact: 
Prof Adrian Slater: ads@dmu.ac.uk 
Suky- Sukvinder Bhamra: suky_bhamra@hotmail.com  
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Appendix 5 Summary of Herbal Medicines Recalled by 
SATMED Participants 
Traditional 
name: 
Commonly 
known as: 
Scientific 
name: 
Therapeutic 
uses: 
Methods of  
consumption: 
Other 
comments:  
Adarak / 
Sond 
Ginger Zingiber 
officinale 
Arthritis  
Colds  
Digestion  
Pain  
Inflammation  
-Mix with honey, 
hot water, and 
lemon 
-Chew it whole 
-Used in cooking  
-Infuse in 
water/tea 
Garam  
Aritha  Soapnut 
tree 
Sapindus 
saponaria 
Cough, helps to 
reduce 
excessive 
mucus and 
phlegm 
-Warm in some 
milk 
- 
Alsi /ulsi Linseed/ 
flaxseed  
Linum 
usitatissimum 
Arthritis  
Pain 
Strength/ 
energy 
Cholesterol  
Diabetes  
Constipation  
-Make into a 
mixtures called 
pajiri mixed with 
fruits and nuts 
-Roast on a hot 
pan and grind 
into a powder 
and take a spoon 
with water/ chew 
Garam  
Ajwain Carum 
seeds/  
Bishop’s 
weed 
Trachyspermu
m ammi  
 
Digestive aid 
Indigestion  
Headache  
Constipation 
-Seeds to be 
chewed 
-Infused in tea 
-Soaked in water 
-Used in cooking  
Garam  
Chew seeds 
with some 
salt 
Amla/ olay  Indian 
gooseberry  
Emblica 
officinalic  
Healthy hair  
Strength/ 
stamina 
Digestion  
-Fruit preserved 
in syrup can be 
eaten 
-Herbal 
formulations 
available e.g. oil 
and tablets 
Found in 
Triphala  
Anjirhi  Figs  Ficus carica Constipation  
Diabetes  
-Infused in milk 
-Drink the juice  
Available 
in 
pharmacies 
too 
Badam  Almonds  Prunus dulcis Energy  
Mental 
stamina/ 
memory 
Skin and hair 
vitality  
-Eat a few daily/ 
soak in water 
before eating 
-Used in cooking 
-Oil massaged on 
skin or in hair  
Very 
expensive 
in India, we 
take them 
from UK  
Baheray  Belleric  Terminalia 
bellirica 
Digestion  -Juice  
-Fruit preserved 
in sugar syrup  
-Herbal 
formulation 
Fruit is 
used. 
Found in 
Triphala 
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Bajri (Bajra) Millet flour  Eleusine 
coracana  
Diabetes  -Used to make 
chapattis instead 
of wheat flour  
Healthier  
chapattis 
Banaksha  English 
violet  
Viola odorata Coughs and 
colds 
-Syrup  
-Tablets  
-Infused in tea/ 
hot water 
 
 
 
 
Imported 
from India 
and 
Pakistan  
Besan  Gram flour  Cicer 
arietinum 
Skin cleanser 
Healthy 
alternative to 
wheat flour  
-Used in cooking 
-Used to make 
face masks, make 
a paste with 
yoghurt and 
lemon 
Made from 
ground 
chick peas 
Bindi Okra  Abelmoschus 
esculentus 
Diabetes  -Infused in water 
overnight  
-Used in cooking 
- 
Chana dhal  Chick peas  Cicer 
arietinum 
Source of 
protein  
General health 
-Used in cooking  - 
Chasku Four leaved 
cassia 
Cassia absus Blood tonic/ 
purifier 
-Seeds soaked in 
water overnight  
Very 
garam   
Dalchini  Cinnamon  Cinnamomum 
verum  
Arthritis  
Cough 
Colds  
Digestion  
Cholesterol  
-Infused in water/ 
tea 
-Used in cooking  
-Mixed with 
other herbs and 
eaten  
-Mix with honey 
Very 
garam  
Can induce 
menstrual 
flow and 
nose bleeds 
Elachi 
(Bhadi) 
Black 
cardamom  
(Big) 
Elettaria 
cadamomum 
 
Nausea 
Indigestion 
Digestion  
Reduces 
phlegm and 
mucus 
-Chew whole 
-Infused in tea or 
water 
-Used in cooking  
Black 
cardamoms 
are garam, 
green ones 
are not 
garam. 
Elachi 
(shoti) 
Green 
Cardamom  
(small) 
Amomum 
subulatum 
Ghanda / 
pyaaz 
Onion  Olea europaea Sickness 
Arthritis  
General health  
-Juice an onion 
and drink if 
feeling sick 
-Rub onto 
affected joints for 
pain relief 
-Used in cooking  
Core of the 
onion is 
harmful, 
can cause 
cancer so 
do not use. 
Gulab jal Rose water  Roas sp Eye health & 
vision 
Skin cleanser  
Reduces spots  
-Instil drops into 
eyes 
-Apply to skin 
- 
Gulkand Sweet 
preserved 
rose petals  
Rosa sp Eye health 
Constipation   
Digestion  
 
 
-Eaten as 
required 
-Used in cooking 
  
- 
253 
Sukvinder Kaur Bhamra 
Haldi Turmeric Curcuma 
longa 
General health 
Arthritis  
Pain relief 
Inflammation 
Immune 
boosting 
effects  
Wound healing 
Skin conditions  
Cancer 
Sore throats/ 
cough  
-Mixed with 
milk, or hot 
water.  
-Make a paste 
using oil or water 
-Mix with honey 
and chew for a 
cough, or apply 
as a paste for 
skin problems 
 
Garam 
 
Can add 
ghee, olive 
oil or black 
pepper to 
liquid 
formulation
s to 
improve 
absorption. 
Hardar  Black 
Myrobalan 
or  Indian 
Gall Nut 
Terminalia 
chebula 
Constipation 
Digestion  
Liver 
protection 
Diarrhoea  
-Fruit preserved 
in sugar syrup 
-Powder taken 
with milk/ water 
-Herbal 
formulations 
Fruit used. 
Found in 
Triphala 
and 
Chyawanpr
ash 
Hing  Asafoetida 
 
Ferula assa-
foetida 
Digestion  
Reduces gas  
-Used in cooking  Garam 
Jaifal Nutmeg Myristica 
fragrans 
 
Digestion  -Used in cooking  - 
Jamun Indian 
blackberry 
Syzygium 
cumini 
Diabetes  
Blood 
circulation and 
purification  
-Eat the fresh or 
dried fruit 
Juice and 
tablets 
available  
Jeera  Cumin 
seeds 
Cuminum 
cyminum 
Arthritis  
  
-Used in cooking 
-Dry roast in hot 
pan and chew/ 
mix with other 
ingredients  
- 
Kachur  White 
turmeric  
Curcuma 
zedoria 
Blood 
purification 
Tonic  
-Used in cooking  
-Drink powder 
dissolved in 
water 
- 
Kadu Pumpkin  Cucurbita 
maxima 
Diabetes 
Eye health 
Cancer 
-Used in cooking - 
Kaju  Cashew  Anacardium 
occidentale 
Strength  
Essential fats  
-Eat a few daily  
-Used in cooking 
Garam  
Kala Jeera  Black 
cumin  
Bunium 
persicum 
Digestive aid -Used in cooking - 
 
 
Kali mirch Black 
pepper  
Piper nigrum Cough  
Digestion  
Vision/ eye 
problems 
-Mix with honey, 
hot water, and 
lemon 
-Chew it whole 
-Used in cooking 
Garam  
Karoth  Walnuts  Juglans regia Arthritis  
Cholesterol 
Diabetes  
Essential fatty 
oil   
-Eat a few daily  
-Grind and mix 
with other 
ingredients  
- 
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Kalonji  Onion / 
black seeds 
Nigella sativa Arthritis  
Pain 
Diabetes  
 
-Seeds 
incorporated in 
cooking 
-Oil rubbed onto 
affected joints 
God given 
remedy by 
the Prophet 
Mohamme
d known to 
cure all 
disease    
Kapuraveli 
leaves 
- Plectranthus 
amboinicus 
Synonym: 
Ocimum vaalae 
Colds  
Congestion  
-Soaked in water 
with black 
pepper & 
sugar candy for 
sore throat 
- 
Karela  Bitter 
gourd  
Momordica 
charantia 
Diabetes  
Blood purifier  
Vitamins  
-Used in cooking 
-Fresh karela 
juiced  
-Juice & tablets 
are available   
Very 
powerful 
anti-
diabetic. 
Too much 
can be 
harmful   
Kaskas  Poppy 
seeds  
Papaver 
somniferum 
Arthritis/ Pain  
Digestion 
Diarrhoea  
-Chew seeds  
-Infuse in tea/ 
water 
-Used in cooking 
- 
Kesar  Saffron  Crocus sativus Enriches blood  
Digestion  
-Used in cooking  
-Infuse in milk 
- 
Kickar  Cape gum Acacia karoo Colds & flu 
Oral hygiene  
-Bark used to 
clean teeth 
-Infuse in water/ 
milk/ tea 
- 
Kori/ pahri 
saunf 
Dill seeds Anethum 
graveolens 
Digestion -Used in cooking 
-Take a pinch 
with water or 
chew it 
-  
Kwar Aloe vera Aloe vera  Arthritis  
Burns 
Diabetes  
Eczema 
Itchy skin 
Skin conditions  
-Apply sap into 
skin 
-Juice to drink 
-Used in cooking 
-Herbal 
formulations 
available (tablets, 
creams) 
Garam  
Lassan Garlic Allium 
sativum, 
Antibacterial  
Earache  
Arthritis  
Digestion  
Skin conditions  
Thins the blood 
Improves 
circulation 
-Infuse in oil and 
put into the ear 
for ear infections 
or apply to 
painful joints 
-Used in cooking 
-Clove rubbed 
directly on to the 
skin  
Garam  
Anti-
bacterial 
properties  
Lauki  Bottle 
gourd  
Lagenaria 
siceraria 
Diabetes  
Digestion 
Weight loss  
-Juiced  
-Used in cooking 
Good to 
boost 
energy if 
unwell 
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Limbro  Curry leaf Murraya 
koenigii 
Digestion  
Diabetes  
-Used in cooking  - 
Long  Clove Syzygium 
aromaticum 
Pain  
Headache  
Toothache  
-Infused in tea 
-Place a clove 
next to a painful 
tooth 
- 
Malathi Liquorice  Glycyrrhiza 
glabra  
Cough 
Digestion  
-Root boiled in 
tea 
-Herbal tablets  
-Sweets available 
Bad for 
high blood 
pressure. 
Garam  
Methi Fenugreek  Trigonella 
foenum-
graecum 
Arthritis  
Diabetes  
Digestion  
-Leaves used in 
cooking 
-Seeds infused in 
water  
Garam  
Mirch  Chilli 
pepper 
Capsicum 
annuum 
  
Pain  
Digestion 
  
-Make a paste 
with salt and 
turmeric and 
apply to joints. 
-Used in cooking 
- 
Mooli  Radish  Raphanus 
sativus 
Diabetes  
Cancer 
Blood pressure  
-Eaten raw 
-Used in cooking  
- 
Moringa  Drumsticks Moringa 
Oleifera 
Arthritis  
Diabetes  
Vitamins & 
minerals  
-Soaked in water 
over night 
-Used in cooking 
Very 
nutritious  
Naaryal  Coconut  Cocos nucifera General health  
Hair health and 
growth   
Skin 
conditioning  
 
 
 
 
-Used in cooking 
-Oil applied to 
hair or skin 
Available in 
many forms 
including oil, 
juice, milk, fresh 
and dry fruit – 
versatile use.  
Garam  
Too much 
can cause 
nose bleeds 
 
Neem/ Nim Neem  Azadirachta 
indica 
Blood purifier  
Diabetes  
Skin conditions  
-Infused in water/ 
tea 
-Leaves rubbed 
onto the skin or 
infused in bath 
water  
-Tablets 
-Juice  
Garam and 
can cause 
internal 
dryness 
must take 
with oil or 
ghee  
Nimbu Lemon  Citrus limon Cough 
Sore throat 
Skin lighter 
Spots & 
pimples  
-Mix juice with 
honey and hot 
water (can add 
cinnamon, ginger 
or black pepper) 
-Rub lemon slice 
over skin to 
lighten or remove 
scars 
-Drink the juice 
or infuse in water 
People with 
arthritis 
shouldn’t 
use lemons. 
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Olive  Olive  Olea europaea Arthritis  
Skin conditions 
e.g. eczema  
Ear infections 
and wax 
-Apply oil to skin 
-Used in cooking   
-Warm oil and 
instil drops into 
ears (can add 
garlic for 
infections) 
Used as a 
base for 
many 
formulation
s  
Paan leaf Betel leaf  Piper betle Digestion  -Leaf is used to 
wrap ingredients 
which make Paan 
- 
Palak Spinach  Spinacia 
oleracea 
Source of iron 
Good for the 
blood and 
internal 
strength  
-Used in cooking  - 
Pipal Sacred fig Ficus religiosa Diarrhoea  
Digestion 
Liver health 
-Leaves used to 
treat wounds 
-Infused in tea/ 
water 
- 
Pista  Pistachio  Pistaci vera Cholesterol 
General health   
-Eat daily  
-Used in cooking 
Garam 
Puthna  Mint Mentha 
arvensis 
Digestion 
Indigestion  
-Leaves infused 
in water or tea 
-Used in cooking 
- 
Ramphal  Custard 
apple 
Annona 
reticulata 
Diarrhoea 
Cancer 
Immune 
boosting 
properties  
 
 
-Consume the 
fruit  
Full of 
vitamins 
and 
minerals  
Saron  Mustard   Brassica 
juncea 
Pain  
Dry skin 
 
-Apply oil to 
affected areas 
-Seeds used in 
cooking 
Oil used as 
a base for 
numerous 
remedies 
Saunf  
(sweet saunf) 
Fennel Foeniculum 
vulgare 
Bloating 
Constipation  
Cough 
Digestion  
-Chew seeds 
-Infuse in tea  
‘Cold’ so 
can cause 
bhye  
Soggi Raisins  Vitus vinifera Blood purifier  
Cough  
-Infused in water  
-Chewed 
-Used in cooking 
Garam 
Suphari  Betel nut Areca catechu Digestion  
Stimulant  
-Nut is crushed 
and chewed 
-Incorporated in 
paan 
-Used in cooking   
Linked to 
causing 
cancer 
Tej patha Bay leaf Laurus nobilis Diabetes  
Digestion  
-Used in cooking  - 
Thil  Sesame 
seeds 
Sesamum 
indicum 
Warms blood 
Improves 
circulation   
Reduce urinary 
frequency  
-Used in cooking 
-Mix seeds with 
jaggery  
-Oil to be applied 
topically  
Garam  
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Thora/ kori 
buti 
Bugleweed Ajuga 
bracteosa 
Gout  
Menstrual 
problems  
-Infused in water - 
Thunia or 
dhania 
Coriander  Coriandrum 
sativum 
Digestion  
Diabetes  
-Leaves used in 
cooking 
-Seeds infused in 
water 
- 
Tulsi  Holy Basil Ocimum 
tenuiflorum 
Asthma  
Coughs and 
colds 
Diabetes 
Antibacterial 
-Chew leaves 
-Infuse in tea/ 
water 
-Rub on to skin 
-Capsules, 
creams, oil& 
juice available  
Can cure 
any disease 
as it 
represents a 
goddess. 
Avoid in 
pregnant 
women. 
 
Other products  
Traditional 
name: 
Commonly 
known as: 
Scientific 
name: 
Therapeutic 
uses: 
Methods of  
consumption: 
Other 
comments:  
Amrat dhara  Polyherbal 
formulation. 
Contains ajwain, 
fennel, camphor 
and other 
herbals. 
Not applicable  Colds  
Headache  
-Rub onto 
forehead/ 
temples  
Imported 
from 
Pakistan  
Churan 
 
Brand: 
Hajmola 
Polyherbal 
formulation. 
Contains black 
pepper, black 
salt, ginger, 
cumin, lemon 
and other 
herbals.  
Not applicable Constipation 
Digestive aid 
-Powder 
-Tablets 
Imported 
from Asia 
but now 
available to 
buy in the 
UK 
Chyawanpras
h 
Polyherbal 
formulation 
of between 
25-80 
ingredients 
including amla, 
ghee, asparagus, 
cardamom, 
cinnamon and 
many other 
herbals.   
More than 
32 herbals 
combined  
Strength & 
nourishment  
Source of 
vitamins & 
minerals 
-Eat a spoonful 
of the solid 
mixture daily 
Have it with 
milk to 
make it 
more 
palatable  
Dushanda Polyherbal 
formulation  
Not applicable Colds and flu 
Cough  
-Dried material 
infused in hot 
water  
-Tea and Juice 
are available 
Imported 
from India 
and Pakistan 
 
Dhud  Milk  Not applicable Source of 
calcium  
Healthy bones  
-Drink daily  
-Used in tea and 
cooking  
A base for 
many other 
ingredients 
e.g. turmeric 
or cinnamon  
Fatkari Alum  Not applicable Skin 
conditions e.g. 
spots/acne  
-Formulations 
available for 
skin conditions  
- 
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Ghee Clarified 
butter 
Not applicable Lubricates 
joints 
Pain 
Wounds  
Constipation  
-Used in 
cooking  
-Paste with 
turmeric for 
wounds and 
pain 
-In hot milk for 
constipation  
- 
Gor Jaggery Not applicable Substitute 
sugar in 
diabetes  
-Used in 
cooking 
-Used as a base 
for many other 
herbal 
formulations  
Makes 
remedies 
more 
palatable  
Jal (Ganga 
jal) 
Holy water Not applicable Heals all 
ailments  
-Drink the water  
-Apply to 
affected areas 
Can cure all 
illnesses if 
god is 
willing 
Kala loon Black salt Not applicable Digestion  
Constipation  
-Sprinkle black 
salt over food/ 
fruit 
-Mix with 
ajwain  
Very 
punjent 
smell 
Kapoor  Camphor Not applicable Pain relief 
Migraine  
-Eaten raw, or 
with some milk  
A waxy 
substance 
that is used 
during 
Hindu 
prayers 
Katha  Paste applied 
to paan 
leaves 
Not applicable Digestion  -Used to flavour 
and line a paan 
leaf 
- 
Masala 
(Garam 
masala) 
Polyherbal 
formulation  
Not applicable Arthritis  
Digestion 
Pain 
(menstrual 
pain)  
-Make tea with 
it in 
-Used in 
cooking  
Garam 
Munaka  Golden raisin  - Coughs  
Sore throat  
-Chew the dried 
fruit 
- 
Mishri Crystallised 
sugar  
Not applicable Sore throat  
Cough  
-Chew with tulsi 
or black pepper 
- 
Semian  Vermicelli Not applicable Colds & flu 
Energy and 
nutritional  
-Cook with milk 
and ghee 
- 
Shilajeet - Not applicable Blood 
circulation & 
purification 
Libido  
Mental & 
physical 
stamina 
-Mix with warm 
milk and drink 
-Crush dried 
resin into a 
powder and mix 
take half a 
teaspoon with 
water 
It is as 
expensive as 
gold and 
difficult to 
obtain, as it 
comes from 
the 
mountains in 
India.  
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Appendix 6 Healthcare Professionals Questionnaire 
Healthcare Professionals’ Views of Traditional Herbal 
Medicines 
 
Your personal use of Herbal Medicines: 
 
1. Is traditional herbal medicine part of your family/ cultural background? 
Yes 
No 
 
2. Do you use any plants, herbs or spices for your own health? 
Yes 
No 
*If Yes, what do you use and why? 
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________  
 
3. Would you prefer to use traditional herbal remedies over conventional Western medicine 
for minor health problems? 
E.g. cold/constipation/mild skin irritation? 
 
Yes 
No 
 
 
4. Can you name any herbal remedies which can be used for the following conditions? 
-If so, please state what could be used. 
Arthritis___________________________________________________________________ 
Cough_____________________________________________________________________ 
Diabetes___________________________________________________________________ 
Indigestion_________________________________________________________________ 
 
 
 
Patients’ use of Herbal Medicines: 
 
5. Do you currently have contact with patients? 
Yes 
No 
 
6. Do your patients tell you about any traditional herbal medicines they use? 
Yes 
No 
Not applicable 
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7. How often do you come across patients who take traditional herbal medicines alongside 
their prescription medicines? 
Daily 
Weekly 
Monthly 
Annually 
Never 
 
8. Have you encountered any adverse effects caused by the consumption of traditional herbal 
medicines? 
Yes 
No 
*If Yes, please give a brief description: 
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________  
 
  
9. Are you aware of any interactions between traditional herbal medicines and conventional 
Western medicines? 
Yes 
No 
*If Yes, please give a brief description: 
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________  
 
Professional opinion of Herbal Medicines: 
 
10. Do you think the use of plants, herbs and spices is effective to prevent or treat various 
health conditions? 
Yes 
No 
 
 
11. Do you think the use of plants, herbs and spices is safe? 
Yes 
No 
 
 
12. Would you ever recommend herbal medicines to your patients? 
Yes 
No 
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*If Yes, what would you recommend and why? 
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________  
 
13. Did you receive any information about herbal medicines during your professional 
training? 
Yes 
No 
 
14. Do you think enough training is provided to you about herbal medicines? 
Yes 
No 
 
15. Any other comments:  
__________________________________________________________________________
__________________________________________________________________________
__________________________________________________________________________ 
 
About you: 
 
16. Gender: 
Male 
Female 
 
17. Age range: 
20 or under 
21-30 
31-40 
41-50 
51-60 
61+ 
 
18. Ethnic origin: 
White: British 
White: Irish 
Black/ Black British: African 
Black/ Black British: Caribbean 
Asian/ Asian British: Indian 
Asian/ Asian British: Pakistani 
Asian/ Asian British: Bangladeshi 
Other 
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Other (please specify) ________________________________________________________ 
 
19. Place of birth: 
United Kingdom 
India 
Pakistan 
Bangladesh 
Africa 
Other (please specify) ________________________________________________________ 
 
 
20. Religion: 
No religion 
Christian 
Hindu 
Sikh 
Muslim 
Other (please specify)_________________________________________________________ 
 
 
21. Highest level of qualification: 
__________________________________________________________________________ 
 
22. Job role: 
__________________________________________________________________________ 
 
  
23. Do you or have you ever worked in the UK? 
Yes 
No 
If Not, please specify: ________________________________________________________ 
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Appendix 7 Healthcare Professionals Information Leaflet 
My name is Sukvinder Bhamra; I am doing my PhD in Ethnopharmacy at De Montfort 
University. I will be exploring the use of traditional herbal remedies by South Asian 
diasporic communities in the UK.  
Nature has provided a pharmacy, which people have recognised and taken full advantage of. 
The knowledge of which plants are medicinally beneficial comes from the use of plants as 
food, trial and error, and now more commonly from scientific research. Many Western 
medicines available have been developed from natural sources; approximately 25% of 
medicines prescribed worldwide are derived from plants. The use of plants, herbs and spices 
to prevent and treat diseases goes back before written records were created and this 
continues to thrive today.   
As healthcare professionals we may be faced with many challenges; including the concurrent 
use of conventional western medicine and traditional herbal medicine. Is it safe or effective 
to consume herbs and spices for medicinal purposes?   
Have your say 
Here is the chance to share your views anonymously. Here is the opportunity to express your 
personal and professional opinions on traditional herbal medicines. 
Taking part 
The questionnaire is designed to explore UK based healthcare professionals’ views and 
opinions on traditional herbal medicines.  In order to participate all you have to do is answer 
a few questions, which will take no more than ten minutes. By completing the questionnaire 
you are consenting for the data to be analysed and published as part of my thesis, in 
academic journals and at conferences.  
Confidentiality  
All completed questionnaires will remain confidential as no unauthorised person will have 
access to the data. As no personal details are required the process ensures anonymity and 
there will be no way of identifying your responses. This study has been approved by the De 
Montfort University Ethics Committee and NHS Leicester City, Clinical Commissioning 
Group. 
 
Sukvinder Bhamra MPharm 
PhD researcher in Ethnopharmacy  
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Appendix 8 Tulsi Project Interview Questions 
Tulsi Project Interview Questions 
Identification of the sample: 
Sample ID number:  
Name of sample donor:  
Contact details of donor:  
Details of sample give: 
No of leaves/ seeds etc 
 
 
 
1. 
 
Where did you get your Tulsi from? 
 
 
2a. 
 
Do you have any Tulsi seeds? 
 
 
2b. 
 
Do you grow your own Tulsi? 
 
 
3. 
 
What type of Tulsi is this? 
 
(Raam/ Krishna/ Vana/ other?) 
 
 
4. 
 
Can you tell me all the different names Tulsi has: 
 
 
5. 
 
Do you keep Tulsi in your home?  
If so why? 
(i.e. for religious reasons/ just for its medicinal purposes/ no 
particular reason just have it) 
 
 
6. 
 
Where did you learn about Tulsi? 
(e.g. family –mother/ grandparents, religious teachings, other…) 
 
 
7. 
Does it have a religious purpose in your life? 
If so what is it? 
 
8. Are there any special requirements for storing/ 
growing/ keeping Tulsi? 
If so what are they? 
 
(e.g. don’t touch at night, keep in one place…) 
 
9. What do you use the Tulsi for? 
 (Any medicinal purposes/ cooking?) 
 
 
10.  What are the medicinal benefits of using Tulsi? 
 
If it is used for medicinal purposes what are the 
formulations used/ how is it prepared/ other 
ingredients used to make the remedy? 
(please list as many as you can think of) 
 
11.  Is there any other information which you think is 
important/ interesting to know about Tulsi? 
 
(e.g. Tulsi Vivah/ any rituals- pray to it twice a day etc) 
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About you: 
  
*What is your gender? Male  
 Female  
   
*What is your age range? Under 20  
 21-30  
 31-40  
 41-50  
 51-60  
 61 +  
   
*What is 
your ethnic 
origin? 
Asian – Indian  Asian- Bangladeshi  
 Asian – Pakistani     
 Black- African  Black- Caribbean  
 Chinese     
 White     
  
          Other please state:..................................................................... 
 
*What is  
your religion? 
 
 Christian  
Hindu  
Muslim  
Sikh  
Other  
 
Please 
state:………………………. 
*Place of birth: United Kingdom  
India   
Africa  
Pakistan  
Other  
  Please 
state:………………………….. 
 
*Parents place of 
birth:  
 
                                                          Mother: 
…………………………….. 
                                                          Father: 
……………………………… 
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Appendix 9 Tulsi Project Participant Information Leaflet  
Tulsi Project Participant Information Leaflet 
My name is Sukvinder Kaur Bhamra. I am doing a PhD at De Montfort University in 
traditional Indian herbal medicine. I have a keen interest in tulsi, Holy basil, Ocimum 
tenuiflorum. 
Tulsi ‘the queen of herbs’ is one of India’s most sacred herbs known for its divine 
healing properties. The tulsi plant holds a prestigious position in every Hindu 
household, as it represents the goddess Virinda Tulsi; a woman of immense purity 
and devotion to God.  
 
My aim is to explore the origins of tulsi, why people keep it in their homes, what 
they use it for and to collect a variety of samples for DNA analysis, to verify the 
genetics of the plant. I would also like to collect tulsi seeds to add to our current tulsi 
nursery.  
In order to participate in this research you must be over eighteen years old, you will 
need to answer some questions, which will take no more than fifteen minutes. By 
answering the questions you are consenting for the data to be analysed and published 
as part of my thesis. If you wish to withdraw from participation, you may choose to 
stop the interview at any point.  
If you have any tulsi products and are happy to give me a sample I only need a small 
amount. If you are happy to be contacted at a later date for further information please 
leave your name and contact details. All samples collected will be given a reference 
number so anonymity will be ensured throughout the process. All information 
disclosed will remain confidential as no unauthorised person will have access to the 
data.I hope you will enjoy this and thank you for participating in my research. 
.............................................................................................................. ........................................ 
For further information please contact:  
Prof Adrian Slater (Supervisor): ads@dmu.ac.uk 
Sukvinder Bhamra: p07246383@myemail.dmu.ac.uk 
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Appendix 10 Tulsi Project Promotion Poster  
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Appendix 11 Tulsi Project Leaflet  
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Appendix 12 Summary of the Ocimum Samples and their 
Identity    
Species identification was based on the reference DNA sequences created using the reference Ocimum specimens 
obtained combined with the reference sequences from GenBank. Identification was based on a 100% match 
across the sequence length after the ends were trimmed to start and end at the same position (*some species 
identified according to the closest match on GenBank).  
Please refer to the external memory device for the sample sequences 
Key: 
- = No result 
n/a = Not applicable as not analysed 
Grey text  = Sample identification failed  
* = Species identified according to the closest match on GenBank 
 
Cat
ego
ry: 
Samp
le  
ID: 
Extra
ction 
Num
ber: 
Sample 
source: 
Type of tulsi 
specified: 
Type of 
Sample: 
Species 
identification –
ITS: 
Species 
identification -
trnH-psbA: 
C
o
m
m
u
n
it
y
 T
u
ls
i 
 s
a
m
p
le
s 
B01 432 K.K TBC Fresh leaves O. gratissimum O. gratissimum 
B02a 433 H.P Raam Fresh leaves O. gratissimum O. gratissimum 
B02b 425 H.P Shyam Fresh leaves O. gratissimum O. gratissimum 
B03 435 A.S TBC Seeds 
Veronica 
species* 
Veronica 
species* 
B04 436 R.M Raam Fresh leaves O. basilicum* O. basilicum* 
B05 437 L.M Raam Fresh leaves O. gratissimum O. gratissimum 
B06 438 L.P Shyam Fresh leaves O. tenuiflorum O. tenuiflorum 
B06g 431 L.P Shyam Seeds O. tenuiflorum O. tenuiflorum 
B07 422 SSHC Raam Fresh leaves O. gratissimum O. gratissimum 
B07g 439 SSHC Raam Seeds O. gratissimum O. gratissimum 
B09 697 
K.P 
India 
TBC Dried leaves - n/a 
L10 459 M.M TBC Dried leaves O. tenuiflorum O. tenuiflorum 
L11 460 M.A TBC Dried leaves O. basilicum* O. basilicum* 
B12 - B.C TBC Seeds n/a n/a 
A14 490 D.N TBC Seeds O. gratissimum O. gratissimum 
B15a 491 H.A Raam Dried leaves O. gratissimum O. gratissimum 
B15b 492 H.A Shyam  Dried leaves O. tenuiflorum O. tenuiflorum 
Li79 840 K.R TBC Dried leaves - O. tenuiflorum 
Li80 841 M.J Basil Dried leaves - O. basilicum* 
U100 892 A.S TBC Dried leaves - O. tenuiflorum 
B101 893 
Apna 
ghar 
TBC Dried leaves - - 
B102
a 
947 R.P Shyam Dried leaves - O. tenuiflorum 
B102
b 
950 R.P Shyam Dried leaves - O. tenuiflorum 
B102
c 
948 R.P Raam Dried leaves - O. tenuiflorum 
B102
d 
949 R.P TBC Dried leaves - O. tenuiflorum 
B105 - R.R TBC Seeds n/a n/a 
C
o
m
m
er
ci
a
l 
T
u
ls
i 
sa
m
p
le
s 
B00 424 
Tesco 
basil 
O. basilicum Fresh leaves O. basilicum* O. basilicum* 
C08 423 
Pukka 
three 
tulsi tea 
bag 
Raam, Shyam 
& lemon tulsi 
Tea bag - O. tenuiflorum 
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C13 461 
Shyam 
tulsi 
seeds 
ebay 
O. tenuiflorum Seeds O. tenuiflorum O. tenuiflorum 
C16 493 
Akamba 
garden 
centre 
O. basilicum Fresh leaves O. basilicum* O. basilicum* 
C20 574 Pukka O. tenuiflorum Capsule - - 
C21 575 Pukka O. tenuiflorum Oil - n/a 
C22 576 Pukka TBC Tulsi beads - n/a 
C23 615 Pukka Raam Dried leaves - - 
C24 616 Pukka Shyam Dried leaves - - 
C25 617 Pukka Lemon tulsi Dried leaves - - 
C40 - 
Herbal 
Veda 
O. tenuiflorum Tulsi juice - n/a 
I44 786 
Fort 
Kochi 
TBC Dried leaves O. tenuiflorum O. tenuiflorum 
I45 787 
Phalada 
Agro 
O. tenuiflorum Dried leaves - O. tenuiflorum 
I46 789 
Phalada 
Agro 
O. tenuiflorum Dried leaves O. tenuiflorum O. tenuiflorum 
I47 790 
Phalada 
Agro 
O. tenuiflorum Dried leaves - O. tenuiflorum 
I48 791 
Phalada 
Agro 
O. tenuiflorum Dried leaves - O. tenuiflorum 
I49 792 
Phalada 
Agro 
TBC Dried leaves - - 
C50 0110 
Organic 
India 
O. tenuiflorum Capsules - n/a 
C51 0111 
Organic 
India 
O. 
gratissimum 
Capsules - n/a 
C52 0112 
Organic 
India 
O. 
gratissimum 
Capsules - n/a 
C53 0113 
Organic 
India 
O. tenuiflorum Capsules - n/a 
C54 0114 
Organic 
India 
O. tenuiflorum 
& gratissimum 
Capsules - n/a 
C55 0115 
Organic 
India 
O. tenuiflorum 
& gratissimum 
Capsules - n/a 
C56 0120 
VASU 
respirato
ry care 
O. tenuiflorum Capsules - n/a 
C57 0121 
Bipha 
pharmac
y 
O. tenuiflorum Tablets - n/a 
C58 0122 
Sudarsa
nam 
O. tenuiflorum Tablets - n/a 
C59 0123 SAINA O. tenuiflorum Tablets - n/a 
C60 0124 
MUCE
X 
O. tenuiflorum Tablets - n/a 
C61 0125 
Madhu
mardan 
O. tenuiflorum Powder - n/a 
C62 0126 
Sitopala
di 
Churna 
powder 
O. tenuiflorum Powder - n/a 
C63 0128 VASU O. tenuiflorum Syrup - n/a 
C64 0129 
Cruz 
cough 
syrup 
O. tenuiflorum Syrup - n/a 
C65 0130 
Krishna 
Tulsi 
cough 
syrup 
O. tenuiflorum Syrup - n/a 
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C66 0131 
Amruth
a 
Kasturo 
cough 
syrup 
O. tenuiflorum Syrup - n/a 
C67 0132 
Bipha 
Tulsi 
essential 
oil 
O. tenuiflorum Oil - n/a 
C68 0133 
KPN 
Ayurved
ic Hair 
oil 
O. tenuiflorum Oil - n/a 
C69 0134 
Krishna 
Tulsi 
Hair 
Tonic 
O. tenuiflorum Oil - n/a 
C70 0315 Dabur O. tenuiflorum Toothpaste - n/a 
C71 - 
Bipha 
Neem 
and 
Tulsi 
soap 
TBC Soap bar - n/a 
C72 - 
Bipha 
Tulsi 
Soap 
TBC Soap bar - n/a 
C73 834 Pukka TBC (Raam) Dried leaves - O. tenuiflorum 
C74 835 Pukka TBC (Raam) Dried leaves - O. tenuiflorum 
C75 836 Pukka TBC (Krishna) Dried leaves - - 
C76 837 Pukka TBC (Krishna) Dried leaves - O. tenuiflorum 
C77 838 Pukka 
TBC(lemon 
vana) 
Dried leaves - - 
C78 839 Pukka 
TBC (lemon 
vana) 
Dried leaves - O. basilicum 
M
is
ce
ll
a
n
eo
u
s 
T
u
ls
i 
sa
m
p
le
s 
A17 571 Egypt TBC Dried leaves O. basilicum* O. africanmum* 
A18 572 Egypt TBC Dried leaves - O. basilicum* 
A19 573 Egypt TBC Dried leaves - O. africanmum* 
I41 783 
Taj 
Hotel 
India 
O. tenuiflorum Dried leaves - O. basilicum* 
I42 784 
Taj 
Hotel 
India 
O. tenuiflorum Dried leaves - O. basilicum* 
I43 785 
Taj 
Hotel 
India 
O. basilicum Dried leaves - O. basilicum* 
R
ef
er
en
ce
  
O
ci
m
u
m
 s
a
m
p
le
s 
G26 618 
Peter 
Nick 
O. tenuiflorum Seeds O. tenuiflorum O. tenuiflorum 
G27 619 
Peter 
Nick 
O. tenuiflorum 
Seeds 
O. tenuiflorum O. tenuiflorum 
G28 620 
Peter 
Nick 
O. africanum 
Seeds 
- O. africanum 
G29 674 
Peter 
Nick 
O. citridorum 
Seeds 
- O. citridorum* 
G30 768 
Peter 
Nick 
O. 
gratissimum 
Seeds 
O. gratissimum O. gratissimum 
G31 676 
Peter 
Nick 
O.kilimandsch
aricum 
Seeds 
- 
O.kilimandschar
icum* 
G32 769 
Peter 
Nick 
O. 
gratissimum 
Seeds 
O. gratissimum O. gratissimum 
G33 678 Peter O. tenuiflorum Seeds - - 
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Nick 
G34 745 
Peter 
Nick 
O. basilicum 
Seeds 
O. basilicum* O. basilicum* 
G35 842 
Peter 
Nick 
O. carnosum 
Seeds 
- - 
G36 746 
Peter 
Nick 
O. tenuiflorum 
Seeds 
O. tenuiflorum O. tenuiflorum 
G37 770 
Peter 
Nick 
O. tenuiflorum 
Seeds 
O. tenuiflorum O. tenuiflorum 
G38 771 
Peter 
Nick 
O. tenuiflorum 
Seeds 
O. tenuiflorum O. tenuiflorum 
G39 844 
Peter 
Nick 
O. tenuiflorum 
Seeds 
- O. tenuiflorum 
C81 1138 Kew 
O. 
gratissimum 
DNA extract O. gratissimum O. gratissimum 
C82 1583 Kew O. selloi DNA extract O. selloi* - 
C83 9936 Kew O. basilicum DNA extract - - 
C84 9937 Kew O. tenuiflorum DNA extract - O. tenuiflorum 
C85 9939 Kew 
O. 
americanum 
DNA extract - 
O. 
americanum* 
V86 865 CAMAG O. tenuiflorum 
Dried 
material 
- O. tenuiflorum 
V87 866 CAMAG O. tenuiflorum 
Dried 
material 
- O. tenuiflorum 
V88 867 CAMAG O. tenuiflorum 
Dried 
material 
- O. tenuiflorum 
V89 868 CAMAG O. tenuiflorum 
Dried 
material 
- - 
V90 869 CAMAG O. tenuiflorum 
Dried 
material 
- O. tenuiflorum 
V91 870 CAMAG 
O. 
americanum 
Dried 
material 
- - 
V92 871 CAMAG O. tenuiflorum 
Dried 
material 
- O. tenuiflorum 
V93 872 CAMAG O. tenuiflorum 
Dried 
material 
O. tenuiflorum O. tenuiflorum 
V94 873 CAMAG O. tenuiflorum 
Dried 
material 
O. tenuiflorum O. tenuiflorum 
V95 874 CAMAG O. tenuiflorum 
Dried 
material 
- - 
V96 875 CAMAG O. tenuiflorum 
Dried 
material 
- O. tenuiflorum 
V97 876 CAMAG O. tenuiflorum 
Dried 
material 
- - 
V98 877 CAMAG O. tenuiflorum 
Dried 
material 
O. tenuiflorum O. tenuiflorum 
V99 878 CAMAG O. tenuiflorum 
Dried 
material 
O. tenuiflorum O. tenuiflorum 
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Appendix 13 DNA Sequences and Multiple Alignments   
*Please refer to the external memory device for DNA sequences and multiple alignments 
created during this research.    
 
All figures included in the thesis can be viewed in pdf format. 
Sequences, contigs and additional multiple alignments can be viewed using a trial version of 
CLC sequence viewer which can be downloaded free from: 
http://www.clcbio.com/products/clc-sequence-viewer/   
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Appendix 14 Ocimum Sequence Accession Numbers from 
GenBank 
ITS 
Ocimum americanum GU810517.1; Ocimum basilicum DQ667240.1; Ocimum basilicum 
GU810522.1; Ocimum basilicum KF815492.1; Ocimum bascilicum x Ocimum gratissimum 
GU810521.1; Ocimum gratissimum FJ593402.1; Ocimum gratissimum GU810520.1; 
Ocimum gratissimum GU810518.1 Ocimum gratissimum GU810516.1; Ocimum 
gratissimum GU810515.1; Ocimum selloi JF301405.1; Ocimum tenuiflorum GU810519.1 
 
trnH-psbA 
Ocimum africanum JX294428.1; Ocimum africanum JX262182.1; Ocimum  africanum 
KP218940.1; Ocimum americanum JX262179.1; Ocimum basilicum DQ667350.1; Ocimum 
basilicum  KF855613.1; Ocimum basilicum JX262185.1; Ocimum basilicum  JQ339256.1; 
Ocimum campechianum  HG963580.1; Ocimum filamentosum JX294429.1; Ocimum 
gratissimum JX262181.1; Ocimum gratissimum  FR726109.1; Ocimum gratissimum 
KF855614.1; Ocimum kilimandscharicum JX262180.1; Ocimum tenuiflorum cultivar 
Krishna tulsi JX262184.1; Ocimum tenuiflorum cultivar Ram tulsi : JX262183.1; Ocimum 
tenuiflorum  FR726110.1;  
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Appendix 15 Ocimum Species Summary Table 
Image: Species: 
General 
Description: 
Description 
of  Leaves: 
Description 
of  Flowers: 
(Inflorescence) 
Description 
of  Fruit: 
Native 
to: 
Any other 
information: 
DNA 
Sequence: 
 Ocimum 
africanum 
 
 
-Annual herb 
-Erect much 
branched 
-Aromatic  
-0.3-1m tall 
-Stem and 
branches are 
quadrangular  
-Hairs on stem 
grow side-wards 
and downwards 
= spreading  
-Simple 
decussate with 
petiolate. 
-lance to 
elliptical 
shape 
-Hairless  
-Glands on 
both upper and 
lower surface  
- -4 nutlets 
-Black  
-Nutlet wall 
produces a 
thick white 
cover in water 
Tropical 
Africa and 
Asia 
Often confused with 
O. basilicum  
 
Synonym: 
O. americanum 
O. canum 
O. brachiatum 
G28_620 
ITS 
ACTGCAAGCAGACCGCGAACACGTG
TTTAACTCATGAATCCCGCCGCCGGC
CCCGGTCGGCGCGCGGGCTAACGAA
CCCCGGCGCGGAACGCGCCAAGGAA
AACTCAAAACGTCGGCGCCGGCCCC
CCCCACCCCGTCCGCGGGTCGTGCG
GGGGGCGCGGGCGTCCATCGACGAA
TGTCAAAACGACTCTCGGCAACGGA
TATCTCGGCTCTCGCATCGATGAAGA
ACGTAGCGAAATGCGATACTTGGTG
TGAATTGCAGAATCCCGTGAACCAT
CGAGTCTTTGAACGCAAGTTGCGCC
CGAAGCCATCAGGCCGAGGGCACGT
CTGCCTGGGCGTCACGCATCGCGTC
GCCCCCCCATCCCCGCGCAATGCGCT
CGGCTTGGGGGGGCGGATACTGGCC
TCCCGTGCGCCCCGCCGCGCGGCCG
GCCCAAATGCGATCCCCCGGCGACC
CGCGTCGCGACAAGTGGTGGTTGAA
CTCATCAATTTCCCCGTCGCGCCCCG
GGTCGTCCGCGCGGATCCTTTAATAA
AAAGAACCCAAGCTCCTCGACCGCG
ACCCCAGGTCAGGCGGGATCACCCG
TTGAGTTTAAC 
 
 
trnH-psbA 
TAATGCTCATAACTTCCCTCTAGACC
TAGCTGCTATTGAAGCTCCAACAAAT
GGCTAAAACTTGTTCTTGGTGTGTAG
AAGTTTTTGAAATATAGATAAATATA
AGGAGCAATAAACCCTTTCTTGTTCT
ATCAAAAGAGGGTTTATTGCTCCTTT
CTTTTATTTTCAATTAGAAGTCCTTTT
GTATTTTTCTAGTAGTATTGGACTTA
CCTAGACTTTTCTTTCCATAAAAGCA
AGAAGATAAAAAAATGATTGAAATT
CTATCTTTTGCTTTTGTTTTACAATTT
TGAAAAAAAAAAAATTCAAAAAGTG
AATTCGTAAATAAATAGAAAATTTA
CTTTTTTAGAATAGTGGGGCGGA 
 Ocimum 
basilicum 
-Annual herb 
-0.3-0.5m tall 
up to 1m 
-Almost hairless 
plant 
= glabrous   
If there are any 
hairs they only 
grow in one 
direction =side-
wards 
-Silky green 
opposite 
(paired) oval 
leaves 
-No hairs  
-Highly 
aromatic with 
glands on 
surface of the 
leaf. 
-Fleshy leaves  
-Convex shape 
-Very few 
hairs on leaf/ 
stem 
-White or  
-Pink 
 
-Large flowers 
Fruits have 
four small 
nutlets, which 
are 
mucilaginous 
when wet 
Tropical 
origins 
Closely related to and 
frequently confused 
with O. africanum 
and O. americanum, 
but they can be 
identified on the basis 
of indumentum (hair 
distribution) and 
flower size. Lemon-
scented cultivars are 
usually the result of 
crosses between  
O. basilicum and  
O. africanum. 
G34_745 
ITS 
ACTCATGAATCCCGCCGCCGGCCCC
GGTCGGCGCGCGGGCTAACGAACCC
CGGCGCGGAACGCGCCAAGGAAAAC
TCAAAACGTCGGCGCCGGCCCCCCC
CCCCCCTTCCCCGGGTCGGGGGGGG
GGGGCGGGGGTCCATCGACGAATGT
CAAAACAACTCTCGGCAACGGATAT
CTCGGCTCTCGCATCTATGAAAAAA
GTAGCGAAATGCGATACTTGGTGTG
AATTGCAGAATCCCGTGAACCATCG
AGTCTTTTAACGCAAGTTGCGCCCGA
AACCATCAGGGCGAGGGGACGTCTG
CCTGGGCGTCACGCATCGCGTCGCC
CCCCCCTCCCCGCGCAATGCGCTCGG
GTTGGGGGGGGGGATACTGGGCTCC
CGTGCGCCCCGCCGCGCGGCCGGCC
CAAATGCGATCCCCCGGCGACCCGC
GTCGCGACAAGTGGTGGTTGAACTC
ATCAATTTCCCCGTCGCGCCCCGGGT
CGTCCGCGCGGATCCTTTTTTAAAAA
AAACCCAACCTCCTCGACCCCCACC
CCAGGTGGGGCGGCATCACCCGTTT
ATTTTAATCATAT 
 
trnH-psbA 
TCCGCCCCACTATTCTAAAAAAGTA
AATTTTCTATTTATTTACGAATTCAC
TTTTTGAATTTTTTTTTTTTCAAAATT
GTAAAACAAAAGCAAAAGATAGAAT
TTCAATCATTTTTTTATCTTCTTGCTT
TTATGGAAAGAAAAGTCTAGGTAAG
TCCAATACTACTAGAAAAATACAAA
AGGACTTCTAATTGAAAATAAAAGA
AAGGAGCAATAAACCCTCTTTTGAT
AGAACAAGAAAGGGTTTATTGCTCC
TTATATTTATCTATATTTCAAAAACT
TCTACACACCAAGAACAAGTTTTAG
CCATTTGTTGGAGCTTCAATAGCAGC
TAG 
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Image: Species: 
General 
Description: 
Description 
of  Leaves: 
Description 
of  Flowers: 
(Inflorescence) 
Description 
of  Fruit: 
Native 
to: 
Any other 
information: 
DNA 
Sequence: 
 
Ocimum 
citridorium 
-20-40cm tall 
-Lemony 
-Spreading hairs  
-Leaves 
similar to basil 
but flatter  
-Strong citrus 
fragrance like 
lemons 
-Pointer leaves 
-Thinner 
leaves AP 
-White 
flowers 
- Northeast 
Africa and 
southern 
Asia 
A hybrid from basil-  
O. basilicum and 
African basil- O. 
americanum  
 
Smells very lemony  
G29_674 
ITS 
CGTGTTTAACTCATGAATCCCGCCGCC
GGCCCCGGTCGGCGCGCGGGCTAAC
GAACCCCGGCGCGGAACGCGCCAAGG
AAAACTCAAAACGTCGGCGCCGGCCC
CCCCCCCCCCCCCCCCGGGGTGGGG
GGGGGGGGCGGGCGTCCCTCGACAAA
TGTCAAAAAAACTCTCTGCAACAGATAT
CTCGGCTCTCGCATCTATAAAAAAAATA
GAAAAAAGAGATATTTGGTGTGAATTGT
AGAATCCCCCGAACCATCGAGTTTTTTA
ACACAAGTTGTGCCCCAAAACATCATG
GCGAGGGGGCGTCTGCCTGGGGGTCA
CACATCGCGTCGCCCCCCCCTCCCCC
CGCAATGCGCTCTGGTTGGGGGGGGG
GATATTGGGCTCCCGTGGGCCCCCCC
GCGCGGGCGGCCCAAATGTGATCCCC
CCGCGACCCCCGTCGCGACAAGTGGG
GGTTGAAAACATCAATTTTTCCCCCGC
GCCCCGGGGGGTCCGCGCGGATCCTT
TTTTAAAAAAAACAAACCCTCCTCCACC
GCCCCCCGGGGTGGGGGGGTATCCCC
C 
 
trnH-psbA 
CATCCGCCCCACTATTCTAAAAAAGTAA
ATTTTCTATTTATTTACGAATTCACTTTT
TGAATTTTTTTTTTTTCAAAATTGTAAAA
CAAAAGCAAAAGATAGAATTTCAATCAT
TTTTTTATCTTCTTGCTTTTATGGAAAGA
AAAGTCTAGGTAAGTCCAATACTACTAG
AAAAATACAAAAGGACTTCTAATTGAAA
ATAAAAGAAAGGAGCAATAAACCCTCTT
TTGATAGAACAAGAAAGGGTTTATTGCT
CCTTATATTTATCTATATTTCAAAAACTT
CTACACACCAAGAACAAGTTTTAGCCAT
TTGTTGGAGCTTCAATAGCAGCTAGGT 
 Ocimum 
gratissimum 
 
 
 
-Herbaceous 
plant. 
-Perennial herb. 
-1-3m tall with 
an erect stem. 
-Highly 
branched which 
is smooth or 
Hairy. 
-Woody base 
-Bright green 
leaves, 
-Large and flat 
egg shaped 
leaves  
 
-Larger leaves 
compared to 
O. 
tenuiflorum. 
 
Greenish 
white petals 
4 dry, 1 
seeded little 
nuts enclosed 
in the 
persistent 
sepal. 
Spherical, 
wrinkled and 
brown. 
Not 
mucilaginous 
in water.  
 
-Calix closes 
when ready to 
seed  
The plant 
is 
indigenous 
to tropical 
areas e.g. 
West 
Africa It is 
cultivated 
in 
Ceylon, 
South Sea 
Islands, 
and also 
within 
Nepal, and 
Bengal 
 
Identified as Raam 
tulsi by South Asian 
communities 
surveyed in the UK. 
G30_768 
ITS 
AGACCGCGAACACGTGTTTAACTCA
TCCCCCGCCGCCGATCGGCGTGCGG
GCTAACGAACCCCGGGCGCGGAAAG
CGCCAAGGAAAACTGTACGTAGCGT
CGGTCCCCCCATCCCGTTCGCGGGTC
GTGCGGGGGATGCGGACGTCTATCG
AATATCAAAACGACTCTCGGCAACG
GATATCTCGGCTCTCGCATCGATGAA
GAACGTAGCGAAATGCGATACTTGG
TGTGAATTGCAGAATCCCGTGAACC
ATCGAGTCTTTGAACGCAAGTTGCGC
CCGAAGCCATTAGGCCGAGGGCACG
TCTGCCTGGGCGTCACGCATCGCGTC
GCCCCCCCTTCCCCGCGCACCGCGCT
CGGGACGGGGGGACGGATATTGGCC
TCCCGTGCGCCCCGGTGCGCGGCCG
GCCCAAATGCGATCCCCCGGCGACC
CGCGTCGCGACAAGTGGTGGTTGAA
ACATCTCAATCTCGCGTCTCGTCGCG
CTTCCGGGTCGTCCGAGCGGGCTCC
AAAAATAACCCAATGGTGCGGCCGT
TACGCCGCGCCCTCGACCGCGACCC
CAGGTCAGG 
 
trnH-psbA 
CATCCGCCCCTCTACTATAAAAAAGT
CAATTTTCTATTTATTTACGAATTCA
CTTTTTCAATTTAAATTTTTTTTTCAA
AATTGTAAAACAAAAGATAGAATTT
CAATCATTTTTTTATCTTCTTGCTTTT
ATGGAAAGAAAAGTCTAGGTAAGTC
CAATACTACTAGAAAAATAGAAAAG
GACTCCTAATTGAAAAGAAAAGAAA
GGAGCAATAAACCCTCTTTTGATAG
AACAAGAAAGGGTTTATTGCTCCTTA
TATTTATCTATATTTCAAAAACTTCT
ACACACCAAGAACAAGTCTTAGCCA
TTTGTTGGAGCTTCAATAGCAGCTAG 
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Image: Species: 
General 
Description: 
Description 
of  Leaves: 
Description 
of  Flowers: 
(Inflorescence) 
Description 
of  Fruit: 
Native 
to: 
Any other 
information: 
DNA 
Sequence: 
 
Ocimum 
kilimandsch
aricum 
 
-Perennial  
-An evergreen 
-Shrubby 
-Very hairy 
-Grows larger 
then tenuiflorum 
-pubescent 
quadrangular 
branchlets 
with simple 
leaves that are 
opposite and 
oblong, 
narrow at the 
base and 
deeply 
serrated  
-Rounded 
leaves  
-Purple 
flowers 
-seeds are 
black and very 
small, 
-oval shaped 
-1mm  
East Africa Common names:  
Kilimanjaro basil, 
Camphor basil, 
Hoary basil,  
Fever plant  
 
G31_676 
ITS 
AAACCAACAAAAGTTTTACAAATGA
AAACAGCCGCCCCCCCCCAGGAGAA
GAAGCGCGGGCGAACAAAAAACCCC
GCGGAAAAAACCAAAAAAAAAAAA
ACAAAAGCGCCCCCCCCCCCCCCCC
CCCGCCCCGGGGCGTGGGGGGGGGG
CGGGCCTCCATCGAAGAAAAACAAA
AAAAAACTCAGCAAAAGATAACTCC
GCTCTTGCATTGAAGAAAAAAGAAA
AGAAAAGCCAAAAATGGGGTTAAAT
GAAAAAAACCGTGAAACAAAAAGTT
TTTGAAAACAAAATGCGCCCGAAAA
CATCAGGGCGAGGGCACGTCTGCCT
GGGCGTCAAGCAAAGCGTCGCCCCC
CCCATCCCCGCGCACCGCGCTTGGGT
AGGGGGGGCGGATACTGGCCTCCCG
TGCGCCCCGCCGCGCGGCCGGCCAA
AATGCATATCCCCCGGCGACCCGCG
TCGCGAAAAGTGGTGGGTAAACTCA
TTAATTTCCCCGT 
 
trnH-psbA 
GCCCCACTATTCTAAAAAAGTAAATT
TTCTATTTATTTACGAATTCACTTTTT
GAATTTTTTTTTTCAAAATTGTAAAA
CAAAAGCAAAAGATAGAATTTCAAT
CATTTTTTTATCTTCTTGCTTTTATGG
AAAGAAAAGTCTAGGTAAGTCCAAT
ACTACTAGAAAAATACAAAAGGACT
TCTAATTGAAAATAAAAGAAAGGAG
CAATAAACCCTCTTTTGATAGAACAA
GAAAGGGTTTATTGCTCCTTATATTT
ATCTATATTTCAAAAACTTCTACACA
CCAAGAACAAGTCTTAGCCATTTGTT
GGAGCTTCAATAGCAGCTAG 
 
Ocimum 
tenuiflorum 
- Short-lived  
perennial herb. 
- Up to 1 m tall 
square stem 
-Green / 
purple  
-Elliptic 
(narrow oval) 
in shape  
-opposite 
decussate 
leaves, with 
numerous oil 
glands which 
secrete 
aromatic oils 
giving the 
plants distinct 
odours  
-smaller 
flowers than 
O. basilicum 
-white and 
yellow to 
purple  
-Flowers are 
more spread 
out  
-can see the 
stalk for each 
flower. 
Four small 
brown nutlets, 
which, unlike 
basil, do not 
produce a lot 
of mucilage 
when wet. 
dark brown 
odourless but 
pungent 
tasting seed  
South Asia Other species in the 
Ocimum genus which 
may be kept as tulsi 
include: O. 
ammericanum,  
O. basilicum, O. 
canum, O. camphora, 
O.kilimandscharicum 
and O. micranthum  
Identified as Shyam/ 
Krishna tulsi. 
ITS_x10 
reference samples 
AGACCGCGAACACGTGTTCAAGCGA
ATCCCCCGCGTCCGCCCCCGGGCGG
CGCGCGGGGCAACCAACCCCGGGCG
CGGAACGCGCCAAGGAAAACGTAAC
TCGGCGCCGGCCCCCCGCATCCCGTC
CGCGGGTCCTGCGCGGGGCGCGGGC
GTCTGTGGAATGTCAAAACGACTCTC
GGCAACGGATATCTCGGCTCTCGCA
TCGATGAAGAACGTAGCGAAATGCG
ATACTTGGTGTGAATTGCAGAATCCC
GTGAACCATCGAGTCTTTGAACGCA
AGTTGCGCCCGAAGCCATTAGGCCG
AGGGCACGTCTGCCTGGGCGTCACG
CATCGCGTCGCCCCCCTCCCCGCGCG
CCGCGCTCGGGACGGGGGGCGGATG
TTGGCCTCCCGTGCGCCCCGCCGCGC
GGCCGGCCCAAACCCGATCCCCCGG
CGACCCGCGTCGCGACAAGTGGTGG
TTGAACGTCTCAATCTCGCGTCTCGT
CGCTCGCGGGCCGTCCGCGCGGGCT
CCGAAGAGGACCCAACGGCGCGGCC
AAGCCGCCGCTCCCTCGACCGCGAC
CCCA 
 
trnH-
psbA_x7 
reference samples 
CATCCGCCCCTCTACTCTAAAAATCT
AAAAAGAAAATTTTCTATTTATTTAC
GAATTCACTTTTTCAATTTGAATTTTT
TTTGCAAAATTGTAAAACAAAAGAT
AAAATTTCAATCATTTTTTTTATCTTC
TTTCTTTTATGGAAAGAAAAGTCTAG
GTAAGTCCAATACTACTAGAAAAAT
AGAAAAGGACTCATAATTGAAAAGA
AAAGAAAGGAGCAATAAACCCTCTT
TTGATAGAACAAGAAAGGGTTTATT
GCTCCTTATATTTATCTATATTTCAA
AAACTTCTACACACCAAGAACAAGT
CTTAGCCATTTGTTGGAGCTTCAATA
GCAGCTAG 
*Images taken from specimen grown at De Montfort University personally and with Mike Storer (Technician). 
**Information from the table obtained from various sources (Maimes, 2001; WHO, 2002b; Paton et al., 2005; Joshi et al., 2012; meeting with A. Paton, 27.02.2014 at The Royal 
Botanic Gardens Kew ). 
***DNA sequences are consensus sequences of three independent reads, of samples grown from seeds, DNA extracted and a PCR with ITS and trnH-psbA regions.  
*Please refer to the external memory device for all the sample sequences* 
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Appendix 16 Traditional Herbal Medicines Focus Group  
*Please refer to the external memory device  
Appendix 16 contains: 
1. Ethical amendment application form for focus groups. 
2. Traditional Herbal Medicines focus group questions. 
3. Focus group participant information leaflet and confirmation of attendance letter. 
  
 
